
<html lang="en"     class="pb-page"  data-request-id="e180883c-a816-438d-b961-5cde72e7d941"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.8b01411;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2018.61.issue-24;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Selective Inhibitors of Human Neuraminidase 1 (NEU1)" /></meta><meta name="dc.Creator" content="Tianlin  Guo" /></meta><meta name="dc.Creator" content="Rachel  Héon-Roberts" /></meta><meta name="dc.Creator" content="Chunxia  Zou" /></meta><meta name="dc.Creator" content="Ruixiang  Zheng" /></meta><meta name="dc.Creator" content="Alexey V.  Pshezhetsky" /></meta><meta name="dc.Creator" content="Christopher W.  Cairo" /></meta><meta name="dc.Description" content="Inhibitors of human neuraminidase enzymes (NEU) are recognized as important tools for the study of the biological functions of NEU and will be potent tools for elucidating the role of these enzymes..." /></meta><meta name="Description" content="Inhibitors of human neuraminidase enzymes (NEU) are recognized as important tools for the study of the biological functions of NEU and will be potent tools for elucidating the role of these enzymes..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 20, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01411" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01411" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01411" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01411" /></link>
        
    
    

<title>Selective Inhibitors of Human Neuraminidase 1 (NEU1) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01411" /></meta><meta property="og:title" content="Selective Inhibitors of Human Neuraminidase 1 (NEU1)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0017.jpeg" /></meta><meta property="og:description" content="Inhibitors of human neuraminidase enzymes (NEU) are recognized as important tools for the study of the biological functions of NEU and will be potent tools for elucidating the role of these enzymes in regulating the repertoire of cellular glycans. Here we report the discovery of selective inhibitors of the human neuraminidase 1 (NEU1) and neuraminidase 2 (NEU2) enzymes with exceptional potency. A library of modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues, with variability in the C5- or C9-position, were synthesized and evaluated against four human neuraminidase isoenyzmes (NEU1–4). Hydrophobic groups with an amide linker at the C5 and C9 positions were well accommodated by NEU1, and a hexanamido group was found to give the best potency at both positions. While the C5-hexanamido-C9-hexanamido-DANA analogue did not show synergistic improvements for combined modification, an extended alkylamide at an individual position combined with a smaller group at the second gave increased potency. The best NEU1 inhibitor identified was a C5-hexanamido-C9-acetamido-DANA that had a Ki of 53 ± 5 nM and 340-fold selectivity over other isoenzymes. Additionally, we demonstrated that C5-modifications combined with a C4-guandino group provided the most potent NEU2 inhibitor reported, with a Ki of 1.3 ± 0.2 μM and 7-fold selectivity over other NEU isoenzymes." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01411"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01411">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01411&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01411&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01411&amp;href=/doi/10.1021/acs.jmedchem.8b01411" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 11261-11279</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01381" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01424" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Selective Inhibitors of Human Neuraminidase 1 (NEU1)</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Tianlin Guo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tianlin Guo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Alberta Glycomics Centre, Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tianlin++Guo">Tianlin Guo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rachel Héon-Roberts</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rachel Héon-Roberts</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Medical Genetics, Sainte-Justine University Hospital Research Center, University of Montreal, Montréal, H3T 1C5, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rachel++H%C3%A9on-Roberts">Rachel Héon-Roberts</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chunxia Zou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chunxia Zou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Alberta Glycomics Centre, Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chunxia++Zou">Chunxia Zou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ruixiang Zheng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ruixiang Zheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Alberta Glycomics Centre, Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ruixiang++Zheng">Ruixiang Zheng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alexey V. Pshezhetsky</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexey V. Pshezhetsky</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Medical Genetics, Sainte-Justine University Hospital Research Center, University of Montreal, Montréal, H3T 1C5, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexey+V.++Pshezhetsky">Alexey V. Pshezhetsky</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6612-1062" title="Orcid link">http://orcid.org/0000-0002-6612-1062</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Christopher W. Cairo</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher W. Cairo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Alberta Glycomics Centre, Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: 780-492-0377. Fax: 780-492-8231. E-mail: <a href="/cdn-cgi/l/email-protection#492a2a28203b26093c28252b2c3b3d28672a28"><span class="__cf_email__" data-cfemail="b5d6d6d4dcc7daf5c0d4d9d7d0c7c1d49bd6d4">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+W.++Cairo">Christopher W. Cairo</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3363-8708" title="Orcid link">http://orcid.org/0000-0003-3363-8708</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01411&amp;href=/doi/10.1021%2Facs.jmedchem.8b01411" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 11261–11279</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 20, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 September 2018</li><li><span class="item_label"><b>Published</b> online</span>20 November 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 December 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01411" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01411</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D11261%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTianlin%2BGuo%252C%2BRachel%2BH%25C3%25A9on-Roberts%252C%2BChunxia%2BZou%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D24%26contentID%3Dacs.jmedchem.8b01411%26title%3DSelective%2BInhibitors%2Bof%2BHuman%2BNeuraminidase%2B1%2B%2528NEU1%2529%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D11279%26publicationDate%3DDecember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01411"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1620</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01411" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Selective Inhibitors of Human Neuraminidase 1 (NEU1)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Tianlin&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Rachel&quot;,&quot;last_name&quot;:&quot;Héon-Roberts&quot;},{&quot;first_name&quot;:&quot;Chunxia&quot;,&quot;last_name&quot;:&quot;Zou&quot;},{&quot;first_name&quot;:&quot;Ruixiang&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Alexey&quot;,&quot;last_name&quot;:&quot;V. Pshezhetsky&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;W. Cairo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;11261-11279&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01411&quot;},&quot;abstract&quot;:&quot;Inhibitors of human neuraminidase enzymes (NEU) are recognized as important tools for the study of the biological functions of NEU and will be potent tools for elucidating the role of these enzymes in regulating the repertoire of cellular glycans. Here we report the discovery of selective inhibitors of the human neuraminidase 1 (NEU1) and neuraminidase 2 (NEU2) enzymes with exceptional potency. A library of modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues, with variability in the C5- or C9-position, were synthesized and evaluated against four human neuraminidase isoenyzmes (NEU1–4). Hydrophobic groups with an amide linker at the C5 and C9 positions were well accommodated by NEU1, and a hexanamido group was found to give the best potency at both positions. While the C5-hexanamido-C9-hexanamido-DANA analogue did not show synergistic improvements for combined modification, an extended alkylamide at an individual position combined with a smaller group at the second gave increased potency. T&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01411&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01411" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01411&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01411" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01411&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01411" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01411&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01411&amp;href=/doi/10.1021/acs.jmedchem.8b01411" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01411" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01411" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01411%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DGuo%26date%3D2018%26atitle%3DSelective%2BInhibitors%2Bof%2BHuman%2BNeuraminidase%2B1%2B%2528NEU1%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D24%26spage%3D11261%26epage%3D11279%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292161" title="Modification">Modification</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291292" title="Selective inhibitors">Selective inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/jmcmar.2018.61.issue-24/20181227/jmcmar.2018.61.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0017.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inhibitors of human neuraminidase enzymes (NEU) are recognized as important tools for the study of the biological functions of NEU and will be potent tools for elucidating the role of these enzymes in regulating the repertoire of cellular glycans. Here we report the discovery of selective inhibitors of the human neuraminidase 1 (NEU1) and neuraminidase 2 (NEU2) enzymes with exceptional potency. A library of modified 2-deoxy-2,3-didehydro-<i>N</i>-acetylneuraminic acid (DANA) analogues, with variability in the C5- or C9-position, were synthesized and evaluated against four human neuraminidase isoenyzmes (NEU1–4). Hydrophobic groups with an amide linker at the C5 and C9 positions were well accommodated by NEU1, and a hexanamido group was found to give the best potency at both positions. While the C5-hexanamido-C9-hexanamido-DANA analogue did not show synergistic improvements for combined modification, an extended alkylamide at an individual position combined with a smaller group at the second gave increased potency. The best NEU1 inhibitor identified was a C5-hexanamido-C9-acetamido-DANA that had a <i>K</i><sub>i</sub> of 53 ± 5 nM and 340-fold selectivity over other isoenzymes. Additionally, we demonstrated that C5-modifications combined with a C4-guandino group provided the most potent NEU2 inhibitor reported, with a <i>K</i><sub>i</sub> of 1.3 ± 0.2 μM and 7-fold selectivity over other NEU isoenzymes.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The structure of glycoconjugates influences their physical properties and regulates intermolecular interactions that are crucial to cell function.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> The addition and removal of sialic acids from the termini of complex glycans are controlled by two major classes of enzymes: sialyltransferases (SiaT) and sialidases (also called neuraminidases, NEU).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Thus, both enzyme families are implicated in extracellular glycan remodeling, a process thought to modify the function of glycans through small structural changes.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> This process provides a rapid mechanism to alter biosynthetically complex glycoconjugates, and sialic acid’s placement at the periphery of the glycan and its unique properties (such as negative charge) make it an ideal participant in such a process.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> In particular, regulation of the sialylation state of glycans for cell surface glycoproteins and gangliosides by NEU is important in disease and in homeostasis.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> The effects of bulk desialylation have often been studied in human cells using bacterial sialidases or unspecific inhibitors such as 2-deoxy-2,3-didehydro-<i>N</i>-acetylneuraminic acid (DANA); however, the precise roles of human homologues continues to be an active area of investigation.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9−12)</a></div><div class="NLM_p">Four isoenzymes of human NEU (hNEU) have been reported: NEU1, NEU2, NEU3, and NEU4.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Since the discovery of human NEU genes almost 20 years ago, investigations of their function have implicated these enzymes in diseases including disorders of metabolism,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> inflammation,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> cancer,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> diabetes,<a onclick="showRef(event, 'ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19">(16−19)</a> and atherosclerosis.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20−23)</a> Although these four isoenzymes vary in their tissue expression, subcellular location, and substrate specificity, their precise biochemical roles remain to be clearly elucidated.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Our group has continued to pursue the development of small molecule inhibitors with selectivity for individual isoenzymes in the hNEU family to be used as research tools to reveal the specific roles of these enzymes.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Several selective inhibitors of human neuraminidases have been previously reported (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Current examples are based on the DANA (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) scaffold, which in recent years has yielded a number of potent inhibitors. Inhibitors designed for viral and bacterial enzymes, such as zanamivir <b>2</b>, have typically shown lower activity against hNEU.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> The first selective inhibitor of hNEU reported was a C9-amido analogue of DANA <b>8</b>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> which was found to have micromolar IC<sub>50</sub> against NEU1 over the other isoenzymes.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Several analogues of DANA with C9-triazolyl groups have shown nanomolar activity for NEU3 and NEU4. The most potent inhibitor reported for NEU4 is C9-4-hydroxymethyltriazolyl DANA (C9-4HMT-DANA <b>3</b>, <i>K</i><sub>i</sub> = 30 ± 19 nM, 500-fold selective).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Modification of DANA with a C9-biphenyltriazolyl generates a bifunctional NEU3/NEU4 inhibitor (C9-4BPT-DANA <b>4</b>, <i>K</i><sub>i</sub> = 280 ± 40 nM for NEU3, <i>K</i><sub>i</sub> = 260 ± 40 nM for NEU4); combining this C9 modification with a C4 guanidino group resulted in a NEU3-selective inhibitor (<b>5</b>, <i>K</i><sub>i</sub> = 320 ± 40 nM, 10-fold selectivity).<a onclick="showRef(event, 'ref26 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref26 ref30 ref31">(26,30,31)</a> These examples all illustrate that modifications of the DANA scaffold can lead to potent and selective inhibitors of hNEU.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported inhibitors for human neuraminidases. Compounds previously reported as selective inhibitors of the human neuraminidase enzymes are shown. DANA <b>1</b> is a pan-selective inhibitor (with carbon atom numbering for the scaffold shown).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The antiviral NEU inhibitor, zanamivir <b>2</b>, has moderate selectivity for NEU3 and NEU2.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The C9-4HMT-DANA <b>3</b> has a 30 nM <i>K</i><sub>i</sub> against NEU4 and is 500-fold selective.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The C9-biphenyltriazole compound <b>4</b> inhibits both NEU3 and NEU4 at submicromolar potency, while compound <b>5</b> is selective for NEU3.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The azidoacetyl derivative <b>6</b> has potency for NEU2.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> Compound <b>7</b> is reported to have selectivity for NEU3.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The C9-pentylamido derivative of DANA <b>8</b> has been reported to have selective inhibition of NEU1 at micromolar potency.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The antiviral NEU inhibitor oseltamivir <b>9</b> (shown as the carboxylate form) has poor in vitro potency against human NEU.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite continued efforts, there have been few reports of selective inhibitors for the NEU1 or NEU2 isoenzymes with good potency. On the basis of substrate specificity studies of NEU2, Chen and co-workers found that Neu5AcN<sub>3</sub>2en <b>6</b> was twice as potent as DANA for this isoenzyme.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31−33)</a> Selectivity for NEU2 was shown for a DANA analogue where the C7–C9 glycerol side chain of DANA was replaced by an amino-linked benzyl group (<b>7</b>), but these modifications resulted in lower potency than the parent DANA.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> To date, C9-BA-DANA is the most selective inhibitor of NEU1 reported (IC<sub>50</sub> 10 μM),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and the compound has been used in biological studies to block NEU1 activity in lung cells.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Antitumor activities have been proposed for oseltamivir <b>9</b> due to activity against NEU1 in vivo;<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> however, in vitro inhibition assays find low activity for this compound against hNEU isoenzymes.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a></div><div class="NLM_p last">In this work, we report on the discovery of the first nanomolar potency NEU1 inhibitors with high selectivity. These compounds were identified from a library of C5-, C9-, and C5, C9-modified DANA analogues. Within the library we also identified inhibitors of NEU2 with single-digit micromolar activity and good selectivity. These findings offer a significant expansion of the tool box for the functional study of human neuraminidases with small molecule inhibitors. Furthermore, the data provide new insights into the topology of the NEU1 active site for which little structural data are available.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Inhibitor Design and Synthesis</h3><div class="NLM_p">Among the four hNEU isoenzymes, NEU1 shows the least sequence identity with NEU2/3/4,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and efforts at molecular modeling of NEU1 have been challenging.<a onclick="showRef(event, 'ref25 ref38'); return false;" href="javascript:void(0);" class="ref ref25 ref38">(25,38)</a> Several factors contribute to the lack of structural information regarding NEU1, including its occurrence in a membrane-associated complex with carboxypeptidase protective protein/cathepsin A (PPCA) and a β-galactosidase,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and the inherent instability of the protein. In the absence of validated structural models of NEU1, we based our design on the limited structure–activity relationship (SAR) studies reported for the target. Magesh et al. screened a panel of amide-linked C9-modified DANA analogues in vitro and found that NEU1 was able to accommodate hydrophobic groups at the C9 position. The ability of NEU1 to accommodate C9-modifications may be the result of a shorter loop between the seventh and eighth strands of the β-propeller fold (the β7−β8 loop) in NEU1 compared with NEU2/3/4.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Interestingly, multiple groups have found that small modifications at C5 have maintained or improved the activity of DANA analogues with NEU2 and NEU3.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31−33)</a> From alignments of NEU1/2/3/4, it can be proposed that the C5 binding pocket of all the four human neuraminidase isoenzymes consists of primarily hydrophobic amino acid residues. On the basis of the above information, we set out to explore the C9- and C5-binding pockets of hNEU with hydrophobic groups.</div><div class="NLM_p">Synthesis of C5-modified DANA analogues began with a previously reported C5-amino-DANA derivative with <i>O</i>-acetyl protection (<b>10</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Amides were generated using the corresponding acyl chloride or anhydride, with subsequent alkaline deprotection of the <i>O</i>-acyl and C1-methyl ester to provide the final compounds (<b>11a</b>–<b>l</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). We also developed compounds with a C5-aryltriazolyl group after coupling <b>10</b> with the <i>N</i>-hydroxysuccinimidyl-2-azidoacetate to provide C5-azidoacetyl-DANA derivative (<b>12</b>, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref33 ref40'); return false;" href="javascript:void(0);" class="ref ref33 ref40">(33,40)</a> A subsequent CuAAC reaction and deprotection was performed to construct C5-aryltriazolyl DANA analogues <b>13a</b>–<b>h</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> We also applied a previous strategy to generate libraries of C9-amido analogues of DANA <b>15a</b>–<b>l</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) using Staudinger reaction of <b>14</b> with activated esters, followed by deprotection of C1-methyl ester (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to C5-Modified DANA Analogues <b>11a</b>–<b>l</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to C5-Modified DANA Analogues <b>13a</b>–<b>h</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route to C9-Modified DANA Analogues <b>15a</b>–<b>l</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next developed a route to doubly modified DANA analogues containing C5-, C9- and C4-, C5-fragments (<a class="ref internalNav" href="#sch4" aria-label="Schemes 4">Schemes 4</a> and <a class="ref internalNav" href="#sch5" aria-label="5">5</a>, respectively). The synthesis of C5, C9-modified compounds was accomplished using compound <b>16</b>, which was synthesized as previously described.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The C9-azido group was converted to a C9-amide moiety using the strategy above. The C5 amide was introduced using the corresponding acyl chlorides or anhydrides after deprotection of <i>tert</i>-butyloxycarbonyl group (Boc) with trifluoroacetic acid. The final C5, C9-products <b>17a</b>–<b>f</b> were obtained after hydrolysis of the C1-methyl ester. Previous work had suggested that C4 modification of DANA could result in improved activity for NEU2 and NEU3.<a onclick="showRef(event, 'ref26 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref26 ref30 ref31">(26,30,31)</a> Thus, we developed a route to compounds that could combine C5-amide modifications with a C4-guanidino group in our library to be tested for selectivity among the hNEU isoenzymes. The C5, C4-doubly modified DANA analogue was synthesized from a globally protected C4-azido-DANA derivative <b>18</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The C5-acetamido group was first protected with di-<i>tert</i>-butyloxydicarbonate (Boc<sub>2</sub>O) and then selectively deacylated under mild conditions to generate compound <b>19</b>.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> After protection of the hydroxy groups, Boc was removed. We introduced a C5-amide group that had increased potency for NEU2 in our screens of C5-modified compounds (vide infra), the 4-methylbutanamido group (<b>11h</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), using the 4-methylbutanoyl chloride, yielding compound <b>20</b>. The C4-azido group was then reduced by triphenylphosphine and transformed to a guanidino using <i>N</i>,<i>N</i>′-di-Boc-1<i>H</i>-pyrazole-1-carboxamidine to form compound <b>21</b>. The final product <b>22</b> was obtained after deprotection of the Boc group and hydrolysis of the acyl groups and methyl ester.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route to C5, C9-Modified DANA Analogues <b>17a</b>–<b>h</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route to C4, C5-Modified DANA Analogue <b>22</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Results for C5-Modified DANA Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0009.gif" alt="" id="gr9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0010.gif" alt="" id="gr10" /></img><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Inhibition Assays</h3><div class="NLM_p">The inhibitory activity of DANA analogues was evaluated using the fluorogenic neuraminidase substrate 2′-(4-methylumbelliferyl)-α-<span class="smallcaps smallerCapital">d</span>-<i>N</i>-acetylneuraminic acid (4MU-NANA) and samples of individual hNEU isoenzymes.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> The IC<sub>50</sub> assay results for each of the four hNEU enzymes are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and are grouped by the site of modification on the DANA scaffold: C5 (<b>11a</b>–<b>l</b>, <b>13a</b>–<b>i</b>; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), C9 (<b>15a</b>–<b>m</b>; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), and C5, C9 (<b>17a</b>–<b>h</b>, <b>22</b>; <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Substituents were linked to DANA analogues through either an amide (<b>11a</b>–<b>l</b>, <b>15a</b>–<b>l</b>, <b>17a</b>–<b>h</b>) or an azidoacetyl group that was converted to a triazole (<b>13a</b>–<b>i</b>). We observed the largest differences in potency for this library against NEU1; however, selective inhibitors of NEU2 and SAR for NEU3 and NEU4 were apparent from these data, as discussed in detail below.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Results for C9-Modified DANA Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0011.gif" alt="" id="gr11" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0012.gif" alt="" id="gr12" /></img><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IC<sub>50</sub> Results for DANA Analogues with Combined Modifications</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0013.gif" alt="" id="gr13" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0014.gif" alt="" id="gr14" /></img><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> C5-Amides with Linear and Branched Alkanes Improve Potency for NEU1</h3><div class="NLM_p">The C5 pocket of NEU1 was sensitive to the length and branching of alkyl groups. Extension of the C5 chain from one methyl (DANA) to as long as a hexyl chain (<b>11a</b>–<b>e</b>) spanned a more than 100-fold range of potency for NEU1 IC<sub>50</sub> from 49 ± 8 μM (DANA <b>1</b>) to 0.42 ± 0.06 μM (<b>11d</b>). Branched alkanes gave mixed results against NEU1. For example, an α-methyl branch in <b>11f</b> (5.3 ± 0.8 μM) had approximately 3-fold improved potency as compared with propylamide <b>11a</b> (18 ± 1 μM). In contrast, the β-methyl group in <b>11g</b> (32 ± 5 μM) caused a 4-fold loss in potency for NEU1 as compared with butylamide <b>11b</b> (8.4 ± 0.5 μM). Introduction of a γ-methyl group in <b>11h</b> (1.7 ± 0.1 μM) may lead to a small decrease in NEU1 potency as compared with the pentylamide <b>11c</b> (0.99 ± 0.07 μM). Small cycloalkanes such as cyclopropyl (<b>11i</b>, 6.9 ± 0.4 μM) and cyclobutyl (<b>11j</b>, 12 ± 2 μM) groups had similar potency to propyl (<b>11b</b>, 8.4 ± 0.5 μM) and ethyl (<b>11a</b>, 18 ± 1 μM) substituents with NEU1. We observed that a benzylamide was also accommodated at the C5 pocket of NEU1 (<b>11k</b>, 11 ± 1 μM), showing a 4-fold increase in potency as compared to DANA and similar to the cyclobutylamide of <b>11j</b>. The polarity of the C5 amide was critical for potency with NEU1. Inclusion of a terminal amine caused a significant loss of activity for NEU1 (<b>11l</b>, 480 ± 260 μM) and NEU2 (>500 μM).</div><div class="NLM_p last">Virtually all large groups at the C5 position resulted in low potency for NEU3 and NEU4. The only exception observed was the C5-butylamide-DANA <b>11b</b> which had modest potency against NEU3 (15 ± 2 μM) and NEU4 (8.4 ± 0.4 μM). These observations confirm that the C5 pocket of NEU3 and NEU4 is relatively restricted.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> C5-Triazolyl Alkyl and Aromatic Groups Improved Selectivity for NEU2</h3><div class="NLM_p">We included a series of compounds containing a triazolyl linker at C5 and observed that this modification abolished activity against NEU1 (<b>13a</b>–<b>i</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). A similar trend was observed for C9 modifications, where analogues containing a triazolyl linker had greatly decreased potency (<b>15m</b>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">C5-modifications were well accommodated by NEU2, in agreement with reports that DANA and Neu5AcN<sub>3</sub>2en <b>6</b> has improved potency for this isoenzyme.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In contrast with NEU1, NEU2 showed a preference for the γ-branched alkyl chain of <b>11h</b> (7.3 ± 1.2 μM for NEU2, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and aryltriazolyl groups (<b>13a</b>–<b>h</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The NEU2 active site was able to accommodate C5-aryltriazolyl DANA analogues with neutral (<b>13d</b>, 3.3 ± 0.3 μM) or basic (<b>13c</b>, 4.4 ± 0.3 μM) substitutions on the benzene ring, while acidic substitution (<b>13h</b>, 180 ± 30 μM) was not well tolerated. Compound <b>11h</b> (7.3 ± 1.2 μM) had the greatest potency among the alkyl series, while <b>13c</b> (4.4 ± 0.3 μM), <b>13d</b> (3.3 ± 0.3 μM), and <b>13f</b> (4.5 ± 0.3 μM) were the best among the aryltriazolyl series. Previous reports have found that a guanidino group at the C4 position could improve activity for NEU2;<a onclick="showRef(event, 'ref26 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref26 ref30 ref31">(26,30,31)</a> thus we decided to generate compounds that combined modifications at C5 and C4. Compound <b>22</b>, containing a C4-guanidino and a γ-branched pentylamide, demonstrated a 3-fold increase in potency against NEU2 (2.1 ± 0.1 μM) as compared to the C5-single modified analogue (<b>11h</b>, 7.3 ± 1.2 μM) or the C4-guanidino-containing zanamivir <b>2</b> (7.8 ± 2.0 μM).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Although <b>22</b> had the greatest potency for NEU2, its selectivity for the isoenzyme was inferior when compared with <b>13c</b> and <b>13d</b>, as <b>22</b> also had moderate potency for NEU1. We measured the <i>K</i><sub>i</sub> values of <b>13c</b> and <b>13d</b> for NEU2 to be 2.1 ± 0.6 μM and 2.7 ± 0.6 μM, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). These values indicate both compounds to be 30-fold selective for NEU2, identifying them as the most selective NEU2 inhibitors reported. Compound <b>22</b>, with a <i>K</i><sub>i</sub> of 1.3 ± 0.2 μM, is the most potent NEU2 inhibitor reported but lacks selectivity for NEU2 over NEU1.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. <i>K</i><sub>i</sub> of NEU1 and NEU2 Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0015.gif" alt="" id="gr15" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0016.gif" alt="" id="gr16" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Values obtained from analysis using a competitive inhibition model.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Indicated compounds exhibited noncompetitive inhibition with α ≤ 1; see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01411/suppl_file/jm8b01411_si_001.pdf" class="ext-link">Table S3</a>.</p></div></div><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> C9-Amide Groups Improved Selectivity and Potency for NEU1</h3><div class="NLM_p">Testing the activity of a series of compounds containing C9-modifications revealed important features of the NEU1 C9 pocket (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). First, while alkylamido groups at this position provide improved potency over DANA <b>1</b> (e.g., <b>8</b>, 3.4 ± 0.2 μM), branching at the α-position of the amide was detrimental to activity (<b>15d</b>, 250 ± 60 μM), while β- or γ-methyl groups (<b>15e</b>, 2.5 ± 0.3 μM; <b>15f</b>, 3.2 ± 0.3 μM) provided similar to the activity of C9-butanamido-DANA <b>8</b> and C9-pentanamido-DANA (<b>15a</b>, 4.0 ± 0.5 μM).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> These results indicate that the C9 binding pocket of NEU1 may have a narrow opening but can accommodate larger groups distal to the C9-amide. The hydrophobic nature of the C9 binding pocket has been previously suggested,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and we sought to explore this further with larger groups. A series of phenylamides (<b>15g</b>–<b>k</b>) suggest that there are specific contacts that can be gained from the C9 pocket. Compound <b>15g</b> (2.5 ± 0.3 μM) had similar potency to <b>8</b> and <b>15b</b> (2.9 ± 0.2 μM). Introduction of a <i>p</i>-amino group on the phenyl ring (<b>15i</b>, 29 ± 5 μM) decreased potency 11-fold as compared to <b>15g</b> (2.5 ± 0.3 μM). Conversion of the <i>p</i>-amino group to a less polar <i>p</i>-acetamido group (<b>15h</b>, 1.9 ± 0.4 μM) maintained similar potency to <b>15g</b>. However, modifications at the meta position of the phenyl group to an amino (<b>15j</b>, 7.5 ± 1 μM) or acetamido (<b>15k</b>, 6.5 ± 0.7 μM) showed a similar, but minor, decrease in potency against NEU1. Extension of a linear alkyl chain from the C9 position with a terminal <i>p</i>-acetamidophenyl group (<b>15l</b>, 240 ± 70 μM) resulted in substantial loss of potency. Finally, we investigated the role of the C9-linker. While the C9-hexanamido derivative <b>15b</b> showed improved potency from DANA against NEU1, a 4-hexanyltriazole (<b>15m</b>, 77 ± 30 μM) showed a significant decrease in potency, confirming that the C9-amide linker was partly responsible for improved potency against NEU1. This series of compounds allowed us to conclude that the NEU1 C9 pocket has distinct steric requirements, such as exclusion of α-branching and specific orientation of polar groups. Additionally, we note that none of the above modifications improved potency over the C5-hexanamido-DANA <b>11d</b>.</div><div class="NLM_p last">The C9-amide-DANA series contained generally poor inhibitors of NEU3 and NEU4. Medium sized amides were tolerated (e.g., <b>15c</b>, 39 ± 8 μM; <b>15g</b>, 34 ± 5 μM for NEU3) but had modest potency. Benzamides <b>15h</b> and <b>15j</b> had single-digit IC<sub>50</sub> values for NEU3 (∼7 μM), and this activity was sensitive to the placement of the amide group (e.g., <b>15i</b>, 31 ± 6 μM vs <b>15j</b>, 7.1 ± 0.7 μM). Comparison of the amide linker with the triazole linker for a pentyl chain (<b>15b</b>, 83 ± 9 μM vs <b>15m</b>, 6.7 ± 1.2 μM) showed a 12-fold preference for the triazole, suggesting that the linker contributes substantially to potency in NEU3.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Combined C5, C9-Alkylamide Modifications Produce High Potency NEU1 Inhibitors</h3><div class="NLM_p last">On the basis of the singly modified series discussed above, we set out to generate combinations of C5- and C9-modifications that could provide increased potency for NEU1. First, we combined the alkyl groups at C5 (<b>11d</b>, 0.42 ± 0.06 μM) and C9 (<b>15b</b>, 2.9 ± 0.2 μM) which had produced the best activity, and synthesized C5-hexanamido, C9-hexanamido-DANA <b>17a</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Unfortunately, <b>17a</b> (4.3 ± 0.8 μM) was 10-fold less potent than the singly modified <b>11d</b> and 1.4-fold less potent than <b>15b</b>. Combination of two shorter chains in the C5-pentanamido, C9-pentanamido-DANA <b>17b</b> (1.5 ± 0.2 μM) was still 1.5-fold less potent than its singly modified counterparts <b>11c</b> (0.99 ± 0.07 μM) but did show a modest improvement in potency over the C9-modified analogue <b>15b</b> (2.9 ± 0.2 μM). We hypothesized that these results could support a bridged model where the C5- and C9-pockets of NEU1 share occupancy. Following on this hypothesis, we tested compounds that combined a long and short alkyl chain modification at these two positions (<b>17c</b>–<b>h</b>). Placing the longer chain at the C9 position (<b>17c</b>, 1.6 ± 0.2 μM; <b>17d</b>, 1.4 ± 0.2 μM) showed modest improvement over <b>8</b> (3.4 ± 0.2 μM), <b>15b</b>, and <b>11a</b> (18 ± 1 μM). The largest improvements were observed when a longer chain was introduced at C5 and a shorter chain was included on C9 (<b>17e</b>–<b>h</b>). The C5-pentanamido, C9-acetamido-DANA <b>17e</b> (0.35 ± 0.03 μM) and C5-hexanamido, C9-acetamido DANA <b>17f</b> (0.14 ± 0.01 μM) were approximately 3-fold more potent than their C5 singly modified DANA analogues <b>11c</b> and <b>11d</b>. The addition of the C9-acetamido group increased inhibitor selectivity for NEU1, while potency for NEU2, NEU3, and NEU4 for these compounds was decreased. Compounds with longer C9-chains, such as C5-hexanamido, C9-propionamido-DANA <b>17g</b> (0.40 ± 0.10 μM) and C5-heptanamido, C9-butanamido-DANA <b>17h</b> (1.2 ± 0.1 μM) had a modest decrease in potency. Measurement of the inhibitory constant for the best compounds from this series confirmed that the C5-hexanamido, C9-acetamido-DANA <b>17f</b> (<i>K</i><sub>i</sub> = 53 ± 5 nM, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) was the most potent inhibitor reported for NEU1 to date. Additionally, the C9-hexanamido-DANA <b>11d</b> (<i>K</i><sub>i</sub> = 180 ± 20 nM), which is more synthetically accessible, had good potency in the nanomolar range.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Activity of Inhibitors against Murine NEU Orthologs</h3><div class="NLM_p">After identifying selective human NEU1 inhibitors through in vitro screening, we proceeded to test their selectivity and potency against mouse orthologs. The availability of NEU knockout (KO) animals allowed us to isolate tissue lacking expression of individual isoenzymes. These tissues then provide a confirmation of in vitro assays using recombinant enzymes.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> We assayed the inhibition of neuraminidase activity by <b>17f</b> in the brain homogenate of wild type mice <named-content content-type="anchor" rid="fig2" type="simple"></named-content>(<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A), NEU1 knockout (<i>Neu1<sup>–/–</sup></i>) mice (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B), and a double NEU3/NEU4 knockout (<i>Neu3<sup>–/–</sup> Neu4<sup>–/–</sup></i>) mice (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> In the brain tissues from wild-type mice (C57B16), up to 40% of total neuraminidase activity was blocked by <b>17f</b>. In contrast, the NEU1 KO tissue showed no significant inhibition when treated with <b>17f</b>, supporting that the compound did not have significant activity against other NEU isoenzymes expressed in the brain (NEU2, NEU3, and NEU4). In the brain tissues of NEU3/NEU4 double knockout mice, the majority of neuraminidase activity was blocked by <b>17f</b> at high concentration. The residual NEU activity in these samples may be the result of NEU2 expression, as small amounts of NEU2 were detected in the WT mice brain,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> with higher levels in the adult brain.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> To further probe the selectivity of <b>17f</b>, we tested its effects on NEU activity from kidney homogenates of wild type mice (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D), which is known to exclusively express NEU1.<a onclick="showRef(event, 'ref44 ref47'); return false;" href="javascript:void(0);" class="ref ref44 ref47">(44,47)</a> Compound <b>17f</b> showed 90% of inhibition of total neuraminidase activity from kidney tissue, confirming its selectivity for NEU1 over other NEU isoenzymes. Differences in the apparent potency of <b>17f</b> as compared to IC<sub>50</sub> determinations are likely due to differences in the substrate concentration and unknown concentration of active NEU isoenzymes.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic illustration of the binding sites of hNEU. (A) Contacts between DANA and the binding site of NEU2 are summarized, with presumed H bond interactions. Residues shown are based on the cocrystal structure previously reported (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1VCU">1VCU</a>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> (B) Model of the NEU1 binding site with <b>17f</b>. We propose that the proximity of the C5 and C9 sites allows crossover of large groups attached at either position, and the C5 and C9 pockets act as a single large pocket, in contrast to other hNEU active sites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of NEU activity in homogenates of murine tissues by <b>17f</b>. Brains and kidneys were extracted from WT C57Bl6, <i>Neu1</i> KO (<i>Neu1<sup>–/–</sup></i>), or <i>Neu3/4</i> double KO (DKO) mice (<i>Neu3<sup>–/–</sup></i>, <i>Neu4<sup>–/–</sup></i>). The homogenates were assayed for inhibition of neuraminidase activity by compound <b>17f</b> against 4MU-NANA. The WT brain homogenate (A) showed partial inhibition (up to 40% at 100 μM) of neuraminidase activity, while the <i>Neu1</i> KO brain homogenate (B) showed no inhibition. The <i>Neu3/4</i> DKO brain homogenate (C) and WT kidney homogenate (D), which express only <i>Neu1</i>, showed dramatic inhibition. All homogenates showed a complete inhibition of neuraminidase activity at 150 μM DANA (data not shown). Points are labeled as significantly different (∗, <i>p</i> < 0.05; ∗∗, <i>p</i> < 0.01; ∗∗∗, <i>p</i> < 0.001) from activity in the absence of the inhibitors (dotted line) according to a <i>t</i> test with a Dunlett post-test. Data are shown as mean values ± SD of four independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Human neuraminidase enzymes are responsible for the cleavage of sialic acid residues from glycoproteins and glycolipids. These enzymes have the potential to rapidly remodel glycan structures and may therefore influence cellular events mediated by glycans. NEU1 has the highest expression level among all the four hNEU isoenzymes.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Deficiency of lysosomal NEU1 can lead to lysosomal storage disorders such as sialidosis and galactosialidosis.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> NEU1 is also found on the plasma membrane and likely plays a role in many signaling pathways in health and disease.<a onclick="showRef(event, 'ref8 ref20 ref22 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref8 ref20 ref22 ref48 ref49">(8,20,22,48,49)</a> One of the major challenges of studying the role of individual hNEU isoenzymes is the existence of multiple isoenzymes and their overlapping biological activity and specificity. For example, both NEU1 and NEU3 are reported to regulate cell signaling pathways mediated by EGFR<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> and IR,<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> as well as lipid metabolism.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">Inhibitors of NEU have become essential research tools to address the issue of multiple isoenzymes. However, no commercially available inhibitors have been designed for specificity against hNEU isoenzymes. NEU inhibitors developed for bacterial or viral targets typically have broad or weak activity against hNEU.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> The role of sialidase activity was investigated with DANA and zanamivir in skin senescence, where sialidases down-regulated myofibroblast differentiation via desialylation of CD44.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> DANA and oseltamivir have been used as hNEU inhibitors for the study of apoptosis and phagocytosis of platelets.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Testing in vitro suggested that zanamivir had modest potency for NEU3 but little activity for NEU1,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> while oseltamivir has very low activity against any hNEU isoenzyme.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> A bispecific inhibitor of NEU3 and NEU4, C9-4BPT-DANA <b>4</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> was used to interrogate the role of NEU1 activity in the tissues of mice exposed to high-fat diet as a model of obesity-induced type 2 diabetes.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> These examples highlight that there remains a need for potent and selective hNEU inhibitors to facilitate biological studies of the role of human NEU isoenzymes.</div><div class="NLM_p">In this work, we generated inhibitors based on the DANA scaffold containing modifications at the C5- and C9-positions to obtain potent and selective inhibitors of NEU1. In an earlier report from Magesh et al., C9-amide derivatives of DANA were found to act as selective inhibitors of NEU1.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> We generated a panel of C9-amido derivatives of DANA with various alkyl chains and found that many of these were accommodated by NEU1. Interestingly, the C9-amide linker was found to be critical to the activity of these compounds as C9-triazolyl derivatives had reduced potency for NEU1 (despite their improved activity for NEU3 and NEU4).<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> The most potent NEU1 inhibitors from the C9-series contained a C9-hexanamido chain, while longer chains had reduced activity. We extended this strategy to the C5 position of DANA. We were surprised to observe that the C5-binding pocket of NEU1 was able to accommodate linear, branched, and cycloalkane groups. Among these DANA analogues, compounds with C5-pentanamido or C5-hexanamido groups gave submicromolar IC<sub>50</sub> values. The C5 pocket of NEU1 did not accommodate alkyl- or aryltriazolyl groups and was sensitive to branching of the alkyl chain.</div><div class="NLM_p">Combined modification of C5 and C9 positions allowed us to generate inhibitors of NEU1 with exceptional potency. Initial combinations of the best alkylamido groups from the singly modified series did not show additive potency. Instead, we found that a single pentanamido or hexanamido group at C5, when combined with a short amido group (e.g., acetamido, ethylamido), had potency as low as 53 nM <i>K</i><sub>i</sub> for NEU1. Furthermore, these compounds show unprecedented selectivity with compounds <b>17e</b>, <b>17f</b>, and <b>17g</b> ranging from 200- to 450-fold preference for NEU1. The selectivity and potency of <b>17f</b> against NEU1 were also confirmed in murine brain homogenates (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), supporting consistency between assays. On the basis of these results, we propose a model for the active site of NEU1 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). The cocrystal structure of DANA in the active site of NEU2 provides a map of the key residues used by that enzyme to complex the inhibitor. Previous work from our group has suggested that the C9 pocket of NEU2 is exquisitely sensitive to increased steric bulk at this position,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and the inhibitors tested here support that conclusion. However, the C5-, C9-, and C5, C9-series suggest a unified C5 and C9 pocket in NEU1. Furthermore, our data suggest that this pocket prefers hydrophobic groups linked through an amide rather than a triazole. This should be contrasted with the C5 pocket of NEU3 and NEU4, which appears to be small and prefers more polar groups.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The C9 pocket of both NEU3 and NEU4 accommodates large hydrophobic groups when linked through a triazole, but the linker provides an additional element of discrimination between the isoenzymes.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p last">The panels of compounds tested here also identified selective inhibitors for NEU2 with low micromolar potency. The C5 pocket of NEU2 was able to accommodate large aryltriazolyl groups, yielding inhibitors with 30-fold selectivity (<b>13c</b>, <b>13d</b>). The presence of a C4-guanidino group in compounds such as zanamivir has been previously found to increase potency for NEU2. We synthesized compound <b>22</b>, bearing a C5-(4-methylpentanamido) together with a C4-guanidino group, which had the most potent <i>K</i><sub>i</sub> reported against NEU2 (<b>22</b>, <i>K</i><sub>i</sub> = 1.3 ± 0.2 μM).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20181" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20181" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Our results establish a rational strategy for the design of improved inhibitors of human NEU isoenzymes NEU1 and NEU2. Using a panel of compounds with C4, C5, C9 and combined modifications, we were able to identify the most potent and selective inhibitors of both isoenzymes reported to date. The best inhibitor of NEU1 tested was <b>17f</b>, with a <i>K</i><sub>i</sub> of 53 ± 5 nM and 330-fold selectivity. The more synthetically accessible compound, <b>11d</b> (<i>K</i><sub>i</sub> = 0.18 ± 0.02 μM), had comparable potency but reduced selectivity of 35-fold. The most potent inhibitor of NEU2 tested was <b>22</b>, with a <i>K</i><sub>i</sub> of 1.3 ± 0.2 μM and 7-fold selectivity, while the most selective inhibitors of NEU2 tested were <b>13c</b> (4.4 ± 0.3 μM) and <b>13d</b> (3.3 ± 0.3 μM), each with 30-fold selectivity for the isoenzyme. Moreover, <b>17f</b> selectively inhibited NEU1 in mouse orthologs from brain and kidney homogenates, demonstrating that these inhibitors will be important new tools for investigation of the role of hNEU enzymes in biological systems.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45230" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45230" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Synthetic Procedures</h3><div class="NLM_p last">All reagents and solvents were purchased from Sigma-Aldrich unless otherwise noted and used without further purification. Reactions were monitored with TLC (Merck TLC silica gel 60 F<sub>254</sub>), and spots were visualized under UV light (254 nm) or by charring with 0.5% H<sub>2</sub>SO<sub>4</sub>/EtOH. Compounds were purified by flash column chromatography with silica gel (SiliCycle SiliaFlash F60, 40–63 μm particle size) or recrystallization. Proton (<sup>1</sup>H) and carbon (<sup>13</sup>C) NMR spectra were recorded on Varian 500 (500 MHz for <sup>1</sup>H; 125 MHz for <sup>13</sup>C) or Varian 700 (700 MHz for <sup>1</sup>H; 175 MHz for <sup>13</sup>C). High-resolution mass spectrometry (HR-MS) analysis was performed on Agilent Technologies 6220 TOF spectrometer. Purity of all final products used for inhibitor assays was determined to be ≥95% by HPLC (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01411/suppl_file/jm8b01411_si_001.pdf" class="ext-link">Supporting Information</a> for details).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 5-Acetamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (DANA, <b>1</b>)</h3><div class="NLM_p last">Compound <b>1</b> was synthesized as previously reported.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.67 (d, <i>J</i> = 2.3 Hz, 1H, H-3), 4.36 (dd, <i>J</i> = 8.6, 2.3 Hz, 1H, H-4), 4.10 (dd, <i>J</i> = 10.9, 1.1 Hz, 1H, H-6), 3.99 (dd, <i>J</i> = 10.9, 8.6 Hz, 1H, H-5), 3.87 (ddd, <i>J</i> = 9.1, 5.4, 3.1 Hz, 1H, H-8), 3.80 (dd, <i>J</i> = 11.4, 3.1 Hz, 1H, H-9), 3.65 (dd, <i>J</i> = 11.4, 5.4 Hz, 1H, H-9′), 3.52 (dd, <i>J</i> = 9.1, 1.1 Hz, 1H, H-7), 2.02 (s, 3H, COCH<sub>3</sub>). <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>OD) δ 174.68, 170.02 (2 × C═O), 149.95 (C-2), 108.34 (C-3), 77.24 (C-6), 71.29 (C-8), 70.22 (C-7), 68.70 (C-4), 64.94 (C-9), 51.96 (C-5), 22.82 (CO<i>C</i>H<sub>3</sub>). HR-MS (ESI) calcd for C<sub>11</sub>H<sub>16</sub>NO<sub>8</sub> [M – H]<sup>−</sup>, 290.0876; found 290.0879.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 5-(<i>N</i>-2-Azidoacetyl)-2,3,5-trideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galacto-2-nonulopyranosonic Acid (<b>6</b>)</h3><div class="NLM_p last">Compound <b>6</b> was synthesized as previously reported.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.86 (d, <i>J</i> = 1.5 Hz, 1H, H-3), 4.46 (dd, <i>J</i> = 8.7, 1.5 Hz, 1H, H-4), 4.24 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 4.07 (dd, <i>J</i> = 10.8, 8.7 Hz, 1H, H-5), 3.97 (q, <i>J</i> = 16.1 Hz, 2H, N–CH<sub>2</sub>–CO), 3.88 (br, 1H, H-8), 3.81 (dd, <i>J</i> = 11.4, 2.6 Hz, 1H, H-9), 3.66 (dd, <i>J</i> = 11.4, 5.2 Hz, 1H, H-9′), 3.57 (d, <i>J</i> = 9.0 Hz, 1H, H-7). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 171.55 (C═O), 111.68 (C-3), 77.43 (C-6), 71.41 (C-8), 70.04 (C-7), 68.23 (C-4), 64.86 (C-9), 53.01 (CH<sub>2</sub>N<sub>3</sub>), 51.93 (C-5). HRMS (ESI) calcd for C<sub>11</sub>H<sub>15</sub>N<sub>4</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 331.0890; found 331.0894.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 5-Acetamido-9-pentanamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>8</b>)</h3><div class="NLM_p last">Compound <b>8</b> was synthesized as previously reported.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.93 (d, <i>J</i> = 1.7 Hz, 1H, H-3), 4.43 (dd, <i>J</i> = 8.6, 1.7 Hz, 1H, H-4), 4.18 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 4.02–3.95 (m, 1H, H-5), 3.95–3.87 (m, 1H, H-8), 3.59 (dd, <i>J</i> = 13.9, 2.9 Hz, 1H, H-9), 3.43 (d, <i>J</i> = 9.0 Hz, 1H, H-7), 3.32–3.27 (m, 1H, H-9′), 2.22 (t, <i>J</i> = 7.6 Hz, 2H, α-CH<sub>2</sub>), 2.03 (s, 3H, COCH<sub>3</sub>), 1.64–1.54 (m, 2H, β-CH<sub>2</sub>), 1.35 (dd, <i>J</i> = 15.0, 7.5 Hz, 2H, γ-CH<sub>2</sub>), 0.92 (t, <i>J</i> = 7.4 Hz, 3H, δ-CH<sub>2</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 177.26, 174.88 (N–C═O), 165.81 (C-1), 145.81 (C-2), 113.17 (C-3), 77.79 (C-6), 71.50 (C-7), 70.24 (C-4), 68.03 (C-8), 51.97 (C-5), 44.40 (C-9), 36.87 (C-α), 29.28 (C-β), 23.44 (γ), 22.86 (CO<i>C</i>H<sub>3</sub>), 14.22 (C-δ). HRMS (ESI) calcd for C<sub>16</sub>H<sub>25</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 373.1616; found 373.1614.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedure for the Synthesis of Compounds <b>11a</b>–<b>l</b></h3><div class="NLM_p last">A solution of compound <b>10</b> in anhydrous dichloromethane and triethylamine (4 equiv) was cooled down to 0 °C, and anhydride or acyl chloride (1.5 equiv) were added dropwise. The solution was allowed to warm to room temperature and kept stirring overnight. After completion, the reaction was quenched with water, concentrated, and purified by flash chromatography to give the protected product. The protected product was then dissolved in methanol, and 0.5 N NaOH was added. The solution was stirred under room temperature until completion. After completion, the solution was neutralized by Amberlite IR 120 (H+). The suspension was then filtered, and the filtrate was concentrated and purified by flash chromatography or precipitated in a mixture of methanol and ethyl acetate to give the desired product.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 5-Propionamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>11a</b>)</h3><div class="NLM_p last">Compound <b>11a</b> was synthesized from compound <b>10</b> using propionic anhydride. 70 mg (65% (86% × 76%), over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.90 (d, <i>J</i> = 2.4 Hz, 1H, H-3), 4.43 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H, H-4), 4.15 (dd, <i>J</i> = 10.8, 0.9 Hz, 1H, H-6), 4.01–3.95 (m, 1H, H-5), 3.91–3.86 (m, 1H, H-8), 3.81 (dd, <i>J</i> = 11.4, 3.0 Hz, 1H, H-9), 3.65 (dd, <i>J</i> = 11.4, 5.4 Hz, 1H, H-9′), 3.55 (dd, <i>J</i> = 9.2, 0.9 Hz, 1H, H-7), 2.31 (q, <i>J</i> = 7.6 Hz, 2H, CH<sub>2</sub>), 1.15 (t, <i>J</i> = 7.6 Hz, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 178.80 (N–C═O), 166.46 (C-1), 112.52 (C-3), 77.98 (C-6), 71.17 (C-8), 70.17 (C-7), 68.10 (C-4), 64.93 (C-9), 51.80 (C-5), 30.20 (C-α), 10.33 (C-β). HRMS (ESI) calcd for C<sub>12</sub>H<sub>18</sub>NO<sub>8</sub> [M – H]<sup>−</sup>, 304.1032; found 304.1039.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 5-Butyramido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>11b</b>)</h3><div class="NLM_p last">Compound <b>11b</b> was synthesized from compound <b>10</b> using butyric anhydride. 21 mg (70% (79% × 89%), over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.89 (d, <i>J</i> = 2.4 Hz, 1H, H-3), 4.42 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H, H-4), 4.15 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 3.99 (dd, <i>J</i> = 10.8, 8.7 Hz, 1H, H-5), 3.89 (ddd, <i>J</i> = 9.0, 5.3, 3.0 Hz, 1H, H-8), 3.81 (dd, <i>J</i> = 11.4, 3.0 Hz, 1H, H-9), 3.63 (dd, <i>J</i> = 11.4, 5.3 Hz, 1H, H-9′), 3.56 (d, <i>J</i> = 9.0 Hz, 1H, H-7), 2.29–2.23 (m, 2H, CH<sub>2</sub>), 1.66 (dt, <i>J</i> = 13.4, 7.0 Hz, 2H, CH<sub>2</sub>), 0.97 (t, <i>J</i> = 7.0 Hz, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 177.98 (N–C═O), 166.50 (C-1), 112.47 (C-3), 78.00 (C-6), 71.17 (C-7), 70.26 (C-4), 68.09 (C-8), 64.99 (C-9), 51.85 (C-5), 39.04 (C-α), 20.31 (C-β), 14.11 (C-γ). HRMS (ESI) calcd for C<sub>13</sub>H<sub>20</sub>NO<sub>8</sub> [M – H]<sup>−</sup>, 318.1189; found 318.1196.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 5-Pentanamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>11c</b>)</h3><div class="NLM_p last">Compound <b>11c</b> was synthesized from compound <b>10</b> using valeric anhydride. 100 mg (56% (64% × 87%), over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.88 (d, <i>J</i> = 2.1 Hz, 1H, H-3), 4.44 (dd, <i>J</i> = 8.8, 2.1 Hz, 1H, H-4), 4.15 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 3.99 (dd, <i>J</i> = 10.8, 8.8 Hz, 1H, H-5), 3.89 (m, 1H, H-8), 3.81 (dd, <i>J</i> = 11.4, 2.9 Hz, 1H, H-9), 3.64 (dd, <i>J</i> = 11.4, 5.3 Hz, 1H, H-9′), 3.57 (d, <i>J</i> = 9.0 Hz, 1H, H-7), 2.29 (t, <i>J</i> = 7.6 Hz, 2H, α-CH<sub>2</sub>), 1.62 (m, 2H, β-CH<sub>2</sub>), 1.37 (dq, <i>J</i> = 14.8, 7.4 Hz, 2H, γ-CH<sub>2</sub>), 0.93 (t, <i>J</i> = 7.4 Hz, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 178.13 (N–C═O), 166.89 (C-1), 146.72 (C-2), 112.33 (C-3), 77.91 (C-6), 71.30 (C-7), 70.18 (C-4), 68.09 (C-8), 64.90 (C-9), 51.76 (C-5), 36.92 (C-α), 29.08 (C-β), 23.46 (C-γ), 14.21 (C-δ). HRMS (ESI) calcd for C<sub>14</sub>H<sub>22</sub>NO<sub>8</sub> [M – H]<sup>−</sup>, 332.1345; found 332.1348.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 5-Hexanamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>11d</b>)</h3><div class="NLM_p last">Compound <b>11d</b> was synthesized from compound <b>10</b> using hexanoic anhydride. 42 mg (60% (85% × 71%), over two steps). <sup>1</sup>H NMR (700 MHz, CD<sub>3</sub>OD) δ 5.95 (d, <i>J</i> = 2.3 Hz, 1H, H-3), 4.43 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H, H-4), 4.16 (dd, <i>J</i> = 10.8, 0.8 Hz, 1H, H-6), 3.99 (dd, <i>J</i> = 10.8, 8.7 Hz, 1H, H-5), 3.91 (brs, 1H, H-8), 3.83 (dd, <i>J</i> = 11.4, 2.9 Hz, 1H, H-9), 3.63 (dd, <i>J</i> = 11.4, 5.5 Hz, 1H, H-9′), 3.56 (dd, <i>J</i> = 9.3, 0.7 Hz, 1H, H-7), 2.29 (t, <i>J</i> = 7.5 Hz, 2H, α-CH<sub>2</sub>), 1.69–1.62 (m, 2H, β-CH<sub>2</sub>), 1.35 (m, 2 × 2H, γ-CH<sub>2</sub>, δ-CH<sub>2</sub>), 0.93 (t, J = 7.0 Hz, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (176 MHz, CD<sub>3</sub>OD) δ 178.20 (N–C═O), 113.34 (C-3), 78.14 (C-6), 71.06 (C-7), 70.27 (C-4), 67.95 (C-8), 65.03 (C-9), 51.81(C-5), 37.06 (C-α), 32.56 (C-β), 26.59 (C-γ), 23.44 (C-δ), 14.27 (C-ε). HRMS (ESI) calcd for C<sub>15</sub>H<sub>25</sub>NO<sub>8</sub> [M – H]<sup>−</sup>, 346.1507; found 346.1506.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 5-Heptanamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>11e</b>)</h3><div class="NLM_p last">Compound <b>11e</b> was synthesized from compound <b>10</b> using heptanoyl chloride. 28 mg (46% (65% × 70%), over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.93 (d, <i>J</i> = 2.1 Hz, 1H, H-3), 4.40 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H, H-4), 4.13 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 3.98 (dd, <i>J</i> = 10.8, 8.7 Hz, 1H, H-5), 3.89 (brs, 1H, H-8), 3.81 (dd, <i>J</i> = 11.4, 2.7 Hz, 1H, H-9), 3.61 (dd, <i>J</i> = 11.4, 5.5 Hz, 1H, H-9′), 3.53 (d, <i>J</i> = 8.8 Hz, 1H, H-7), 2.27 (t, <i>J</i> = 7.5 Hz, 2H, α-CH<sub>2</sub>), 1.69–1.55 (m, 2H, β-CH<sub>2</sub>), 1.42–1.16 (m, 3 × 2H, γ-CH<sub>2</sub>, δ-CH<sub>2</sub>, ε-CH<sub>2</sub>), 0.89 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 178.23 (N–C═O), 113.38 (C-3), 78.18 (C-6), 71.07 (C-7), 70.32 (C-4), 67.98 (C-8), 65.06 (C-9), 51.84 (C-5), 37.12 (C-α), 32.72 (C-β), 30.06 (C-γ), 26.89 (C-δ), 23.58 (C-ε), 14.40 (C-ζ). HRMS (ESI) calcd for C<sub>16</sub>H<sub>26</sub>NO<sub>8</sub> [M – H]<sup>−</sup>, 360.1664; found 360.1665.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 5-Isobutyramido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>11f</b>)</h3><div class="NLM_p last">Compound <b>11f</b> was synthesized from compound <b>10</b> using isobutyryl chloride. 25 mg (38% (54% × 70%), over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.93 (d, <i>J</i> = 2.5 Hz, 1H, H-3), 4.43 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H, H-4), 4.15 (dd, <i>J</i> = 10.8, 1.1 Hz, 1H, H-6), 3.95 (dd, <i>J</i> = 10.8, 8.7 Hz, 1H, H-5), 3.88 (s, 1H, H-8), 3.80 (dd, <i>J</i> = 11.4, 2.9 Hz, 1H, H-9), 3.62 (dd, <i>J</i> = 11.4, 5.4 Hz, 1H, H-9′), 3.52 (dd, <i>J</i> = 9.2, 1.1 Hz, 1H, H-7), 2.57–2.46 (m, 1H, α-CH), 1.14 (dd, <i>J</i> = 6.9, 2.4 Hz, 6H, 2 × β-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 182.10 (N–C═O), 165.49 (C-1), 113.48 (C-3), 78.20 (C-6), 71.05 (C-7), 70.21 (C-4), 67.89 (C-8), 64.98 (C-9), 51.68 (C-5), 36.41 (C-α), 20.10, 19.70 (2 × C-β). HRMS (ESI) calcd for C<sub>13</sub>H<sub>21</sub>NO<sub>8</sub> [M – H]<sup>−</sup>, 318.1194; found 318.1193.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 5-(3-Methylbutanamido)-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>11g</b>)</h3><div class="NLM_p last">Compound <b>11g</b> was synthesized from compound <b>10</b> using isovaleryl chloride. 30 mg (43% (62% × 69%), over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.93 (d, <i>J</i> = 2.5 Hz, 1H, H-3), 4.40 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H, H-4), 4.14 (dd, <i>J</i> = 10.8, 1.1 Hz, 1H, H-6), 3.98 (dd, <i>J</i> = 10.8, 8.7 Hz, 1H, H-5), 3.89 (s, 1H, H-8), 3.80 (dd, <i>J</i> = 11.4, 2.9 Hz, 1H, H-9), 3.61 (dd, <i>J</i> = 11.4, 5.5 Hz, 1H, H-9′), 3.57 (dd, <i>J</i> = 9.3, 1.1 Hz, 1H, H-7), 2.17–2.04 (m, 3H, α-CH<sub>2</sub>, β-CH<sub>2</sub>), 0.96 (dd, <i>J</i> = 6.5, 3.8 Hz, 6H, 2 × γ-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 177.53 (N–C═O), 113.50 (C-3), 78.18 (C-6), 71.05 (C-7), 70.34 (C-4), 67.95 (C-8), 65.04 (C-9), 51.87 (C-5), 46.33 (C-α), 27.43 (C-β), 22.89, 22.83 (2 × C-γ). HRMS (ESI) calcd for C<sub>14</sub>H<sub>22</sub>NO<sub>8</sub> [M – H]<sup>−</sup>, 332.1351; found 332.1348.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 5-(4-Methylpentanamido)-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>11h</b>)</h3><div class="NLM_p last">Compound <b>11h</b> was synthesized from compound <b>10</b> using 4-methylpentanoyl chloride. 30 mg (41% (56% × 74%), over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.93 (d, <i>J</i> = 2.3 Hz, 1H, H-3), 4.42 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H, H-4), 4.14 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 3.96 (dd, <i>J</i> = 10.8, 8.8 Hz, 1H, H-5), 3.89 (s, 1H, H-8), 3.81 (dd, <i>J</i> = 11.4, 2.8 Hz, 1H, H-9), 3.62 (dd, <i>J</i> = 11.4, 5.4 Hz, 1H, H-9′), 3.54 (d, <i>J</i> = 8.7 Hz, 1H, H-7), 2.32–2.25 (m, 2H, α-CH<sub>2</sub>), 1.62–1.47 (m, 3H, β-CH<sub>2</sub>, γ-CH), 0.91 (dd, <i>J</i> = 6.4, 1.1 Hz, 6H, 2 × δ-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 178.46 (N–C═O), 113.46 (C-3), 78.14 (C-6), 71.07 (C-7), 70.22 (C-4), 67.97 (C-8), 64.99 (C-9), 51.81 (C-5), 35.86 (C-α), 35.19 (C-β), 29.00 (C-γ), 22.75, 22.67 (2 × C-δ). HRMS (ESI) calcd for C<sub>15</sub>H<sub>24</sub>NO<sub>8</sub> [M – H]<sup>−</sup>, 346.1507; found 346.1496.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5-Cyclopropanecarboxamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>11i</b>)</h3><div class="NLM_p last">Compound <b>11i</b> was synthesized from compound <b>10</b> using cyclopropanecarbonyl chloride. 30 mg (13% (17% × 77%), over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.26 (d, <i>J</i> = 8.4 Hz, 1H, NH), 5.88 (d, <i>J</i> = 1.5 Hz, 1H, H-3), 4.47 (d, <i>J</i> = 8.7 Hz, 1H, H-4), 4.16 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 4.01 (m, 1H, H-5), 3.93–3.85 (m, 1H, H-8), 3.80 (dd, <i>J</i> = 11.4, 2.6 Hz, 1H, H-9), 3.69–3.62 (m, 1H, H-9), 3.56 (d, <i>J</i> = 9.0 Hz, 1H, H-7), 1.69–1.66 (m, 1H, CH), 0.92–0.88 (m, 2H, CH<sub>2</sub>), 0.81–0.78 (m, 2H, CH<sub>2</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 178.35 (N–C═O), 166.87 (C-1), 112.31 (C-3), 78.06 (C-6), 71.28 (C-7), 70.10 (C-4), 68.19 (C-8), 64.84 (C-9), 51.96 (C-5), 15.10 (C-α), 8.10 (C-β), 7.75 (C-β′). HRMS (ESI) calcd for C<sub>13</sub>H<sub>18</sub>NO<sub>8</sub> [M – H]<sup>−</sup>, 316.1032; found 316.1030.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5-Cyclobutanecarboxamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>11j</b>)</h3><div class="NLM_p last">Compound <b>11j</b> was synthesized from compound <b>10</b> using cyclobutanecarbonyl chloride. 35 mg (16% (18% × 88%), over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.89 (d, <i>J</i> = 1.7 Hz, 1H, H-3), 4.44 (dd, <i>J</i> = 8.9, 1.7 Hz, 1H, H-4), 4.15 (d, <i>J</i> = 10.6 Hz, 1H, H-6), 3.99 (dd, <i>J</i> = 10.6, 8.9 Hz, 1H, H-5), 3.88 (m, 1H, H-8), 3.80 (dd, <i>J</i> = 11.4, 2.7 Hz, 1H, H-9), 3.65 (dd, <i>J</i> = 11.4, 5.2 Hz, 1H, H-9′), 3.53 (d, <i>J</i> = 9.0 Hz, 1H, H-7), 3.19 (p, <i>J</i> = 8.5 Hz, 1H, CH), 2.30–2.22 (m, 2H, CH<sub>2</sub>), 2.20–2.10 (m, 2H, CH<sub>2</sub>), 1.89–1.82 (m, 2H, CH<sub>2</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 179.57 (N–C═O), 166.68 (C-1), 112.52 (C-3), 77.96 (C-6), 71.26 (C-7), 70.10 (C-4), 68.04 (C-8), 64.87 (C-9), 51.69 (C-5), 40.83 (C-α), 26.42 (C-β), 26.09 (C-β′), 19.08 (C-γ). HRMS (ESI) calcd for C<sub>14</sub>H<sub>20</sub>NO<sub>8</sub> [M – H]<sup>−</sup>, 330.1189; found 330.1195.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5-Benzamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>11k</b>)</h3><div class="NLM_p last">Compound <b>11k</b> was synthesized from compound <b>10</b> using benzyl chloride. 21 mg (28% (44% × 64%), two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.88 (dd, <i>J</i> = 8.3, 1.2 Hz, 2H, Ar–H), 7.57–7.50 (m, 1H, Ar–H), 7.49–7.41 (m, 2H, Ar–H), 5.98 (d, <i>J</i> = 2.3 Hz, 1H, H-3), 4.64 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H, H-4), 4.32 (d, <i>J</i> = 11.0 Hz, 1H, H-6), 4.24 (dd, <i>J</i> = 11.0, 8.7 Hz, 1H, H-5), 3.92 (s, 1H, H-8), 3.80 (dd, <i>J</i> = 11.5, 2.8 Hz, 1H, H-9), 3.68–3.59 (m, 2H, H-9′, H-7). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 171.74 (N–C═O), 135.08, 133.05, 129.55, 128.67 (Ar–C), 113.62 (C-3), 78.17 (C-6), 71.16 (C-7), 70.17 (C-4), 68.06 (C-8), 64.86 (C-9), 52.47 (C-5). HRMS (ESI) calcd for C<sub>16</sub>H<sub>18</sub>NO<sub>8</sub> [M – H]<sup>−</sup>, 352.1038; found 352.1035.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5-(5-Amino)pentanamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>11l</b>)</h3><div class="NLM_p last">Compound <b>11l</b> was synthesized from compound <b>10</b> using 5-((<i>tert</i>-butoxycarbonyl)amino)pentanoic anhydride. 20 mg (20% (87% × 23% yield for two deprotection steps), over three steps). <sup>1</sup>H NMR (700 MHz, D<sub>2</sub>O) δ 5.71 (d, <i>J</i> = 2.2 Hz, 1H, H-3), 4.49 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H, H-4), 4.25 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 4.09 (dd, <i>J</i> = 10.8, 8.8 Hz, 1H, H-5), 3.99–3.93 (m, 1H, H-8), 3.89 (dd, <i>J</i> = 12.0, 2.6 Hz, 1H, H-9), 3.68 (dd, <i>J</i> = 12.0, 5.9 Hz, 1H, H-9′), 3.61 (d, <i>J</i> = 9.4 Hz, 1H, H-7), 2.98 (t, <i>J</i> = 6.8 Hz, 2H, δ-CH<sub>2</sub>), 2.40 (t, <i>J</i> = 6.9 Hz, 2H, α-CH<sub>2</sub>), 1.73–1.67 (m, 4H, γ-CH<sub>2</sub>, β-CH<sub>2</sub>). <sup>13</sup>C NMR (126 MHz, D<sub>2</sub>O) δ 177.71 (C═O), 170.62 (C-1), 148.86 (C-2), 108.65 (C-3), 76.24 (C-6), 70.65 (C-8), 69.22 (C-7), 68.47 (C-4), 63.98 (C-9), 50.78 (C-5), 40.15 (δ-C), 36.15 (α-C), 27.49 (γ-C), 23.12 (β-C). HRMS (ESI) calcd for C<sub>12</sub>H<sub>23</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 347.1460; found 347.1458.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 5-(<i>N</i>-2-Azido)acetyl-4,7,8,9-tetra-O-acetyl-2,3,5-trideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galacto-2-nonulopyranosonate (<b>12</b>)</h3><div class="NLM_p last">Compound <b>12</b> was synthesized using <i>N</i>-hydroxysuccinimidyl-2-azidoacetate as reported.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> 600 mg (62%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.93 (t, <i>J</i> = 2.7 Hz, 1H, H-3), 5.59 (dd, <i>J</i> = 8.7, 2.7 Hz, 1H, H-4), 5.48 (dd, <i>J</i> = 6.5, 2.4 Hz, 1H, H-7), 5.34 (td, <i>J</i> = 6.2, 2.8 Hz, 1H, H-8), 4.55 (dd, <i>J</i> = 12.5, 2.8 Hz, 1H, H-9), 4.50 (dd, <i>J</i> = 10.5, 2.4 Hz, 1H, H-6), 4.29 (dd, <i>J</i> = 10.5, 8.7 Hz, 1H, H-5), 4.15 (dd, <i>J</i> = 12.5, 6.2 Hz, 1H, H-9′), 3.86–3.73 (m, 5H, N–CH<sub>2</sub>–CO, COOCH<sub>3</sub>), 2.09, 2.03, 2.01(3 × s, 12H, 4 × COOCH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 172.41, 172.24, 171.72, 171.45, 170.47 (C═O), 163.11 (C-1), 146.75 (C-2), 109.78 (C-3), 77.56 (C-6), 71.51 (C-8), 70.57 (C-7), 68.68 (C-4), 63.12 (C-9), 53.10, 53.07 (COO<i>C</i>H<sub>3</sub>, CH<sub>2</sub>N<sub>3</sub>), 47.84 (C-5), 20.91, 20.85, 20.82, 20.74 (CO<i>C</i>H<sub>3</sub>). HRMS (ESI) calcd for C<sub>20</sub>H<sub>26</sub>N<sub>4</sub>NaO<sub>12</sub> [M + Na]<sup>+</sup>, 537.1445; found 537.1436.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> General Procedure of Cuaac Reaction and Hydrolysis of Methyl Ester for Synthesis of Compounds <b>13a</b>–<b>h</b></h3><div class="NLM_p last">To a solution of methyl 5-acetamido-9-azido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonate (<b>12</b>)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (1 equiv) and the corresponding alkyne (1.5 equiv) in THF–H<sub>2</sub>O (2:1), sodium <span class="smallcaps smallerCapital">l</span>-ascorbate (0.5 equiv) and copper(II) sulfate (0.5 equiv) were added sequentially. The reaction mixture was kept stirring at room temperature and monitored by TLC until no azide remained. Silica gel was then added to the reaction mixture, and the solvent was removed under reduced pressure. The residue was separated by flash chromatography to provide the desired products with yields of 42–88%. To hydrolyze the C1-methyl ester, the product was dissolved in MeOH, and 0.5 M NaOH was added. The mixture was kept stirring at room temperature. After completion, the pH of the solution was adjusted to 2 with Amberlite IR 120 (H<sup>+</sup>). The solution was filtered and purified by flash chromatography to provide the desired products with yields of 45–88%.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 5-(2-(4-(4-(Dimethylamino)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl))acetamido-2,3,5-trideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galacto-2-nonulopyranosonic Acid (<b>13a</b>)</h3><div class="NLM_p last">Compound <b>13a</b> was synthesized from compound <b>12</b> using 4-dimethylaminophenylacetylene. 13 mg (20% (50% × 41%), two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.18 (s, 1H, triazole-H), 7.57 (d, <i>J</i> = 8.6 Hz, 2H, Ar–H), 6.81 (d, <i>J</i> = 8.5 Hz, 2H, Ar–H), 5.70 (d, <i>J</i> = 2.2 Hz, 1H, H-3), 5.28 (s, 2H, N–CH<sub>2</sub>–CO), 4.47 (dd, <i>J</i> = 8.7, 2.2 Hz, 1H, H-4), 4.25 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 4.09 (dd, <i>J</i> = 10.8, 8.7 Hz, 1H, H-5), 3.93–3.86 (m, 1H, H-8), 3.83 (dd, <i>J</i> = 11.6, 2.8 Hz, 1H, H-9), 3.66 (dd, <i>J</i> = 11.6, 5.7 Hz, 1H, H-9′), 3.60 (d, <i>J</i> = 9.3 Hz, 1H, H-7). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 169.93 (CH<sub>3</sub><i>C</i>O), 169.04 (C-1), 149.58, 122.78 (triazole-C), 148.93 (C-2), 127.94, 121.52, 117.07 (Ar–C), 108.57 (C-3), 76.73 (C-6), 71.42 (C-8), 70.02 (C-7), 68.81 (C-4), 64.87 (C-9), 53.35 (N–<i>C</i>H<sub>2</sub>–CO), 52.19 (C-5). HRMS (ESI) calcd for C<sub>19</sub>H<sub>22</sub>N<sub>5</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 448.1468; found 448.1481.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-(2-(4-(4-Acetamido)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl))acetamido-2,3,5-trideoxy- <span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galacto-2-nonulopyranosonic Acid (<b>13b</b>)</h3><div class="NLM_p last">Compound <b>13b</b> was synthesized from compound <b>12</b> using 4-acetamidophenylacetylene. 35 mg (46% (59% × 79%), two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.30 (s, 1H, triazole-H), 7.75 (d, <i>J</i> = 8.6 Hz, 2H, Ar–H), 7.62 (d, <i>J</i> = 8.6 Hz, 2H, Ar–H), 5.69 (d, <i>J</i> = 2.2 Hz, 1H, H-3), 5.26 (s, 2H, N–CH<sub>2</sub>–CO), 4.43 (dd, <i>J</i> = 8.6, 2.2 Hz, 1H, H-4), 4.23 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 4.10 (dd, <i>J</i> = 10.8, 8.6 Hz, 1H, H-5), 3.90–3.84 (m, 1H, H-8), 3.81 (dd, <i>J</i> = 11.4, 2.9 Hz, 1H, H-9), 3.67 (dd, <i>J</i> = 11.4, 5.3 Hz, 1H, H-9′), 3.57 (d, <i>J</i> = 9.2 Hz, 1H, H-7), 2.13 (s, 3H, NAc).<sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 171.70 (CH<sub>3</sub><i>C</i>O), 169.98 (C-1), 168.75 (C═O), 150.14 (C-1), 148.58, 123.59 (triazole-C), 140.08, 127.37, 127.17, 121.36 (Ar–C), 108.11 (C-3), 76.80 (C-6), 71.44 (C-8), 70.17 (C-7), 68.78 (C-4), 64.92 (C-9), 53.30 (N–<i>C</i>H<sub>2</sub>–CO), 52.23 (C-5), 23.90 (CH<sub>3</sub>). HRMS (ESI) calcd for C<sub>21</sub>H<sub>25</sub>N<sub>5</sub>O<sub>9</sub> [M – H]<sup>−</sup>, 490.1574; found 490.1584.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 5-(2-(4-(4-Aminophenyl)-1<i>H</i>-1,2,3-triazol-1-yl)) acetamido-2,3,5-trideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galacto-2-nonulopyranosonic Acid (<b>13c</b>)</h3><div class="NLM_p last">Compound <b>13c</b> was synthesized from compound <b>12</b> using 4-aminophenylacetylene. 27 mg (31% (63% × 50%), two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.18 (s, 1H, triazole-H), 7.57 (d, <i>J</i> = 8.6 Hz, 2H, Ar–H), 6.81 (d, <i>J</i> = 8.5 Hz, 2H, Ar–H), 5.70 (d, <i>J</i> = 2.2 Hz, 1H, H-3), 5.28 (s, 2H, N–CH<sub>2</sub>–CO), 4.47 (dd, <i>J</i> = 8.7, 2.2 Hz, 1H, H-4), 4.25 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 4.09 (dd, <i>J</i> = 10.8, 8.7 Hz, 1H, H-5), 3.93–3.86 (m, 1H, H-8), 3.83 (dd, <i>J</i> = 11.6, 2.8 Hz, 1H, H-9), 3.66 (dd, <i>J</i> = 11.6, 5.7 Hz, 1H, H-9′), 3.60 (d, <i>J</i> = 9.3 Hz, 1H, H-7). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 169.93 (CH<sub>3</sub><i>C</i>O), 169.04 (C-1), 149.58, 122.78 (triazole-C), 148.93 (C-2), 127.94, 121.52, 117.07 (Ar–C), 108.57 (C-3), 76.73 (C-6), 71.42 (C-8), 70.02 (C-7), 68.81 (C-4), 64.87 (C-9), 53.35 (N–<i>C</i>H<sub>2</sub>–CO), 52.19 (C-5). HRMS (ESI) calcd for C<sub>19</sub>H<sub>22</sub>N<sub>5</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 448.1468; found 448.1481.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 5-(2-(4-(4-<i>p</i>-Tolyl)-1<i>H</i>-1,2,3-triazol-1-yl)) acetamido-2,3,5-trideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galacto-2-nonulopyranosonic Acid (<b>13d</b>)</h3><div class="NLM_p last">Compound <b>13d</b> was synthesized from compound <b>12</b> using 4-methylphenylacetylene. 35 mg (52% (74% × 70%), two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.31 (s, 1H, triazole-H), 7.70 (d, <i>J</i> = 8.1 Hz, 2H, Ar–H), 7.24 (d, <i>J</i> = 8.0 Hz, 2H), 5.87 (d, <i>J</i> = 2.2 Hz, 1H, H-3), 5.29 (s, 2H, N–CH<sub>2</sub>–CO), 4.49 (dd, <i>J</i> = 8.7, 2.2 Hz, 1H, H-4), 4.29 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 4.10 (dd, <i>J</i> = 10.7, 8.7 Hz, 1H, H-5), 3.91–3.84 (m, 1H, H-8), 3.81 (dd, <i>J</i> = 11.4, 2.9 Hz, 1H, H-9), 3.67 (dd, <i>J</i> = 11.4, 5.3 Hz, 1H, H-9′), 3.64 (d, <i>J</i> = 9.1 Hz, 1H, H-7), 2.35 (s, 3H, PhCH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD/DMSO-<i>d</i><sub>6</sub>) δ 168.97 (CH<sub>3</sub><i>C</i>O), 167.13 (C-1), 148.95, 123.68 (triazole-C), 146.97 (C-2), 139.45, 130.64, 128.89, 126.71 (Ar–C), 111.62 (C-3), 77.42 (C-6), 71.51 (C-8), 70.06 (C-7), 68.30 (C-4), 64.86 (C-9), 53.29 (N–<i>C</i>H<sub>2</sub>–CO), 52.18 (C-5), 21.37 (Ph<i>C</i>H<sub>3</sub>). HRMS (ESI) calcd for C<sub>20</sub>H<sub>23</sub>N<sub>4</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 447.1516; found 447.1520.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 5-(2-(4-(4-Methoxyphenyl)-1<i>H</i>-1,2,3-triazol-1-yl))acetamido-2,3,5-trideoxy- <span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galacto-2-nonulopyranosonic Acid (<b>13e</b>)</h3><div class="NLM_p last">Compound <b>13e</b> was synthesized from compound <b>12</b> using 4-methoxylphenylacetylene. 40 mg (51% (82% × 62%), two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.27 (s, 1H, triazole-H), 7.74 (d, <i>J</i> = 8.7 Hz, 2H, Ar–H), 7.01 (d, <i>J</i> = 8.7 Hz, 2H, Ar–H), 5.89 (d, <i>J</i> = 1.8 Hz, 1H, H-3), 5.31 (s, 2H, N–CH<sub>2</sub>–CO), 4.56–4.45 (m, 1H, H-4), 4.33 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 4.11 (dd, <i>J</i> = 10.5, 8.9 Hz, 1H, H-5), 3.92–3.86 (m, 1H, H-8), 3.85–3.83 (m, 4H, H-9, OCH<sub>3</sub>), 3.70–3.63 (m, 2H, H-7, H-9′). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD/DMSO-<i>d</i><sub>6</sub>) δ 169.15 (CH<sub>3</sub><i>C</i>O), 167.27 (C-1), 148.92, 123.53 (triazole-C), 146.62 (C-2), 161.19, 128.28, 124.06 115.61 (Ar–C), 112.08 (C-3), 77.26 (C-6), 71.38 (C-8), 69.81 (C-7), 68.41 (C-4), 64.77 (C-9), 56.20 (PhO<i>C</i>H<sub>3</sub>), 53.38 (N–<i>C</i>H<sub>2</sub>–CO), 52.02 (C-5). HRMS (ESI) calcd for C<sub>20</sub>H<sub>23</sub>N<sub>4</sub>O<sub>9</sub> [M – H]<sup>−</sup>, 463.1465; found 463.1471</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 5-(2-(4-(4-Fluorophenyl)-1<i>H</i>-1,2,3-triazol-1-yl))acetamido-2,3,5-trideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galacto-2-nonulopyranosonic Acid (<b>13f</b>)</h3><div class="NLM_p last">Compound <b>13f</b> was synthesized from compound <b>12</b> using 4-fluorophenylacetylene. 25 mg (46% (79% × 59%), two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.33 (s, 1H, triazole-H), 7.81 (dd, <i>J</i> = 8.6, 5.4 Hz, 2H, Ar–H), 7.14 (t, <i>J</i> = 8.7 Hz, 2H, Ar–H), 5.80 (s, 1H, H-3), 5.29 (s, 2H, N–CH<sub>2</sub>–CO), 4.48 (d, <i>J</i> = 8.2 Hz, 1H, H-4), 4.27 (d, <i>J</i> = 10.7 Hz, 1H, H-6), 4.14–4.07 (m, 1H, H-5), 3.88 (m, 1H, H-8), 3.81 (d, <i>J</i> = 11.0 Hz, 1H, H-9), 3.73–3.60 (m, 2H, H-9′, H-7). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 168.94 (CH<sub>3</sub><i>C</i>O), 168.64 (C-1), 165.11, 163.15 (d, <i>J</i> = 246.3 Hz), 148.28 (C-2), 147.97, 123.91 (triazole-C), 128.70 (d, <i>J</i> = 8.2 Hz, Ar–C), 128.11 (d, <i>J</i> = 3.2 Hz, Ar–C), 116.78 (d, <i>J</i> = 22.0 Hz, Ar–C), 110.10 (C-3), 77.12 (C-6), 71.64 (C-8), 69.99 (C-7), 68.50 (C-4), 64.75 (C-9), 53.32 (N–<i>C</i>H<sub>2</sub>–CO), 52.18 (C-5). HRMS (ESI) calcd for C<sub>19</sub>H<sub>20</sub>N<sub>4</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 451.1265; found 451.1271.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 5-(2-(4-(4-(Trifluoromethyl)phenyl)-1<i>H</i>-1,2,3-triazol-1-yl))acetamido-2,3,5-trideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galacto-2-nonulopyranosonic Acid (<b>13g</b>)</h3><div class="NLM_p last">Compound <b>13g</b> was synthesized from compound <b>12</b> using 4-trifluoromethylphenylacetylene. 25 mg (32% (78% × 41%), two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.47 (s, 1H, triazole-H), 7.97 (d, <i>J</i> = 8.1 Hz, 2H, Ar–H), 7.68 (d, <i>J</i> = 8.3 Hz, 2H, Ar–H), 5.76 (s, 1H, H-3), 5.32 (s, 2H, N–CH<sub>2</sub>–CO), 4.47 (dd, <i>J</i> = 8.6, 1.5 Hz, 1H, H-4), 4.27 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 4.12 (dd, <i>J</i> = 10.8, 8.6 Hz, 1H, H-5), 3.89 (br, 1H, H-8), 3.84–3.76 (m, 1H, H-9), 3.69 (dd, <i>J</i> = 11.4, 5.1 Hz, 1H, H-9′), 3.64 (d, <i>J</i> = 8.9 Hz, 1H, H-7). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 168.79 (CH<sub>3</sub><i>C</i>O), 147.36, 125.07 (triazole-C), 135.56 (Ar–C), 130.94 (q, <i>J</i> = 32.3 Hz, Ar–C), 127.05 (Ar–C), 127.87 (q, <i>J</i> = 3.7 Hz, Ar–C), 109.19 (C-3), 76.99 (C-6), 71.60 (C-8), 70.06 (C-7), 68.68 (C-4), 64.80 (9), 53.36 (N–<i>C</i>H<sub>2</sub>–CO), 52.24 (C-5). HRMS (ESI) calcd for C<sub>20</sub>H<sub>20</sub>F<sub>3</sub>N<sub>4</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 501.1233; found 501.1243.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 5-(2-(4-(4-Carboxyphenyl)-1<i>H</i>-1,2,3-triazol-1-yl)) acetamido-2,3,5-trideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span> -galacto-2-nonulopyranosonic Acid (<b>13h</b>)</h3><div class="NLM_p last">Compound <b>13h</b> was synthesized from compound <b>12</b> using 4-carboxylphenylacetylene. 30 mg (52% (86% × 60%), two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.48 (s, 1H, triazole-H), 8.10–8.04 (m, 2H, Ar–H), 7.95–7.90 (m, 2H, Ar–H), 5.88 (d, <i>J</i> = 2.4 Hz, 1H, H-3), 5.32 (s, 2H, N–CH<sub>2</sub>–CO), 4.49 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H, H-4), 4.30 (dd, <i>J</i> = 10.8, 0.6 Hz, 1H, H-6), 4.11 (dd, <i>J</i> = 10.8, 8.7 Hz, 1H, H-5), 3.91–3.86 (m, 1H, H-8), 3.82 (dd, <i>J</i> = 11.4, 3.0 Hz, 1H, H-9), 3.68 (dd, <i>J</i> = 11.5, 5.4 Hz, 1H, H-9′), 3.64 (dd, <i>J</i> = 9.2, 0.6 Hz, 1H, H-7). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD/DMSO-<i>d<sub>6</sub></i>) δ 169.44, 168.85 (C═O), 167.00 (C-1), 147.83, 125.04 (triazole-C), 146.85 (C-2), 136.10, 131.60, 131.48, 126.53 (Ar–C), 111.73 (C-3), 77.44 (C-6), 71.45 (C-8), 70.09 (C-7), 68.32 (C-4), 64.88 (C-9), 53.32 (N–<i>C</i>H<sub>2</sub>–CO), 52.21 (C-5). HRMS (ESI) calcd for C<sub>20</sub>H<sub>21</sub>N<sub>4</sub>O<sub>10</sub> [M – H]<sup>−</sup>, 477.1258; found 477.1268.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 5-(2-(4-Pentyl-1<i>H</i>-1,2,3-triazol-1-yl))acetamido-2,3,5-trideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galacto-2-nonulopyranosonic Acid (<b>13i</b>)</h3><div class="NLM_p last">Compound <b>13i</b> was synthesized from compound <b>12</b> using 1-heptyne. 33 mg (52% (85% × 61%), two steps). <sup>1</sup>H NMR (700 MHz, CD<sub>3</sub>OD) δ 7.84 (s, 1H, triazole-H5), 5.96 (d, <i>J</i> = 2.2 Hz, 1H, H-3), 5.21 (s, 2H, N–CH<sub>2</sub>–CO), 4.47 (dd, <i>J</i> = 8.7, 2.2 Hz, 1H, H-4), 4.30 (d, <i>J</i> = 10.7 Hz, 1H, H-6), 4.08 (dd, <i>J</i> = 10.5, 8.7 Hz, 1H, H-5), 3.91–3.86 (m, 1H, H-8), 3.82 (dd, <i>J</i> = 11.4, 2.7 Hz, 1H, H-9), 3.66 (dd, <i>J</i> = 11.4, 5.4 Hz, 1H, H-9′), 3.61 (d, <i>J</i> = 9.3 Hz, 1H, H-7), 2.76–2.68 (m, 2H, α-CH<sub>2</sub>), 1.73–1.66 (m, 2H, β-CH<sub>2</sub>), 1.37 (dd, <i>J</i> = 7.0, 3.6 Hz, 4H, γ-CH<sub>2</sub>, δ-CH<sub>2</sub>), 0.92 (t, <i>J</i> = 6.9 Hz, 3H, ε-CH<sub>3</sub>). <sup>13</sup>C NMR (176 MHz, CD<sub>3</sub>OD) δ 168.93 (CH<sub>3</sub><i>C</i>O), 165.52 (C-1), 145.41(triazole-C4), 125.30 (triazole-C5), 113.18 (C-3), 77.68 (C-6), 71.26 (C-7), 70.07 (C-4), 68.07 (C-8), 64.89 (C-9), 53.17 (N–<i>C</i>H<sub>2</sub>–CO), 52.12 (C-5), 32.44 (C-α), 30.09 (C-β), 26.15 (C-γ), 23.41(C-δ), 14.30 (C-ε). HRMS (ESI) calcd for C<sub>18</sub>H<sub>27</sub>N<sub>4</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 427.1834; found 427.1837.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> General Procedure of Staudinger Reaction for Synthesis of Compounds of <b>15a</b>–<b>l</b></h3><div class="NLM_p last">The C9-azido DANA methyl ester (<b>14</b>) was dissolved in THF–H<sub>2</sub>O and cooled to 0 °C with an ice water bath. Triphenylphosphine was then added followed by anhydride or acyl chloride. The solution was allowed to warm to room temperature and kept stirring overnight. After completion, the reaction was quenched with water, concentrated, and purified by flash chromatography to give the desired product. The product was then dissolved in MeOH, and 0.5 M NaOH was added. The mixture was kept stirring at room temperature. After completion, the mixture was neutralized with Amberlite IR 120 (H<sup>+</sup>), filtered, and purified by flash chromatography to provide the desired products.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 5-Acetamido-9-butyramido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>15a</b>)</h3><div class="NLM_p last">Compound <b>15a</b> was synthesized from compound <b>14</b> using butyryl anhydride (60% (68% × 89%), over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.93 (d, <i>J</i> = 2.5 Hz, 1H, H-3), 4.41 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H, H-4), 4.20–4.15 (m, 1H, H-6), 3.96 (dd, <i>J</i> = 10.7, 8.7 Hz, 1H, H-5), 3.94–3.88 (m, 1H, H-8), 3.57 (dd, <i>J</i> = 14.0, 3.3 Hz, 1H, H-9), 3.41 (dd, <i>J</i> = 9.1, 1.1 Hz, 1H, H-7), 2.22–2.15 (m, 2H, α-CH<sub>2</sub>), 2.00 (d, <i>J</i> = 9.2 Hz, 3H, COCH<sub>3</sub>), 1.62 (dd, <i>J</i> = 14.8, 7.4 Hz, 2H, β-CH<sub>2</sub>), 0.93 (t, <i>J</i> = 7.4 Hz, 3H, γ-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 177.13, 174.87 (C═O), 165.51 (C-1), 113.36 (C-3), 77.83 (C-6), 71.49 (C-7), 70.17 (C-4), 67.96 (C-8), 52.01 (C-5), 44.40 (C-9), 38.97 (C-α), 22.73 (CO<i>C</i>H<sub>3</sub>), 20.45 (C-β), 14.05 (C-γ). HRMS (ESI) calcd for C<sub>16</sub>H<sub>25</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 359.1460; found 359.1453.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 5-Acetamido-9-hexanamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>15b</b>)</h3><div class="NLM_p last">Compound <b>15b</b> was synthesized from compound <b>14</b> using hexanoic anhydride. 66 mg (58% (79% × 72%), over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.92 (d, <i>J</i> = 2.5 Hz, 1H, H-3), 4.42 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H, H-4), 4.17 (dd, <i>J</i> = 10.7, 1.0 Hz, 1H, H-6), 3.97 (dd, <i>J</i> = 10.7, 8.7 Hz, 1H, H-5), 3.94–3.88 (m, 1H, H-8), 3.59 (dd, <i>J</i> = 13.9, 3.3 Hz, 1H, H-9), 3.42 (dd, <i>J</i> = 9.0, 1.0 Hz, 1H, H-7), 3.31–3.27 (m, 1H, H-9′), 2.23–2.16 (m, 2H, α-CH<sub>2</sub>), 2.01 (s, 3H, COCH<sub>3</sub>), 1.59 (dt, <i>J</i> = 15.0, 7.6 Hz, 2H, β-CH<sub>2</sub>), 1.39–1.25 (m, 4H, γ-CH<sub>2</sub>, δ-CH<sub>2</sub>), 0.89 (t, <i>J</i> = 7.1 Hz, 3H, ε-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 177.25, 174.87 (C═O), 165.63 (C-1), 113.30 (C-3), 77.82 (C-6), 71.55 (C-7), 70.24 (C-4), 67.98 (C-8), 51.97 (C-5), 44.41 (C-9), 37.09 (C-α), 32.58 (C-β), 26.81 (C-γ), 23.45 (C-δ), 22.81 (CO<i>C</i>H<sub>3</sub>), 14.32 (C-ε). HRMS (ESI) calcd for C<sub>17</sub>H<sub>27</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 387.1773; found 387.1766.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 5-Acetamido-9-heptanamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>15c</b>)</h3><div class="NLM_p last">Compound <b>15c</b> was synthesized from compound <b>14</b> using heptanoyl chloride. 18 mg (45% (74% × 61%), over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.77 (d, <i>J</i> = 2.3 Hz, 1H, H-3), 4.37 (dd, <i>J</i> = 8.6, 2.3 Hz, 1H, H-4), 4.16–4.08 (m, 1H, H-6), 3.97 (dd, <i>J</i> = 10.7, 8.7 Hz, 1H, H-5), 3.89 (ddd, <i>J</i> = 8.7, 7.1, 3.4 Hz, 1H, H-8), 3.58 (dd, <i>J</i> = 13.8, 3.4 Hz, 1H, H-9), 3.40 (d, <i>J</i> = 8.7 Hz, 1H, H-7), 3.28–3.23 (m, 1H, H-9′), 2.26–2.13 (m, 2H, α-CH<sub>2</sub>), 2.01 (s, 3H, COCH<sub>3</sub>), 1.64–1.52 (m, 2H, β-CH<sub>2</sub>), 1.37–1.23 (m, 6H, γ-CH<sub>2</sub>, δ-CH<sub>2</sub>, ε-CH<sub>3</sub>), 0.88 (dd, <i>J</i> = 8.8, 5.1 Hz, 3H, ζ-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 177.04, 174.70 (N–C═O), 110.32 (C-3), 77.35 (C-6), 71.50 (C-7), 70.44 (C-4), 68.36 (C-8), 51.99 (C-5), 44.23 (C-9), 37.15 (C-α), 32.73 (C-β), 30.07 (C-γ), 27.10(C-δ), 23.58 (C-ε), 22.80 (C-ζ), 14.39 (CO<i>C</i>H<sub>3</sub>). HRMS (ESI) calcd for C<sub>18</sub>H<sub>29</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 401.1929; found 401.1931.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 5-Acetamido-9-isobutyramido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>15d</b>)</h3><div class="NLM_p last">Compound <b>15d</b> was synthesized from compound <b>14</b> using isobutyryl chloride. 15 mg (21% (40% × 52%), over two steps). <sup>1</sup>H NMR (700 MHz, CD<sub>3</sub>OD) δ 5.74 (d, <i>J</i> = 2.3 Hz, 1H, H-3), 4.37 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H, H-4), 4.14 (dd, <i>J</i> = 10.8, 1.0 Hz, 1H, H-6), 3.99 (dd, <i>J</i> = 10.8, 8.7 Hz, 1H, H-5), 3.91 (ddd, <i>J</i> = 9.1, 6.9, 3.4 Hz, 1H, H-8), 3.58 (dd, <i>J</i> = 13.8, 3.4 Hz, 1H, H-9), 3.40 (dd, <i>J</i> = 9.1, 1.0 Hz, 1H, H-7), 3.33 (dd, <i>J</i> = 13.8, 6.9 Hz, 1H, H-9′), 2.49 (dt, <i>J</i> = 13.8, 6.9 Hz, 1H, α-CH<sub>2</sub>), 2.02 (s, 3H, COCH<sub>3</sub>), 1.12 (dd, <i>J</i> = 6.9, 0.5 Hz, 6H, 2 × β-CH<sub>3</sub>). <sup>13</sup>C NMR (176 MHz, CD<sub>3</sub>OD) δ 180.76, 174.56 (N–C═O), 109.51 (C-3), 77.30 (C-6), 71.67 (C-7), 70.20 (C-4), 68.50 (C-8), 52.07 (C-5), 44.23 (C-9), 36.28 (C-α), 22.73, 19.96, 19.90 (2 × C-β, CO<i>C</i>H<sub>3</sub>). HRMS (ESI) calcd for C<sub>15</sub>H<sub>23</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 359.1460; found 359.1458.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5-Acetamido-9-(3-methylbutanamido)-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>15e</b>)</h3><div class="NLM_p last">Compound <b>15e</b> was synthesized from compound <b>14</b> using 3-methylbutanoyl chloride. 18 mg (24% (44% × 55%), over two steps). <sup>1</sup>H NMR (700 MHz, CD<sub>3</sub>OD) δ 5.74 (d, <i>J</i> = 2.3 Hz, 1H, H-3), 4.37 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H, H-4), 4.13 (dd, <i>J</i> = 10.8, 1.0 Hz, 1H, H-6), 3.99 (dd, <i>J</i> = 10.8, 8.7 Hz, 1H, H-5), 3.91 (ddd, <i>J</i> = 9.0, 6.9, 3.4 Hz, 1H, H-8), 3.60 (dd, <i>J</i> = 13.8, 3.4 Hz, 1H, H-9), 3.43–3.39 (dd, <i>J</i> = 13.8, 6.9 Hz, 1H, H-9′), 3.33 (m, 1H, H-7), 2.10–2.09 (m, 2H, α-CH<sub>2</sub>), 2.08–2.03 (m, 1H, β-CH), 2.02 (s, 3H, COCH<sub>3</sub>), 0.96 (dd, <i>J</i> = 6.4, 1.6 Hz, 6H, 2 × γ-CH<sub>3</sub>). <sup>13</sup>C NMR (176 MHz, CD<sub>3</sub>OD) δ 176.27, 174.60 (N–C═O), 109.43 (C-3), 77.30 (C-6), 71.71 (C-7), 70.26 (C-4), 68.51 (C-8), 52.08 (C-5), 46.32 (C-9), 44.18 (C-α), 27.42 (C-β), 22.77, 22.75, 22.74 (2 × C-γ, CO<i>C</i>H<sub>3</sub>). HRMS (ESI) calcd for C<sub>16</sub>H<sub>25</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 373.1616; found 373.1617.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 5-Acetamido-9-(4-methylpentanamido)-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>15f</b>)</h3><div class="NLM_p last">Compound <b>15f</b> was synthesized from compound <b>14</b> using 4-methylpentanoyl chloride. 18 mg (23% (38% × 61%), over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.69 (d, <i>J</i> = 2.3 Hz, 1H, H-3), 4.36 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H, H-4), 4.10 (dd, <i>J</i> = 10.8, 0.8 Hz, 1H, H-6), 3.97 (dd, <i>J</i> = 10.8, 8.7 Hz, 1H, H-5), 3.92–3.85 (m, 1H, H-8), 3.58 (dd, <i>J</i> = 13.8, 3.3 Hz, 1H, H-9), 3.38 (dd, <i>J</i> = 8.9, 0.8 Hz, 1H, H-7), 3.28–3.21 (m, 1H, H-9′), 2.25–2.18 (m, 2H, α-CH<sub>2</sub>), 2.01 (s, 3H, COCH<sub>3</sub>), 1.60–1.44 (m, 3H, β-CH<sub>2</sub>, γ-CH), 0.90 (d, <i>J</i> = 6.5 Hz, 6H, 2 × δ-CH<sub>3</sub>). 13C NMR (126 MHz, CD<sub>3</sub>OD) δ 177.19, 174.68 (N–C═O), 108.93 (C-3), 77.12 (C-6), 71.55 (C-7), 70.35 (C-4), 68.59 (C-8), 52.00 (C-5), 44.22 (C-9), 36.12 (C-α), 35.23 (C-β), 29.04 (C-γ), 22.86, 22.74 (2 × C-δ, CO<i>C</i>H<sub>3</sub>). HRMS (ESI) calcd for C<sub>17</sub>H<sub>27</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 387.1773; found 387.1765.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 5-Acetamido-9-benzamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>15g</b>)</h3><div class="NLM_p last">Compound <b>15g</b> was synthesized from compound <b>14</b> using benzyl chloride. 20 mg (25% (37% × 68%), over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.85–7.79 (m, 2H, Ar–H), 7.54–7.48 (m, 1H, Ar–H), 7.43 (dd, <i>J</i> = 10.3, 4.7 Hz, 2H, Ar–H), 5.84 (d, <i>J</i> = 2.3 Hz, 1H, H-3), 4.40 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H, H-4), 4.18 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 4.07–3.96 (m, 2H, H-8, H-5), 3.77 (dd, <i>J</i> = 13.8, 3.4 Hz, 1H, H-9), 3.55 (dd, <i>J</i> = 13.8, 6.8 Hz, 1H, H-9′), 3.48 (d, <i>J</i> = 8.9 Hz, 1H, H-7), 1.96 (s, 3H, COCH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 174.79, 170.91 (2 × N–C═O), 135.63, 132.71, 129.57, 128.36 (Ar–C), 111.64 (C-3), 77.53 (C-6), 71.60 (C-7), 70.35 (C-4), 68.20 (C-8), 51.92 (C-5), 45.02 (C-9), 22.74 (CO<i>C</i>H<sub>3</sub>). HRMS (ESI) calcd for C<sub>18</sub>H<sub>21</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 393.1303; found 393.1302.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 5-Acetamido-9-(4-acetamido)benzamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>15h</b>)</h3><div class="NLM_p last">Compound <b>15h</b> was synthesized from compound <b>14</b> using 4-acetamidobenzyl chloride. 45 mg (28% (36% × 77%), over two steps). <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O) δ 7.80 (d, <i>J</i> = 8.2 Hz, 2H, Ar–H), 7.58 (d, <i>J</i> = 8.2 Hz, 2H, Ar–H), 5.95 (s, 1H, H-3), 4.54 (d, <i>J</i> = 7.8 Hz, 1H, H-4), 4.33 (d, <i>J</i> = 10.9 Hz, 1H, H-6), 4.14 (t, <i>J</i> = 9.5 Hz, 2H, H-5, H-8), 3.86–3.80 (m, 1H, H-9), 3.68–3.58 (m, 2H, H-7, H-9′), 2.22 (s, 3H, COCH<sub>3</sub>), 2.07 (s, 3H, COCH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, D<sub>2</sub>O) δ 175.64, 173.90, 171.46 (3 × N–C═O), 168.07 (C-1), 141.49, 130.56, 129.13, 121.72 (Ar–C), 111.40 (C-3), 76.57 (C-6), 70.37 (C-7), 69.56 (C-4), 68.16 (C-8), 50.72 (C-5), 44.12 (C-9), 24.04, 23.02 (2 × CO<i>C</i>H<sub>3</sub>). HRMS (ESI) calcd for C<sub>18</sub>H<sub>21</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 450.1518; found 450.1525.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 5-Acetamido-9-(4-amino)benzamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>15i</b>)</h3><div class="NLM_p last">Compound <b>15i</b> was synthesized from compound <b>14</b> using <i>N</i>-hydroxysuccinimidyl-4-((<i>tert</i>-butoxycarbonyl)amino)benzoate. 30 mg (20% (45% × 45%, yields for two steps of deprotection), over three steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.91 (d, <i>J</i> = 7.3 Hz, 2H), 7.33 (d, <i>J</i> = 7.3 Hz, 2H), 5.94 (s, 1H, H-3), 4.46 (d, <i>J</i> = 8.0 Hz, 1H, H-4), 4.21 (d, <i>J</i> = 10.6 Hz, 1H, H-6), 4.08–3.96 (m, 2H, H-5, H-8), 3.77 (d, <i>J</i> = 12.9 Hz, 1H, H-9), 3.51 (m, 2H, H-9′, H-7), 1.97 (s, 3H, COCH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 165.66 (C-1), 145.21, 130.38, 122.41 (Ar–C), 113.68 (C-3), 77.75 (C-6), 71.40 (C-7), 70.28 (C-4), 67.93 (C-8), 51.73 (C-5), 45.05 (C-9), 22.92 (CO<i>C</i>H<sub>3</sub>). HRMS (ESI) calcd for C<sub>18</sub>H<sub>21</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 408.1412; found 408.1415.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 5-Acetamido-9-(3-acetamido)benzamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>15j</b>)</h3><div class="NLM_p last">Compound <b>15j</b> was synthesized from compound <b>14</b> using 3-acetamidobenzyl chloride. 40 mg (30% (36% × 82%), over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.97 (t, <i>J</i> = 1.5 Hz, 1H, Ar–H), 7.69 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H, Ar–H), 7.52 (d, <i>J</i> = 7.9 Hz, 1H, Ar–H), 7.37 (t, <i>J</i> = 7.9 Hz, 1H, Ar–H), 5.78 (d, <i>J</i> = 2.0 Hz, 1H, H-3), 4.38 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H, H-4), 4.16 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 4.00 (m, 2H, H-5, H-8), 3.76 (dd, <i>J</i> = 13.8, 3.3 Hz, 1H, H-9), 3.53 (dd, <i>J</i> = 13.8, 6.8 Hz, 1H, H-9′), 3.47 (d, <i>J</i> = 8.8 Hz, 1H, H-7), 2.12 (s, 3H, COCH<sub>3</sub>), 1.97 (s, 3H, COCH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 174.74, 171.81, 170.56 (3 × N–C═O), 140.21, 136.51, 130.03, 124.15, 123.74, 120.14 (Ar–C), 110.38 (C-3), 77.38 (C-6), 71.78 (C-7), 70.21 (C-4), 68.40 (C-8), 51.96 (C-5), 45.07 (C-9), 23.86, 22.77 (2 × CO<i>C</i>H<sub>3</sub>). HRMS (ESI) calcd for C<sub>18</sub>H<sub>21</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 450.1518; found 450.1515.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 5-Acetamido-9-(3-amino)benzamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>15k</b>)</h3><div class="NLM_p last">Compound <b>15k</b> was synthesized from compound <b>14</b> using 3-amidobenzyl chloride. 30 mg (18% (46% × 40%, over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.94 (d, <i>J</i> = 7.8 Hz, 1H, Ar–H), 7.89 (s, 1H, Ar–H), 7.63 (t, <i>J</i> = 7.8 Hz, 1H, Ar–H), 7.60–7.56 (m, 1H, Ar–H), 5.95 (d, <i>J</i> = 2.4 Hz, 1H, H-3), 4.45 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H, H-4), 4.21 (d, <i>J</i> = 10.9 Hz, 1H, H-6), 4.08–3.97 (m, 2H, H-5, H-8), 3.84–3.79 (m, 1H, H-9), 3.57–3.48 (m, 2H, H-7, H-9′), 1.99 (s, 3H, COCH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 175.00, 168.86 (2 × N–C═O), 165.60 (C-1), 145.27 (C-2), 137.83, 132.62, 131.55, 128.67, 127.16, 123.51 (Ar–C), 113.61 (C-3), 77.79 (C-6), 71.72 (C-7), 70.03 (C-4), 67.90 (C-8), 51.81 (C-5), 45.29 (C-9), 22.80 (CO<i>C</i>H<sub>3</sub>). HRMS (ESI) calcd for C<sub>18</sub>H<sub>21</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 408.1412; found 408.1411.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 5-Acetamido-9-(5-(4-acetamidobenzamido))pentanamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>15l</b>)</h3><div class="NLM_p last">Compound <b>15l</b> was synthesized from compound <b>14</b> using <i>N</i>-hydroxysuccinimidyl-5-(4-acetamidobenzamido)pentanoate. 30 mg (22% (42% × 53%, over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.77 (d, <i>J</i> = 8.7 Hz, 2H, Ar–H), 7.64 (d, <i>J</i> = 8.7 Hz, 2H, Ar–H), 5.90 (d, <i>J</i> = 2.3 Hz, 1H, H-3), 4.42 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H, H-4), 4.19–4.13 (d, <i>J</i> = 10.7, 1H, H-6), 3.98 (dd, <i>J</i> = 10.7, 8.7 Hz, 1H, H-5), 3.93–3.86 (m, 1H, H-8), 3.59 (dd, <i>J</i> = 13.8, 3.1 Hz, 1H, H-9), 3.42 (d, <i>J</i> = 8.9 Hz, 1H, H-7), 3.37 (t, <i>J</i> = 6.0 Hz, 2H, δ-CH<sub>2</sub>), 2.27 (t, <i>J</i> = 7.1 Hz, 2H, α-CH<sub>2</sub>), 2.13, 2.01 (2 × s, 2 × 3H, 2 × COCH<sub>3</sub>), 1.73–1.56 (m, 4H, β-CH<sub>2</sub>, γ-CH<sub>2</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 176.77, 174.82, 171.90, 169.57 (4 × N–C═O), 143.07 (C-2), 130.74, 129.15, 120.26 (Ar–C), 112.90 (C-3), 77.69 (C-6), 71.35(C-8), 70.24 (C-7), 51.81 (C-4), 49.88 (C-5), 44.28 (C-9), 40.53 (δ-CH<sub>2</sub>), 36.59 (α-CH<sub>2</sub>), 30.04 (γ-CH<sub>2</sub>), 24.42 (α-CH<sub>2</sub>), 24.03, 22.86 (2 × CO<i>C</i>H<sub>3</sub>). HRMS (ESI) calcd for C<sub>25</sub>H<sub>33</sub>N<sub>4</sub>O<sub>10</sub> [M – H]<sup>−</sup>, 549.2202; found 549.2207.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 5-Acetamido-9-(4-pentyltriazolyl)-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>15m</b>)</h3><div class="NLM_p last">To a solution of methyl 5-acetamido-9-azido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonate (<b>14</b>) (50 mg, 1 equiv) and 1-heptyne (30 mg, 2 equiv) in THF–H<sub>2</sub>O (2:1), sodium <span class="smallcaps smallerCapital">l</span>-ascorbate (5 mg, 0.3 equiv) and copper(II) sulfate (3 mg, 0.3 equiv) were added. The reaction mixture was kept stirring at room temperature and monitored by TLC until compound <b>14</b> was consumed. Solvents were then removed, and the residue was separated by flash chromatography to provide the desired C1-methyl ester product 59 mg (92%). The product was dissolved in 2 mL of MeOH, and 0.5 M NaOH was added. The mixture was kept stirring at room temperature. After completion, the pH of the solution was adjusted to 2 with Amberlite IR 120 (H+). The solution was filtered, concentrated, and dissolved in a minimum amount of methanol. Ethyl acetate was added to allow the product precipitate. The solid was collected by filtration and dried in vacuum. 40 mg (70%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.71 (s, 1H, triazole-H), 5.91 (d, <i>J</i> = 2.3 Hz, 1H, H-3), 4.77 (dd, <i>J</i> = 14.0, 2.5 Hz, 1H, H-9), 4.44–4.33 (m, 2H, H-4, H-6), 4.24–4.16 (m, 1H, H-8), 4.14–4.12 (m, 1H, H-9′), 3.98 (dd, <i>J</i> = 10.7, 8.7 Hz, 1H, H-5), 3.39 (d, <i>J</i> = 9.1 Hz, 1H, H-7), 2.66 (t, <i>J</i> = 7.7 Hz, 2H, α-CH<sub>2</sub>), 2.01 (s, 3H, COCH<sub>3</sub>), 1.71–1.59 (m, β-2H), 1.39–1.27 (m, 4H, γ-CH<sub>2</sub>, δ-CH<sub>2</sub>), 0.89 (dd, <i>J</i> = 9.7, 4.3 Hz, 3H, ε-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 175.10 (<i>C</i>OCH<sub>3</sub>), 166.11 (C-1), 145.91 (triazole-C4), 124.31 (triazole-C5), 112.97 (C-3), 77.69 (C-6), 71.34 (C-7), 69.86 (C-4), 67.93 (C-8), 55.00 (C-9), 51.92 (C-5), 32.51 (C-α), 30.36 (C-β), 26.29 (C-γ), 23.46 (C-δ), 22.72 (CO<i>C</i>H<sub>3</sub>), 14.35 (C-ε). HRMS (ESI) calcd for C<sub>18</sub>H<sub>27</sub>N<sub>4</sub>O<sub>7</sub> [M – H]<sup>−</sup>, 411.1885; found 411.1889.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> General Procedure for Synthesis of C5, C9 Double Modified DANA Analogues <b>17a</b>–<b>f</b></h3><div class="NLM_p last">Compound <b>16</b> was dissolved in THF–H<sub>2</sub>O and cooled to 0 °C with an ice–water bath. Triphenylphosphine was then added followed by activated esters. The solution was allowed to warm to room temperature and kept stirring overnight. After completion, the reaction was quenched with water, concentrated, and purified by flash chromatography to give the desired C9-modified product. The product was then dissolved in anhydrous TFA–DCM (10%), and the solution was stirred for 2–4 h at ambient temperature. Solvents were removed under vacuum, and the residue was dissolved in anhydrous DCM, and TEA was added. The solution was cooled to 0 °C, and the corresponding activated esters for C5 modification were added dropwise. The solution was allowed to warm to room temperature and kept stirring overnight. After completion, the reaction was quenched with water, concentrated, and purified by flash chromatography to give the desired C5-modified product. The product was then dissolved in MeOH, and 0.5 N NaOH was added. The mixture was kept stirring at room temperature. After completion, the mixture was neutralized with Amberlite IR 120 (H<sup>+</sup>), filtered, and purified by flash chromatography to provide the final C5, C9-double modified compounds.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 5-Hexanamido-9-hexanamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>17a</b>)</h3><div class="NLM_p last">Compound <b>17a</b> was synthesized from compound <b>16</b> using hexanoic anhydride. 20 mg (22% (77% × 54% × 52%), over three steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.78 (s, 1H, H-3), 4.38 (d, <i>J</i> = 8.5 Hz, 1H, H-4), 4.13 (d, <i>J</i> = 10.6 Hz, 1H, H-6), 4.02–3.86 (m, 2H, H-5, H-8), 3.56 (d, <i>J</i> = 13.2 Hz, 1H, H-9), 3.42 (d, <i>J</i> = 7.9 Hz, 1H, H-7), 2.31–2.12 (m, 4H, α-CH<sub>2</sub>, α′-CH<sub>2</sub>), 1.68–1.53 (m, 4H, β-CH<sub>2</sub>, β′-CH<sub>2</sub>), 1.40–1.23 (m, 8H, γ-CH<sub>2</sub>, γ′-CH<sub>2</sub>, δ-CH<sub>2</sub>, δ′-CH<sub>2</sub>), 0.90 (q, <i>J</i> = 6.9 Hz, 6H, ε-CH<sub>3</sub>, ε′-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 177.85, 177.06 (N–C═O), 110.69 (C-3), 77.49 (C-6), 71.39 (C-7), 70.66 (C-4), 68.30 (C-8), 51.88 (C-5), 44.25 (C-9), 37.18, 37.11(C-α, C-α′), 32.64, 32.61 (C-β, C-β′), 26.78, 26.66 (C-γ, C-γ′), 23.46 (C-δ, C-δ′), 14.32, 14.30 (C-ε, C-ε′). HRMS (ESI) calcd for C<sub>21</sub>H<sub>35</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 443.2399; found 443.2396.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 5-Pentanamido-9-pentanamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>17b</b>)</h3><div class="NLM_p last">Compound <b>17b</b> was synthesized from compound <b>16</b> using valeric anhydride. 50 mg (36% (90% × 72% × 55%), over three steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.74 (d, <i>J</i> = 1.9 Hz, 1H, H-3), 4.38 (dd, <i>J</i> = 8.7, 1.9 Hz, 1H, H-4), 4.11 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 3.97 (dd, <i>J</i> = 10.7, 8.8 Hz, 1H, H-5), 3.93–3.85 (m, 1H, H-8), 3.57 (dd, <i>J</i> = 13.4, 3.1 Hz, 1H, H-9), 3.38 (d, <i>J</i> = 8.7 Hz, 1H, H-7), 3.26 (dd, <i>J</i> = 13.4, 6.0 Hz, 1H, H-9′), 2.30–2.23 (m, 2H, α-CH<sub>2</sub>), 2.23–2.15 (m, 2H, α′-CH<sub>2</sub>), 1.59 (tdd, <i>J</i> = 15.3, 11.2, 7.5 Hz, 4H, β-CH<sub>2</sub>, β′-CH<sub>2</sub>), 1.34 (dq, <i>J</i> = 22.0, 7.4 Hz, 4H, γ-CH<sub>2</sub>, γ′-CH<sub>2</sub>), 0.92 (q, <i>J</i> = 7.4 Hz, 6H, δ-CH<sub>3</sub>, δ′-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 177.78, 176.97 (N–C═O), 109.98 (C-3), 77.36 (C-6), 71.51 (C-7), 70.36 (C-4), 68.40 (C-8), 51.87 (C-5), 44.27(C-9), 36.96, 36.89 (C-α, C-α′), 29.24, 29.11 (C-β, C-β′), 23.49, 23.45 (C-γ, C-γ′), 14.19 (C-δ, C-δ′). HRMS (ESI) calcd for C<sub>19</sub>H<sub>31</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 415.2086; found 415.2081.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 5-Propionamido-9-pentanamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>17c</b>)</h3><div class="NLM_p last">Compound <b>17c</b> was synthesized from compound <b>16</b> using valeric anhydride and propionic anhydride. 15 mg (18% (60% × 53% × 58%), over three steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.90 (d, <i>J</i> = 2.4 Hz, 1H, H-3), 4.41 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H, H-4), 4.16 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 4.01–3.87 (m, 2H, H-5, H-8), 3.61–3.53 (m, 1H, H-9), 3.41–3.35 (m, 1H, H-7), 2.28 (q, <i>J</i> = 7.6 Hz, 2H, α-CH<sub>2</sub>), 2.24–2.17 (m, 2H, α-CH<sub>2</sub>′), 1.57 (dt, <i>J</i> = 13.0, 7.5 Hz, 2H, β′-CH<sub>2</sub>), 1.33 (dq, <i>J</i> = 14.7, 7.4 Hz, 2H, γ′-CH<sub>2</sub>), 1.14 (t, <i>J</i> = 7.6 Hz, 3H, β-CH<sub>3</sub>), 0.91 (t, <i>J</i> = 7.4 Hz, 3H, δ′-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 178.61, 177.24 (N–C═O), 112.84 (C-3), 77.83 (C-6), 71.51 (C-7), 70.19 (C-4), 68.00 (C-8), 51.87 (C-5), 44.40 (C-9), 36.82 (C-α′), 30.20 (C-β′), 29.23 (C-γ′), 23.42 (C-α), 14.13 (C-δ′), 10.37 (C-β). HRMS (ESI) calcd for C<sub>17</sub>H<sub>27</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 387.1773; found 387.1770.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 5-Propionamido-9-hexanamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>17d</b>)</h3><div class="NLM_p last">Compound <b>17d</b> was synthesized from compound <b>16</b> using hexanoic anhydride and propionic anhydride. 13 mg (17% (63% × 46% × 60%), over three steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.89 (s, 1H, H-3), 4.40 (d, <i>J</i> = 8.7 Hz, 1H, H-4), 4.15 (d, <i>J</i> = 10.7 Hz, 1H, H-6), 4.01–3.86 (m, 2H, H-5, H-8), 3.57 (d, <i>J</i> = 11.9 Hz, 1H, H-9), 3.39 (d, <i>J</i> = 8.6 Hz, 1H, H-7), 2.28 (q, <i>J</i> = 7.5 Hz, 2H, α-CH<sub>2</sub>), 2.24–2.14 (m, 2H, α′-CH<sub>2</sub>), 1.59 (dt, <i>J</i> = 14.8, 7.5 Hz, 2H, β′-CH<sub>2</sub>), 1.38–1.25 (m, 4H,, γ′-CH<sub>2</sub>, δ′-CH<sub>3</sub>), 1.14 (t, <i>J</i> = 7.6 Hz, 3H, β-CH<sub>3</sub>), 0.89 (t, <i>J</i> = 7.0 Hz, 3H, ε-CH<sub>3</sub>′). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 178.60, 177.22 (2 × N–C═O), 112.68 (C-3), 77.89 (C-6), 71.56 (C-7), 70.25 (C-4), 68.10 (C-8), 51.87 (C-6), 44.40 (C-9), 37.07 (C-α′), 32.58 (C-β′), 30.21 (C-γ′), 26.77 (C-δ′), 23.44 (C-α), 14.27(C-ε′), 10.37 (C-β). HRMS (ESI) calcd for C<sub>18</sub>H<sub>29</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 401.1929; found 401.1926.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 5-Pentanamido-9-acetamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>17e</b>)</h3><div class="NLM_p last">Compound <b>17e</b> was synthesized from compound <b>16</b> using acetic anhydride and valeric anhydride. 20 mg (24% (74% × 50% × 65%), over three steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.86 (d, <i>J</i> = 2.4 Hz, 1H, H-3), 4.40 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H, H-4), 4.14 (d, <i>J</i> = 10.7 Hz, 1H, H-6), 3.96 (dd, <i>J</i> = 10.7, 8.7 Hz, 1H, H-5), 3.93–3.87 (m, 1H, H-8), 3.58 (dd, <i>J</i> = 13.9, 3.2 Hz, 1H, H-9), 3.38 (dd, <i>J</i> = 9.0, 0.7 Hz, 1H, H-7), 3.27–3.23 (m, 1H, H-9′), 2.27 (t, 2H, <i>J</i> = 7.5 Hz, α-CH<sub>2</sub>), 1.95 (s, 3H, COCH<sub>3</sub>), 1.61 (dt, <i>J</i> = 13.1, 7.5 Hz, 2H, β-CH<sub>2</sub>), 1.37 (dt, <i>J</i> = 15.0, 7.4 Hz, 2H, γ-CH<sub>2</sub>), 0.93 (t, <i>J</i> = 7.4 Hz, 3H, δ-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 177.96, 174.02 (2 × N–C═O), 166.67 (C-1), 112.19 (C-3), 77.73 (C-6), 71.69 (C-7), 70.00 (C-4), 68.08 (C-8), 51.87 (C-5), 44.58 (C-9), 36.90 (C-α), 29.13 (C-β), 23.45 (C-γ), 22.58 (CO<i>C</i>H<sub>3</sub>), 14.16 (C-δ). HRMS (ESI) calcd for C<sub>16</sub>H<sub>25</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 373.1616; found 373.1615.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 5-Hexanamido-9-acetamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>17f</b>)</h3><div class="NLM_p last">Compound <b>17f</b> was synthesized from compound <b>16</b> using acetic anhydride and hexanoic anhydride. 24 mg (30% (74% × 55% × 74%), over three steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.74 (d, <i>J</i> = 2.3 Hz, 1H, H-3), 4.39 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H, H-4), 4.11 (d, <i>J</i> = 10.8 Hz, 1H, H-6), 3.96 (dd, <i>J</i> = 10.8, 8.7 Hz, 1H, H-5), 3.93–3.87 (m, 1H, H-8), 3.60 (dd, <i>J</i> = 13.8, 3.2 Hz, 1H, H-9), 3.40–3.35 (m, 1H, H-7), 3.23 (dd, <i>J</i> = 13.8, 7.2 Hz, 1H, H-9′), 2.29–2.23 (m, 2H, α-CH<sub>2</sub>), 1.95 (s, 3H, COCH<sub>3</sub>), 1.66–1.59 (m, 2H, β-CH<sub>2</sub>), 1.37–1.28 (m, 4H, γ-CH<sub>2</sub>, δ-CH<sub>3</sub>), 0.90 (t, <i>J</i> = 7.0 Hz, 3H, ε-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 178.01, 174.03 (2 × N–C═O), 168.67 (C-1), 110.16 (C-3), 77.34 (C-6), 71.71 (C-7), 70.06 (C-4), 68.37 (C-8), 51.82 (C-5), 44.53 (C-9), 37.25 (C-α), 32.61(C-β), 26.70 (C-γ), 23.45 (C-δ), 22.69 (CO<i>C</i>H<sub>3</sub>), 14.37 (C-ε). HRMS (ESI) calcd for C<sub>16</sub>H<sub>25</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 387.1773; found 387.1774.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 5-Hexanamido-9-propionamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>17g</b>)</h3><div class="NLM_p last">Compound <b>17g</b> was synthesized from compound <b>16</b> using propionic anhydride and hexanoic anhydride. 20 mg (30% (96% × 41% × 75%), over three steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.73 (d, <i>J</i> = 2.3 Hz, 1H, H-3), 4.36 (dd, <i>J</i> = 8.6, 2.3 Hz, 1H, H-4), 4.10 (dd, <i>J</i> = 10.8, 0.8 Hz, 1H, H-6), 3.97 (dd, <i>J</i> = 10.8, 8.7 Hz, 1H, H-5), 3.89 (ddd, <i>J</i> = 9.2, 5.2, 2.7 Hz, 1H, H-8), 3.59 (dd, <i>J</i> = 13.8, 3.2 Hz, 1H, H-9), 3.36 (dd, <i>J</i> = 9.0, 0.7 Hz, 1H, H-7), 3.25 (dd, <i>J</i> = 13.8, 7.1 Hz, 1H, H-9′), 2.29–2.15 (m, 4H, α-CH<sub>2</sub>, α′-CH<sub>2</sub>), 1.63 (dt, <i>J</i> = 14.8, 7.6 Hz, 2H, β-CH<sub>2</sub>), 1.38–1.28 (m, 4H, γ-CH<sub>2</sub>, δ-CH<sub>2</sub>), 1.11 (t, <i>J</i> = 7.6 Hz, 3H, β′-CH<sub>3</sub>), 0.91 (t, <i>J</i> = 7.0 Hz, 3H, ε-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 177.78, 177.58 (2 × N–C═O), 109.74 (C-3), 77.38 (C-6), 71.81 (C-7), 70.10 (C-4), 68.43 (C-8), 51.87 (C-5), 44.43 (C-9), 37.17 (C-α), 32.63 (C-β), 30.18 (C-α′), 26.67 (C-γ), 23.45 (C-δ), 14.32 (C-ε), 10.55 (C-β′). HRMS (ESI) calcd for C<sub>18</sub>H<sub>29</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 401.1929; found 401.1929</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 5-Hexanamido-9-butanamido-2,6-anhydro-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>17h</b>)</h3><div class="NLM_p last">Compound <b>17h</b> was synthesized from compound <b>16</b> using butyric anhydride and hexanoic anhydride. 22 mg (34% (96% × 46% × 78%), over three steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.70 (d, <i>J</i> = 2.2 Hz, 1H, H-3), 4.36 (dd, <i>J</i> = 8.6, 2.3 Hz, 1H, H-4), 4.09 (dd, <i>J</i> = 10.8, 0.8 Hz, 1H, H-6), 3.97 (dd, <i>J</i> = 10.8, 8.7 Hz, 1H, H-5), 3.92–3.85 (m, 1H, H-8), 3.59 (dd, <i>J</i> = 13.8, 3.2 Hz, 1H, H-9), 3.36 (d, <i>J</i> = 8.9 Hz, 1H, H-7), 3.25 (dd, <i>J</i> = 13.8, 7.0 Hz, 1H, H-9′), 2.29–2.21 (m, 2H, α-CH<sub>2</sub>), 2.20–2.11 (m, 2H, α′-CH<sub>2</sub>), 1.62 (ddd, <i>J</i> = 14.9, 7.5, 2.6 Hz, 4H, β-CH<sub>2</sub>, β′-CH<sub>2</sub>), 1.34–1.32 (m, 4H, γ-CH<sub>2</sub>, δ-CH<sub>2</sub>), 0.94–0.89 (m, 6H, ε-CH<sub>3</sub>, γ′-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 177.75, 176.70 (2 × N–C═O), 109.28 (C-3), 77.31 (C-4), 71.74 (C-7), 70.22 (C-6), 68.50 (C-8), 51.89 (C-5), 44.32 (C-9), 39.04 (C-α), 37.18 (C-α′), 32.63 (C-β), 26.66 (C-γ), 23.46 (C-β′), 20.44 (C-δ), 14.33 (C-ε), 14.08 (C-γ′). HRMS (ESI) calcd for C<sub>19</sub>H<sub>32</sub>N<sub>2</sub>O<sub>8</sub> [M – H]<sup>−</sup>, 415.2086; found 415.2088.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Methyl 5-(<i>tert</i>-Butoxycarbonyl)amino-4-azido-2,6-anhydro-3,4,5-trideoxydideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonate (<b>19</b>)</h3><div class="NLM_p last">Compound <b>18</b> (200 mg, 1 equiv), di-<i>tert</i>-butyl dicarbonate (241 mg, 2.7 equiv), and 4-dimethylaminopyridine (76 mg, 1.6 equiv) were dissolved in 60 mL of anhydrous THF. The solution was then refluxed for 2 h. After completion, solvents were removed under reduced pressure and the residue was separated by flash chromatography, providing crude product (240 mg). The crude product was dissolved in 10 mL of MeOH. After the solution was cooled down to 0 °C, NaOMe (20 mg, 1 equiv) was added slowly. The mixture was stirred at 0 °C for 1 h. After completion, Amberlite IR 120 (H+) was added to adjust the pH of the solution to 2. After filtration, solvent was removed under reduced pressure and the residue was purified by flash chromatography, providing the desired product 140 mg (82%, over two steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.86 (d, <i>J</i> = 2.4 Hz, 1H, H-3), 4.31 (dd, <i>J</i> = 9.4, 2.4 Hz, 1H, H-4), 4.21 (d, <i>J</i> = 10.9 Hz, 1H, H-6), 3.88–3.79 (m, 3H, H-5, H-8, H-9), 3.77 (s, 3H, COOCH<sub>3</sub>), 3.71–3.61 (m, 2H, H-7, H-9′), 1.45 (s, 9H, <i><sup>t</sup></i>Boc). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 169.53, 163.95 (C-1), 158.44 (<i><sup>t</sup></i>Boc-OCO), 146.55 (C-2), 108.74 (C-3), 81.25 (<sup>t</sup>Boc-<i>C</i>CH<sub>3</sub>), 78.40 (C-6), 71.28 (C-8), 69.75 (C-7), 64.87 (C-9), 60.08 (C-4), 53.00 (C-5), 50.53 (COO<i>C</i>H<sub>3</sub>), 28.57 (<i><sup>t</sup></i>Boc-CH<sub>3</sub>). HRMS (ESI) calcd for C<sub>15</sub>H<sub>24</sub>N<sub>4</sub>NaO<sub>8</sub> [M – H]<sup>−</sup>, 411.1486; found 411.1487.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Methyl 5-(4-Methylpentanamido)-4-azido-7,8,9-tri<i>-O-</i>acetyl-2,6-anhydro-3,4,5-trideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonate (<b>20</b>)</h3><div class="NLM_p last">A solution of compound <b>19</b> (140 mg, 1 equiv) in anhydrous pyridine was cooled to 0 °C, and acetic anhydride (400 μL, 10 equiv) was added dropwise. The mixture was then allowed to warm to ambient temperature and kept stirring overnight. After completion, the reaction was quenched with methanol and solvents were removed under reduced pressure. The residue was dissolved in 200 mL of ethyl acetate and carefully washed with 0.1 M HCl, water, brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solution was concentrated to give 160 mg as a yellow oil, which was dissolved in 20 mL of anhydrous DCM, and 2 mL of TFA was added slowly. The solution was then stirred at room temperature for 2 h. After completion, DCM and TFA were removed under reduced pressure. The residue was dissolved in 10 mL of anhydrous DCM, and TEA (124 μL, 3 equiv) was added. The mixture was then cooled to 0 °C, and 4-methylpentanoyl chloride (75 mg, 1.2 equiv) was added. The solution was allowed to warm to room temperature and kept stirring overnight. After completion, the reaction was quenched with water, concentrated, and purified by flash chromatography to give the desired product. 105 mg (52%, over three steps). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.05 (d, <i>J</i> = 8.3 Hz, 1H, NH), 5.94 (d, <i>J</i> = 2.1 Hz, 1H, H-3), 5.41 (d, <i>J</i> = 5.2 Hz, 1H, H-7), 5.29 (td, <i>J</i> = 6.5, 2.7 Hz, 1H, H-8), 4.59 (dd, <i>J</i> = 12.4, 2.6 Hz, 1H, H-9), 4.54–4.50 (m, H5, H-4), 4.16 (dd, <i>J</i> = 12.4, 6.6 Hz, 1H, H-9′), 3.78 (s, 3H, COOCH<sub>3</sub>), 2.17 (t, <i>J</i> = 7.8 Hz, 2H, α-CH<sub>2</sub>), 2.11, 2.03, 2.02 (3 × s, 9H, 3 × COCH<sub>3</sub>), 1.62–1.43 (m, 3H, β-CH<sub>2</sub>, γ-CH), 0.88 (d, <i>J</i> = 6.3 Hz, 6H, 2 × δ-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 174.00, 170.69, 170.27, 170.08 (4 × C═O), 161.55 (C-1), 145.05 (C-2), 107.66 (C-3), 75.58 (C-6), 70.66 (C-8), 67.74 (C-7), 62.00 (C-9), 57.51 (C-4), 52.56 (COO<i>C</i>H<sub>3</sub>), 48.74 (C-5), 34.71 (C-β), 34.00(C- γ), 27.72, 22.24, 22.20 (3 × CO<i>C</i>H<sub>3</sub>), 20.82, 20.72 (2 × C-δ). HRMS (ESI) calcd for C<sub>22</sub>H<sub>32</sub>N<sub>4</sub>NaO<sub>8</sub> [M – H]<sup>−</sup>, 535.2011; found 535.2003.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Methyl 5-(4-Methylpentanamido)-7,8,9-tri<i>-O-</i>acetyl-2,6-anhydro-4-[2,3-bis(<i>tert</i>-butoxycarbonyl)guanidino]-3,4,5-trideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonate (<b>21</b>)</h3><div class="NLM_p last">To a solution of compound <b>20</b> (50 mg, 1 equiv) in THF (2 mL), 1 N HCl (200 μL, 2.2 equiv) was added, followed by triphenylphosphine (29 mg, 1.2 equiv). The resulting mixture was stirred at room temperature overnight. After completion, solvents were removed under reduced pressure and the residue was purified by flash chromatography, providing crude product (50 mg). The residue was dissolved in 5 mL of anhydrous DCM, and TEA (50 μL, 4 equiv) was added. The solution was cooled to 0 °C, and <i>N</i>,<i>N′</i>-di-Boc-1<i>H</i>-pyrazole-1-carboxamidine (600 mg, 2 equiv) added. The reaction mixture was allowed to warm up to room temperature and kept stirring overnight. After completion, the reaction was quenched with water, extracted with ethyl acetate. The organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and purified by flash chromatography to give the desired product. 60 mg (87%, over two steps). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.46 (d, <i>J</i> = 8.9 Hz, 1H, NH), 7.76 (brs, 1H, NH), 6.16 (d, <i>J</i> = 9.2 Hz, 1H, NH), 5.88 (d, <i>J</i> = 2.4 Hz, 1H, H-3), 5.42 (dd, <i>J</i> = 4.9, 1.7 Hz, 1H, H-7), 5.28 (ddd, <i>J</i> = 7.4, 4.9, 2.7 Hz, 1H, H-8), 5.19 (td, <i>J</i> = 9.7, 2.4 Hz, 1H, H-4), 4.67 (dd, <i>J</i> = 12.4, 2.7 Hz, 1H, H-9), 4.31 (dd, <i>J</i> = 10.5, 9.7 Hz, 1H, H-5), 4.26 (dd, <i>J</i> = 10.5, 1.7 Hz, 1H, H-6), 4.15 (dd, <i>J</i> = 12.4, 7.4 Hz, 1H, H-9′), 3.79 (s, 3H, COOCH<sub>3</sub>), 2.17–1.96 (m, 11H, 3 × COCH<sub>3</sub>, α-CH<sub>2</sub>), 1.56–1.33 (m, 21H, 2 × <i><sup>t</sup></i>Boc, β-CH<sub>2</sub>, γ-CH), 0.85 (dd, <i>J</i> = 6.5, 2.7 Hz, 6H, 2 × δ-CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 174.01, 170.56, 170.24, 170.07 (4 × C═O), 161.70 (<i><sup>t</sup></i>Boc-OCO), 157.23 (C-1), 152.62 (C═N), 145.07(C-2), 109.71 (C-3), 83.87, 79.77 (<i><sup>t</sup></i>Boc-<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 78.11 (C-6), 71.57(C-8), 67.76 (C-7), 62.29(C-9), 52.45 (COO<i>C</i>H<sub>3</sub>), 48.88 (C-4), 47.60 (C-5), (CO<i>C</i>H<sub>3</sub>), 34.67 (C-α), 34.12 (C-β), 28.27, 28.03 (<sup>t</sup>Boc-C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 27.70 (C-γ), 22.32, 22.13 (C-δ), 20.91, 20.87, 20.79 (CO<i>C</i>H<sub>3</sub>). HRMS (ESI) calcd for C<sub>33</sub>H<sub>52</sub>N<sub>4</sub>NaO<sub>14</sub> [M + Na]<sup>+</sup>, 751.3372; found 751.3378.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 5-(4-Methylpentanamido)-2,6-anhydro-4-guanidino-3,4,5-trideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-enonic Acid (<b>22</b>)</h3><div class="NLM_p last">To a solution of compound <b>21</b> (60 mg) in 5 mL of DCM, 500 μL of TFA was added. The solution was then stirred at room temperature for 2 h. After completion, DCM and TFA were removed under reduced pressure. The residue was dissolved in methanol and 2 mL of 1 N NaOH was added. The solution was stirred at room temperature for 1 h. After completion, the reaction mixture was added with Amberlite IR 120 (H+) to make the pH of the solution 7. The suspension was then filtered, and the filtrate was concentrated to give a light yellow oil. The residue was dissolved in a minimum of methanol, and the product was precipitated by ethyl acetate. The product was obtained by filtering as a white solid. 15 mg (48%, over two steps). <sup>1</sup>H NMR (700 MHz, CD<sub>3</sub>OD) δ 5.50 (s, 1H, H-3), 4.37 (d, <i>J</i> = 8.5 Hz, 1H, H-4), 4.33 (d, <i>J</i> = 10.0 Hz, 1H, H-6), 4.19 (t, <i>J</i> = 9.4 Hz, 1H, H-5), 3.89–3.79 (m, 2H, H-8, H-9), 3.65 (dd, <i>J</i> = 11.3, 5.4 Hz, 1H, H-9′), 3.58 (d, <i>J</i> = 9.2 Hz, 1H, H-7), 2.26 (t, <i>J</i> = 7.5 Hz, 2H, α-CH<sub>2</sub>), 1.61–1.49 (m, 3H, β-CH<sub>2</sub>, γ-CH), 0.92 (d, <i>J</i> = 6.4 Hz, 6H, 2 × δ-CH<sub>3</sub>). <sup>13</sup>C NMR (176 MHz, CD<sub>3</sub>OD) δ 177.19 (<i>C</i>OCH<sub>3</sub>), 169.63 (C-1), 158.78 (C═N), 151.58 (C-2), 103.33 (C-3), 77.04 (C-6), 71.33 (C-8), 70.31 (C-7), 64.88 (C-9), 52.26 (C-4), 35.85 (C-α), 35.21 (C-β), 28.86 (C-γ), 22.72, 22.63 (2 × C-δ). HRMS (ESI) calcd for C<sub>33</sub>H<sub>52</sub>N<sub>4</sub>NaO<sub>14</sub> [M + Na]<sup>+</sup>, 387.1885; found 387.1879.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Inhibition Assays</h3><div class="NLM_p">Inhibition assays against 4MU-NANA hydrolysis was performed using protocols reported previously.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> NEU3 and NEU2 were expressed as N-terminal MBP fusion proteins in <i>E. coli</i> and purified as previously reported.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> NEU4 was expressed as an MBP fusion protein in <i>E. coli</i> and purified.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> NEU1 was overexpressed as a (His)<sub>6</sub> fusion protein in HEK293 cells, and used as a crude preparation from cell lysate.<a onclick="showRef(event, 'ref30 ref57'); return false;" href="javascript:void(0);" class="ref ref30 ref57">(30,57)</a> All assays were conducted in 0.1 M sodium acetate buffer at optimum pH for each enzyme (4.5 for NEU1, NEU3, and NEU4; 5.5 for NEU2).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> To get comparable IC<sub>50</sub> measurements among the four isoenzymes, similar activity units of each enzyme were used in the assay.</div><div class="NLM_p last">For assays using 4MU-NANA as the substrate, inhibitors over 3-fold serial dilutions of concentration were incubated with enzyme at 0 °C for 15 min. 4MU-NANA was then added to the mixture, making the final concentration of 4MU-NANA 50 μM and the total volume of the reaction mixture 20 μL. After incubation at 37 °C for 30 min, the reaction was quenched with 100 μL of 0.2 M sodium glycine buffer (pH 10.2). The reaction mixture was transferred to a 386-well plate, and the enzyme activity was determined by measuring fluorescence (λ<sub>ex</sub> = 365 nm; λ<sub>em</sub> = 445 nm) using a plate reader (Molecular Devices, Sunnyvale, CA). Assays were performed with duplicates for each point, and IC<sub>50</sub> was obtained by plotting the data with GraphPad Prism 7.0. For curves that showed less than a 50% decrease in signal, fits were conducted using maximum inhibition values found for DANA.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> <i>K</i><sub>i</sub> Determinations</h3><div class="NLM_p last">Enzymes were incubated with serial concentrations of inhibitors at 0 °C for 15 min, and serial concentrations of 4MU-NANA were added. The reaction mixture was transferred to 386-well plate immediately, and the rate of product formation was obtained by measuring fluorescence (λ<sub>ex</sub> = 315 nm; λ<sub>em</sub> = 450 nm) every 1 min over 30 min. Lineweaver–Burk plots for some inhibitors indicated noncompetitive inhibition, sometimes called mixed inhibition (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01411/suppl_file/jm8b01411_si_001.pdf" class="ext-link">Figure S2</a>).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Kinetic data were processed with GraphPad Prism 7.0 using a competitive or noncompetitive inhibition models to obtain <i>K</i><sub>i</sub> and α values.<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> Competitive inhibition dominates most of the inhibitors (with α > 4); compounds that had significant noncompetitive character are noted in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, and fit <i>K</i><sub>i</sub> and α values for the noncompetitive model are provided in <a href="/doi/suppl/10.1021/acs.jmedchem.8b01411/suppl_file/jm8b01411_si_001.pdf" class="ext-link">Table S3</a>. We note that noncompetitive or mixed inhibition has been previously observed for other sialidase enzymes.<a onclick="showRef(event, 'ref60 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref60 ref61 ref62">(60−62)</a></div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Neuraminidase Assay in Mouse Tissue Homogenates</h3><div class="NLM_p">Mice with a targeted disruption of the <i>Neu1</i> gene (<i>Neu1<sup>–/–</sup></i>) or a combined deficiency of the <i>Neu3</i> and <i>Neu4</i> genes (<i>Neu3</i><sup>–/–</sup>; <i>Neu4</i><sup>–/–</sup>) have been previously described.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Mice were housed in an enriched environment with continuous access to food and water, under constant temperature and humidity, and on a 12 h light/dark cycle. Approval for the animal care and use in experiments was granted by the Animal Care and Use Committee of the Sainte-Justine University Hospital Research Center.</div><div class="NLM_p last">At the age of 24 weeks for the <i>Neu3/4</i> DKO mice and 8 weeks for the WT and <i>Neu1</i> KO mice, the animals were anesthetized with isoflurane and sacrificed by cervical dislocation and their brains and kidneys extracted, snap-frozen with liquid nitrogen, and kept at −80 °C. For the measurement of neuraminidase activity, 50 mg of frozen brain tissue was homogenized in water in a ratio of 250 μL of water per 50 mg of tissue in 1.5 mL Eppendorf tubes using a sonic dismembrator (Artek Systems Corporation). Protein concentration in the homogenate was measured by the Bradford method using the Bio-Rad reagent. Acidic α-neuraminidase activity was assayed at pH 4.6 using fluorogenic 4MU-NANA substrate as previously described.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The reaction mixture contained an aliquot of homogenate corresponding to 100 μg of total protein, neuraminidase inhibitor in a concentration of 0–150 μM, and substrate in a final concentration of 250 μM. The reaction was carried on at 37 °C for 60 min after which it was terminated by the addition of 960 μL of 0.4 M glycine buffer, pH 10.4. For blank samples, the reaction mixture contained buffer, inhibitor, and substrate, and the same volume of homogenate was added after termination of the reaction.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01411" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75047" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75047" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01411" class="ext-link">10.1021/acs.jmedchem.8b01411</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Protein expression protocols, HPLC traces for intermediates and final products, IC<sub>50</sub> curves, <i>K</i><sub>i</sub> determinations, <sup>1</sup>H and <sup>13</sup>C NMR data, and HR-MS data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01411/suppl_file/jm8b01411_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and IC<sub>50</sub> data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01411/suppl_file/jm8b01411_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01411/suppl_file/jm8b01411_si_001.pdf">jm8b01411_si_001.pdf (22.7 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01411/suppl_file/jm8b01411_si_002.csv">jm8b01411_si_002.csv (5.14 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01411" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher W. Cairo</span> - <span class="hlFld-Affiliation affiliation">Alberta
Glycomics Centre, Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3363-8708" title="Orcid link">http://orcid.org/0000-0003-3363-8708</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#721111131b001d3207131e10170006135c1113"><span class="__cf_email__" data-cfemail="442727252d362b0431252826213630256a2725">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tianlin Guo</span> - <span class="hlFld-Affiliation affiliation">Alberta
Glycomics Centre, Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rachel Héon-Roberts</span> - <span class="hlFld-Affiliation affiliation">Division
of Medical Genetics, Sainte-Justine University
Hospital Research Center, University of Montreal, Montréal, H3T 1C5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunxia Zou</span> - <span class="hlFld-Affiliation affiliation">Alberta
Glycomics Centre, Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruixiang Zheng</span> - <span class="hlFld-Affiliation affiliation">Alberta
Glycomics Centre, Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexey V. Pshezhetsky</span> - <span class="hlFld-Affiliation affiliation">Division
of Medical Genetics, Sainte-Justine University
Hospital Research Center, University of Montreal, Montréal, H3T 1C5, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6612-1062" title="Orcid link">http://orcid.org/0000-0002-6612-1062</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>T.G. synthesized and characterized all compounds, conducted IC50 and Ki measurements, and wrote the manuscript. R.H.-R. conducted mouse ortholog experiments. R.H.-R. and A.V.P. designed ortholog experiments and wrote the manuscript. C.Z. and R.Z. developed and implemented protein purification protocols. C.W.C. designed experiments and wrote the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): The authors note that a provisional patent has been filed on a portion of this work.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Dr. Michele R. Richards (University of Alberta) for helpful discussions. The authors acknowledge financial support for this work from the Canadian Glycomics Network and Canadian Institutes for Health Research.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">NEU</td><td class="NLM_def"><p class="first last">neuraminidase enzyme</p></td></tr><tr><td class="NLM_term">Neu5Ac</td><td class="NLM_def"><p class="first last">5-amino-3,5-dideoxy-<span class="smallcaps smallerCapital">d</span>-glycero-<span class="smallcaps smallerCapital">d</span>-galactonon-2-ulosonic acid</p></td></tr><tr><td class="NLM_term">DANA</td><td class="NLM_def"><p class="first last">2-deoxy-2,3-didehydro-<i>N</i>-acetylneuraminic acid</p></td></tr><tr><td class="NLM_term">4MU-NANA</td><td class="NLM_def"><p class="first last">2′-(4-methylumbelliferyl)-α-<span class="smallcaps smallerCapital">d</span>-<i>N</i>-acetylneuraminic acid</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">CuAAC</td><td class="NLM_def"><p class="first last">copper-catalyzed azide–alkyne cycloaddition</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86318" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86318" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 64 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guillot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauchez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belloy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonquet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debelle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martiny, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durlach, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaise, S.</span></span> <span> </span><span class="NLM_article-title">Impact of sialic acids on the molecular dynamic of bi-antennary and tri-antennary glycans</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">35666</span>, <span class="refDoi"> DOI: 10.1038/srep35666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1038%2Fsrep35666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=27759083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjtbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=35666&author=A.+Guillotauthor=M.+Dauchezauthor=N.+Belloyauthor=J.+Jonquetauthor=L.+Ducaauthor=B.+Romierauthor=P.+Mauriceauthor=L.+Debelleauthor=L.+Martinyauthor=V.+Durlachauthor=S.+Baudauthor=S.+Blaise&title=Impact+of+sialic+acids+on+the+molecular+dynamic+of+bi-antennary+and+tri-antennary+glycans&doi=10.1038%2Fsrep35666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of sialic acids on the molecular dynamic of bi-antennary and tri-antennary glycans</span></div><div class="casAuthors">Guillot, Alexandre; Dauchez, Manuel; Belloy, Nicolas; Jonquet, Jessica; Duca, Laurent; Romier, Beatrice; Maurice, Pascal; Debelle, Laurent; Martiny, Laurent; Durlach, Vincent; Baud, Stephanie; Blaise, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35666</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sialic acids (SA) are monosaccharides that can be located at the terminal position of glycan chains on a wide range of proteins.  The post-translational modifications, such as N-glycan chains, are fundamental to protein functions.  Indeed, the hydrolysis of SA by specific enzymes such as neuraminidases can lead to drastic modifications of protein behavior.  However, the relationship between desialylation of N-glycan chains and possible alterations of receptor function remains unexplored.  Thus, the aim of the present study is to establish the impact of SA removal from N-glycan chains on their conformational behavior.  We therefore undertook an in silico investigation using mol. dynamics to predict the structure of an isolated glycan chain.  We performed, for the first time, 3 independent 500 ns simulations on bi-antennary and tri-antennary glycan chains displaying or lacking SA.  We show that desialylation alters both the preferential conformation and the flexibility of the glycan chain.  This study suggests that the behavior of glycan chains induced by presence or absence of SA may explain the changes in the protein function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohSThdR1HtI7Vg90H21EOLACvtfcHk0lhbhkMK7EBGXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjtbfJ&md5=2c735234dabda38efc7afdc5c0592b73</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fsrep35666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep35666%26sid%3Dliteratum%253Aachs%26aulast%3DGuillot%26aufirst%3DA.%26aulast%3DDauchez%26aufirst%3DM.%26aulast%3DBelloy%26aufirst%3DN.%26aulast%3DJonquet%26aufirst%3DJ.%26aulast%3DDuca%26aufirst%3DL.%26aulast%3DRomier%26aufirst%3DB.%26aulast%3DMaurice%26aufirst%3DP.%26aulast%3DDebelle%26aufirst%3DL.%26aulast%3DMartiny%26aufirst%3DL.%26aulast%3DDurlach%26aufirst%3DV.%26aulast%3DBaud%26aufirst%3DS.%26aulast%3DBlaise%26aufirst%3DS.%26atitle%3DImpact%2520of%2520sialic%2520acids%2520on%2520the%2520molecular%2520dynamic%2520of%2520bi-antennary%2520and%2520tri-antennary%2520glycans%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D35666%26doi%3D10.1038%2Fsrep35666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varki, A.</span></span> <span> </span><span class="NLM_article-title">Sialic acids in human health and disease</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2008.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.molmed.2008.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=18606570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVCltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=351-360&author=A.+Varki&title=Sialic+acids+in+human+health+and+disease&doi=10.1016%2Fj.molmed.2008.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Sialic acids in human health and disease</span></div><div class="casAuthors">Varki, Ajit</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">351-360</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The surfaces of all vertebrate cells are decorated with a dense and complex array of sugar chains, which are mostly attached to proteins and lipids.  Most sol. secreted proteins are also similarly decorated with such glycans.  Sialic acids are a diverse family of sugar units with a nine-carbon backbone that are typically found attached to the outermost ends of these chains.  Given their location and ubiquitous distribution, sialic acids can mediate or modulate a wide variety of physiol. and pathol. processes.  This review considers some examples of their established and newly emerging roles in aspects of human physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIcCu4se_5o7Vg90H21EOLACvtfcHk0lhbhkMK7EBGXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVCltrk%253D&md5=fc4d8eb51bcc4509dc8b03cf7533a1c1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2008.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2008.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DVarki%26aufirst%3DA.%26atitle%3DSialic%2520acids%2520in%2520human%2520health%2520and%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D351%26epage%3D360%26doi%3D10.1016%2Fj.molmed.2008.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buschiazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzari, P. M.</span></span> <span> </span><span class="NLM_article-title">Structural insights into sialic acid enzymology</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2008.06.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.cbpa.2008.06.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=18625334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KgsbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=565-572&author=A.+Buschiazzoauthor=P.+M.+Alzari&title=Structural+insights+into+sialic+acid+enzymology&doi=10.1016%2Fj.cbpa.2008.06.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into sialic acid enzymology</span></div><div class="casAuthors">Buschiazzo, Alejandro; Alzari, Pedro M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">565-572</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sialic acids are a diverse family of neg. charged sugars that play essential biol. roles.  Their presence and relative abundance in different cells is ultimately regulated by the concerted action of a large set of enzymes.  In this review, we focus on the most recent advances on the enzymes that govern sialic acid metab., with emphasis on structural work.  Major progress has been made in dissecting the catalytic mechanism of sialidases, revealing a modified scenario of the typical glycosidase ping-pong mechanism.  Similarly, x-ray structures of sialyltransferases uncover significant variations of formerly known glycosyltransferase foldings.  Both sialidases and sialyltransferases seem to tell us that sialic acid-handling enzymes have evolved important modifications related to the distinctive features of sialic acid itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcI4bl9QyfJLVg90H21EOLACvtfcHk0lhN1RgzaXKqKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KgsbbO&md5=32b3743627a48164b79bb59630a33759</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2008.06.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2008.06.017%26sid%3Dliteratum%253Aachs%26aulast%3DBuschiazzo%26aufirst%3DA.%26aulast%3DAlzari%26aufirst%3DP.%2BM.%26atitle%3DStructural%2520insights%2520into%2520sialic%2520acid%2520enzymology%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D12%26spage%3D565%26epage%3D572%26doi%3D10.1016%2Fj.cbpa.2008.06.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parker, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohler, J. J.</span></span> <span> </span><span class="NLM_article-title">Regulation of intracellular signaling by extracellular glycan remodeling</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1021/cb9002514</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb9002514" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=35-46&author=R.+B.+Parkerauthor=J.+J.+Kohler&title=Regulation+of+intracellular+signaling+by+extracellular+glycan+remodeling&doi=10.1021%2Fcb9002514"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fcb9002514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb9002514%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DR.%2BB.%26aulast%3DKohler%26aufirst%3DJ.%2BJ.%26atitle%3DRegulation%2520of%2520intracellular%2520signaling%2520by%2520extracellular%2520glycan%2520remodeling%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D35%26epage%3D46%26doi%3D10.1021%2Fcb9002514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasirikenari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhardt, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashline, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanneman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhold, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, J. T. Y.</span></span> <span> </span><span class="NLM_article-title">Platelets support extracellular sialylation by supplying the sugar donor substrate</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">8742</span>– <span class="NLM_lpage">8748</span>, <span class="refDoi"> DOI: 10.1074/jbc.C113.546713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1074%2Fjbc.C113.546713" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=8742-8748&author=M.+M.+Leeauthor=M.+Nasirikenariauthor=C.+T.+Manhardtauthor=D.+J.+Ashlineauthor=A.+J.+Hannemanauthor=V.+N.+Reinholdauthor=J.+T.+Y.+Lau&title=Platelets+support+extracellular+sialylation+by+supplying+the+sugar+donor+substrate&doi=10.1074%2Fjbc.C113.546713"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C113.546713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C113.546713%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BM.%26aulast%3DNasirikenari%26aufirst%3DM.%26aulast%3DManhardt%26aufirst%3DC.%2BT.%26aulast%3DAshline%26aufirst%3DD.%2BJ.%26aulast%3DHanneman%26aufirst%3DA.%2BJ.%26aulast%3DReinhold%26aufirst%3DV.%2BN.%26aulast%3DLau%26aufirst%3DJ.%2BT.%2BY.%26atitle%3DPlatelets%2520support%2520extracellular%2520sialylation%2520by%2520supplying%2520the%2520sugar%2520donor%2520substrate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D8742%26epage%3D8748%26doi%3D10.1074%2Fjbc.C113.546713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tauber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reutter, W.</span></span> <span> </span><span class="NLM_article-title">Intramolecular heterogeneity of degradation in plasma membrane glycoproteins - evidence for a general characteristic</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">4026</span>– <span class="NLM_lpage">4029</span>, <span class="refDoi"> DOI: 10.1073/pnas.80.13.4026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1073%2Fpnas.80.13.4026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1983&pages=4026-4029&author=R.+Tauberauthor=C.+S.+Parkauthor=W.+Reutter&title=Intramolecular+heterogeneity+of+degradation+in+plasma+membrane+glycoproteins+-+evidence+for+a+general+characteristic&doi=10.1073%2Fpnas.80.13.4026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.80.13.4026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.80.13.4026%26sid%3Dliteratum%253Aachs%26aulast%3DTauber%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DC.%2BS.%26aulast%3DReutter%26aufirst%3DW.%26atitle%3DIntramolecular%2520heterogeneity%2520of%2520degradation%2520in%2520plasma%2520membrane%2520glycoproteins%2520-%2520evidence%2520for%2520a%2520general%2520characteristic%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1983%26volume%3D80%26spage%3D4026%26epage%3D4029%26doi%3D10.1073%2Fpnas.80.13.4026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span> <span> </span><span class="NLM_article-title">Mammalian sialidases: Physiological and pathological roles in cellular functions</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">880</span>– <span class="NLM_lpage">896</span>, <span class="refDoi"> DOI: 10.1093/glycob/cws057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fglycob%2Fcws057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=22377912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1agtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=880-896&author=T.+Miyagiauthor=K.+Yamaguchi&title=Mammalian+sialidases%3A+Physiological+and+pathological+roles+in+cellular+functions&doi=10.1093%2Fglycob%2Fcws057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian sialidases: Physiological and pathological roles in cellular functions</span></div><div class="casAuthors">Miyagi, Taeko; Yamaguchi, Kazunori</div><div class="citationInfo"><span class="NLM_cas:title">Glycobiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">880-896</span>CODEN:
                <span class="NLM_cas:coden">GLYCE3</span>;
        ISSN:<span class="NLM_cas:issn">0959-6658</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Sialic acids are terminal acidic monosaccharides, which influence the chem. and biol. features of glycoconjugates.  Their removal catalyzed by a sialidase modulates various biol. processes through change in conformation and creation or loss of binding sites of functional mols.  Sialidases exist widely in vertebrates and also in a variety of microorganisms.  Recent research on mammalian sialidases has provided evidence for great importance of these enzymes in various cellular functions, including lysosomal catabolism, whereas microbial sialidases appear to play roles limited to nutrition and pathogenesis.  Four types of mammalian sialidases have been identified and characterized to date, designated as NEU1, NEU2, NEU3 and NEU4.  They are encoded by different genes and differ in major subcellular localization and enzymic properties including substrate specificity, and each has been found to play a unique role depending on its particular properties.  This review is an attempt to concisely summarize current knowledge concerning mammalian sialidases, with an especial focus on their properties and physiol. and pathol. roles in cellular functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxmmcFwUsmhbVg90H21EOLACvtfcHk0lhUuihOYoto3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1agtbc%253D&md5=11db2be4246b76ed8a66cedaa2c53a13</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcws057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcws057%26sid%3Dliteratum%253Aachs%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DYamaguchi%26aufirst%3DK.%26atitle%3DMammalian%2520sialidases%253A%2520Physiological%2520and%2520pathological%2520roles%2520in%2520cellular%2520functions%26jtitle%3DGlycobiology%26date%3D2012%26volume%3D22%26spage%3D880%26epage%3D896%26doi%3D10.1093%2Fglycob%2Fcws057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashmarina, L. I.</span></span> <span> </span><span class="NLM_article-title">Desialylation of surface receptors as a new dimension in cell signaling</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">736</span>– <span class="NLM_lpage">745</span>, <span class="refDoi"> DOI: 10.1134/S0006297913070067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1134%2FS0006297913070067" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=736-745&author=A.+V.+Pshezhetskyauthor=L.+I.+Ashmarina&title=Desialylation+of+surface+receptors+as+a+new+dimension+in+cell+signaling&doi=10.1134%2FS0006297913070067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1134%2FS0006297913070067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1134%252FS0006297913070067%26sid%3Dliteratum%253Aachs%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26aulast%3DAshmarina%26aufirst%3DL.%2BI.%26atitle%3DDesialylation%2520of%2520surface%2520receptors%2520as%2520a%2520new%2520dimension%2520in%2520cell%2520signaling%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D78%26spage%3D736%26epage%3D745%26doi%3D10.1134%2FS0006297913070067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harada, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, M. D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passarelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintão, E. C. R.</span></span> <span> </span><span class="NLM_article-title">Lipoprotein desialylation simultaneously enhances the cell cholesterol uptake and impairs the reverse cholesterol transport system: in vitro evidences utilizing neuraminidase-treated lipoproteins and mouse peritoneal macrophages</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/S0021-9150(98)00057-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2FS0021-9150%2898%2900057-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1998&pages=65-75&author=L.+M.+Haradaauthor=M.+D.+T.+Carvalhoauthor=M.+Passarelliauthor=E.+C.+R.+Quint%C3%A3o&title=Lipoprotein+desialylation+simultaneously+enhances+the+cell+cholesterol+uptake+and+impairs+the+reverse+cholesterol+transport+system%3A+in+vitro+evidences+utilizing+neuraminidase-treated+lipoproteins+and+mouse+peritoneal+macrophages&doi=10.1016%2FS0021-9150%2898%2900057-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0021-9150%2898%2900057-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9150%252898%252900057-4%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DL.%2BM.%26aulast%3DCarvalho%26aufirst%3DM.%2BD.%2BT.%26aulast%3DPassarelli%26aufirst%3DM.%26aulast%3DQuint%25C3%25A3o%26aufirst%3DE.%2BC.%2BR.%26atitle%3DLipoprotein%2520desialylation%2520simultaneously%2520enhances%2520the%2520cell%2520cholesterol%2520uptake%2520and%2520impairs%2520the%2520reverse%2520cholesterol%2520transport%2520system%253A%2520in%2520vitro%2520evidences%2520utilizing%2520neuraminidase-treated%2520lipoproteins%2520and%2520mouse%2520peritoneal%2520macrophages%26jtitle%3DAtherosclerosis%26date%3D1998%26volume%3D139%26spage%3D65%26epage%3D75%26doi%3D10.1016%2FS0021-9150%2898%2900057-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Vliet, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lino, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kooyk, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadokoro, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Videira, P. A.</span></span> <span> </span><span class="NLM_article-title">Sialic acid removal from dendritic cells improves antigen cross presentation and boosts anti-tumor immune responses</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">41053</span>– <span class="NLM_lpage">41066</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.9419</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.18632%2Foncotarget.9419" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=41053-41066&author=M.+Silvaauthor=Z.+Silvaauthor=G.+Marquesauthor=T.+Ferroauthor=M.+Goncalvesauthor=M.+Monteiroauthor=S.+J.+van+Vlietauthor=E.+Mohrauthor=A.+C.+Linoauthor=A.+R.+Fernandesauthor=F.+A.+Limaauthor=Y.+van+Kooykauthor=T.+Matosauthor=C.+E.+Tadokoroauthor=P.+A.+Videira&title=Sialic+acid+removal+from+dendritic+cells+improves+antigen+cross+presentation+and+boosts+anti-tumor+immune+responses&doi=10.18632%2Foncotarget.9419"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.9419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.9419%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DM.%26aulast%3DSilva%26aufirst%3DZ.%26aulast%3DMarques%26aufirst%3DG.%26aulast%3DFerro%26aufirst%3DT.%26aulast%3DGoncalves%26aufirst%3DM.%26aulast%3DMonteiro%26aufirst%3DM.%26aulast%3Dvan%2BVliet%26aufirst%3DS.%2BJ.%26aulast%3DMohr%26aufirst%3DE.%26aulast%3DLino%26aufirst%3DA.%2BC.%26aulast%3DFernandes%26aufirst%3DA.%2BR.%26aulast%3DLima%26aufirst%3DF.%2BA.%26aulast%3Dvan%2BKooyk%26aufirst%3DY.%26aulast%3DMatos%26aufirst%3DT.%26aulast%3DTadokoro%26aufirst%3DC.%2BE.%26aulast%3DVideira%26aufirst%3DP.%2BA.%26atitle%3DSialic%2520acid%2520removal%2520from%2520dendritic%2520cells%2520improves%2520antigen%2520cross%2520presentation%2520and%2520boosts%2520anti-tumor%2520immune%2520responses%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D41053%26epage%3D41066%26doi%3D10.18632%2Foncotarget.9419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, M.</span></span> <span> </span><span class="NLM_article-title">CD8+ T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">27445</span>, <span class="refDoi"> DOI: 10.1038/srep27445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1038%2Fsrep27445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=27321376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVahu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=27445&author=J.+Qiuauthor=X.+Liuauthor=X.+Liauthor=X.+Zhangauthor=P.+Hanauthor=H.+Zhouauthor=L.+Shaoauthor=Y.+Houauthor=Y.+Minauthor=Z.+Kongauthor=Y.+Wangauthor=Y.+Weiauthor=X.+Liuauthor=H.+Niauthor=J.+Pengauthor=M.+Hou&title=CD8%2B+T+cells+induce+platelet+clearance+in+the+liver+via+platelet+desialylation+in+immune+thrombocytopenia&doi=10.1038%2Fsrep27445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">CD8+ T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia</span></div><div class="casAuthors">Qiu, Jihua; Liu, Xuena; Li, Xiaoqing; Zhang, Xu; Han, Panpan; Zhou, Hai; Shao, Linlin; Hou, Yu; Min, Yanan; Kong, Zhangyuan; Wang, Yawen; Wei, Yu; Liu, Xinguang; Ni, Heyu; Peng, Jun; Hou, Ming</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27445</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In addn. to antiplatelet autoantibodies, CD8+ cytotoxic T lymphocytes (CTLs) play an important role in the increased platelet destruction in immune thrombocytopenia (ITP).  Recent studies have highlighted that platelet desialylation leads to platelet clearance via hepatocyte asialoglycoprotein receptors (ASGPRs).  Whether CD8+ T cells induce platelet desialylation in ITP remains unclear.  Here, we investigated the cytotoxicity of CD8+ T cells towards platelets and platelet desialylation in ITP.  We found that the desialylation of fresh platelets was significantly higher in ITP patients with pos. cytotoxicity of CD8+ T cells than those without cytotoxicity and controls.  In vitro, CD8+ T cells from ITP patients with pos. cytotoxicity induced significant platelet desialylation, neuraminidase-1 expression on the platelet surface, and platelet phagocytosis by hepatocytes.  To study platelet survival and clearance in vivo, CD61 knockout mice were immunized and their CD8+ splenocytes were used.  Platelets co-cultured with these CD8+ splenocytes demonstrated decreased survival in the circulation and increased phagocytosis in the liver.  Both neuraminidase inhibitor and ASGPRs competitor significantly improved platelet survival and abrogated platelet clearance caused by CD8+ splenocytes.  These findings suggest that CD8+ T cells induce platelet desialylation and platelet clearance in the liver in ITP, which may be a novel mechanism of ITP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz8sAP_9UlprVg90H21EOLACvtfcHk0lil4Nrf11lkvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVahu7vJ&md5=9a2e9106fe8efc64a3dc8f9849ca1738</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fsrep27445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep27445%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DShao%26aufirst%3DL.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DMin%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DNi%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DM.%26atitle%3DCD8%252B%2520T%2520cells%2520induce%2520platelet%2520clearance%2520in%2520the%2520liver%2520via%2520platelet%2520desialylation%2520in%2520immune%2520thrombocytopenia%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D27445%26doi%3D10.1038%2Fsrep27445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashmarina, M.</span></span> <span> </span><span class="NLM_article-title">Keeping it trim: roles of neuraminidases in CNS function</span>. <i>Glycoconjugate J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1007/s10719-018-9837-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1007%2Fs10719-018-9837-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=30088207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVKiu7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2018&pages=375-386&author=A.+V.+Pshezhetskyauthor=M.+Ashmarina&title=Keeping+it+trim%3A+roles+of+neuraminidases+in+CNS+function&doi=10.1007%2Fs10719-018-9837-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Keeping it trim: roles of neuraminidases in CNS function</span></div><div class="casAuthors">Pshezhetsky, Alexey V.; Ashmarina, Mila</div><div class="citationInfo"><span class="NLM_cas:title">Glycoconjugate Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-386</span>CODEN:
                <span class="NLM_cas:coden">GLJOEW</span>;
        ISSN:<span class="NLM_cas:issn">0282-0080</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The sialylated glyconjugates (SGC) are found in abundance on the surface of brain cells, where they form a dense array of glycans mediating cell/cell and cell/protein recognition in numerous physiol. and pathol. processes.  Metabolic genetic blocks in processing and catabolism of SGC result in development of severe storage disorders, dominated by CNS involvement including marked neuroinflammation and neurodegeneration, the pathophysiol. mechanisms of which are still discussed.  SGC patterns in the brain are cell and organelle-specific, dynamic and maintained by highly coordinated processes of their biosynthesis, trafficking, processing and catabolism.  The changes in the compn. of SGC during development and aging of the brain cannot be explained based solely on the regulation of the SGC-synthesizing enzymes, sialyltransferases, suggesting that neuraminidases (sialidases) hydrolyzing the removal of terminal sialic acid residues also play an essential role.  In the current review we summarize the roles of three mammalian neuraminidases: neuraminidase 1, neuraminidase 3 and neuraminidase 4 in processing brain SGC.  Emerging data demonstrate that these enzymes with different, yet overlapping expression patterns, intracellular localization and substrate specificity play essential roles in the physiol. of the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVPfxjHp8mYbVg90H21EOLACvtfcHk0lil4Nrf11lkvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVKiu7bI&md5=822d7a61e43df9316c5a8f9ef311826e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs10719-018-9837-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10719-018-9837-4%26sid%3Dliteratum%253Aachs%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26aulast%3DAshmarina%26aufirst%3DM.%26atitle%3DKeeping%2520it%2520trim%253A%2520roles%2520of%2520neuraminidases%2520in%2520CNS%2520function%26jtitle%3DGlycoconjugate%2520J.%26date%3D2018%26volume%3D35%26spage%3D375%26epage%3D386%26doi%3D10.1007%2Fs10719-018-9837-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonten, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arts, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covanis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donati, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zammarchi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Azzo, A.</span></span> <span> </span><span class="NLM_article-title">Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2715</span>– <span class="NLM_lpage">2725</span>, <span class="refDoi"> DOI: 10.1093/hmg/9.18.2715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fhmg%2F9.18.2715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=11063730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVKktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=2715-2725&author=E.+J.+Bontenauthor=W.+F.+Artsauthor=M.+Beckauthor=A.+Covanisauthor=M.+A.+Donatiauthor=R.+Pariniauthor=E.+Zammarchiauthor=A.+d%E2%80%99Azzo&title=Novel+mutations+in+lysosomal+neuraminidase+identify+functional+domains+and+determine+clinical+severity+in+sialidosis&doi=10.1093%2Fhmg%2F9.18.2715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis</span></div><div class="casAuthors">Bonten, Erik. J.; Arts, Willem F.; Beck, Michael; Covanis, A.; Donati, Maria A.; Parini, Rossella; Zammarchi, Enrico; D'Azzo, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2715-2725</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Lysosomal neuraminidase is the key enzyme for the intralysosomal catabolism of sialylated glycoconjugates and is deficient in two neurodegenerative lysosomal disorders, sialidosis and galactosialidosis.  Here we report the identification of eight novel mutations in the neuraminidase gene of 11 sialidosis patients with various degrees of disease penetrance.  Comparison of the primary structure of human neuraminidase with the primary and tertiary structures of bacterial sialidases indicated that most of the single amino acid substitutions occurred in functional motifs or conserved residues.  On the basis of the subcellular distribution and residual catalytic activity of the mutant neuraminidases we assigned the mutant proteins to three groups: (i) catalytically inactive and not lysosomal; (ii) catalytically inactive, but localized in lysosome; and (iii) catalytically active and lysosomal.  In general, there was a close correlation between the residual activity of the mutant enzymes and the clin. severity of disease.  Patients with the severe infantile type II disease had mutations from group I, whereas patients with a mild form of type I disease had at least one mutation from group III.  Mutations from the second group were mainly found in juvenile type II patients with intermediate clin. severity.  Overall, our findings explain the clin. heterogeneity obsd. in sialidosis and may help in the assignment of existing or new allelic combinations to specific phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWsEJ32DIivLVg90H21EOLACvtfcHk0lil4Nrf11lkvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVKktbs%253D&md5=0473d7520bb409273c0c3d13bcfa3188</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F9.18.2715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F9.18.2715%26sid%3Dliteratum%253Aachs%26aulast%3DBonten%26aufirst%3DE.%2BJ.%26aulast%3DArts%26aufirst%3DW.%2BF.%26aulast%3DBeck%26aufirst%3DM.%26aulast%3DCovanis%26aufirst%3DA.%26aulast%3DDonati%26aufirst%3DM.%2BA.%26aulast%3DParini%26aufirst%3DR.%26aulast%3DZammarchi%26aufirst%3DE.%26aulast%3Dd%25E2%2580%2599Azzo%26aufirst%3DA.%26atitle%3DNovel%2520mutations%2520in%2520lysosomal%2520neuraminidase%2520identify%2520functional%2520domains%2520and%2520determine%2520clinical%2520severity%2520in%2520sialidosis%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2000%26volume%3D9%26spage%3D2715%26epage%3D2725%26doi%3D10.1093%2Fhmg%2F9.18.2715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carubelli, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamatos, N. M.</span></span> <span> </span><span class="NLM_article-title">Sialidase expression in activated human T lymphocytes influences production of IFN-γ</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1189/jlb.1105692</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1189%2Fjlb.1105692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=17028199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A280%3ADC%252BD28jkslWhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=284-296&author=X.+Nanauthor=I.+Carubelliauthor=N.+M.+Stamatos&title=Sialidase+expression+in+activated+human+T+lymphocytes+influences+production+of+IFN-%CE%B3&doi=10.1189%2Fjlb.1105692"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Sialidase expression in activated human T lymphocytes influences production of IFN-gamma</span></div><div class="casAuthors">Nan Xinli; Carubelli Ivan; Stamatos Nicholas M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of leukocyte biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">284-96</span>
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    </div><div class="casAbstract">Sialidases influence cellular activity by removing terminal sialic acid from glycoproteins and glycolipids.  Four genetically distinct sialidases (Neu1-4) have been identified in mammalian cells.  In this study, we demonstrate that only lysosomal Neu1 and plasma membrane-associated Neu3 are detected in freshly isolated and activated human T lymphocytes.  Activation of lymphocytes by exposure to anti-CD3 and anti-CD28 IgG resulted in a ninefold increase in Neu1-specific activity after growth of cells in culture for 5 days.  In contrast, the activity of Neu3 changed minimally in activated lymphocytes.  The increase in Neu1 enzyme activity correlated with increased synthesis of Neu1-specific mRNA.  Neu1 was present on the surface of freshly isolated and activated CD4 and CD8 T lymphocytes, as determined by staining intact cells with anti-Neu1 IgG and analysis by flow cytometry and by Western blot analysis of biotin-labeled cell surface proteins.  Cell surface Neu1 was found tightly associated with a subunit of protective protein/cathepsin A (PPCA).  Compared with freshly isolated lymphocytes, activated cells expressed more surface binding sites for galactose-recognizing lectins Erythrina cristagalli (ECA) and Arachis hypogaea.  Growth of cells in the presence of sialidase inhibitors 2,3-dehydro-2-deoxy-N-acetylneuraminic acid or 4-guanidino-2-deoxy-2,3-dehydro-N-acetylneuraminic acid resulted in a smaller increase in number of ECA-binding sites and a greater amount of cell surface sialic acid in activated cells.  Inhibition of sialidase activity also resulted in reduced expression of IFN-gamma in activated cells.  The down-regulation of IFN-gamma occurred at the transcriptional level.  Thus, sialidase activity in activated T lymphocytes contributes to the hyposialylation of specific cell surface glycoconjugates and to the production of IFN-gamma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQwcLV8JlYIRe4jJGKT5N0fW6udTcc2eaB3ezuRQFnsrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jkslWhtQ%253D%253D&md5=3cfd524c10437f334b8e83cdba8fec2b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1189%2Fjlb.1105692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.1105692%26sid%3Dliteratum%253Aachs%26aulast%3DNan%26aufirst%3DX.%26aulast%3DCarubelli%26aufirst%3DI.%26aulast%3DStamatos%26aufirst%3DN.%2BM.%26atitle%3DSialidase%2520expression%2520in%2520activated%2520human%2520T%2520lymphocytes%2520influences%2520production%2520of%2520IFN-%25CE%25B3%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2007%26volume%3D81%26spage%3D284%26epage%3D296%26doi%3D10.1189%2Fjlb.1105692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, O. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Läubli, H.</span></span> <span> </span><span class="NLM_article-title">Sialic acids in cancer biology and immunity</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1093/glycob/cwv097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fglycob%2Fcwv097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=26518624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12rsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=111-128&issue=2&author=O.+M.+T.+Pearceauthor=H.+L%C3%A4ubli&title=Sialic+acids+in+cancer+biology+and+immunity&doi=10.1093%2Fglycob%2Fcwv097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Sialic acids in cancer biology and immunity</span></div><div class="casAuthors">Pearce, Oliver M. T.; Laeubli, Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Glycobiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-128</span>CODEN:
                <span class="NLM_cas:coden">GLYCE3</span>;
        ISSN:<span class="NLM_cas:issn">0959-6658</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">During malignant transformation, glycosylation is heavily altered compared with healthy tissue due to differential expression of glycosyltransferases, glycosidases and monosaccharide transporters within the cancer microenvironment.  One key change of malignant tissue glycosylation is the alteration of sialic acid processing that leads to a general upregulation of sialylated glycans (hypersialylation) on cell surfaces and an increased introduction of the non-human sialic acid N-glycolylneuraminic acid (Neu5Gc) instead of N-acetyl-neuraminic acid into cell surface glycans.  These changes have been shown to be the result of altered sialyltransferase and sialidase expression.  Functionally, cancer-assocd. hypersialylation appears to directly impact tumor cell interaction with the microenvironment, in particular the modulation of sialic acid-binding lectins on immune cells.  Moreover, Neu5Gc expression in human tissues enhances inflammation due to an anti-Neu5Gc immune response, which can potentially influence inflammation-induced cancer and cancer-assocd. inflammation.  In this review, we summarize the changes of sialic acid biol. within the malignant microenvironment and the resulting effect on cancer immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLNZJ4KazaIrVg90H21EOLACvtfcHk0lhjc0NrUEp--Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12rsbnN&md5=f208432a974f6c9312952ce697a40b18</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcwv097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcwv097%26sid%3Dliteratum%253Aachs%26aulast%3DPearce%26aufirst%3DO.%2BM.%2BT.%26aulast%3DL%25C3%25A4ubli%26aufirst%3DH.%26atitle%3DSialic%2520acids%2520in%2520cancer%2520biology%2520and%2520immunity%26jtitle%3DGlycobiology%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D111%26epage%3D128%26doi%3D10.1093%2Fglycob%2Fcwv097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alghamdi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulkhalek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amith, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczuk, M. R.</span></span> <span> </span><span class="NLM_article-title">A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1368</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2014.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.cellsig.2014.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=24583283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltl2ksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=1355-1368&author=F.+Alghamdiauthor=M.+Guoauthor=S.+Abdulkhalekauthor=N.+Crawfordauthor=S.+R.+Amithauthor=M.+R.+Szewczuk&title=A+novel+insulin+receptor-signaling+platform+and+its+link+to+insulin+resistance+and+type+2+diabetes&doi=10.1016%2Fj.cellsig.2014.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes</span></div><div class="casAuthors">Alghamdi, Farah; Guo, Merry; Abdulkhalek, Samar; Crawford, Nicola; Amith, Schammim Ray; Szewczuk, Myron R.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1355-1368</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Insulin-induced insulin receptor (IR) tyrosine kinase activation and insulin cell survival responses have been reported to be under the regulation of a membrane assocd. mammalian neuraminidase-1 (Neu1).  The mol. mechanism(s) behind this process is unknown.  Here, we uncover a novel Neu1 and matrix metalloproteinase-9 (MMP-9) cross-talk in alliance with neuromedin B G-protein coupled receptor (GPCR), which is essential for insulin-induced IR activation and cellular signaling.  Neu1, MMP-9 and neuromedin B GPCR form a complex with IRβ subunit on the cell surface.  Oseltamivir phosphate (Tamiflu), anti-Neu1 antibodies, broad range MMP inhibitors piperazine and galardin (GM6001), MMP-9 specific inhibitor (MMP-9i), and GPCR neuromedin B specific antagonist BIM-23127 dose-dependently inhibited Neu1 activity assocd. with insulin stimulated rat hepatoma cells (HTCs) that overly express human IRs (HTC-IR).  Tamiflu, anti-Neu1 antibodies and MMP-9i attenuated phosphorylation of IRβ and insulin receptor substrate-1 (IRS1) assocd. with insulin-stimulated cells.  Olanzapine, an antipsychotic agent assocd. with insulin resistance, induced Neu3 sialidase activity in WG544 or 1140F01 human sialidosis fibroblast cells genetically defective in Neu1.  Neu3 antagonist 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) and anti-Neu3 antibodies inhibited sialidase activity assocd. with olanzapine treated murine Neu4 knockout macrophage cells.  Olanzapine attenuated phosphorylation of IGF-R and IRS1 assocd. with insulin-stimulated human wild-type fibroblast cells.  Our findings identify a novel insulin receptor-signaling platform that is critically essential for insulin-induced IRβ tyrosine kinase activation and cellular signaling.  Olanzapine-induced Neu3 sialidase activity attenuated insulin-induced IGF-R and IRS1 phosphorylation contributing to insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2rVeu0VmYnrVg90H21EOLACvtfcHk0lhjc0NrUEp--Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltl2ksLc%253D&md5=a5c585d8c4ba2dc091309bae8c8ae5b6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2014.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2014.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DAlghamdi%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DAbdulkhalek%26aufirst%3DS.%26aulast%3DCrawford%26aufirst%3DN.%26aulast%3DAmith%26aufirst%3DS.%2BR.%26aulast%3DSzewczuk%26aufirst%3DM.%2BR.%26atitle%3DA%2520novel%2520insulin%2520receptor-signaling%2520platform%2520and%2520its%2520link%2520to%2520insulin%2520resistance%2520and%2520type%25202%2520diabetes%26jtitle%3DCell.%2520Signalling%26date%3D2014%26volume%3D26%26spage%3D1355%26epage%3D1368%26doi%3D10.1016%2Fj.cellsig.2014.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dridi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyrantepe, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fougerat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneil, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibault, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heveker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issad, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span> <span> </span><span class="NLM_article-title">Positive regulation of insulin signaling by neuraminidase 1</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2338</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.2337/db12-1825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.2337%2Fdb12-1825" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=2338-46&author=L.+Dridiauthor=V.+Seyrantepeauthor=A.+Fougeratauthor=X.+Panauthor=E.+Bonneilauthor=P.+Thibaultauthor=A.+Moreauauthor=G.+A.+Mitchellauthor=N.+Hevekerauthor=C.+W.+Cairoauthor=T.+Issadauthor=A.+Hinekauthor=A.+V.+Pshezhetsky&title=Positive+regulation+of+insulin+signaling+by+neuraminidase+1&doi=10.2337%2Fdb12-1825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2337%2Fdb12-1825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb12-1825%26sid%3Dliteratum%253Aachs%26aulast%3DDridi%26aufirst%3DL.%26aulast%3DSeyrantepe%26aufirst%3DV.%26aulast%3DFougerat%26aufirst%3DA.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DBonneil%26aufirst%3DE.%26aulast%3DThibault%26aufirst%3DP.%26aulast%3DMoreau%26aufirst%3DA.%26aulast%3DMitchell%26aufirst%3DG.%2BA.%26aulast%3DHeveker%26aufirst%3DN.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26aulast%3DIssad%26aufirst%3DT.%26aulast%3DHinek%26aufirst%3DA.%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26atitle%3DPositive%2520regulation%2520of%2520insulin%2520signaling%2520by%2520neuraminidase%25201%26jtitle%3DDiabetes%26date%3D2013%26volume%3D62%26spage%3D2338%26epage%3D46%26doi%3D10.2337%2Fdb12-1825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinokio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunoda, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aburatani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oka, Y.</span></span> <span> </span><span class="NLM_article-title">Increased hepatic expression of ganglioside-specific sialidase, NEU3, improves insulin sensitivity and glucose tolerance in mice</span>. <i>Metab., Clin. Exp.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">420</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1016/j.metabol.2006.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.metabol.2006.10.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=17292733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1CltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=420-429&author=S.+Yoshizumiauthor=S.+Suzukiauthor=M.+Hiraiauthor=Y.+Hinokioauthor=T.+Yamadaauthor=T.+Yamadaauthor=U.+Tsunodaauthor=H.+Aburataniauthor=K.+Yamaguchiauthor=T.+Miyagiauthor=Y.+Oka&title=Increased+hepatic+expression+of+ganglioside-specific+sialidase%2C+NEU3%2C+improves+insulin+sensitivity+and+glucose+tolerance+in+mice&doi=10.1016%2Fj.metabol.2006.10.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Increased hepatic expression of ganglioside-specific sialidase, NEU3, improves insulin sensitivity and glucose tolerance in mice</span></div><div class="casAuthors">Yoshizumi, Shinsuke; Suzuki, Susumu; Hirai, Masashi; Hinokio, Yoshinori; Yamada, Tetsuya; Yamada, Takahiro; Tsunoda, Uiko; Aburatani, Hiroyuki; Yamaguchi, Kazunori; Miyagi, Taeko; Oka, Yoshitomo</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">420-429</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Membrane microdomains rich in gangliosides are recognized as being crit. for proper compartmentalization of insulin signaling.  Plasma membrane-assocd. sialidase, NEU3, is a key enzyme for ganglioside hydrolysis.  We previously reported that mice overexpressing NEU3 mainly in muscles developed severe insulin-resistant diabetes.  To examine the possible contributions of NEU3 to in vivo insulin sensitivity and glucose tolerance, NEU3 was expressed by using adenoviral vectors in the livers of C57BL/6 mice on std. and high-fat diets, and insulin-resistant KKAy mice on std. diets.  Hepatic NEU3 overexpression paradoxically improved glucose tolerance and insulin sensitivity in the C57BL/6 mice fed std. diets, and glucose tolerance in the C57BL/6 mice fed high-fat diets and in KKAy mice.  Hepatic NEU3 overexpression increased hepatic glycogen deposition and triglyceride accumulation, and enhanced the hepatic peroxisome proliferator-activated receptor γ and fetuin expression in the C57BL/6 mice on std. and high-fat diets, and in KKAy mice.  Thin-layer chromatog. anal. demonstrated increased levels of GM1 and markedly reduced GM3 in the livers of mice with hepatic NEU3 overexpression (NEU3 mice).  Basal and insulin-stimulated tyrosine phosphorylations of insulin receptor substrate 1 were significantly increased, but tyrosine phosphorylations of the insulin receptor and insulin receptor substrate 2 in the NEU3 liver were unchanged.  Insulin-stimulated tyrosine phosphorylations of the insulin receptor were increased in adipose tissues of NEU3 mice.  These results suggest that hepatic NEU3 overexpression improves insulin sensitivity and glucose tolerance through modification of ganglioside compn. and peroxisome proliferator-activated receptor γ signaling.  Our findings also provide further evidence that NEU3 is an important regulator of insulin sensitivity and glucose tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaWiBCD5SS9rVg90H21EOLACvtfcHk0liBl9wzGUEQjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1CltL8%253D&md5=63fce3323abb7b6e63f1664963392450</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2006.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2006.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DYoshizumi%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DHirai%26aufirst%3DM.%26aulast%3DHinokio%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DT.%26aulast%3DYamada%26aufirst%3DT.%26aulast%3DTsunoda%26aufirst%3DU.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DOka%26aufirst%3DY.%26atitle%3DIncreased%2520hepatic%2520expression%2520of%2520ganglioside-specific%2520sialidase%252C%2520NEU3%252C%2520improves%2520insulin%2520sensitivity%2520and%2520glucose%2520tolerance%2520in%2520mice%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D2007%26volume%3D56%26spage%3D420%26epage%3D429%26doi%3D10.1016%2Fj.metabol.2006.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nardi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grace, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundal, H. S.</span></span> <span> </span><span class="NLM_article-title">NEU3 sialidase as a marker of insulin sensitivity: Regulation by fatty acids</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1742</span>– <span class="NLM_lpage">1750</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2015.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.cellsig.2015.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=26022181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC2MXps1els7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=1742-1750&author=C.+Lipinaauthor=F.+Nardiauthor=H.+Graceauthor=H.+S.+Hundal&title=NEU3+sialidase+as+a+marker+of+insulin+sensitivity%3A+Regulation+by+fatty+acids&doi=10.1016%2Fj.cellsig.2015.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">NEU3 sialidase as a marker of insulin sensitivity: Regulation by fatty acids</span></div><div class="casAuthors">Lipina, Christopher; Nardi, Francesca; Grace, Helen; Hundal, Harinder S.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1742-1750</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The plasma membrane-assocd. enzyme NEU3 sialidase functions to cleave sialic acid residues from the ganglioside GM3 thereby promoting its degrdn., and has been implicated in the modulation of insulin action.  Herein, we report for the first time that impaired insulin sensitivity in skeletal muscle and liver of obese Zucker fatty rats and aged C57BL/6 mice coincides with reduced NEU3 protein abundance.  In addn., high fat feeding was found to significantly reduce NEU3 protein in white adipose tissue of rats.  Notably, we also demonstrate the ability of the fatty acids palmitate and oleate to repress and induce NEU3 protein in L6 myotubes, concomitant with their insulin desensitizing and enhancing effects, resp.  Moreover, we show that the palmitate-driven loss in NEU3 protein is mediated, at least in part, by intracellular ceramide synthesis but does not involve the proteasomal pathway.  Strikingly, we further reveal that protein kinase B (PKB/Akt) acts as a key pos. modulator of NEU3 protein abundance.  Together, our findings implicate NEU3 as a potential biomarker of insulin sensitivity, and provide novel mechanistic insight into the regulation of NEU3 expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKEUyRJGfHTbVg90H21EOLACvtfcHk0liBl9wzGUEQjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXps1els7w%253D&md5=6851d7ddfae36f4b5ca5ae60b4ccffb7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2015.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2015.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DLipina%26aufirst%3DC.%26aulast%3DNardi%26aufirst%3DF.%26aulast%3DGrace%26aufirst%3DH.%26aulast%3DHundal%26aufirst%3DH.%2BS.%26atitle%3DNEU3%2520sialidase%2520as%2520a%2520marker%2520of%2520insulin%2520sensitivity%253A%2520Regulation%2520by%2520fatty%2520acids%26jtitle%3DCell.%2520Signalling%26date%3D2015%26volume%3D27%26spage%3D1742%26epage%3D1750%26doi%3D10.1016%2Fj.cellsig.2015.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyulay, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trigatti, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igdoura, S. A.</span></span> <span> </span><span class="NLM_article-title">Hypomorphic sialidase expression decreases serum cholesterol by downregulation of VLDL production in mice</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2573</span>– <span class="NLM_lpage">2585</span>, <span class="refDoi"> DOI: 10.1194/jlr.M027300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1194%2Fjlr.M027300" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=2573-2585&author=A.+Yangauthor=G.+Gyulayauthor=M.+Mitchellauthor=E.+Whiteauthor=B.+L.+Trigattiauthor=S.+A.+Igdoura&title=Hypomorphic+sialidase+expression+decreases+serum+cholesterol+by+downregulation+of+VLDL+production+in+mice&doi=10.1194%2Fjlr.M027300"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M027300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M027300%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DA.%26aulast%3DGyulay%26aufirst%3DG.%26aulast%3DMitchell%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DE.%26aulast%3DTrigatti%26aufirst%3DB.%2BL.%26aulast%3DIgdoura%26aufirst%3DS.%2BA.%26atitle%3DHypomorphic%2520sialidase%2520expression%2520decreases%2520serum%2520cholesterol%2520by%2520downregulation%2520of%2520VLDL%2520production%2520in%2520mice%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2012%26volume%3D53%26spage%3D2573%26epage%3D2585%26doi%3D10.1194%2Fjlr.M027300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">d’Azzo, A.</span></span> <span> </span><span class="NLM_article-title">LSDs caused by deficiency of components of the PPCA/NEU1/beta-GAL enzyme complex: pathogenesis and therapy</span>. <i>Mol. Genet. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2005&pages=199-199&author=A.+d%E2%80%99Azzo&title=LSDs+caused+by+deficiency+of+components+of+the+PPCA%2FNEU1%2Fbeta-GAL+enzyme+complex%3A+pathogenesis+and+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dd%25E2%2580%2599Azzo%26aufirst%3DA.%26atitle%3DLSDs%2520caused%2520by%2520deficiency%2520of%2520components%2520of%2520the%2520PPCA%252FNEU1%252Fbeta-GAL%2520enzyme%2520complex%253A%2520pathogenesis%2520and%2520therapy%26jtitle%3DMol.%2520Genet.%2520Metab.%26date%3D2005%26volume%3D84%26spage%3D199%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Golovanova, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gracheva, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Il’inskaya, O.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tararak, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokazova, N. V.</span></span> <span> </span><span class="NLM_article-title">Sialidase activity in normal and atherosclerotic human aortic intima</span>. <i>Biochemistry (Moscow)</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1230</span>– <span class="NLM_lpage">1234</span>, <span class="refDoi"> DOI: 10.1023/A:1021393119906</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1023%2FA%3A1021393119906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=12495418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD38XptFOjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=1230-1234&author=N.+K.+Golovanovaauthor=E.+V.+Grachevaauthor=O.%0AP.+Il%E2%80%99inskayaauthor=E.+M.+Tararakauthor=N.+V.+Prokazova&title=Sialidase+activity+in+normal+and+atherosclerotic+human+aortic+intima&doi=10.1023%2FA%3A1021393119906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sialidase Activity in Normal and Atherosclerotic Human Aortic Intima</span></div><div class="casAuthors">Golovanova, N. K.; Gracheva, E. V.; Il'inskaya, O. P.; Tararak, E. M.; Prokazova, N. V.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry (Moscow, Russian Federation)(Translation of Biokhimiya (Moscow, Russian Federation))</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1230-1234</span>CODEN:
                <span class="NLM_cas:coden">BIORAK</span>;
        ISSN:<span class="NLM_cas:issn">0006-2979</span>.
    
            (<span class="NLM_cas:orgname">MAIK Nauka/Interperiodica Publishing</span>)
        </div><div class="casAbstract">Sialidase activity has been detd. in homogenates of human aortic intima by measuring the amt. of GM1 formed during the incubation of ganglioside GD1a with the tissue homogenates.  Areas with atherosclerotic lesions as well as adjacent areas without histol. evidence of atherosclerosis were taken for comparison.  The rate of GM1 formation from GD1a in the presence of homogenates of the atherosclerotic intima was 20 pmol/h per mg protein.  Homogenates of the unaffected intima did not desialylate GD1a.  Sialidase activity of the atherosclerotic intima was linear for 1.5 h at GD1a content up to 1.5 nmol and at homogenate protein up to 1 μg.  NH4Cl and NeuAc2en, inhibitors of lysosomal function and plasma membrane-bound sialidase, resp., reduced sialidase activity of homogenates of the atherosclerotic intima by 94%.  The results indicate that atherosclerotic lesions and unaffected intima differ in their activity and specificity of sialidases that cleave gangliosides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2F-d5AnTchrVg90H21EOLACvtfcHk0lgwVlYf6fFIAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptFOjt7g%253D&md5=3d10ca1763f0a43e47256d3b60c7578f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1023%2FA%3A1021393119906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1021393119906%26sid%3Dliteratum%253Aachs%26aulast%3DGolovanova%26aufirst%3DN.%2BK.%26aulast%3DGracheva%26aufirst%3DE.%2BV.%26aulast%3DIl%25E2%2580%2599inskaya%26aufirst%3DO.%2BP.%26aulast%3DTararak%26aufirst%3DE.%2BM.%26aulast%3DProkazova%26aufirst%3DN.%2BV.%26atitle%3DSialidase%2520activity%2520in%2520normal%2520and%2520atherosclerotic%2520human%2520aortic%2520intima%26jtitle%3DBiochemistry%2520%2528Moscow%2529%26date%3D2002%26volume%3D67%26spage%3D1230%26epage%3D1234%26doi%3D10.1023%2FA%3A1021393119906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abekura, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. H.</span></span> <span> </span><span class="NLM_article-title">Monosialyl ganglioside GM3 decreases apolipoprotein B-100 secretion in liver cells</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">2168</span>– <span class="NLM_lpage">2181</span>, <span class="refDoi"> DOI: 10.1002/jcb.25860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1002%2Fjcb.25860" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2017&pages=2168-2181&author=H.+Choiauthor=U.+H.+Jinauthor=S.+K.+Kangauthor=F.+Abekuraauthor=J.+Y.+Parkauthor=K.+M.+Kwonauthor=S.+J.+Suhauthor=S.+H.+Choauthor=K.+T.+Haauthor=Y.+C.+Leeauthor=T.+W.+Chungauthor=C.+H.+Kim&title=Monosialyl+ganglioside+GM3+decreases+apolipoprotein+B-100+secretion+in+liver+cells&doi=10.1002%2Fjcb.25860"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fjcb.25860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.25860%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DU.%2BH.%26aulast%3DKang%26aufirst%3DS.%2BK.%26aulast%3DAbekura%26aufirst%3DF.%26aulast%3DPark%26aufirst%3DJ.%2BY.%26aulast%3DKwon%26aufirst%3DK.%2BM.%26aulast%3DSuh%26aufirst%3DS.%2BJ.%26aulast%3DCho%26aufirst%3DS.%2BH.%26aulast%3DHa%26aufirst%3DK.%2BT.%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DChung%26aufirst%3DT.%2BW.%26aulast%3DKim%26aufirst%3DC.%2BH.%26atitle%3DMonosialyl%2520ganglioside%2520GM3%2520decreases%2520apolipoprotein%2520B-100%2520secretion%2520in%2520liver%2520cells%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2017%26volume%3D118%26spage%3D2168%26epage%3D2181%26doi%3D10.1002%2Fjcb.25860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of the human neuraminidase enzymes</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1074</span>, <span class="refDoi"> DOI: 10.1039/C4MD00089G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1039%2FC4MD00089G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1067-1074&author=C.+W.+Cairo&title=Inhibitors+of+the+human+neuraminidase+enzymes&doi=10.1039%2FC4MD00089G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the human neuraminidase enzymes</span></div><div class="casAuthors">Cairo, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1067-1074</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The human neuraminidase enzymes (hNEU) are a family of four isoenzymes that hydrolyze sialosides, including gangliosides and glycoproteins.  These enzymes are proposed to play roles in several important signaling pathways and are implicated in diseases such as diabetes and cancer.  Despite their importance, only a limited no. of studies have sought to identify potent inhibitors for these enzymes.  This review summarizes the substrate specificity and known inhibitors of the hNEU isoenzymes, as well as the emerging work on development of isoenzyme-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqigoQZk4kNMLVg90H21EOLACvtfcHk0liULY9oI1y4NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrrL&md5=e8cf43cbe3af6d8200f27b0c25c307af</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC4MD00089G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00089G%26sid%3Dliteratum%253Aachs%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DInhibitors%2520of%2520the%2520human%2520neuraminidase%2520enzymes%26jtitle%3DMedChemComm%26date%3D2014%26volume%3D5%26spage%3D1067%26epage%3D1074%26doi%3D10.1039%2FC4MD00089G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richards, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Molecular dynamics simulations of viral neuraminidase inhibitors with the human neuraminidase enzymes: Insights into isoenzyme selectivity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5349</span>– <span class="NLM_lpage">5358</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.05.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.bmc.2018.05.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=29903413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFWhs7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=5349-5358&author=M.+R.+Richardsauthor=T.+Guoauthor=C.+D.+Hunterauthor=C.+W.+Cairo&title=Molecular+dynamics+simulations+of+viral+neuraminidase+inhibitors+with+the+human+neuraminidase+enzymes%3A+Insights+into+isoenzyme+selectivity&doi=10.1016%2Fj.bmc.2018.05.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics simulations of viral neuraminidase inhibitors with the human neuraminidase enzymes: Insights into isoenzyme selectivity</span></div><div class="casAuthors">Richards, Michele R.; Guo, Tianlin; Hunter, Carmanah D.; Cairo, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5349-5358</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibitors of viral neuraminidase enzymes have been previously developed as therapeutics.  Humans can express multiple forms of neuraminidase enzymes (NEU1, NEU2, NEU3, NEU4) that share a similar active site and enzymic mechanism with their viral counterparts.  Using a panel of purified human neuraminidase enzymes, we tested the inhibitory activity of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (DANA), zanamivir, oseltamivir, and peramivir against each of the human isoenzymes.  We find that, with the exceptions of DANA and zanamivir, these compds. show generally poor activity against the human neuraminidase enzymes.  To provide insight into the interactions of viral inhibitors with human neuraminidases, we conducted mol. dynamics simulations using homol. models based on coordinates reported for NEU2.  Simulations revealed that an organized water is displaced by zanamivir in binding to NEU2 and NEU3 and confirmed the crit. importance of engaging the binding pocket of the C7-C9 glycerol sidechain.  Our results suggest that compds. designed to target the human neuraminidases should provide more selective tools for interrogating these enzymes.  Furthermore, they emphasize a need for addnl. structural data to enable structure-based drug design in these systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvC3eNA252U7Vg90H21EOLACvtfcHk0liULY9oI1y4NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFWhs7zJ&md5=c996a2e9279bdf31454c5d7a8132128b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.05.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.05.035%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DM.%2BR.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DHunter%26aufirst%3DC.%2BD.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DMolecular%2520dynamics%2520simulations%2520of%2520viral%2520neuraminidase%2520inhibitors%2520with%2520the%2520human%2520neuraminidase%2520enzymes%253A%2520Insights%2520into%2520isoenzyme%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D5349%26epage%3D5358%26doi%3D10.1016%2Fj.bmc.2018.05.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koseki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yingsakmongkon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodeoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Itzstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, T.</span></span> <span> </span><span class="NLM_article-title">Limited inhibitory effects of oseltamivir and zanamivir on human sialidases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3484</span>– <span class="NLM_lpage">3491</span>, <span class="refDoi"> DOI: 10.1128/AAC.00344-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1128%2FAAC.00344-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=18694948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3484-3491&author=K.+Hataauthor=K.+Kosekiauthor=K.+Yamaguchiauthor=S.+Moriyaauthor=Y.+Suzukiauthor=S.+Yingsakmongkonauthor=G.+Hiraiauthor=M.+Sodeokaauthor=M.+Von+Itzsteinauthor=T.+Miyagi&title=Limited+inhibitory+effects+of+oseltamivir+and+zanamivir+on+human+sialidases&doi=10.1128%2FAAC.00344-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Limited inhibitory effects of oseltamivir and zanamivir on human sialidases</span></div><div class="casAuthors">Hata, Keiko; Koseki, Koichi; Yamaguchi, Kazunori; Moriya, Setsuko; Suzuki, Yasuo; Yingsakmongkon, Sangchai; Hirai, Go; Sodeoka, Mikiko; von Itzstein, Mark; Miyagi, Taeko</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3484-3491</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Oseltamivir (Tamiflu) and zanamivir (Relenza), two extensively used clin. effective anti-influenza drugs, are viral sialidase (also known as neuraminidase) inhibitors that prevent the release of progeny virions and thereby limit the spread of infection.  Recently mortalities and neuropsychiatric events have been reported with the use of oseltamivir, esp. in pediatric cases in Japan, suggesting that these drugs might also inhibit endogenous enzymes involved in sialic acid metab., including sialidase, sialyltransferase, and CMP-synthase, in addn. to their inhibitory effects on the viral sialidase.  The possible inhibition could account for some of the rare side effects of oseltamivir.  However, there has been little direct evidence in regard to the sensitivities of animal sialidases to these drugs.  Here, we examd. whether these inhibitors might indeed affect the activities of human sialidases, which differ in primary structures and enzyme properties but possess tertiary structures similar to those of the viral enzymes.  Using recombinant enzymes corresponding to the four human sialidases identified so, far we found that oseltamivir carboxylate scarcely affected the activities of any of the sialidases, even at 1 mM, while zanamivir significantly inhibited the human sialidases NEU3 and NEU2 in the micromolar range (Ki, 3.7 ± 0.48 and 12.9 ± 0.07 μM, resp.), providing a contrast to the low nanomolar concns. at which these drugs block the activity of the viral sialidases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp11nk1bBmG_rVg90H21EOLACvtfcHk0liULY9oI1y4NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjO&md5=88b0081e7eb7bb7f944c64399afb2041</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.00344-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00344-08%26sid%3Dliteratum%253Aachs%26aulast%3DHata%26aufirst%3DK.%26aulast%3DKoseki%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DMoriya%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DYingsakmongkon%26aufirst%3DS.%26aulast%3DHirai%26aufirst%3DG.%26aulast%3DSodeoka%26aufirst%3DM.%26aulast%3DVon%2BItzstein%26aufirst%3DM.%26aulast%3DMiyagi%26aufirst%3DT.%26atitle%3DLimited%2520inhibitory%2520effects%2520of%2520oseltamivir%2520and%2520zanamivir%2520on%2520human%2520sialidases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3484%26epage%3D3491%26doi%3D10.1128%2FAAC.00344-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="note"><p class="first last">This compound has been previously named as a C9-butyl-<i>N</i>-amide derivative of DANA (C9-BA-DANA). This could more appropriately be named as a C9-pentylamide, but we maintain the previous nomenclature for consistency with the literature.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: Selective inhibitors of lysosomal sialidase (Neu1)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.11.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.bmcl.2007.11.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=18068975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosFWgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=532-537&author=S.+Mageshauthor=S.+Moriyaauthor=T.+Suzukiauthor=T.+Miyagiauthor=H.+Ishidaauthor=M.+Kiso&title=Design%2C+synthesis%2C+and+biological+evaluation+of+human+sialidase+inhibitors.+Part+1%3A+Selective+inhibitors+of+lysosomal+sialidase+%28Neu1%29&doi=10.1016%2Fj.bmcl.2007.11.084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: Selective inhibitors of lysosomal sialidase (NEU1)</span></div><div class="casAuthors">Magesh, Sadagopan; Moriya, Setsuko; Suzuki, Tohru; Miyagi, Taeko; Ishida, Hideharu; Kiso, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">532-537</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We here report the design and synthesis of selective human lysosomal sialidase (NEU1) inhibitors.  A series of amide-linked C9 modified DANA (2-deoxy-2,3-dehydro-N-acetylneuraminic acid) analogs were synthesized and their inhibitory activities against all four human sialidases (NEU1-NEU4) were detd.  Structure-based approach was used to investigate the basis of selectivity of the compds. with exptl. obsd. activity.  Results from the present study are found to be informative in a qual. manner for the further design of isoform selective human sialidase inhibitors for therapeutic value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdeSV9eH47GLVg90H21EOLACvtfcHk0lhS7L4fvhKZ4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosFWgtQ%253D%253D&md5=3beef27b55b27fa8b688d9a7e06d207b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.11.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.11.084%26sid%3Dliteratum%253Aachs%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DMoriya%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DKiso%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520human%2520sialidase%2520inhibitors.%2520Part%25201%253A%2520Selective%2520inhibitors%2520of%2520lysosomal%2520sialidase%2520%2528Neu1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D532%26epage%3D537%26doi%3D10.1016%2Fj.bmcl.2007.11.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albohy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smutova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Identification of selective nanomolar inhibitors of the human neuraminidase, NEU4</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1021/ml400080t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400080t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=532-537&author=A.+Albohyauthor=Y.+Zhangauthor=V.+Smutovaauthor=A.+V.+Pshezhetskyauthor=C.+W.+Cairo&title=Identification+of+selective+nanomolar+inhibitors+of+the+human+neuraminidase%2C+NEU4&doi=10.1021%2Fml400080t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU4</span></div><div class="casAuthors">Albohy, Amgad; Zhang, Yi; Smutova, Victoria; Pshezhetsky, Alexey V.; Cairo, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">532-537</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The human neuraminidase enzymes (hNEU) play important roles in human physiol. and pathol.  The lack of potent and selective inhibitors toward these enzymes has limited our understanding of their function and the development of therapeutic applications.  Here we report the evaluation of a panel of compds. against the four human neuraminidase isoenzymes.  Among the compds. tested, we identified the first selective, nanomolar inhibitors of the human neuraminidase 4 enzyme (NEU4).  The most potent NEU4 inhibitor (5-acetamido-9-[4-hydroxymethyl[1,2,3]triazol-1-yl]-2,3,5,9-tetradeoxy-D-glycero-D-galacto-2-nonulopyranosonic acid) was found to have an inhibitory const. (Ki) of 30±19 nM and was 500-fold selective for its target over the other hNEU isoenzymes tested in vitro (NEU1, NEU2, and NEU3).  This is the first report of any inhibitor of hNEU with nanomolar potency, and this confirms that the 2,3-didehydro-2-deoxy-N-acetylneuraminic acid (DANA) scaffold can be exploited to develop new, potent, and selective inhibitors that target this important family of human enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnSRXjEnHBnbVg90H21EOLACvtfcHk0lhS7L4fvhKZ4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtrg%253D&md5=d582936f805cd74ccfd888334e8e0fdb</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fml400080t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400080t%26sid%3Dliteratum%253Aachs%26aulast%3DAlbohy%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSmutova%26aufirst%3DV.%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DIdentification%2520of%2520selective%2520nanomolar%2520inhibitors%2520of%2520the%2520human%2520neuraminidase%252C%2520NEU4%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D532%26epage%3D537%26doi%3D10.1021%2Fml400080t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datwyler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fougerat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Selective inhibitors of human neuraminidase 3</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1990</span>– <span class="NLM_lpage">2008</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01574</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVGktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1990-2008&author=T.+Guoauthor=P.+Datwylerauthor=E.+Deminaauthor=M.+R.+Richardsauthor=P.+Geauthor=C.+Zouauthor=R.+Zhengauthor=A.+Fougeratauthor=A.+V.+Pshezhetskyauthor=B.+Ernstauthor=C.+W.+Cairo&title=Selective+inhibitors+of+human+neuraminidase+3&doi=10.1021%2Facs.jmedchem.7b01574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibitors of Human Neuraminidase 3</span></div><div class="casAuthors">Guo, Tianlin; Datwyler, Philipp; Demina, Ekaterina; Richards, Michele R.; Ge, Peng; Zou, Chunxia; Zheng, Ruixiang; Fougerat, Anne; Pshezhetsky, Alexey V.; Ernst, Beat; Cairo, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1990-2008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5-Acetamido-9-pentanamido-2,6-anhydro-3,5-dideoxy-D-glycero-D-galacto-non-2-enonic Acid.  Human neuraminidases (NEU) are assocd. with human diseases including cancer, atherosclerosis, and diabetes.  To obtain small mol. inhibitors as research tools for the study of their biol. functions, we designed a library of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogs with modifications at C4 and C9 positions.  This library allowed us to discover selective inhibitors targeting the human NEU3 isoenzyme.  Our most selective inhibitor for NEU3 has a Ki of 320 ± 40 nM and a 15-fold selectivity over other human neuraminidase isoenzymes.  This inhibitor blocks glycolipid processing by NEU3 in vitro.  To improve their pharmacokinetic properties, various esters of the best inhibitors were synthesized and evaluated.  Finally, we confirmed that our best compds. exhibited selective inhibition of NEU orthologues from murine brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzyYhfRWnhorVg90H21EOLACvtfcHk0lhS7L4fvhKZ4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVGktr8%253D&md5=7f8d7e91e8259b237cf3138dfad55dc2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01574%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DDatwyler%26aufirst%3DP.%26aulast%3DDemina%26aufirst%3DE.%26aulast%3DRichards%26aufirst%3DM.%2BR.%26aulast%3DGe%26aufirst%3DP.%26aulast%3DZou%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DR.%26aulast%3DFougerat%26aufirst%3DA.%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26aulast%3DErnst%26aufirst%3DB.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DSelective%2520inhibitors%2520of%2520human%2520neuraminidase%25203%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1990%26epage%3D2008%26doi%3D10.1021%2Facs.jmedchem.7b01574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiarto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1039/c0mb00244e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1039%2Fc0mb00244e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=21206954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFGht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=1060-1072&author=Y.+Liauthor=H.+Caoauthor=H.+Yuauthor=Y.+Chenauthor=K.+Lauauthor=J.+Quauthor=V.+Thonauthor=G.+Sugiartoauthor=X.+Chen&title=Identifying+selective+inhibitors+against+the+human+cytosolic+sialidase+NEU2+by+substrate+specificity+studies&doi=10.1039%2Fc0mb00244e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies</span></div><div class="casAuthors">Li, Yan-Hong; Cao, Hong-Zhi; Yu, Hai; Chen, Yi; Lau, Kam; Qu, Jing-Yao; Thon, Vireak; Sugiarto, Go; Chen, Xi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1060-1072</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Aberrant expression of human sialidases has been shown to assoc. with various pathol. conditions.  Despite the effort in the sialidase inhibitor design, less attention has been paid to designing specific inhibitors against human sialidases and characterizing the substrate specificity of different sialidases regarding diverse terminal sialic acid forms and sialyl linkages.  This is mainly due to the lack of sialoside probes and efficient screening methods, as well as limited access to human sialidases.  A low cellular expression level of the human sialidase NEU2 hampers its functional and inhibitory studies.  Here we report the successful cloning and expression of the human sialidase NEU2 in E. coli.  About 11 mg of sol. active NEU2 was routinely obtained from 1 L of E. coli cell culture.  Substrate specificity studies of the recombinant human NEU2 using twenty p-nitrophenol (pNP)-tagged α2-3- or α2-6-linked sialyl galactosides contg. different terminal sialic acid forms including common N-acetylneuraminic acid (Neu5Ac), non-human N-glycolylneuraminic acid (Neu5Gc), 2-keto-3-deoxy-d-glycero-d-galacto-nonulosonic acid (Kdn), or their C5-derivs. in a microtiter plate-based high-throughput colorimetric assay identified a unique structural feature specifically recognized by the human NEU2 but not two bacterial sialidases.  The results obtained from substrate specificity studies were used to guide the design of a sialidase inhibitor that was selective against human NEU2.  The selectivity of the inhibitor was revealed by the comparison of sialidase crystal structures and inhibitor docking studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX23NmQCdm_7Vg90H21EOLACvtfcHk0lh8_mH2tD05HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFGht7s%253D&md5=8aac070f465e3dd1b0fb425b5a122110</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2Fc0mb00244e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0mb00244e%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DQu%26aufirst%3DJ.%26aulast%3DThon%26aufirst%3DV.%26aulast%3DSugiarto%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DIdentifying%2520selective%2520inhibitors%2520against%2520the%2520human%2520cytosolic%2520sialidase%2520NEU2%2520by%2520substrate%2520specificity%2520studies%26jtitle%3DMol.%2520BioSyst.%26date%3D2011%26volume%3D7%26spage%3D1060%26epage%3D1072%26doi%3D10.1039%2Fc0mb00244e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khedri, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthana, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">6112</span>– <span class="NLM_lpage">6120</span>, <span class="refDoi"> DOI: 10.1039/c2ob25335f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1039%2Fc2ob25335f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=22641268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSmu7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=6112-6120&author=Z.+Khedriauthor=Y.+Liauthor=H.+Caoauthor=J.+Quauthor=H.+Yuauthor=M.+M.+Muthanaauthor=X.+Chen&title=Synthesis+of+selective+inhibitors+against+V.+cholerae+sialidase+and+human+cytosolic+sialidase+NEU2&doi=10.1039%2Fc2ob25335f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2</span></div><div class="casAuthors">Khedri, Zahra; Li, Yanhong; Cao, Hongzhi; Qu, Jingyao; Yu, Hai; Muthana, Musleh M.; Chen, Xi</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">6112-6120</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Sialidases or neuraminidases catalyze the hydrolysis of terminal sialic acid residues from sialyl oligosaccharides and glycoconjugates.  Despite successes in developing potent inhibitors specifically against influenza virus neuraminidases, the progress in designing and synthesizing selective inhibitors against bacterial and human sialidases has been slow.  Guided by sialidase substrate specificity studies and sialidase crystal structural anal., a no. of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (DANA or Neu5Ac2en) analogs with modifications at C9 or at both C5 and C9 were synthesized.  Inhibition studies of various bacterial sialidases and human cytosolic sialidase NEU2 revealed that Neu5Gc9N32en and Neu5AcN39N32en are selective inhibitors against V. cholerae sialidase and human NEU2, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxY07DjtFooLVg90H21EOLACvtfcHk0lh8_mH2tD05HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSmu7fE&md5=9efb3730ef24448630f75d955cf1643e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1039%2Fc2ob25335f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob25335f%26sid%3Dliteratum%253Aachs%26aulast%3DKhedri%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DQu%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DMuthana%26aufirst%3DM.%2BM.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DSynthesis%2520of%2520selective%2520inhibitors%2520against%2520V.%2520cholerae%2520sialidase%2520and%2520human%2520cytosolic%2520sialidase%2520NEU2%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26spage%3D6112%26epage%3D6120%26doi%3D10.1039%2Fc2ob25335f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albohy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandbhor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of human neuraminidase 3 (NEU3) by <i>C</i>9-triazole derivatives of 2,3-didehydro-<i>N</i>-acetyl-neuraminic acid</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">7529</span>– <span class="NLM_lpage">7533</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.09.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.bmcl.2010.09.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKjtbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7529-7533&author=Y.+Zouauthor=A.+Albohyauthor=M.+Sandbhorauthor=C.+W.+Cairo&title=Inhibition+of+human+neuraminidase+3+%28NEU3%29+by+C9-triazole+derivatives+of+2%2C3-didehydro-N-acetyl-neuraminic+acid&doi=10.1016%2Fj.bmcl.2010.09.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-N-acetyl-neuraminic acid</span></div><div class="casAuthors">Zou, Yao; Albohy, Amgad; Sandbhor, Mahendra; Cairo, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7529-7533</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report the synthesis of a series of C9 and N5Ac modified analogs of 2,3-didehydro-N-acetyl-neuraminic acid (DANA) and their inhibitory potency for the human neuraminidase 3 (NEU3) enzyme.  We were able to generate a small library of compds. through the synthesis of azide derivs. of DANA, followed by Cu-catalyzed azide-alkyne cycloaddn. (CuAAC) to generate triazole-contg. inhibitors.  Our results suggest that NEU3 can tolerate large hydrophobic groups at the C9 position; however, none of the derivs. made at the N5Ac side-chain were active.  We identify three new inhibitors that have comparable potency to the best reported inhibitors of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtln8QUVkF9rVg90H21EOLACvtfcHk0lh8_mH2tD05HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKjtbvF&md5=27a65cd223b8b80263f6f9120a004662</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.111%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DY.%26aulast%3DAlbohy%26aufirst%3DA.%26aulast%3DSandbhor%26aufirst%3DM.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DInhibition%2520of%2520human%2520neuraminidase%25203%2520%2528NEU3%2529%2520by%2520C9-triazole%2520derivatives%2520of%25202%252C3-didehydro-N-acetyl-neuraminic%2520acid%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7529%26epage%3D7533%26doi%3D10.1016%2Fj.bmcl.2010.09.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albohy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smutova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2948</span>– <span class="NLM_lpage">2958</span>, <span class="refDoi"> DOI: 10.1021/jm301892f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301892f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2948-2958&author=Y.+Zhangauthor=A.+Albohyauthor=Y.+Zouauthor=V.+Smutovaauthor=A.+V.+Pshezhetskyauthor=C.+W.+Cairo&title=Identification+of+selective+inhibitors+for+human+neuraminidase+isoenzymes+using+C4%2CC7-modified+2-deoxy-2%2C3-didehydro-N-acetylneuraminic+acid+%28DANA%29+analogues&doi=10.1021%2Fjm301892f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm301892f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301892f%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DAlbohy%26aufirst%3DA.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DSmutova%26aufirst%3DV.%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DIdentification%2520of%2520selective%2520inhibitors%2520for%2520human%2520neuraminidase%2520isoenzymes%2520using%2520C4%252CC7-modified%25202-deoxy-2%252C3-didehydro-N-acetylneuraminic%2520acid%2520%2528DANA%2529%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2948%26epage%3D2958%26doi%3D10.1021%2Fjm301892f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hyun, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verceles, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kommagalla, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kona, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzina, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atamas, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piepenbrink, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundberg, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lillehoj, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldblum, S. E.</span></span> <span> </span><span class="NLM_article-title">The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">834</span>– <span class="NLM_lpage">849</span>, <span class="refDoi"> DOI: 10.1093/glycob/cww060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fglycob%2Fcww060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=27226251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKms7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=834-849&author=S.+W.+Hyunauthor=A.+G.+Liuauthor=Z.+G.+Liuauthor=A.+S.+Crossauthor=A.+C.+Vercelesauthor=S.+Mageshauthor=Y.+Kommagallaauthor=C.+Konaauthor=H.+Andoauthor=I.+G.+Luzinaauthor=S.+P.+Atamasauthor=K.+H.+Piepenbrinkauthor=E.+J.+Sundbergauthor=W.+Guangauthor=H.+Ishidaauthor=E.+P.+Lillehojauthor=S.+E.+Goldblum&title=The+NEU1-selective+sialidase+inhibitor%2C+C9-butyl-amide-DANA%2C+blocks+sialidase+activity+and+NEU1-mediated+bioactivities+in+human+lung+in+vitro+and+murine+lung+in+vivo&doi=10.1093%2Fglycob%2Fcww060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo</span></div><div class="casAuthors">Hyun, Sang W.; Liu, Anguo; Liu, Zhenguo; Cross, Alan S.; Verceles, Avelino C.; Magesh, Sadagopan; Kommagalla, Yadagiri; Kona, Chandrababunaidu; Ando, Hiromune; Luzina, Irina G.; Atamas, Sergei P.; Piepenbrink, Kurt H.; Sundberg, Eric J.; Guang, Wei; Ishida, Hideharu; Erik, P.; Goldblum, Simeon E.</div><div class="citationInfo"><span class="NLM_cas:title">Glycobiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">834-849</span>CODEN:
                <span class="NLM_cas:coden">GLYCE3</span>;
        ISSN:<span class="NLM_cas:issn">0959-6658</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Neuraminidase-1 (NEU1) is the predominant sialidase expressed in human airway epithelia and lung microvascular endothelia where it mediates multiple biol. processes.  We tested whether the NEU1-selective sialidase inhibitor, C9-butyl-amide-2-deoxy-2,3-dehydro-N-acetylneuraminic acid (C9-BA-DANA), inhibits one or more established NEU1-mediated bioactivities in human lung cells.  We established the IC50 values of C9-BA-DANA for total sialidase activity in human airway epithelia, lung microvascular endothelia and lung fibroblasts to be 3.74 μM, 13.0 μM and 4.82 μM, resp.  In human airway epithelia, C9-BA-DANA dose-dependently inhibited flagellin-induced, NEU1-mediated mucin-1 ectodomain desialylation, adhesiveness for Pseudomonas aeruginosa and shedding.  In lung microvascular endothelia, C9-BA-DANA reversed NEU1-driven restraint of cell migration into a wound and disruption of capillary-like tube formation.  NEU1 and its chaperone/transport protein, protective protein/cathepsin A (PPCA), were differentially expressed in these same cells.  Normalized NEU1 protein expression correlated with total sialidase activity whereas PPCA expression did not.  In contrast to eukaryotic sialidases, C9-BA-DANA exerted far less inhibitory activity for three selected bacterial neuraminidases (IC50 > 800 μM).  Structural modeling of the four human sialidases and three bacterial neuraminidases revealed a loop between the seventh and eighth strands of the β-propeller fold, that in NEU1, was substantially shorter than that seen in the six other enzymes.  Predicted steric hindrance between this loop and C9-BA-DANA could explain its selectivity for NEU1.  Finally, pretreatment of mice with C9-BA-DANA completely protected against flagellin-induced increases in lung sialidase activity.  Our combined data indicate that C9-BA-DANA inhibits endogenous and ectopically expressed sialidase activity and established NEU1-mediated bioactivities in human airway epithelia, lung microvascular endothelia, and fibroblasts in vitro and murine lungs in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk2UrrjX8jl7Vg90H21EOLACvtfcHk0ljp3S78q_3OHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKms7jM&md5=09ea6103345880a5e0d1059df7ec9f9d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcww060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcww060%26sid%3Dliteratum%253Aachs%26aulast%3DHyun%26aufirst%3DS.%2BW.%26aulast%3DLiu%26aufirst%3DA.%2BG.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26aulast%3DCross%26aufirst%3DA.%2BS.%26aulast%3DVerceles%26aufirst%3DA.%2BC.%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DKommagalla%26aufirst%3DY.%26aulast%3DKona%26aufirst%3DC.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DLuzina%26aufirst%3DI.%2BG.%26aulast%3DAtamas%26aufirst%3DS.%2BP.%26aulast%3DPiepenbrink%26aufirst%3DK.%2BH.%26aulast%3DSundberg%26aufirst%3DE.%2BJ.%26aulast%3DGuang%26aufirst%3DW.%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DLillehoj%26aufirst%3DE.%2BP.%26aulast%3DGoldblum%26aufirst%3DS.%2BE.%26atitle%3DThe%2520NEU1-selective%2520sialidase%2520inhibitor%252C%2520C9-butyl-amide-DANA%252C%2520blocks%2520sialidase%2520activity%2520and%2520NEU1-mediated%2520bioactivities%2520in%2520human%2520lung%2520in%2520vitro%2520and%2520murine%2520lung%2520in%2520vivo%26jtitle%3DGlycobiology%26date%3D2016%26volume%3D26%26spage%3D834%26epage%3D849%26doi%3D10.1093%2Fglycob%2Fcww060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulkhalek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neufeld, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczuk, M. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.2147/OTT.S55344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.2147%2FOTT.S55344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=24470763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ynu77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=117-134&author=L.+K.+O%E2%80%99Sheaauthor=S.+Abdulkhalekauthor=S.+Allisonauthor=R.+J.+Neufeldauthor=M.+R.+Szewczuk&title=Therapeutic+targeting+of+Neu1+sialidase+with+oseltamivir+phosphate+%28Tamiflu%29+disables+cancer+cell+survival+in+human+pancreatic+cancer+with+acquired+chemoresistance&doi=10.2147%2FOTT.S55344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance</span></div><div class="casAuthors">O'Shea, Leah K.; Abdulkhalek, Samar; Allison, Stephanie; Neufeld, Ronald J.; Szewczuk, Myron R.</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117-134, 18 pp.</span>CODEN:
                <span class="NLM_cas:coden">OTNHAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Resistance to drug therapy, along with high rates of metastasis, contributes to the low survival rate in patients diagnosed with pancreatic cancer.  An alternate treatment for human pancreatic cancer involving targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu) was investigated in human pancreatic cancer (PANC1) cells with acquired resistance to cisplatin and gemcitabine.  Its efficacy in overcoming the intrinsic resistance of the cell to chemotherapeutics and metastasis was evaluated.  Methods: Microscopic imaging, immunocytochem., immunohistochem., and WST-1 cell viability assays were used to evaluate cell survival, morphol. changes, and expression levels of E-cadherin, N-cadherin, and VE-cadherin before and after treatment with oseltamivir phosphate in PANC1 cells with established resistance to cisplatin, gemcitabine, or a combination of the two agents, and in archived paraffin-embedded PANC1 tumors grown in RAGxCγ double mutant mice.  Results: Oseltamivir phosphate overcame the chemoresistance of PANC1 to cisplatin and gemcitabine alone or in combination in a dose-dependent manner, and disabled the cancer cell survival mechanism(s).  Oseltamivir phosphate also reversed the epithelial-mesenchymal transition characteristic of the phenotypic E-cadherin to N-cadherin changes assocd. with resistance to drug therapy.  Low-dose oseltamivir phosphate alone or in combination with gemcitabine in heterotopic xenografts of PANC1 tumors growing in RAGxCγ double mutant mice did not prevent metastatic spread to the liver and lung.  Conclusion: Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate at the growth factor receptor level disables the intrinsic signaling platform for cancer cell survival in human pancreatic cancer with acquired chemoresistance.  These findings provide evidence for oseltamivir phosphate (Tamiflu) as a potential therapeutic agent for pancreatic cancer resistant to drug therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogNMCU3s0MmrVg90H21EOLACvtfcHk0ljp3S78q_3OHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ynu77L&md5=d9a8d9851d043209ccd3e9720719328b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2147%2FOTT.S55344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S55344%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DL.%2BK.%26aulast%3DAbdulkhalek%26aufirst%3DS.%26aulast%3DAllison%26aufirst%3DS.%26aulast%3DNeufeld%26aufirst%3DR.%2BJ.%26aulast%3DSzewczuk%26aufirst%3DM.%2BR.%26atitle%3DTherapeutic%2520targeting%2520of%2520Neu1%2520sialidase%2520with%2520oseltamivir%2520phosphate%2520%2528Tamiflu%2529%2520disables%2520cancer%2520cell%2520survival%2520in%2520human%2520pancreatic%2520cancer%2520with%2520acquired%2520chemoresistance%26jtitle%3DOncoTargets%2520Ther.%26date%3D2014%26volume%3D7%26spage%3D117%26epage%3D134%26doi%3D10.2147%2FOTT.S55344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, M.</span></span> <span> </span><span class="NLM_article-title">Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: Hints for the design of selective NEU3 inhibitors</span>. <i>J. Mol. Graphics Modell.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">196</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1016/j.jmgm.2005.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.jmgm.2005.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Gis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=196-207&author=S.+Mageshauthor=T.+Suzukiauthor=T.+Miyagiauthor=H.+Ishidaauthor=M.+Kiso&title=Homology+modeling+of+human+sialidase+enzymes+NEU1%2C+NEU3+and+NEU4+based+on+the+crystal+structure+of+NEU2%3A+Hints+for+the+design+of+selective+NEU3+inhibitors&doi=10.1016%2Fj.jmgm.2005.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: Hints for the design of selective NEU3 inhibitors</span></div><div class="casAuthors">Magesh, Sadagopan; Suzuki, Tohru; Miyagi, Taeko; Ishida, Hideharu; Kiso, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-207</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Four types of human sialidases have been cloned and characterized at the mol. level.  They are classified according to their major intracellular location as intralysomal (NEU1), cytosolic (NEU2), plasma membrane (NEU3) and lysosomal or mitochondrial membrane (NEU4) assocd. sialidases.  These human isoforms are distinct from each other in their enzymic properties as well as their substrate specificity.  Altered expression of sialidases has been correlated with malignant transformation of cells and different sialidases have been known to behave differently during carcinogenesis.  Particularly, increased expression of NEU3 has been implicated in the survival of various cancer cells and also in the development of insulin resistance.  In the present study, we have modeled three-dimensional structures of NEU1, NEU3 and NEU4 based on the crystal structure of NEU2 using the homol. modeling program MODELER.  The best model in each enzyme case was chosen on the basis of various std. protein anal. programs.  Predicted structures and the exptl. protein-ligand complex of NEU2 were compared to identify similarities and differences among the active sites.  The mol. electrostatic potential (MEP) was calcd. for the predicted models to identify the differences in charge distribution around the active site and its vicinity.  The primary objective of the present work is to identify the structural differences between the different isoforms of human sialidases, namely NEU1, NEU2, NEU3 and NEU4, thus providing a better insight into the differences in the active sites of these enzymes.  This can in turn guide us in the better understanding and rationale of the differential substrate recognition and activity, thereby aiding in the structure-based design of selective NEU3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgAbMhbiWborVg90H21EOLACvtfcHk0lgh7pfxWs3U1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Gis78%253D&md5=835062eb55957af9dbe7a8b8bd3321ad</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2005.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2005.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DKiso%26aufirst%3DM.%26atitle%3DHomology%2520modeling%2520of%2520human%2520sialidase%2520enzymes%2520NEU1%252C%2520NEU3%2520and%2520NEU4%2520based%2520on%2520the%2520crystal%2520structure%2520of%2520NEU2%253A%2520Hints%2520for%2520the%2520design%2520of%2520selective%2520NEU3%2520inhibitors%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2006%26volume%3D25%26spage%3D196%26epage%3D207%26doi%3D10.1016%2Fj.jmgm.2005.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonta, C.</span></span> <span> </span><span class="NLM_article-title">From structure to chemical shift and vice-versa</span>. <i>Prog. Nucl. Magn. Reson. Spectrosc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1016/j.pnmrs.2005.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.pnmrs.2005.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFaktrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2005&pages=27-39&author=C.+A.+Hunterauthor=M.+J.+Packerauthor=C.+Zonta&title=From+structure+to+chemical+shift+and+vice-versa&doi=10.1016%2Fj.pnmrs.2005.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">From structure to chemical shift and vice-versa</span></div><div class="casAuthors">Hunter, Christopher A.; Packer, Martin J.; Zonta, Cristiano</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Nuclear Magnetic Resonance Spectroscopy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">27-39</span>CODEN:
                <span class="NLM_cas:coden">PNMRAT</span>;
        ISSN:<span class="NLM_cas:issn">0079-6565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmNFFSXwPhNLVg90H21EOLACvtfcHk0lgh7pfxWs3U1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFaktrfM&md5=8e7504692a5452ca58f19d106916291b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.pnmrs.2005.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnmrs.2005.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DC.%2BA.%26aulast%3DPacker%26aufirst%3DM.%2BJ.%26aulast%3DZonta%26aufirst%3DC.%26atitle%3DFrom%2520structure%2520to%2520chemical%2520shift%2520and%2520vice-versa%26jtitle%3DProg.%2520Nucl.%2520Magn.%2520Reson.%2520Spectrosc.%26date%3D2005%26volume%3D47%26spage%3D27%26epage%3D39%26doi%3D10.1016%2Fj.pnmrs.2005.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonten, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Spoel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fornerod, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosveld, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Azzo, A.</span></span> <span> </span><span class="NLM_article-title">Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3156</span>– <span class="NLM_lpage">3169</span>, <span class="refDoi"> DOI: 10.1101/gad.10.24.3156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1101%2Fgad.10.24.3156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=8985184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADyaK2sXjsFWjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=3156-3169&author=E.+Bontenauthor=A.+van+der+Spoelauthor=M.+Fornerodauthor=G.+Grosveldauthor=A.+d%E2%80%99Azzo&title=Characterization+of+human+lysosomal+neuraminidase+defines+the+molecular+basis+of+the+metabolic+storage+disorder+sialidosis&doi=10.1101%2Fgad.10.24.3156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis</span></div><div class="casAuthors">Bonten, Erik; van der Spoel, Aarnoud; Fornerod, Maarten; Grosveld, Gerard; d'Azzo, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3156-3169</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Neuraminidases (sialidases) have an essential role in the removal of terminal sialic acid residues from sialoglycoconjugates and are distributed widely in nature.  The human lysosomal enzyme occurs in complex with β-galactosidase and protective protein/cathepsin A (PPCA), and is deficient in two genetic disorders: sialidosis, caused by a structural defect in the neuraminidase gene, and galactosialidosis, in which the loss of neuraminidase activity is secondary to a deficiency of PPCA.  The authors identified a full-length cDNA clone in the dbEST data base, of which the predicted amino acid sequence has extensive homol. to other mammalian and bacterial neuraminidases, including the F(Y)RIP domain and "Asp-boxes".  In situ hybridization localized the human neuraminidase gene to chromosome band 6p21, a region known to contain the HLA locus.  Transient expression of the cDNA in deficient human fibroblasts showed that the enzyme is compartmentalized in lysosomes and restored neuraminidase activity in a PPCA-dependent manner.  The authenticity of the cDNA was verified by the identification of three independent mutations in the open reading frame of the mRNA from clin. distinct sialidosis patients.  Coexpression of the mutant cDNAs with PPCA failed to generate neuraminidase activity, confirming the inactivating effect of the mutations.  These results establish the mol. basis of sialidosis in these patients, and clearly identify the cDNA-encoded protein as lysosomal neuraminidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUaX03DrwFRLVg90H21EOLACvtfcHk0lgh7pfxWs3U1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsFWjtg%253D%253D&md5=3af0ff8e03dd21760dde6209b4bc7a4e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1101%2Fgad.10.24.3156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.10.24.3156%26sid%3Dliteratum%253Aachs%26aulast%3DBonten%26aufirst%3DE.%26aulast%3Dvan%2Bder%2BSpoel%26aufirst%3DA.%26aulast%3DFornerod%26aufirst%3DM.%26aulast%3DGrosveld%26aufirst%3DG.%26aulast%3Dd%25E2%2580%2599Azzo%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520human%2520lysosomal%2520neuraminidase%2520defines%2520the%2520molecular%2520basis%2520of%2520the%2520metabolic%2520storage%2520disorder%2520sialidosis%26jtitle%3DGenes%2520Dev.%26date%3D1996%26volume%3D10%26spage%3D3156%26epage%3D3169%26doi%3D10.1101%2Fgad.10.24.3156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loka, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadek, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romaniuk, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Conjugation of synthetic N-acetyl-lactosamine to azide-containing proteins using the Staudinger ligation</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1842</span>– <span class="NLM_lpage">1849</span>, <span class="refDoi"> DOI: 10.1021/bc100209r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc100209r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=1842-1849&author=R.+S.+Lokaauthor=C.+M.+Sadekauthor=N.+A.+Romaniukauthor=C.+W.+Cairo&title=Conjugation+of+synthetic+N-acetyl-lactosamine+to+azide-containing+proteins+using+the+Staudinger+ligation&doi=10.1021%2Fbc100209r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation of Synthetic N-Acetyl-Lactosamine to Azide-Containing Proteins Using the Staudinger Ligation</span></div><div class="casAuthors">Loka, Ravi S.; Sadek, Christopher M.; Romaniuk, Nikolas A.; Cairo, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1842-1849</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Generation of defined glycoconjugates is necessary for the study of glycoprotein function, as well as the development of therapeutics.  The biosynthesis of glycoproteins produces multiple glycoforms, proteins which differ only in the structure of the attached glycan.  This inherent heterogeneity complicates the study of isolated glycans and, in particular, could obscure the role of individual glycan epitopes in biol. function.  The authors present a general strategy based on the Staudinger ligation to introduce specific glycan epitopes onto azide-contg. proteins.  The use of a phosphane-based Staudinger reagent allows for extremely mild reaction conditions which can be applied to aq. proteins or cells.  The authors demonstrate that multiple carbohydrate epitopes can be incorporated onto a protein backbone, and that the resulting glycans are competent for recognition by lectins.  The authors propose that this general strategy will allow for testing the role of specific glycan epitopes in cellular and biochem. assays and increasing the stability of protein conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6TgKAnJPzM7Vg90H21EOLACvtfcHk0ljGGNO92BgWlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtLrL&md5=cecfefeaa87a4ffdecc8d3f9ec78acae</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fbc100209r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc100209r%26sid%3Dliteratum%253Aachs%26aulast%3DLoka%26aufirst%3DR.%2BS.%26aulast%3DSadek%26aufirst%3DC.%2BM.%26aulast%3DRomaniuk%26aufirst%3DN.%2BA.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DConjugation%2520of%2520synthetic%2520N-acetyl-lactosamine%2520to%2520azide-containing%2520proteins%2520using%2520the%2520Staudinger%2520ligation%26jtitle%3DBioconjugate%2520Chem.%26date%3D2010%26volume%3D21%26spage%3D1842%26epage%3D1849%26doi%3D10.1021%2Fbc100209r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shidmoossavee, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennet, A. J.</span></span> <span> </span><span class="NLM_article-title">Chemical insight into the emergence of influenza virus strains that are resistant to Relenza</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">13254</span>– <span class="NLM_lpage">13257</span>, <span class="refDoi"> DOI: 10.1021/ja405916q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja405916q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGntbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=13254-13257&author=F.+S.+Shidmoossaveeauthor=J.+N.+Watsonauthor=A.+J.+Bennet&title=Chemical+insight+into+the+emergence+of+influenza+virus+strains+that+are+resistant+to+Relenza&doi=10.1021%2Fja405916q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Insight into the Emergence of Influenza Virus Strains That Are Resistant to Relenza</span></div><div class="casAuthors">Shidmoossavee, Fahimeh S.; Watson, Jacqueline N.; Bennet, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">13254-13257</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A reagent panel contg. ten 4-substituted 4-nitrophenyl α-d-sialosides and a second panel of the corresponding sialic acid glycals were synthesized and used to probe the inhibition mechanism for two neuraminidases, the N2 enzyme from influenza type A virus and the enzyme from Micromonospora viridifaciens.  For the viral enzyme the logarithm of the inhibition const. (Ki) correlated with neither the logarithm of the catalytic efficiency (kcat/Km) nor catalytic proficiency (kcat/Kmkun).  These linear free energy relationship data support the notion that these inhibitors, which include the therapeutic agent Relenza, are not transition state mimics for the enzyme-catalyzed hydrolysis reaction.  Moreover, for the influenza enzyme, a correlation (slope, 0.80 ± 0.08) is obsd. between the logarithms of the inhibition (Ki) and Michaelis (Km) consts.  We conclude that the free energy for Relenza binding to the influenza enzyme mimics the enzyme-substrate interactions at the Michaelis complex.  Thus, an influenza mutational response to a 4-substituted sialic acid glycal inhibitor can weaken the interactions between the inhibitor and the viral neuraminidase without a concomitant decrease in free energy of binding for the substrate at the enzyme-catalyzed hydrolysis transition state.  The current findings make it clear that new structural motifs and/or substitution patterns need to be developed in the search for a bona fide influenza viral neuraminidase transition state analog inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc1UqIwwur7rVg90H21EOLACvtfcHk0ljGGNO92BgWlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGntbbM&md5=6b65e745d148c69c0e96750de39219ce</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fja405916q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja405916q%26sid%3Dliteratum%253Aachs%26aulast%3DShidmoossavee%26aufirst%3DF.%2BS.%26aulast%3DWatson%26aufirst%3DJ.%2BN.%26aulast%3DBennet%26aufirst%3DA.%2BJ.%26atitle%3DChemical%2520insight%2520into%2520the%2520emergence%2520of%2520influenza%2520virus%2520strains%2520that%2520are%2520resistant%2520to%2520Relenza%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D13254%26epage%3D13257%26doi%3D10.1021%2Fja405916q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Potier, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mameli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bélisle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallaire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melancon, S. B.</span></span> <span> </span><span class="NLM_article-title">Fluorometric assays of neuraminidase with a sodium (4-methylumbellifery-α-D-N-Acetylneuraminate) substrate</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1016/0003-2697(79)90362-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2F0003-2697%2879%2990362-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1979&pages=287-296&author=M.-C.+Potierauthor=L.+Mameliauthor=M.+B%C3%A9lisleauthor=L.+Dallaireauthor=S.+B.+Melancon&title=Fluorometric+assays+of+neuraminidase+with+a+sodium+%284-methylumbellifery-%CE%B1-D-N-Acetylneuraminate%29+substrate&doi=10.1016%2F0003-2697%2879%2990362-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2879%2990362-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252879%252990362-2%26sid%3Dliteratum%253Aachs%26aulast%3DPotier%26aufirst%3DM.-C.%26aulast%3DMameli%26aufirst%3DL.%26aulast%3DB%25C3%25A9lisle%26aufirst%3DM.%26aulast%3DDallaire%26aufirst%3DL.%26aulast%3DMelancon%26aufirst%3DS.%2BB.%26atitle%3DFluorometric%2520assays%2520of%2520neuraminidase%2520with%2520a%2520sodium%2520%25284-methylumbellifery-%25CE%25B1-D-N-Acetylneuraminate%2529%2520substrate%26jtitle%3DAnal.%2520Biochem.%26date%3D1979%26volume%3D94%26spage%3D287%26epage%3D296%26doi%3D10.1016%2F0003-2697%2879%2990362-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warner, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, J. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2′-(4-methylumbelliferyl)-.alpha.-D-N-acetylneuraminic acid and detection of skin fibroblast neuraminidase in normal humans and in sialidosis</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2783</span>– <span class="NLM_lpage">2787</span>, <span class="refDoi"> DOI: 10.1021/bi00580a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00580a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1979&pages=2783-2787&author=T.+G.+Warnerauthor=J.+S.+O%E2%80%99Brien&title=Synthesis+of+2%E2%80%B2-%284-methylumbelliferyl%29-.alpha.-D-N-acetylneuraminic+acid+and+detection+of+skin+fibroblast+neuraminidase+in+normal+humans+and+in+sialidosis&doi=10.1021%2Fbi00580a014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fbi00580a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00580a014%26sid%3Dliteratum%253Aachs%26aulast%3DWarner%26aufirst%3DT.%2BG.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BS.%26atitle%3DSynthesis%2520of%25202%25E2%2580%25B2-%25284-methylumbelliferyl%2529-.alpha.-D-N-acetylneuraminic%2520acid%2520and%2520detection%2520of%2520skin%2520fibroblast%2520neuraminidase%2520in%2520normal%2520humans%2520and%2520in%2520sialidosis%26jtitle%3DBiochemistry%26date%3D1979%26volume%3D18%26spage%3D2783%26epage%3D2787%26doi%3D10.1021%2Fbi00580a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Aragão, C. D. B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco-Martin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priestman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturiale, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garozzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platt, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamarche-Vane, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span> <span> </span><span class="NLM_article-title">Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3467</span>– <span class="NLM_lpage">3483</span>, <span class="refDoi"> DOI: 10.1096/fj.201601299R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1096%2Ffj.201601299R" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=3467-3483&issue=8&author=X.+Panauthor=C.+D.+B.+P.+De+Arag%C3%A3oauthor=J.+P.+Velasco-Martinauthor=D.+A.+Priestmanauthor=H.+Y.+Wuauthor=K.+Takahashiauthor=K.+Yamaguchiauthor=L.+Sturialeauthor=D.+Garozzoauthor=F.+M.+Plattauthor=N.+Lamarche-Vaneauthor=C.+R.+Moralesauthor=T.+Miyagiauthor=A.+V.+Pshezhetsky&title=Neuraminidases+3+and+4+regulate+neuronal+function+by+catabolizing+brain+gangliosides&doi=10.1096%2Ffj.201601299R"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1096%2Ffj.201601299R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201601299R%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DX.%26aulast%3DDe%2BArag%25C3%25A3o%26aufirst%3DC.%2BD.%2BB.%2BP.%26aulast%3DVelasco-Martin%26aufirst%3DJ.%2BP.%26aulast%3DPriestman%26aufirst%3DD.%2BA.%26aulast%3DWu%26aufirst%3DH.%2BY.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DSturiale%26aufirst%3DL.%26aulast%3DGarozzo%26aufirst%3DD.%26aulast%3DPlatt%26aufirst%3DF.%2BM.%26aulast%3DLamarche-Vane%26aufirst%3DN.%26aulast%3DMorales%26aufirst%3DC.%2BR.%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26atitle%3DNeuraminidases%25203%2520and%25204%2520regulate%2520neuronal%2520function%2520by%2520catabolizing%2520brain%2520gangliosides%26jtitle%3DFASEB%2520J.%26date%3D2017%26volume%3D31%26issue%3D8%26spage%3D3467%26epage%3D3483%26doi%3D10.1096%2Ffj.201601299R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koseki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, T.</span></span> <span> </span><span class="NLM_article-title">Human cytosolic sialidase Neu2-low general tissue expression but involvement in PC-3 prostate cancer cell survival</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>428</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2012.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.bbrc.2012.10.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=23068092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsF2ms7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2012&pages=142-149&author=K.+Kosekiauthor=T.+Wadaauthor=M.+Hosonoauthor=K.+Hataauthor=K.+Yamaguchiauthor=K.+Nittaauthor=T.+Miyagi&title=Human+cytosolic+sialidase+Neu2-low+general+tissue+expression+but+involvement+in+PC-3+prostate+cancer+cell+survival&doi=10.1016%2Fj.bbrc.2012.10.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Human cytosolic sialidase NEU2-low general tissue expression but involvement in PC-3 prostate cancer cell survival</span></div><div class="casAuthors">Koseki, Koichi; Wada, Tadashi; Hosono, Masahiro; Hata, Keiko; Yamaguchi, Kazunori; Nitta, Kazuo; Miyagi, Taeko</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">142-149</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Unlike other human sialidases, human cytosolic sialidase NEU2 expression as assessed by quant. real-time PCR was found to be extremely low or undetectable in many human tissues and cells, with notable exceptions like the placenta and testis.  The gene forms obtained by PCR with cDNAs synthesized from poly (A)+ RNA of human brain and colon were verified to encode cytosolic sialidase with appropriate activity, regardless of the brain gene feature of SNPs.  Among a series of human cancer cell lines examd., only prostate cancer PC-3 cells exhibited relatively high expression and NEU2-silencing with an siRNA resulted in decreased cell survival and motility.  To gain insights into the significance of the high levels, transcription factors in the promoter region of the NEU2 gene were surveyed for involvement.  PC-3 cells were characterized by high expression of Runx2 and Sp3, and their silencing reduced NEU2, suggesting regulatory roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHeKiTVafo17Vg90H21EOLACvtfcHk0lhtRkW4DbpKDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsF2ms7nF&md5=4f62010bfa811792c96c13b970b12fe5</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2012.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2012.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DKoseki%26aufirst%3DK.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DHata%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DNitta%26aufirst%3DK.%26aulast%3DMiyagi%26aufirst%3DT.%26atitle%3DHuman%2520cytosolic%2520sialidase%2520Neu2-low%2520general%2520tissue%2520expression%2520but%2520involvement%2520in%2520PC-3%2520prostate%2520cancer%2520cell%2520survival%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2012%26volume%3D428%26spage%3D142%26epage%3D149%26doi%3D10.1016%2Fj.bbrc.2012.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngamukote, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagisawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R. K.</span></span> <span> </span><span class="NLM_article-title">Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">2327</span>– <span class="NLM_lpage">2341</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2007.04910.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1111%2Fj.1471-4159.2007.04910.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=17883393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOns7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2007&pages=2327-2341&author=S.+Ngamukoteauthor=M.+Yanagisawaauthor=T.+Arigaauthor=S.+Andoauthor=R.+K.+Yu&title=Developmental+changes+of+glycosphingolipids+and+expression+of+glycogenes+in+mouse+brains&doi=10.1111%2Fj.1471-4159.2007.04910.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains</span></div><div class="casAuthors">Ngamukote, Sathaporn; Yanagisawa, Makoto; Ariga, Toshio; Ando, Susumu; Yu, Robert K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2327-2341</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Glycosphingolipids (GSLs) and their sialic acid-contg. derivs., gangliosides, are important cellular components and are abundant in the nervous system.  They are known to undergo dramatic changes during brain development.  However, knowledge on the mechanisms underlying their qual. and qual. changes is still fragmentary.  In this investigation, we have provided a detailed study on the developmental changes of the expression patterns of GSLs, GM3, GM1, GD3, GD1a, GD2, GD1b, GT1b, GQ1b, A2B5 antigens (c-series gangliosides such as GT3 and GQ1c), Chol-1α (GT1aα and GQ1bα), glucosylceramide, galactosylceramide (O1 antigen), sulfatide (O4 antigen), stage-specific embryonic antigen-1 (Lewis x) glycolipids, and human natural killer-1 glycolipid (sulfoglucuronosyl paragloboside) in developing mouse brains [embryonic day 12 (E12) to adult].  In E12-E14 brains, GD3 was a predominant ganglioside.  After E16, the concns. of GD3 and GM3 markedly decreased, and the concns. of a-series gangliosides, such as GD1a, increased.  GT3, glucosylceramide, and stage-specific embryonic antigen-1 were expressed in embryonic brains.  Human natural killer-1 glycolipid was expressed transiently in embryonic brains.  On the other hand, Chol-1α, galactosylceramide, and sulfatide were exclusively found after birth.  To provide a better understanding of the metabolic basis for these changes, we analyzed glycogene expression patterns in the developing brains and found that GSL expression is regulated primarily by glycosyltransferases, and not by glycosidases.  In parallel studies using primary neural precursor cells in culture as a tool for studying developmental events, dramatic changes in ganglioside and glycosyltransferase gene expression were also detected in neurons induced to differentiate from neural precursor cells, including the expression of GD3, followed by up-regulation of complex a- and b-series gangliosides.  These changes in cell culture systems resemble that occurring in brain.  We conclude that the dramatic changes in GSL pattern and content can serve as useful markers in neural development and that these changes are regulated primarily at the level of glycosyltransferase gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrutKcdeKaAV7Vg90H21EOLACvtfcHk0lhtRkW4DbpKDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOns7jE&md5=94feefc56b74193ce73bfcfca1c55e3b</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.04910.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.04910.x%26sid%3Dliteratum%253Aachs%26aulast%3DNgamukote%26aufirst%3DS.%26aulast%3DYanagisawa%26aufirst%3DM.%26aulast%3DAriga%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DR.%2BK.%26atitle%3DDevelopmental%2520changes%2520of%2520glycosphingolipids%2520and%2520expression%2520of%2520glycogenes%2520in%2520mouse%2520brains%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D103%26spage%3D2327%26epage%3D2341%26doi%3D10.1111%2Fj.1471-4159.2007.04910.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Geest, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonten, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sousa-Hitzler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Azzo, A.</span></span> <span> </span><span class="NLM_article-title">Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1455</span>– <span class="NLM_lpage">1464</span>, <span class="refDoi"> DOI: 10.1093/hmg/11.12.1455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fhmg%2F11.12.1455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=12023988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD38XksFWmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=1455-1464&author=N.+de%0AGeestauthor=E.+Bontenauthor=L.+Mannauthor=J.+de+Sousa-Hitzlerauthor=C.+Hahnauthor=A.+d%E2%80%99Azzo&title=Systemic+and+neurologic+abnormalities+distinguish+the+lysosomal+disorders+sialidosis+and+galactosialidosis+in+mice&doi=10.1093%2Fhmg%2F11.12.1455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice</span></div><div class="casAuthors">De Geest, Natalie; Bonten, Erik; Mann, Linda; De Sousa-Hitzler, Jean; Hahn, Christopher; D'Azzo, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1455-1464</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Neuraminidase initiates the hydrolysis of sialo-glycoconjugates by removing their terminal sialic acid residues.  In humans, primary or secondary deficiency of this enzyme leads to two clin. similar neurodegenerative lysosomal storage disorders: sialidosis and galactosialidosis (GS).  Mice nullizygous at the Neu1 locus develop clin. abnormalities reminiscent of early-onset sialidosis in children, including severe nephropathy, progressive edema, splenomegaly, kyphosis and urinary excretion of sialylated oligosaccharides.  Although the sialidosis mouse model shares clin. and histopathol. features with GS mice and GS patients, we have identified phenotypic abnormalities that seem specific for sialidosis mice.  These include progressive deformity of the spine, high incidence of premature death, age-related extramedullary hematopoiesis, and lack of early degeneration of cerebellar Purkinje cells.  The differences and similarities identified in these sialidosis and GS mice may help to better understand the pathophysiol. of these diseases in children and to identify more targeted therapies for each of these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdVVFAz7idcrVg90H21EOLACvtfcHk0lg_a5A5ODxKdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksFWmsLk%253D&md5=a9c4e88ef9af3417c8945df577a28d66</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F11.12.1455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F11.12.1455%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BGeest%26aufirst%3DN.%26aulast%3DBonten%26aufirst%3DE.%26aulast%3DMann%26aufirst%3DL.%26aulast%3Dde%2BSousa-Hitzler%26aufirst%3DJ.%26aulast%3DHahn%26aufirst%3DC.%26aulast%3Dd%25E2%2580%2599Azzo%26aufirst%3DA.%26atitle%3DSystemic%2520and%2520neurologic%2520abnormalities%2520distinguish%2520the%2520lysosomal%2520disorders%2520sialidosis%2520and%2520galactosialidosis%2520in%2520mice%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2002%26volume%3D11%26spage%3D1455%26epage%3D1464%26doi%3D10.1093%2Fhmg%2F11.12.1455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocharova, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocharov, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuznetsov, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawecki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocquet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorisse, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghirardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaise, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martiny, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauchez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efremov, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debelle, L.</span></span> <span> </span><span class="NLM_article-title">New insights into molecular organization of human neuraminidase-1: transmembrane topology and dimerization ability</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">38363</span>, <span class="refDoi"> DOI: 10.1038/srep38363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1038%2Fsrep38363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=27917893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC2sXps1OitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=38363&author=P.+Mauriceauthor=S.+Baudauthor=O.+V.+Bocharovaauthor=E.+V.+Bocharovauthor=A.+S.+Kuznetsovauthor=C.+Kaweckiauthor=O.+Bocquetauthor=B.+Romierauthor=L.+Gorisseauthor=M.+Ghirardiauthor=L.+Ducaauthor=S.+Blaiseauthor=L.+Martinyauthor=M.+Dauchezauthor=R.+G.+Efremovauthor=L.+Debelle&title=New+insights+into+molecular+organization+of+human+neuraminidase-1%3A+transmembrane+topology+and+dimerization+ability&doi=10.1038%2Fsrep38363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">New Insights into Molecular Organization of Human Neuraminidase-1: Transmembrane Topology and Dimerization Ability</span></div><div class="casAuthors">Maurice, Pascal; Baud, Stephanie; Bocharova, Olga V.; Bocharov, Eduard V.; Kuznetsov, Andrey S.; Kawecki, Charlotte; Bocquet, Olivier; Romier, Beatrice; Gorisse, Laetitia; Ghirardi, Maxime; Duca, Laurent; Blaise, Sebastien; Martiny, Laurent; Dauchez, Manuel; Efremov, Roman G.; Debelle, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38363</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuraminidase 1 (NEU1) is a lysosomal sialidase catalyzing the removal of terminal sialic acids from sialyloconjugates.  A plasma membrane-bound NEU1 modulating a plethora of receptors by desialylation, has been consistently documented from the last ten years.  Despite a growing interest of the scientific community to NEU1, its membrane organization is not understood and current structural and biochem. data cannot account for such membrane localization.  By combining mol. biol. and biochem. analyses with structural biophysics and computational approaches, we identified here two regions in human NEU1 - segments 139-159 (TM1) and 316-333 (TM2) - as potential transmembrane (TM) domains.  In membrane mimicking environments, the corresponding peptides form stable α-helixes and TM2 is suited for self-assocn.  This was confirmed with full-size NEU1 by co-immunopptns. from membrane prepns. and split-ubiquitin yeast two hybrids.  The TM2 region was shown to be crit. for dimerization since introduction of point mutations within TM2 leads to disruption of NEU1 dimerization and decrease of sialidase activity in membrane.  In conclusion, these results bring new insights in the mol. organization of membrane-bound NEU1 and demonstrate, for the first time, the presence of two potential TM domains that may anchor NEU1 in the membrane, control its dimerization and sialidase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGhOsakHzPzbVg90H21EOLACvtfcHk0lg_a5A5ODxKdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXps1OitQ%253D%253D&md5=7f1a7d3e9fc04e7cf47d3ea909b744a5</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fsrep38363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep38363%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DP.%26aulast%3DBaud%26aufirst%3DS.%26aulast%3DBocharova%26aufirst%3DO.%2BV.%26aulast%3DBocharov%26aufirst%3DE.%2BV.%26aulast%3DKuznetsov%26aufirst%3DA.%2BS.%26aulast%3DKawecki%26aufirst%3DC.%26aulast%3DBocquet%26aufirst%3DO.%26aulast%3DRomier%26aufirst%3DB.%26aulast%3DGorisse%26aufirst%3DL.%26aulast%3DGhirardi%26aufirst%3DM.%26aulast%3DDuca%26aufirst%3DL.%26aulast%3DBlaise%26aufirst%3DS.%26aulast%3DMartiny%26aufirst%3DL.%26aulast%3DDauchez%26aufirst%3DM.%26aulast%3DEfremov%26aufirst%3DR.%2BG.%26aulast%3DDebelle%26aufirst%3DL.%26atitle%3DNew%2520insights%2520into%2520molecular%2520organization%2520of%2520human%2520neuraminidase-1%253A%2520transmembrane%2520topology%2520and%2520dimerization%2520ability%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D38363%26doi%3D10.1038%2Fsrep38363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haxho, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neufeld, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczuk, M. R.</span></span> <span> </span><span class="NLM_article-title">Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">40860</span>– <span class="NLM_lpage">40903</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.8396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.18632%2Foncotarget.8396" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=40860-40903&author=F.+Haxhoauthor=R.+J.+Neufeldauthor=M.+R.+Szewczuk&title=Neuraminidase-1%3A+A+novel+therapeutic+target+in+multistage+tumorigenesis&doi=10.18632%2Foncotarget.8396"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8396%26sid%3Dliteratum%253Aachs%26aulast%3DHaxho%26aufirst%3DF.%26aulast%3DNeufeld%26aufirst%3DR.%2BJ.%26aulast%3DSzewczuk%26aufirst%3DM.%2BR.%26atitle%3DNeuraminidase-1%253A%2520A%2520novel%2520therapeutic%2520target%2520in%2520multistage%2520tumorigenesis%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D40860%26epage%3D40903%26doi%3D10.18632%2Foncotarget.8396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itakura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoda, M.</span></span> <span> </span><span class="NLM_article-title">Sialylation regulates myofibroblast differentiation of human skin fibroblasts</span>. <i>Stem Cell Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">81</span>, <span class="refDoi"> DOI: 10.1186/s13287-017-0534-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1186%2Fs13287-017-0534-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=28420408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFyjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=81&issue=1&author=N.+Sasakiauthor=Y.+Itakuraauthor=M.+Toyoda&title=Sialylation+regulates+myofibroblast+differentiation+of+human+skin+fibroblasts&doi=10.1186%2Fs13287-017-0534-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Sialylation regulates myofibroblast differentiation of human skin fibroblasts</span></div><div class="casAuthors">Sasaki, Norihiko; Itakura, Yoko; Toyoda, Masashi</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cell Research & Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">81/1-81/13</span>CODEN:
                <span class="NLM_cas:coden">SCRTEK</span>;
        ISSN:<span class="NLM_cas:issn">1757-6512</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Fibroblasts are key players in maintaining skin homeostasis and in orchestrating physiol. tissue repair and skin regeneration.  Dysfunctions in fibroblasts that occur with aging and the senescent process lead to the delayed healing obsd. in elderly people.  The mol. mechanisms leading to fibroblast dysfunction during aging and the senescent process have not yet been clarified.  Previously, changes in patterns of glycosylation were obsd. in fibroblasts in aging and the senescent process, but the effect of these changes on the function of fibroblasts has not been well documented.  Here, we investigated whether changes in glycosylation during the process to senescence may have functional effects on fibroblasts.  Methods: The changes in cell surface glycans on skin fibroblasts during the process to senescence were examd. in early-passage (EP) and late-passage (LP) skin fibroblasts by fluorescence-activated cell sorting anal. using lectins.  The contributors to the changes in cell surface glycans were examd. by real-time polymerase chain reaction or Western blot anal.  The effects of changes in glycosylation on proliferation, migration, induction of cellular senescence, and myofibroblast differentiation induced by transforming growth factor (TGF)-β1 stimulation were examd. in EP fibroblasts.  The changes in glycosylation were performed by GalNAc-α-O-benzyl or sialidase treatment.  Results: A decrease in sialylation of glycoproteins and an increase in sialidase NEU1 were obsd. in LP fibroblasts.  The redn. of sialylation did not have any effect on proliferation, migration, or induction of cellular senescence.  On the other hand, myofibroblast differentiation was inhibited by the redn. of sialylation, indicating that sialylation is important for myofibroblast differentiation.  The localization of CD44 in lipid rafts, which is required for myofibroblast differentiation, was inhibited by the redn. of sialylation.  Furthermore, reduced myofibroblast differentiation in LP fibroblasts was restored by a sialidase inhibitor.  Conclusions: Desialylation of CD44 with increased sialidase during the process to senescence reduced the localization of CD44 in lipid rafts after TGF-β1 stimulation, leading to the inhibition of myofibroblast differentiation.  Thus, regulation of sialylation may be an attractive strategy for the prevention and regenerative therapy of age-related skin diseases, cosmetic skin alterations, and chronic wounds caused by delayed healing in elderly people.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVqDduTOTPM7Vg90H21EOLACvtfcHk0lhagU25YkeIng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFyjt7o%253D&md5=8c904ff4e9074caffb5d000f2b5182f2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1186%2Fs13287-017-0534-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13287-017-0534-1%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DN.%26aulast%3DItakura%26aufirst%3DY.%26aulast%3DToyoda%26aufirst%3DM.%26atitle%3DSialylation%2520regulates%2520myofibroblast%2520differentiation%2520of%2520human%2520skin%2520fibroblasts%26jtitle%3DStem%2520Cell%2520Res.%2520Ther.%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D81%26doi%3D10.1186%2Fs13287-017-0534-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forcella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Difrancesco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernasconi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonnis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedeschi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzucchelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fusi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frattini, M.</span></span> <span> </span><span class="NLM_article-title">NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levels</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">868</span>, <span class="refDoi"> DOI: 10.1093/glycob/cwv026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fglycob%2Fcwv026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=855-868&author=A.+Mozziauthor=M.+Forcellaauthor=A.+Rivaauthor=C.+Difrancescoauthor=F.+Molinariauthor=V.+Martinauthor=N.+Papiniauthor=B.+Bernasconiauthor=S.+Nonnisauthor=G.+Tedeschiauthor=L.+Mazzucchelliauthor=E.+Montiauthor=P.+Fusiauthor=M.+Frattini&title=NEU3+activity+enhances+EGFR+activation+without+affecting+EGFR+expression+and+acts+on+its+sialylation+levels&doi=10.1093%2Fglycob%2Fcwv026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcwv026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcwv026%26sid%3Dliteratum%253Aachs%26aulast%3DMozzi%26aufirst%3DA.%26aulast%3DForcella%26aufirst%3DM.%26aulast%3DRiva%26aufirst%3DA.%26aulast%3DDifrancesco%26aufirst%3DC.%26aulast%3DMolinari%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DV.%26aulast%3DPapini%26aufirst%3DN.%26aulast%3DBernasconi%26aufirst%3DB.%26aulast%3DNonnis%26aufirst%3DS.%26aulast%3DTedeschi%26aufirst%3DG.%26aulast%3DMazzucchelli%26aufirst%3DL.%26aulast%3DMonti%26aufirst%3DE.%26aulast%3DFusi%26aufirst%3DP.%26aulast%3DFrattini%26aufirst%3DM.%26atitle%3DNEU3%2520activity%2520enhances%2520EGFR%2520activation%2520without%2520affecting%2520EGFR%2520expression%2520and%2520acts%2520on%2520its%2520sialylation%2520levels%26jtitle%3DGlycobiology%26date%3D2015%26volume%3D25%26spage%3D855%26epage%3D868%26doi%3D10.1093%2Fglycob%2Fcwv026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. J.</span></span> <span> </span><span class="NLM_article-title">Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">116</span>, <span class="refDoi"> DOI: 10.1186/s13045-015-0216-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1186%2Fs13045-015-0216-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=26497387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsFyntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=116&author=X.+H.+Zhangauthor=Q.+M.+Wangauthor=J.+M.+Zhangauthor=F.+E.+Fengauthor=F.+R.+Wangauthor=H.+Chenauthor=Y.+Y.+Zhangauthor=Y.+H.+Chenauthor=W.+Hanauthor=L.+P.+Xuauthor=K.+Y.+Liuauthor=X.+J.+Huang&title=Desialylation+is+associated+with+apoptosis+and+phagocytosis+of+platelets+in+patients+with+prolonged+isolated+thrombocytopenia+after+allo-HSCT&doi=10.1186%2Fs13045-015-0216-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT</span></div><div class="casAuthors">Zhang, Xiao-Hui; Wang, Qian-Ming; Zhang, Jia-Min; Feng, Fei-Er; Wang, Feng-Rong; Chen, Huan; Zhang, Yuan-Yuan; Chen, Yu-Hong; Han, Wei; Xu, Lan-Ping; Liu, Kai-Yan; Huang, Xiao-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">116/1-116/15</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Prolonged isolated thrombocytopenia (PT) is a frequent complication in patients who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT), and it is assocd. with an adverse prognosis.  In this study, we hypothesized that desialylation on platelet surfaces was assocd. with PT after allo-HSCT.  The mechanisms participating in this process may include NEU1 translocation, platelet apoptosis, and phagocytosis by macrophages.  Methods: PT was defined as a peripheral platelet count less than 100 × 109/L without sustained anemia or leukopenia for more than 3 mo after allo-HSCT.  34 Patients were identified consecutively from a cohort of 255 patients who underwent allo-HSCT for hematol. malignancies between May and Oct. 2014 at Peking University Institute of Hematol.  Desialylation, enzyme expression, and phagocytosis were detected using flow cytometry, immunofluorescence, RT-PCR, Western blot, and so on.  Results: Platelets from the PT patients had significantly fewer sialic acids (P = .001) and increased β-galactose exposure indicative of desialylation on the surface (P = .042), and serum from the PT patients showed a higher sialic acid concn. (8.400 ± 0.2209 μmol/L, P < .001).  The sialidase NEU1 was over-expressed from mRNA to protein levels, and its catalytic activity was increased in platelets from the PT patients.  Desialylation of GPIba in the PT patients was correlated with changes in 14-3-3ζ distribution, which, relative to Bad activation, modulated the expression of Bcl-2 family proteins, depolarized the inner membrane of the mitochondria, and initiated the intrinsic mitochondria-dependent pathway of apoptosis.  Macrophages derived from the THP-1 cell line preferred to phagocytize desialylated platelets from the PT patients in vitro.  We also revealed that oseltamivir (400 μmol/L) could inhibit 50 % of the sialidase activity on platelets and could protect 20 % of platelets from phagocytosis in vitro.  Conclusions: Desialylation of platelets was assocd. with platelet apoptosis and phagocytosis, whereas oseltamivir could reduce platelet destruction in the periphery, indicating a potential novel treatment for PT after allo-HSCT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruw3Ghdm9j1bVg90H21EOLACvtfcHk0lhagU25YkeIng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsFyntro%253D&md5=35ae044b173926da8b3bc5ff003ef44c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1186%2Fs13045-015-0216-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13045-015-0216-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%2BH.%26aulast%3DWang%26aufirst%3DQ.%2BM.%26aulast%3DZhang%26aufirst%3DJ.%2BM.%26aulast%3DFeng%26aufirst%3DF.%2BE.%26aulast%3DWang%26aufirst%3DF.%2BR.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%2BY.%26aulast%3DChen%26aufirst%3DY.%2BH.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DL.%2BP.%26aulast%3DLiu%26aufirst%3DK.%2BY.%26aulast%3DHuang%26aufirst%3DX.%2BJ.%26atitle%3DDesialylation%2520is%2520associated%2520with%2520apoptosis%2520and%2520phagocytosis%2520of%2520platelets%2520in%2520patients%2520with%2520prolonged%2520isolated%2520thrombocytopenia%2520after%2520allo-HSCT%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2015%26volume%3D8%26spage%3D116%26doi%3D10.1186%2Fs13045-015-0216-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fougerat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smutova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heveker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issad, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrivee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span> <span> </span><span class="NLM_article-title">Neuraminidase 1 activates insulin receptor and reverses insulin resistance in obese mice</span>. <i>Mol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/j.molmet.2018.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.molmet.2018.03.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=29735266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFWiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=76-88&author=A.+Fougeratauthor=X.+Panauthor=V.+Smutovaauthor=N.+Hevekerauthor=C.+W.+Cairoauthor=T.+Issadauthor=B.+Larriveeauthor=J.+A.+Medinauthor=A.+V.+Pshezhetsky&title=Neuraminidase+1+activates+insulin+receptor+and+reverses+insulin+resistance+in+obese+mice&doi=10.1016%2Fj.molmet.2018.03.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Neuraminidase 1 activates insulin receptor and reverses insulin resistance in obese mice</span></div><div class="casAuthors">Fougerat, Anne; Pan, Xuefang; Smutova, Victoria; Heveker, Nikolaus; Cairo, Christopher W.; Issad, Tarik; Larrivee, Bruno; Medin, Jeffrey A.; Pshezhetsky, Alexey V.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">76-88</span>CODEN:
                <span class="NLM_cas:coden">MMOEAS</span>;
        ISSN:<span class="NLM_cas:issn">2212-8778</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Neuraminidase 1 (NEU1) cleaves terminal sialic acids of glycoconjugates during lysosomal catabolism.  It also modulates the structure and activity of cellular surface receptors affecting diverse pathways.  Previously we demonstrated that NEU1 activates the insulin receptor (IR) and that NEU1-deficient CathAS190A-Neo mice (hypomorph of the NEU1 activator protein, cathepsin A/CathA) on a high-fat diet (HFD) develop hyperglycemia and insulin resistance faster than wild-type animals.  The major objective of the current work was to reveal the mol. mechanism by which NEU1 desialylation activates the IR and to test if increase of NEU1 activity in insulin target tissues reverses insulin resistance and glucose intolerance.To test if desialylation causes a conformational change in the IR dimer we measured interaction between the receptor subunits by Bioluminescence Resonance Energy Transfer in the HEK293T cells either overexpressing NEU1 or treated with the NEU1 inhibitor.  The influence of NEU1 overexpression on insulin resistance was studied in vitro in palmitate-treated HepG2 cells transduced with NEU1-expressing lentivirus and in vivo in C57Bl6 mice treated with HFD and either pharmacol. inducer of NEU1, Ambroxol or NEU1-expressing adenovirus.  NEU1-deficient CathAS190A-Neo mice were used as a control.By desialylation of IR, NEU1 induced formation of its active dimer leading to insulin signaling.  Overexpression of NEU1 in palmitate-treated HepG2 cells restored insulin signaling, suggesting that increased NEU1 levels may reverse insulin resistance.  Five-day treatment of glycemic C57Bl6 mice receiving HFD with the activator of the lysosomal gene network, Ambroxol, increased NEU1 expression and activity in muscle tissue, normalized fasting glucose levels, and improved physiol. and mol. responses to glucose and insulin.  Ambroxol did not improve insulin sensitivity in obese insulin-resistant CathAS190A-Neo mice indicating that the Ambroxol effect is mediated through NEU1 induction.  Sustained increase of liver NEU1 activity through adenovirus-based gene transfer failed to attenuate insulin resistance most probably due to neg. feedback regulation of IR expression.Together our results demonstrate that increase of NEU1 activity in insulin target tissues reverses insulin resistance and glucose intolerance suggesting that a pharmacol. modulation of NEU1 activity may be potentially explored for restoring insulin sensitivity and resolving hyperglycemia assocd. with T2DM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcXl6lWll-mLVg90H21EOLACvtfcHk0ljdwP7uslShMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFWiu74%253D&md5=b88f10399b04d21d87c0cdec2ace4118</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.molmet.2018.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmet.2018.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DFougerat%26aufirst%3DA.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DSmutova%26aufirst%3DV.%26aulast%3DHeveker%26aufirst%3DN.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26aulast%3DIssad%26aufirst%3DT.%26aulast%3DLarrivee%26aufirst%3DB.%26aulast%3DMedin%26aufirst%3DJ.%2BA.%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26atitle%3DNeuraminidase%25201%2520activates%2520insulin%2520receptor%2520and%2520reverses%2520insulin%2520resistance%2520in%2520obese%2520mice%26jtitle%3DMol.%2520Metab.%26date%3D2018%26volume%3D12%26spage%3D76%26epage%3D88%26doi%3D10.1016%2Fj.molmet.2018.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezaei Darestani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klassen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Human neuraminidase isoenzymes show variable activities for 9-O-acetyl-sialoside substrates</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">922</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00952</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00952" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=922-932&author=C.+D.+Hunterauthor=N.+Khannaauthor=M.+R.+Richardsauthor=R.+Rezaei+Darestaniauthor=C.+Zouauthor=J.+S.+Klassenauthor=C.+W.+Cairo&title=Human+neuraminidase+isoenzymes+show+variable+activities+for+9-O-acetyl-sialoside+substrates&doi=10.1021%2Facschembio.7b00952"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00952%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DC.%2BD.%26aulast%3DKhanna%26aufirst%3DN.%26aulast%3DRichards%26aufirst%3DM.%2BR.%26aulast%3DRezaei%2BDarestani%26aufirst%3DR.%26aulast%3DZou%26aufirst%3DC.%26aulast%3DKlassen%26aufirst%3DJ.%2BS.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DHuman%2520neuraminidase%2520isoenzymes%2520show%2520variable%2520activities%2520for%25209-O-acetyl-sialoside%2520substrates%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D922%26epage%3D932%26doi%3D10.1021%2Facschembio.7b00952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albohy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Insight into substrate recognition and catalysis by the human neuraminidase 3 (Neu3) through molecular modeling and site-directed mutagenesis</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1127</span>– <span class="NLM_lpage">1138</span>, <span class="refDoi"> DOI: 10.1093/glycob/cwq077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fglycob%2Fcwq077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=20511247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFSqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1127-1138&author=A.+Albohyauthor=M.+D.+Liauthor=R.+B.+Zhengauthor=C.+Zouauthor=C.+W.+Cairo&title=Insight+into+substrate+recognition+and+catalysis+by+the+human+neuraminidase+3+%28Neu3%29+through+molecular+modeling+and+site-directed+mutagenesis&doi=10.1093%2Fglycob%2Fcwq077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into substrate recognition and catalysis by the human neuraminidase 3 (NEU3) through molecular modeling and site-directed mutagenesis</span></div><div class="casAuthors">Albohy, Amgad; Li, Matthew D.; Zheng, Ruixiang Blake; Zou, Chunxia; Cairo, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Glycobiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1127-1138</span>CODEN:
                <span class="NLM_cas:coden">GLYCE3</span>;
        ISSN:<span class="NLM_cas:issn">0959-6658</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The mammalian neuraminidase (NEU) enzymes are found in diverse cellular compartments.  Members of the family, such as NEU2 and NEU1, are cytosolic or lysosomal, while NEU3 and NEU4 are membrane-assocd.  NEU enzymes that act on substrates in the plasma membrane could modulate cellular signaling, cell surface glycoforms and the compn. of plasma membrane glycolipids.  Therefore, their substrates and mechanism of action are of interest for discerning their physiol. roles.  We have studied the structure of the human NEU3 using mol. modeling to predict residues involved in the recognition and hydrolysis of glycolipid substrates.  To test the model, we have used site-directed mutagenesis of the recombinant protein.  Enzymic studies of the relative activity of these mutants, as well as their pH profiles and inhibition by 2-deoxy-2,3-dehydro-N-acetylneuraminic acid, are reported.  Using NMR spectroscopy, we confirmed that the enzyme is a retaining exo-sialidase, and we propose that the key catalytic residues of the enzyme consist of the general acid-base D50 and the nucleophilic Y370-E225 pair.  Mutations of residues expected to interact directly with the sialic acid N5-acetyl (A160, M87, I105) and C7-C9 glycerol side-chain (E113, Y179, Y181) reduced enzymic activity.  We identified several active mutants of the enzyme which contain modifications at the periphery of the active site.  Truncations at the N- or C-terminus of more than 10 residues abolished enzyme activity.  We propose a catalytic mechanism consistent with the data and identify residues that contribute to glycolipid recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzBrTTIbVQZLVg90H21EOLACvtfcHk0ljdwP7uslShMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFSqtrk%253D&md5=0e04279a474d6e4a795f261ddbb999db</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcwq077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcwq077%26sid%3Dliteratum%253Aachs%26aulast%3DAlbohy%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DM.%2BD.%26aulast%3DZheng%26aufirst%3DR.%2BB.%26aulast%3DZou%26aufirst%3DC.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DInsight%2520into%2520substrate%2520recognition%2520and%2520catalysis%2520by%2520the%2520human%2520neuraminidase%25203%2520%2528Neu3%2529%2520through%2520molecular%2520modeling%2520and%2520site-directed%2520mutagenesis%26jtitle%3DGlycobiology%26date%3D2010%26volume%3D20%26spage%3D1127%26epage%3D1138%26doi%3D10.1093%2Fglycob%2Fcwq077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albohy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2817</span>– <span class="NLM_lpage">2822</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.03.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.bmc.2011.03.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2817-2822&author=A.+Albohyauthor=S.+Mohanauthor=R.+B.+Zhengauthor=B.+M.+Pintoauthor=C.+W.+Cairo&title=Inhibitor+selectivity+of+a+new+class+of+oseltamivir+analogs+against+viral+neuraminidase+over+human+neuraminidase+enzymes&doi=10.1016%2Fj.bmc.2011.03.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.03.039%26sid%3Dliteratum%253Aachs%26aulast%3DAlbohy%26aufirst%3DA.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DR.%2BB.%26aulast%3DPinto%26aufirst%3DB.%2BM.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DInhibitor%2520selectivity%2520of%2520a%2520new%2520class%2520of%2520oseltamivir%2520analogs%2520against%2520viral%2520neuraminidase%2520over%2520human%2520neuraminidase%2520enzymes%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2817%26epage%3D2822%26doi%3D10.1016%2Fj.bmc.2011.03.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, M.</span></span> <span> </span><span class="NLM_article-title">Association of N-acetylgalactosamine-6-sulfate sulfatase with the multienzyme lysosomal complex of β-galactosidase, cathepsin A, and neuraminidase: possible implication for intralysosomal catabolism of keratan sulfate</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">28359</span>– <span class="NLM_lpage">28365</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.45.28359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1074%2Fjbc.271.45.28359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=8910459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADyaK28XmvVWqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=28359-28365&author=A.+V.+Pshezhetskyauthor=M.+Potier&title=Association+of+N-acetylgalactosamine-6-sulfate+sulfatase+with+the+multienzyme+lysosomal+complex+of+%CE%B2-galactosidase%2C+cathepsin+A%2C+and+neuraminidase%3A+possible+implication+for+intralysosomal+catabolism+of+keratan+sulfate&doi=10.1074%2Fjbc.271.45.28359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Association of N-acetylgalactosamine-6-sulfate sulfatase with the multienzyme lysosomal complex of β-galactosidase, cathepsin A, and neuraminidase. Possible implication for intralysosomal catabolism of keratan sulfate</span></div><div class="casAuthors">Pshezhetsky, Alexey V.; Potier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">28359-28365</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">N-Acetylgalactosamine-6-sulfate sulfatase (GALNS) catalyzes the first step of intralysosomal keratan sulfate (KS) catabolism.  In Morquio type A syndrome GALNS deficiency causes the accumulation of KS in tissues and results in generalized skeletal dysplasia in affected patients.  We show that in normal cells GALNS is in a 1.27-MDa complex with three other lysosomal hydrolases: β-galactosidase, α-neuraminidase, and cathepsin A (protective protein).  GALNS copurifies with the complex by different chromatog. techniques: affinity chromatog. on both cathepsin a-binding and β-galactosidase-binding columns, gel filtration, and chromatofocusing.  Anti-human cathepsin A rabbit antiserum coppts. GALNS together with cathepsin A, β-galactosidase, and α-neuraminidase in both a purified prepn. of the 1.27-MDa complex and crude glycoprotein fraction from human placenta ext.  Gel filtration anal. of fibroblast exts. of patients deficient in either β-galactosidase (β-galactosidosis) or cathepsin A (galactosialidosis), which accumulate KS, demonstrates that the 1.27-MDa complex is disrupted and that GALNS is present only in free homodimeric form.  The GALNS activity and cross-reacting material are reduced in the fibroblasts of patients affected with galactosialidosis, indicating that the complex with cathepsin A may protect GALNS in the lysosome.  We suggest that the 1.27-MDa complex of lysosomal hydrolases is essential for KS catabolism and that the disruption of this complex may be responsible for the KS accumulation in β-galactosidosis and galactosialidosis patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptD6yEfSo5VrVg90H21EOLACvtfcHk0lhgbbFWP97C_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvVWqsLw%253D&md5=2dd0842ddcfc12006ade3106307761ba</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.45.28359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.45.28359%26sid%3Dliteratum%253Aachs%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26aulast%3DPotier%26aufirst%3DM.%26atitle%3DAssociation%2520of%2520N-acetylgalactosamine-6-sulfate%2520sulfatase%2520with%2520the%2520multienzyme%2520lysosomal%2520complex%2520of%2520%25CE%25B2-galactosidase%252C%2520cathepsin%2520A%252C%2520and%2520neuraminidase%253A%2520possible%2520implication%2520for%2520intralysosomal%2520catabolism%2520of%2520keratan%2520sulfate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D28359%26epage%3D28365%26doi%3D10.1074%2Fjbc.271.45.28359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">Reversible Inhibitors</span>.  <i>Enzymes</i>; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2002</span>; Chapter 8, pp  <span class="NLM_fpage">266</span>– <span class="NLM_lpage">304</span>, <span class="refDoi"> DOI: 10.1002/0471220639.ch8</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1002%2F0471220639.ch8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=266-304&author=R.+A.+Copeland&title=Enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2F0471220639.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471220639.ch8%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DReversible%2520Inhibitors%26btitle%3DEnzymes%26pub%3DWiley-VCH%26date%3D2002%26spage%3D266%26epage%3D304%26doi%3D10.1002%2F0471220639.ch8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T. P.</span></span> <span> </span><span class="NLM_article-title">Enzymes as Drug Targets</span>. In  <i>Pharmacology in Drug Discovery</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T. P.</span></span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Boston, MA</span>, <span class="NLM_year">2012</span>; Chapter 6, pp  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">124</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2FB978-0-12-384856-7.00006-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=105-124&author=T.+P.+Kenakinauthor=T.+P.+Kenakin&title=Pharmacology+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-384856-7.00006-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-384856-7.00006-9%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26atitle%3DEnzymes%2520as%2520Drug%2520Targets%26btitle%3DPharmacology%2520in%2520Drug%2520Discovery%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26pub%3DAcademic%2520Press%26date%3D2012%26spage%3D105%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, P. H.</span></span> <span> </span><span class="NLM_article-title">Identification, synthesis, and evaluation of new neuraminidase inhibitors</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5060</span>– <span class="NLM_lpage">5063</span>, <span class="refDoi"> DOI: 10.1021/ol502410x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol502410x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKnsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=5060-5063&author=V.+Kumarauthor=C.+K.+Changauthor=K.+P.+Tanauthor=Y.+S.+Jungauthor=S.+H.+Chenauthor=Y.+S.+Chengauthor=P.+H.+Liang&title=Identification%2C+synthesis%2C+and+evaluation+of+new+neuraminidase+inhibitors&doi=10.1021%2Fol502410x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Identification, Synthesis, and Evaluation of New Neuraminidase Inhibitors</span></div><div class="casAuthors">Kumar, Vathan; Chang, Chih-Kang; Tan, Kian-Pin; Jung, Young-Sik; Chen, Shih-Hsun; Cheng, Yih-Shyun E.; Liang, Po-Huang</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5060-5063</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High-throughput screening was performed on ∼6800 compds. to identify KR-72039 as an inhibitor of H1N1 and H5N1 neuraminidases (NAs).  Structure-activity relationship studies led to I, which inhibited H5N1 NA with an IC50 of 2.8 μM and blocked viral replication.  Docking anal. shows that compds. bind to loop-430 around the NA active site.  Compd. II addnl. inhibited H7N9 NA, making it a dual inhibitor of N1- and N2-type NAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSoAkL_PI7qbVg90H21EOLACvtfcHk0lhgbbFWP97C_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKnsL%252FL&md5=5e6785dd3c756c3abb8277726f37c1c8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fol502410x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol502410x%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DChang%26aufirst%3DC.%2BK.%26aulast%3DTan%26aufirst%3DK.%2BP.%26aulast%3DJung%26aufirst%3DY.%2BS.%26aulast%3DChen%26aufirst%3DS.%2BH.%26aulast%3DCheng%26aufirst%3DY.%2BS.%26aulast%3DLiang%26aufirst%3DP.%2BH.%26atitle%3DIdentification%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520new%2520neuraminidase%2520inhibitors%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D5060%26epage%3D5063%26doi%3D10.1021%2Fol502410x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. S.</span></span> <span> </span><span class="NLM_article-title">Selective and slow-binding inhibition of shikonin derivatives isolated from Lithospermum erythrorhizon on glycosyl hydrolase 33 and 34 sialidases</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1740</span>– <span class="NLM_lpage">1748</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2012.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.bmc.2012.01.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1740-1748&author=J.+Y.+Kimauthor=H.+J.+Jeongauthor=J.-Y.+Parkauthor=Y.+M.+Kimauthor=S.-J.+Parkauthor=J.+K.+Choauthor=K.+H.+Parkauthor=Y.+B.+Ryuauthor=W.+S.+Lee&title=Selective+and+slow-binding+inhibition+of+shikonin+derivatives+isolated+from+Lithospermum+erythrorhizon+on+glycosyl+hydrolase+33+and+34+sialidases&doi=10.1016%2Fj.bmc.2012.01.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DJeong%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DJ.-Y.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DPark%26aufirst%3DS.-J.%26aulast%3DCho%26aufirst%3DJ.%2BK.%26aulast%3DPark%26aufirst%3DK.%2BH.%26aulast%3DRyu%26aufirst%3DY.%2BB.%26aulast%3DLee%26aufirst%3DW.%2BS.%26atitle%3DSelective%2520and%2520slow-binding%2520inhibition%2520of%2520shikonin%2520derivatives%2520isolated%2520from%2520Lithospermum%2520erythrorhizon%2520on%2520glycosyl%2520hydrolase%252033%2520and%252034%2520sialidases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D1740%26epage%3D1748%26doi%3D10.1016%2Fj.bmc.2012.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uddin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis-Long, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuk, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. H.</span></span> <span> </span><span class="NLM_article-title">Potent bacterial neuraminidase inhibitors, anthraquinone glucosides from Polygonum cuspidatum and their inhibitory mechanism</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.jep.2016.08.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.jep.2016.08.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2016&pages=283-292&author=Z.+Uddinauthor=Y.+H.+Songauthor=M.+J.+Curtis-Longauthor=J.+Y.+Kimauthor=H.+J.+Yukauthor=K.+H.+Park&title=Potent+bacterial+neuraminidase+inhibitors%2C+anthraquinone+glucosides+from+Polygonum+cuspidatum+and+their+inhibitory+mechanism&doi=10.1016%2Fj.jep.2016.08.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.jep.2016.08.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jep.2016.08.026%26sid%3Dliteratum%253Aachs%26aulast%3DUddin%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DY.%2BH.%26aulast%3DCurtis-Long%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DYuk%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DK.%2BH.%26atitle%3DPotent%2520bacterial%2520neuraminidase%2520inhibitors%252C%2520anthraquinone%2520glucosides%2520from%2520Polygonum%2520cuspidatum%2520and%2520their%2520inhibitory%2520mechanism%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2016%26volume%3D193%26spage%3D283%26epage%3D292%26doi%3D10.1016%2Fj.jep.2016.08.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seyrantepe, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canuel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpentier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caqueret, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gravel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchesini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwingmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levade, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span> <span> </span><span class="NLM_article-title">Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1556</span>– <span class="NLM_lpage">1568</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddn043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fhmg%2Fddn043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=18270209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFSrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1556-1568&author=V.+Seyrantepeauthor=M.+Canuelauthor=S.+Carpentierauthor=K.+Landryauthor=S.+Durandauthor=F.+Liangauthor=J.+Zengauthor=A.+Caqueretauthor=R.+A.+Gravelauthor=S.+Marchesiniauthor=C.+Zwingmannauthor=J.+Michaudauthor=C.+R.+Moralesauthor=T.+Levadeauthor=A.+V.+Pshezhetsky&title=Mice+deficient+in+Neu4+sialidase+exhibit+abnormal+ganglioside+catabolism+and+lysosomal+storage&doi=10.1093%2Fhmg%2Fddn043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage</span></div><div class="casAuthors">Seyrantepe, Volkan; Canuel, Maryssa; Carpentier, Stephane; Landry, Karine; Durand, Stephanie; Liang, Feng; Zeng, Jibin; Caqueret, Aurore; Gravel, Roy A.; Marchesini, Sergio; Zwingmann, Claudia; Michaud, Jacques; Morales, Carlos R.; Levade, Thierry; Pshezhetsky, Alexey V.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1556-1568</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mammalian sialidase Neu4, ubiquitously expressed in human tissues, is located in the lysosomal and mitochondrial lumen and has broad substrate specificity against sialylated glycoconjugates.  To investigate whether Neu4 is involved in ganglioside catabolism, we transfected β-hexosaminidase-deficient neuroglia cells from a Tay-Sachs patient with a Neu4-expressing plasmid and demonstrated the correction of storage due to the clearance of accumulated GM2 ganglioside.  To further clarify the biol. role of Neu4, we have generated a stable loss-of-function phenotype in cultured HeLa cells and in mice with targeted disruption of the Neu4 gene.  The silenced HeLa cells showed reduced activity against gangliosides and had large heterogeneous lysosomes contg. lamellar structures.  Neu4-/- mice were viable, fertile and lacked gross morphol. abnormalities, but showed a marked vacuolization and lysosomal storage in lung and spleen cells.  Lysosomal storage bodies were also present in cultured macrophages preloaded with gangliosides.  Thin-layer chromatog. showed increased relative level of GD1a ganglioside and a markedly decreased level of GM1 ganglioside in brain of Neu4-/- mice suggesting that Neu4 may be important for desialylation of brain gangliosides and consistent with the in situ hybridization data.  Increased levels of cholesterol, ceramide and polyunsatd. fatty acids were also detected in the lungs and spleen of Neu4-/- mice by high-resoln. NMR spectroscopy.  Together, our data suggest that Neu4 is a functional component of the ganglioside-metabolizing system, contributing to the postnatal development of the brain and other vital organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqZLR9yo-jXLVg90H21EOLACvtfcHk0lhf-Qel30mGZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFSrtbk%253D&md5=269b30e8fde885fb728c0a3216a28f04</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddn043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddn043%26sid%3Dliteratum%253Aachs%26aulast%3DSeyrantepe%26aufirst%3DV.%26aulast%3DCanuel%26aufirst%3DM.%26aulast%3DCarpentier%26aufirst%3DS.%26aulast%3DLandry%26aufirst%3DK.%26aulast%3DDurand%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DCaqueret%26aufirst%3DA.%26aulast%3DGravel%26aufirst%3DR.%2BA.%26aulast%3DMarchesini%26aufirst%3DS.%26aulast%3DZwingmann%26aufirst%3DC.%26aulast%3DMichaud%26aufirst%3DJ.%26aulast%3DMorales%26aufirst%3DC.%2BR.%26aulast%3DLevade%26aufirst%3DT.%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26atitle%3DMice%2520deficient%2520in%2520Neu4%2520sialidase%2520exhibit%2520abnormal%2520ganglioside%2520catabolism%2520and%2520lysosomal%2520storage%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2008%26volume%3D17%26spage%3D1556%26epage%3D1568%26doi%3D10.1093%2Fhmg%2Fddn043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chavas, L. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tringali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fusi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venerando, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tettamanti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakatsuki, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the human cytosolic sialidase Neu2 - Evidence for the dynamic nature of substrate recognition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1074/jbc.M411506200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1074%2Fjbc.M411506200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=469-475&author=L.+M.+G.+Chavasauthor=C.+Tringaliauthor=P.+Fusiauthor=B.+Venerandoauthor=G.+Tettamantiauthor=R.+Katoauthor=E.+Montiauthor=S.+Wakatsuki&title=Crystal+structure+of+the+human+cytosolic+sialidase+Neu2+-+Evidence+for+the+dynamic+nature+of+substrate+recognition&doi=10.1074%2Fjbc.M411506200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M411506200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M411506200%26sid%3Dliteratum%253Aachs%26aulast%3DChavas%26aufirst%3DL.%2BM.%2BG.%26aulast%3DTringali%26aufirst%3DC.%26aulast%3DFusi%26aufirst%3DP.%26aulast%3DVenerando%26aufirst%3DB.%26aulast%3DTettamanti%26aufirst%3DG.%26aulast%3DKato%26aufirst%3DR.%26aulast%3DMonti%26aufirst%3DE.%26aulast%3DWakatsuki%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520cytosolic%2520sialidase%2520Neu2%2520-%2520Evidence%2520for%2520the%2520dynamic%2520nature%2520of%2520substrate%2520recognition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D469%26epage%3D475%26doi%3D10.1074%2Fjbc.M411506200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':[],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jennifer J. Klein, Nancy C. Baker, Daniel H. Foil, Kimberley M. Zorn, Fabio Urbina, Ana C. Puhl, <span class="NLM_string-name hlFld-ContribAuthor">Sean Ekins</span>. </span><span class="cited-content_cbyCitation_article-title">Using Bibliometric Analysis and Machine Learning to Identify Compounds Binding to Sialidase-1. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (4)
                                     , 3186-3193. <a href="https://doi.org/10.1021/acsomega.0c05591" title="DOI URL">https://doi.org/10.1021/acsomega.0c05591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c05591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c05591%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DUsing%252BBibliometric%252BAnalysis%252Band%252BMachine%252BLearning%252Bto%252BIdentify%252BCompounds%252BBinding%252Bto%252BSialidase-1%26aulast%3DKlein%26aufirst%3DJennifer%2BJ.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D16112020%26date%3D05012021%26date%3D20012021%26volume%3D6%26issue%3D4%26spage%3D3186%26epage%3D3193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Md. Amran Howlader, Tianlin Guo, Radhika Chakraberty, <span class="NLM_string-name hlFld-ContribAuthor">Christopher W. Cairo</span>. </span><span class="cited-content_cbyCitation_article-title">Isoenzyme-Selective Inhibitors of Human Neuraminidases Reveal Distinct Effects on Cell Migration. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2020,</strong> <em>15 </em>
                                    (6)
                                     , 1328-1339. <a href="https://doi.org/10.1021/acschembio.9b00975" title="DOI URL">https://doi.org/10.1021/acschembio.9b00975</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.9b00975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.9b00975%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DIsoenzyme-Selective%252BInhibitors%252Bof%252BHuman%252BNeuraminidases%252BReveal%252BDistinct%252BEffects%252Bon%252BCell%252BMigration%26aulast%3DHowlader%26aufirst%3DMd.%2BAmran%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D04122019%26date%3D20042020%26date%3D06052020%26date%3D20042020%26volume%3D15%26issue%3D6%26spage%3D1328%26epage%3D1339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William H. D.  Bowles</span>, <span class="hlFld-ContribAuthor ">Tracey M.  Gloster</span>. </span><span class="cited-content_cbyCitation_article-title">Sialidase and Sialyltransferase Inhibitors: Targeting Pathogenicity and Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.3389/fmolb.2021.705133" title="DOI URL">https://doi.org/10.3389/fmolb.2021.705133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2021.705133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2021.705133%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DSialidase%252Band%252BSialyltransferase%252BInhibitors%25253A%252BTargeting%252BPathogenicity%252Band%252BDisease%26aulast%3DBowles%26aufirst%3DWilliam%2BH.%2BD.%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haruki  Odaka</span>, <span class="hlFld-ContribAuthor ">Tadahiro  Numakawa</span>, <span class="hlFld-ContribAuthor ">Minami  Soga</span>, <span class="hlFld-ContribAuthor ">Jun  Kido</span>, <span class="hlFld-ContribAuthor ">Shiro  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Ryutaro  Kajihara</span>, <span class="hlFld-ContribAuthor ">Toshika  Okumiya</span>, <span class="hlFld-ContribAuthor ">Naoki  Tani</span>, <span class="hlFld-ContribAuthor ">Yuki  Tanoue</span>, <span class="hlFld-ContribAuthor ">Takaichi  Fukuda</span>, <span class="hlFld-ContribAuthor ">Hirokazu  Furuya</span>, <span class="hlFld-ContribAuthor ">Takafumi  Inoue</span>, <span class="hlFld-ContribAuthor ">Takumi  Era</span>. </span><span class="cited-content_cbyCitation_article-title">An iPSC-based neural model of sialidosis uncovers glycolytic impairment-causing presynaptic dysfunction and deregulation of Ca2+ dynamics. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Disease</span><span> <strong>2021,</strong> <em>152 </em>, 105279. <a href="https://doi.org/10.1016/j.nbd.2021.105279" title="DOI URL">https://doi.org/10.1016/j.nbd.2021.105279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nbd.2021.105279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nbd.2021.105279%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Disease%26atitle%3DAn%252BiPSC-based%252Bneural%252Bmodel%252Bof%252Bsialidosis%252Buncovers%252Bglycolytic%252Bimpairment-causing%252Bpresynaptic%252Bdysfunction%252Band%252Bderegulation%252Bof%252BCa2%25252B%252Bdynamics%26aulast%3DOdaka%26aufirst%3DHaruki%26date%3D2021%26volume%3D152%26spage%3D105279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Camille  Albrecht</span>, <span class="hlFld-ContribAuthor ">Zachée Louis Evariste  Akissi</span>, <span class="hlFld-ContribAuthor ">Philomène Akoua  Yao-Kouassi</span>, <span class="hlFld-ContribAuthor ">Abdulmagid  Alabdul Magid</span>, <span class="hlFld-ContribAuthor ">Pascal  Maurice</span>, <span class="hlFld-ContribAuthor ">Laurent  Duca</span>, <span class="hlFld-ContribAuthor ">Laurence  Voutquenne-Nazabadioko</span>, <span class="hlFld-ContribAuthor ">Amar  Bennasroune</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Evaluation of New Potential Inhibitors of Human Neuraminidase 1 Extracted from Olyra latifolia L.: A Preliminary Study. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (4)
                                     , 411. <a href="https://doi.org/10.3390/biomedicines9040411" title="DOI URL">https://doi.org/10.3390/biomedicines9040411</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines9040411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines9040411%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DIdentification%252Band%252BEvaluation%252Bof%252BNew%252BPotential%252BInhibitors%252Bof%252BHuman%252BNeuraminidase%252B1%252BExtracted%252Bfrom%252BOlyra%252Blatifolia%252BL.%25253A%252BA%252BPreliminary%252BStudy%26aulast%3DAlbrecht%26aufirst%3DCamille%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D4%26spage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akira  Minami</span>, <span class="hlFld-ContribAuthor ">Yuuki  Kurebayashi</span>, <span class="hlFld-ContribAuthor ">Tadanobu  Takahashi</span>, <span class="hlFld-ContribAuthor ">Tadamune  Otsubo</span>, <span class="hlFld-ContribAuthor ">Kiyoshi  Ikeda</span>, <span class="hlFld-ContribAuthor ">Takashi  Suzuki</span>. </span><span class="cited-content_cbyCitation_article-title">The Function of Sialidase Revealed by Sialidase Activity Imaging Probe. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (6)
                                     , 3187. <a href="https://doi.org/10.3390/ijms22063187" title="DOI URL">https://doi.org/10.3390/ijms22063187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22063187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22063187%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DThe%252BFunction%252Bof%252BSialidase%252BRevealed%252Bby%252BSialidase%252BActivity%252BImaging%252BProbe%26aulast%3DMinami%26aufirst%3DAkira%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D6%26spage%3D3187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ekaterina P.  Demina</span>, <span class="hlFld-ContribAuthor ">Victoria  Smutova</span>, <span class="hlFld-ContribAuthor ">Xuefang  Pan</span>, <span class="hlFld-ContribAuthor ">Anne  Fougerat</span>, <span class="hlFld-ContribAuthor ">Tianlin  Guo</span>, <span class="hlFld-ContribAuthor ">Chunxia  Zou</span>, <span class="hlFld-ContribAuthor ">Radhika  Chakraberty</span>, <span class="hlFld-ContribAuthor ">Brendan D.  Snarr</span>, <span class="hlFld-ContribAuthor ">Tze C.  Shiao</span>, <span class="hlFld-ContribAuthor ">Rene  Roy</span>, <span class="hlFld-ContribAuthor ">Alexander N.  Orekhov</span>, <span class="hlFld-ContribAuthor ">Taeko  Miyagi</span>, <span class="hlFld-ContribAuthor ">Muriel  Laffargue</span>, <span class="hlFld-ContribAuthor ">Donald C.  Sheppard</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Cairo</span>, <span class="hlFld-ContribAuthor ">Alexey V.  Pshezhetsky</span>. </span><span class="cited-content_cbyCitation_article-title">Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low‐Density Lipoproteins and Increasing Their Uptake by Macrophages. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Heart Association</span><span> <strong>2021,</strong> <em>10 </em>
                                    (4)
                                     <a href="https://doi.org/10.1161/JAHA.120.018756" title="DOI URL">https://doi.org/10.1161/JAHA.120.018756</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/JAHA.120.018756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FJAHA.120.018756%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Heart%2520Association%26atitle%3DNeuraminidases%252B1%252Band%252B3%252BTrigger%252BAtherosclerosis%252Bby%252BDesialylating%252BLow%2525E2%252580%252590Density%252BLipoproteins%252Band%252BIncreasing%252BTheir%252BUptake%252Bby%252BMacrophages%26aulast%3DDemina%26aufirst%3DEkaterina%2BP.%26date%3D2021%26volume%3D10%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Coralie  Assailly</span>, <span class="hlFld-ContribAuthor ">Clarisse  Bridot</span>, <span class="hlFld-ContribAuthor ">Amélie  Saumonneau</span>, <span class="hlFld-ContribAuthor ">Paul  Lottin</span>, <span class="hlFld-ContribAuthor ">Benoit  Roubinet</span>, <span class="hlFld-ContribAuthor ">Eva‐Maria  Krammer</span>, <span class="hlFld-ContribAuthor ">Francesca  François</span>, <span class="hlFld-ContribAuthor ">Federica  Vena</span>, <span class="hlFld-ContribAuthor ">Ludovic  Landemarre</span>, <span class="hlFld-ContribAuthor ">Dimitri  Alvarez Dorta</span>, <span class="hlFld-ContribAuthor ">David  Deniaud</span>, <span class="hlFld-ContribAuthor ">Cyrille  Grandjean</span>, <span class="hlFld-ContribAuthor ">Charles  Tellier</span>, <span class="hlFld-ContribAuthor ">Sagrario  Pascual</span>, <span class="hlFld-ContribAuthor ">Véronique  Montembault</span>, <span class="hlFld-ContribAuthor ">Laurent  Fontaine</span>, <span class="hlFld-ContribAuthor ">Franck  Daligault</span>, <span class="hlFld-ContribAuthor ">Julie  Bouckaert</span>, <span class="hlFld-ContribAuthor ">Sébastien G.  Gouin</span>. </span><span class="cited-content_cbyCitation_article-title">Polyvalent Transition‐State Analogues of Sialyl Substrates Strongly Inhibit Bacterial Sialidases**. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (9)
                                     , 3142-3150. <a href="https://doi.org/10.1002/chem.202004672" title="DOI URL">https://doi.org/10.1002/chem.202004672</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202004672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202004672%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DPolyvalent%252BTransition%2525E2%252580%252590State%252BAnalogues%252Bof%252BSialyl%252BSubstrates%252BStrongly%252BInhibit%252BBacterial%252BSialidases%252A%252A%26aulast%3DAssailly%26aufirst%3DCoralie%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D9%26spage%3D3142%26epage%3D3150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed  Mahal</span>, <span class="hlFld-ContribAuthor ">Meitao  Duan</span>, <span class="hlFld-ContribAuthor ">Dhafer S.  Zinad</span>, <span class="hlFld-ContribAuthor ">Ranjan K.  Mohapatra</span>, <span class="hlFld-ContribAuthor ">Ahmad J.  Obaidullah</span>, <span class="hlFld-ContribAuthor ">Xiaoyi  Wei</span>, <span class="hlFld-ContribAuthor ">Manoj K.  Pradhan</span>, <span class="hlFld-ContribAuthor ">Debadutta  Das</span>, <span class="hlFld-ContribAuthor ">Venkataramana  Kandi</span>, <span class="hlFld-ContribAuthor ">Hany S.  Zinad</span>, <span class="hlFld-ContribAuthor ">Quanhong  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in chemical approaches for the development of novel neuraminidase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     , 1804-1840. <a href="https://doi.org/10.1039/D0RA07283D" title="DOI URL">https://doi.org/10.1039/D0RA07283D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA07283D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA07283D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DRecent%252Bprogress%252Bin%252Bchemical%252Bapproaches%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bnovel%252Bneuraminidase%252Binhibitors%26aulast%3DMahal%26aufirst%3DAhmed%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D3%26spage%3D1804%26epage%3D1840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irina G.  Luzina</span>, <span class="hlFld-ContribAuthor ">Erik P.  Lillehoj</span>, <span class="hlFld-ContribAuthor ">Virginia  Lockatell</span>, <span class="hlFld-ContribAuthor ">Sang W.  Hyun</span>, <span class="hlFld-ContribAuthor ">Katerina N.  Lugkey</span>, <span class="hlFld-ContribAuthor ">Akihiro  Imamura</span>, <span class="hlFld-ContribAuthor ">Hideharu  Ishida</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Cairo</span>, <span class="hlFld-ContribAuthor ">Sergei P.  Atamas</span>, <span class="hlFld-ContribAuthor ">Simeon E.  Goldblum</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Effect of Neuraminidase-1–Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2021,</strong> <em>376 </em>
                                    (1)
                                     , 136-146. <a href="https://doi.org/10.1124/jpet.120.000223" title="DOI URL">https://doi.org/10.1124/jpet.120.000223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.120.000223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.120.000223%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DTherapeutic%252BEffect%252Bof%252BNeuraminidase-1%2525E2%252580%252593Selective%252BInhibition%252Bin%252BMouse%252BModels%252Bof%252BBleomycin-Induced%252BPulmonary%252BInflammation%252Band%252BFibrosis%26aulast%3DLuzina%26aufirst%3DIrina%2BG.%26date%3D2021%26date%3D2020%26volume%3D376%26issue%3D1%26spage%3D136%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olivier  Bocquet</span>, <span class="hlFld-ContribAuthor ">Amandine  Wahart</span>, <span class="hlFld-ContribAuthor ">Thomas  Sarazin</span>, <span class="hlFld-ContribAuthor ">Elise  Vincent</span>, <span class="hlFld-ContribAuthor ">Christophe  Schneider</span>, <span class="hlFld-ContribAuthor ">Anne  Fougerat</span>, <span class="hlFld-ContribAuthor ">Stéphanie  Gayral</span>, <span class="hlFld-ContribAuthor ">Aubéri  Henry</span>, <span class="hlFld-ContribAuthor ">Sébastien  Blaise</span>, <span class="hlFld-ContribAuthor ">Béatrice  Romier-Crouzet</span>, <span class="hlFld-ContribAuthor ">Camille  Boulagnon</span>, <span class="hlFld-ContribAuthor ">Stéphane  Jaisson</span>, <span class="hlFld-ContribAuthor ">Philippe  Gillery</span>, <span class="hlFld-ContribAuthor ">Amar  Bennasroune</span>, <span class="hlFld-ContribAuthor ">Hervé  Sartelet</span>, <span class="hlFld-ContribAuthor ">Muriel  Laffargue</span>, <span class="hlFld-ContribAuthor ">Laurent  Martiny</span>, <span class="hlFld-ContribAuthor ">Laurent  Duca</span>, <span class="hlFld-ContribAuthor ">Pascal  Maurice</span>. </span><span class="cited-content_cbyCitation_article-title">Adverse Effects of Oseltamivir Phosphate Therapy on the Liver of LDLR−/− Mice Without Any Benefit on Atherosclerosis and Thrombosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cardiovascular Pharmacology</span><span> <strong>2021,</strong> <em>77 </em>
                                    (5)
                                     , 660-672. <a href="https://doi.org/10.1097/FJC.0000000000001002" title="DOI URL">https://doi.org/10.1097/FJC.0000000000001002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/FJC.0000000000001002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FFJC.0000000000001002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cardiovascular%2520Pharmacology%26atitle%3DAdverse%252BEffects%252Bof%252BOseltamivir%252BPhosphate%252BTherapy%252Bon%252Bthe%252BLiver%252Bof%252BLDLR%2525E2%252588%252592%25252F%2525E2%252588%252592%252BMice%252BWithout%252BAny%252BBenefit%252Bon%252BAtherosclerosis%252Band%252BThrombosis%26aulast%3DBocquet%26aufirst%3DOlivier%26date%3D2021%26date%3D2021%26volume%3D77%26issue%3D5%26spage%3D660%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Camille  Albrecht</span>, <span class="hlFld-ContribAuthor ">Andrey S.  Kuznetsov</span>, <span class="hlFld-ContribAuthor ">Aline  Appert-Collin</span>, <span class="hlFld-ContribAuthor ">Zineb  Dhaideh</span>, <span class="hlFld-ContribAuthor ">Maïté  Callewaert</span>, <span class="hlFld-ContribAuthor ">Yaroslav V.  Bershatsky</span>, <span class="hlFld-ContribAuthor ">Anatoly S.  Urban</span>, <span class="hlFld-ContribAuthor ">Eduard V.  Bocharov</span>, <span class="hlFld-ContribAuthor ">Dominique  Bagnard</span>, <span class="hlFld-ContribAuthor ">Stéphanie  Baud</span>, <span class="hlFld-ContribAuthor ">Sébastien  Blaise</span>, <span class="hlFld-ContribAuthor ">Béatrice  Romier-Crouzet</span>, <span class="hlFld-ContribAuthor ">Roman G.  Efremov</span>, <span class="hlFld-ContribAuthor ">Manuel  Dauchez</span>, <span class="hlFld-ContribAuthor ">Laurent  Duca</span>, <span class="hlFld-ContribAuthor ">Marc  Gueroult</span>, <span class="hlFld-ContribAuthor ">Pascal  Maurice</span>, <span class="hlFld-ContribAuthor ">Amar  Bennasroune</span>. </span><span class="cited-content_cbyCitation_article-title">Transmembrane Peptides as a New Strategy to Inhibit Neuraminidase-1 Activation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cell and Developmental Biology</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fcell.2020.611121" title="DOI URL">https://doi.org/10.3389/fcell.2020.611121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcell.2020.611121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcell.2020.611121%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DTransmembrane%252BPeptides%252Bas%252Ba%252BNew%252BStrategy%252Bto%252BInhibit%252BNeuraminidase-1%252BActivation%26aulast%3DAlbrecht%26aufirst%3DCamille%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akira  Minami</span>, <span class="hlFld-ContribAuthor ">Yuka  Fujita</span>, <span class="hlFld-ContribAuthor ">Sumika  Shimba</span>, <span class="hlFld-ContribAuthor ">Mako  Shiratori</span>, <span class="hlFld-ContribAuthor ">Yukiko K.  Kaneko</span>, <span class="hlFld-ContribAuthor ">Toshiaki  Sawatani</span>, <span class="hlFld-ContribAuthor ">Tadamune  Otsubo</span>, <span class="hlFld-ContribAuthor ">Kiyoshi  Ikeda</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Kanazawa</span>, <span class="hlFld-ContribAuthor ">Yasuyo  Mikami</span>, <span class="hlFld-ContribAuthor ">Risa  Sekita</span>, <span class="hlFld-ContribAuthor ">Yuuki  Kurebayashi</span>, <span class="hlFld-ContribAuthor ">Tadanobu  Takahashi</span>, <span class="hlFld-ContribAuthor ">Taeko  Miyagi</span>, <span class="hlFld-ContribAuthor ">Tomohisa  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Takashi  Suzuki</span>. </span><span class="cited-content_cbyCitation_article-title">The sialidase inhibitor 2,3-dehydro-2-deoxy-N-acetylneuraminic acid is a glucose-dependent potentiator of insulin secretion. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-62203-8" title="DOI URL">https://doi.org/10.1038/s41598-020-62203-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-62203-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-62203-8%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DThe%252Bsialidase%252Binhibitor%252B2%25252C3-dehydro-2-deoxy-N-acetylneuraminic%252Bacid%252Bis%252Ba%252Bglucose-dependent%252Bpotentiator%252Bof%252Binsulin%252Bsecretion%26aulast%3DMinami%26aufirst%3DAkira%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmanah D.  Hunter</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Porter</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Cairo</span>. </span><span class="cited-content_cbyCitation_article-title">Human neuraminidases have reduced activity towards modified sialic acids on glycoproteins. </span><span class="cited-content_cbyCitation_journal-name">Carbohydrate Research</span><span> <strong>2020,</strong> <em>497 </em>, 108139. <a href="https://doi.org/10.1016/j.carres.2020.108139" title="DOI URL">https://doi.org/10.1016/j.carres.2020.108139</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.carres.2020.108139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.carres.2020.108139%26sid%3Dliteratum%253Aachs%26jtitle%3DCarbohydrate%2520Research%26atitle%3DHuman%252Bneuraminidases%252Bhave%252Breduced%252Bactivity%252Btowards%252Bmodified%252Bsialic%252Bacids%252Bon%252Bglycoproteins%26aulast%3DHunter%26aufirst%3DCarmanah%2BD.%26date%3D2020%26volume%3D497%26spage%3D108139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amar  Bennasroune</span>, <span class="hlFld-ContribAuthor ">Béatrice  Romier-Crouzet</span>, <span class="hlFld-ContribAuthor ">Sébastien  Blaise</span>, <span class="hlFld-ContribAuthor ">Muriel  Laffargue</span>, <span class="hlFld-ContribAuthor ">Roman G.  Efremov</span>, <span class="hlFld-ContribAuthor ">Laurent  Martiny</span>, <span class="hlFld-ContribAuthor ">Pascal  Maurice</span>, <span class="hlFld-ContribAuthor ">Laurent  Duca</span>. </span><span class="cited-content_cbyCitation_article-title">Elastic fibers and elastin receptor complex: Neuraminidase-1 takes the center stage. </span><span class="cited-content_cbyCitation_journal-name">Matrix Biology</span><span> <strong>2019,</strong> <em>84 </em>, 57-67. <a href="https://doi.org/10.1016/j.matbio.2019.06.007" title="DOI URL">https://doi.org/10.1016/j.matbio.2019.06.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.matbio.2019.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.matbio.2019.06.007%26sid%3Dliteratum%253Aachs%26jtitle%3DMatrix%2520Biology%26atitle%3DElastic%252Bfibers%252Band%252Belastin%252Breceptor%252Bcomplex%25253A%252BNeuraminidase-1%252Btakes%252Bthe%252Bcenter%252Bstage%26aulast%3DBennasroune%26aufirst%3DAmar%26date%3D2019%26volume%3D84%26spage%3D57%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0017.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported inhibitors for human neuraminidases. Compounds previously reported as selective inhibitors of the human neuraminidase enzymes are shown. DANA <b>1</b> is a pan-selective inhibitor (with carbon atom numbering for the scaffold shown).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The antiviral NEU inhibitor, zanamivir <b>2</b>, has moderate selectivity for NEU3 and NEU2.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The C9-4HMT-DANA <b>3</b> has a 30 nM <i>K</i><sub>i</sub> against NEU4 and is 500-fold selective.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The C9-biphenyltriazole compound <b>4</b> inhibits both NEU3 and NEU4 at submicromolar potency, while compound <b>5</b> is selective for NEU3.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The azidoacetyl derivative <b>6</b> has potency for NEU2.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> Compound <b>7</b> is reported to have selectivity for NEU3.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The C9-pentylamido derivative of DANA <b>8</b> has been reported to have selective inhibition of NEU1 at micromolar potency.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The antiviral NEU inhibitor oseltamivir <b>9</b> (shown as the carboxylate form) has poor in vitro potency against human NEU.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to C5-Modified DANA Analogues <b>11a</b>–<b>l</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to C5-Modified DANA Analogues <b>13a</b>–<b>h</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route to C9-Modified DANA Analogues <b>15a</b>–<b>l</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route to C5, C9-Modified DANA Analogues <b>17a</b>–<b>h</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route to C4, C5-Modified DANA Analogue <b>22</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic illustration of the binding sites of hNEU. (A) Contacts between DANA and the binding site of NEU2 are summarized, with presumed H bond interactions. Residues shown are based on the cocrystal structure previously reported (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1VCU">1VCU</a>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> (B) Model of the NEU1 binding site with <b>17f</b>. We propose that the proximity of the C5 and C9 sites allows crossover of large groups attached at either position, and the C5 and C9 pockets act as a single large pocket, in contrast to other hNEU active sites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/medium/jm-2018-01411p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of NEU activity in homogenates of murine tissues by <b>17f</b>. Brains and kidneys were extracted from WT C57Bl6, <i>Neu1</i> KO (<i>Neu1<sup>–/–</sup></i>), or <i>Neu3/4</i> double KO (DKO) mice (<i>Neu3<sup>–/–</sup></i>, <i>Neu4<sup>–/–</sup></i>). The homogenates were assayed for inhibition of neuraminidase activity by compound <b>17f</b> against 4MU-NANA. The WT brain homogenate (A) showed partial inhibition (up to 40% at 100 μM) of neuraminidase activity, while the <i>Neu1</i> KO brain homogenate (B) showed no inhibition. The <i>Neu3/4</i> DKO brain homogenate (C) and WT kidney homogenate (D), which express only <i>Neu1</i>, showed dramatic inhibition. All homogenates showed a complete inhibition of neuraminidase activity at 150 μM DANA (data not shown). Points are labeled as significantly different (∗, <i>p</i> < 0.05; ∗∗, <i>p</i> < 0.01; ∗∗∗, <i>p</i> < 0.001) from activity in the absence of the inhibitors (dotted line) according to a <i>t</i> test with a Dunlett post-test. Data are shown as mean values ± SD of four independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01411/20181226/images/large/jm-2018-01411p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01411&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i86">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41363" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41363" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 64 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guillot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauchez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belloy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonquet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debelle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martiny, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durlach, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaise, S.</span></span> <span> </span><span class="NLM_article-title">Impact of sialic acids on the molecular dynamic of bi-antennary and tri-antennary glycans</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">35666</span>, <span class="refDoi"> DOI: 10.1038/srep35666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1038%2Fsrep35666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=27759083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjtbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=35666&author=A.+Guillotauthor=M.+Dauchezauthor=N.+Belloyauthor=J.+Jonquetauthor=L.+Ducaauthor=B.+Romierauthor=P.+Mauriceauthor=L.+Debelleauthor=L.+Martinyauthor=V.+Durlachauthor=S.+Baudauthor=S.+Blaise&title=Impact+of+sialic+acids+on+the+molecular+dynamic+of+bi-antennary+and+tri-antennary+glycans&doi=10.1038%2Fsrep35666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of sialic acids on the molecular dynamic of bi-antennary and tri-antennary glycans</span></div><div class="casAuthors">Guillot, Alexandre; Dauchez, Manuel; Belloy, Nicolas; Jonquet, Jessica; Duca, Laurent; Romier, Beatrice; Maurice, Pascal; Debelle, Laurent; Martiny, Laurent; Durlach, Vincent; Baud, Stephanie; Blaise, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35666</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sialic acids (SA) are monosaccharides that can be located at the terminal position of glycan chains on a wide range of proteins.  The post-translational modifications, such as N-glycan chains, are fundamental to protein functions.  Indeed, the hydrolysis of SA by specific enzymes such as neuraminidases can lead to drastic modifications of protein behavior.  However, the relationship between desialylation of N-glycan chains and possible alterations of receptor function remains unexplored.  Thus, the aim of the present study is to establish the impact of SA removal from N-glycan chains on their conformational behavior.  We therefore undertook an in silico investigation using mol. dynamics to predict the structure of an isolated glycan chain.  We performed, for the first time, 3 independent 500 ns simulations on bi-antennary and tri-antennary glycan chains displaying or lacking SA.  We show that desialylation alters both the preferential conformation and the flexibility of the glycan chain.  This study suggests that the behavior of glycan chains induced by presence or absence of SA may explain the changes in the protein function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohSThdR1HtI7Vg90H21EOLACvtfcHk0ljvuLZYKPHaiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjtbfJ&md5=2c735234dabda38efc7afdc5c0592b73</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fsrep35666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep35666%26sid%3Dliteratum%253Aachs%26aulast%3DGuillot%26aufirst%3DA.%26aulast%3DDauchez%26aufirst%3DM.%26aulast%3DBelloy%26aufirst%3DN.%26aulast%3DJonquet%26aufirst%3DJ.%26aulast%3DDuca%26aufirst%3DL.%26aulast%3DRomier%26aufirst%3DB.%26aulast%3DMaurice%26aufirst%3DP.%26aulast%3DDebelle%26aufirst%3DL.%26aulast%3DMartiny%26aufirst%3DL.%26aulast%3DDurlach%26aufirst%3DV.%26aulast%3DBaud%26aufirst%3DS.%26aulast%3DBlaise%26aufirst%3DS.%26atitle%3DImpact%2520of%2520sialic%2520acids%2520on%2520the%2520molecular%2520dynamic%2520of%2520bi-antennary%2520and%2520tri-antennary%2520glycans%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D35666%26doi%3D10.1038%2Fsrep35666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varki, A.</span></span> <span> </span><span class="NLM_article-title">Sialic acids in human health and disease</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2008.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.molmed.2008.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=18606570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVCltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=351-360&author=A.+Varki&title=Sialic+acids+in+human+health+and+disease&doi=10.1016%2Fj.molmed.2008.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Sialic acids in human health and disease</span></div><div class="casAuthors">Varki, Ajit</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">351-360</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The surfaces of all vertebrate cells are decorated with a dense and complex array of sugar chains, which are mostly attached to proteins and lipids.  Most sol. secreted proteins are also similarly decorated with such glycans.  Sialic acids are a diverse family of sugar units with a nine-carbon backbone that are typically found attached to the outermost ends of these chains.  Given their location and ubiquitous distribution, sialic acids can mediate or modulate a wide variety of physiol. and pathol. processes.  This review considers some examples of their established and newly emerging roles in aspects of human physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIcCu4se_5o7Vg90H21EOLACvtfcHk0ljvuLZYKPHaiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVCltrk%253D&md5=fc4d8eb51bcc4509dc8b03cf7533a1c1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2008.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2008.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DVarki%26aufirst%3DA.%26atitle%3DSialic%2520acids%2520in%2520human%2520health%2520and%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D351%26epage%3D360%26doi%3D10.1016%2Fj.molmed.2008.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buschiazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzari, P. M.</span></span> <span> </span><span class="NLM_article-title">Structural insights into sialic acid enzymology</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2008.06.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.cbpa.2008.06.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=18625334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KgsbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=565-572&author=A.+Buschiazzoauthor=P.+M.+Alzari&title=Structural+insights+into+sialic+acid+enzymology&doi=10.1016%2Fj.cbpa.2008.06.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into sialic acid enzymology</span></div><div class="casAuthors">Buschiazzo, Alejandro; Alzari, Pedro M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">565-572</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sialic acids are a diverse family of neg. charged sugars that play essential biol. roles.  Their presence and relative abundance in different cells is ultimately regulated by the concerted action of a large set of enzymes.  In this review, we focus on the most recent advances on the enzymes that govern sialic acid metab., with emphasis on structural work.  Major progress has been made in dissecting the catalytic mechanism of sialidases, revealing a modified scenario of the typical glycosidase ping-pong mechanism.  Similarly, x-ray structures of sialyltransferases uncover significant variations of formerly known glycosyltransferase foldings.  Both sialidases and sialyltransferases seem to tell us that sialic acid-handling enzymes have evolved important modifications related to the distinctive features of sialic acid itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcI4bl9QyfJLVg90H21EOLACvtfcHk0lgB_VWA9A76Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KgsbbO&md5=32b3743627a48164b79bb59630a33759</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2008.06.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2008.06.017%26sid%3Dliteratum%253Aachs%26aulast%3DBuschiazzo%26aufirst%3DA.%26aulast%3DAlzari%26aufirst%3DP.%2BM.%26atitle%3DStructural%2520insights%2520into%2520sialic%2520acid%2520enzymology%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D12%26spage%3D565%26epage%3D572%26doi%3D10.1016%2Fj.cbpa.2008.06.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parker, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohler, J. J.</span></span> <span> </span><span class="NLM_article-title">Regulation of intracellular signaling by extracellular glycan remodeling</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1021/cb9002514</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb9002514" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=35-46&author=R.+B.+Parkerauthor=J.+J.+Kohler&title=Regulation+of+intracellular+signaling+by+extracellular+glycan+remodeling&doi=10.1021%2Fcb9002514"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fcb9002514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb9002514%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DR.%2BB.%26aulast%3DKohler%26aufirst%3DJ.%2BJ.%26atitle%3DRegulation%2520of%2520intracellular%2520signaling%2520by%2520extracellular%2520glycan%2520remodeling%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D35%26epage%3D46%26doi%3D10.1021%2Fcb9002514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasirikenari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhardt, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashline, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanneman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhold, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, J. T. Y.</span></span> <span> </span><span class="NLM_article-title">Platelets support extracellular sialylation by supplying the sugar donor substrate</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">8742</span>– <span class="NLM_lpage">8748</span>, <span class="refDoi"> DOI: 10.1074/jbc.C113.546713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1074%2Fjbc.C113.546713" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=8742-8748&author=M.+M.+Leeauthor=M.+Nasirikenariauthor=C.+T.+Manhardtauthor=D.+J.+Ashlineauthor=A.+J.+Hannemanauthor=V.+N.+Reinholdauthor=J.+T.+Y.+Lau&title=Platelets+support+extracellular+sialylation+by+supplying+the+sugar+donor+substrate&doi=10.1074%2Fjbc.C113.546713"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C113.546713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C113.546713%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BM.%26aulast%3DNasirikenari%26aufirst%3DM.%26aulast%3DManhardt%26aufirst%3DC.%2BT.%26aulast%3DAshline%26aufirst%3DD.%2BJ.%26aulast%3DHanneman%26aufirst%3DA.%2BJ.%26aulast%3DReinhold%26aufirst%3DV.%2BN.%26aulast%3DLau%26aufirst%3DJ.%2BT.%2BY.%26atitle%3DPlatelets%2520support%2520extracellular%2520sialylation%2520by%2520supplying%2520the%2520sugar%2520donor%2520substrate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D8742%26epage%3D8748%26doi%3D10.1074%2Fjbc.C113.546713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tauber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reutter, W.</span></span> <span> </span><span class="NLM_article-title">Intramolecular heterogeneity of degradation in plasma membrane glycoproteins - evidence for a general characteristic</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">4026</span>– <span class="NLM_lpage">4029</span>, <span class="refDoi"> DOI: 10.1073/pnas.80.13.4026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1073%2Fpnas.80.13.4026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1983&pages=4026-4029&author=R.+Tauberauthor=C.+S.+Parkauthor=W.+Reutter&title=Intramolecular+heterogeneity+of+degradation+in+plasma+membrane+glycoproteins+-+evidence+for+a+general+characteristic&doi=10.1073%2Fpnas.80.13.4026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.80.13.4026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.80.13.4026%26sid%3Dliteratum%253Aachs%26aulast%3DTauber%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DC.%2BS.%26aulast%3DReutter%26aufirst%3DW.%26atitle%3DIntramolecular%2520heterogeneity%2520of%2520degradation%2520in%2520plasma%2520membrane%2520glycoproteins%2520-%2520evidence%2520for%2520a%2520general%2520characteristic%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1983%26volume%3D80%26spage%3D4026%26epage%3D4029%26doi%3D10.1073%2Fpnas.80.13.4026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span> <span> </span><span class="NLM_article-title">Mammalian sialidases: Physiological and pathological roles in cellular functions</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">880</span>– <span class="NLM_lpage">896</span>, <span class="refDoi"> DOI: 10.1093/glycob/cws057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fglycob%2Fcws057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=22377912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1agtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=880-896&author=T.+Miyagiauthor=K.+Yamaguchi&title=Mammalian+sialidases%3A+Physiological+and+pathological+roles+in+cellular+functions&doi=10.1093%2Fglycob%2Fcws057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian sialidases: Physiological and pathological roles in cellular functions</span></div><div class="casAuthors">Miyagi, Taeko; Yamaguchi, Kazunori</div><div class="citationInfo"><span class="NLM_cas:title">Glycobiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">880-896</span>CODEN:
                <span class="NLM_cas:coden">GLYCE3</span>;
        ISSN:<span class="NLM_cas:issn">0959-6658</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Sialic acids are terminal acidic monosaccharides, which influence the chem. and biol. features of glycoconjugates.  Their removal catalyzed by a sialidase modulates various biol. processes through change in conformation and creation or loss of binding sites of functional mols.  Sialidases exist widely in vertebrates and also in a variety of microorganisms.  Recent research on mammalian sialidases has provided evidence for great importance of these enzymes in various cellular functions, including lysosomal catabolism, whereas microbial sialidases appear to play roles limited to nutrition and pathogenesis.  Four types of mammalian sialidases have been identified and characterized to date, designated as NEU1, NEU2, NEU3 and NEU4.  They are encoded by different genes and differ in major subcellular localization and enzymic properties including substrate specificity, and each has been found to play a unique role depending on its particular properties.  This review is an attempt to concisely summarize current knowledge concerning mammalian sialidases, with an especial focus on their properties and physiol. and pathol. roles in cellular functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxmmcFwUsmhbVg90H21EOLACvtfcHk0lioabrhF-8RWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1agtbc%253D&md5=11db2be4246b76ed8a66cedaa2c53a13</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcws057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcws057%26sid%3Dliteratum%253Aachs%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DYamaguchi%26aufirst%3DK.%26atitle%3DMammalian%2520sialidases%253A%2520Physiological%2520and%2520pathological%2520roles%2520in%2520cellular%2520functions%26jtitle%3DGlycobiology%26date%3D2012%26volume%3D22%26spage%3D880%26epage%3D896%26doi%3D10.1093%2Fglycob%2Fcws057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashmarina, L. I.</span></span> <span> </span><span class="NLM_article-title">Desialylation of surface receptors as a new dimension in cell signaling</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">736</span>– <span class="NLM_lpage">745</span>, <span class="refDoi"> DOI: 10.1134/S0006297913070067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1134%2FS0006297913070067" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=736-745&author=A.+V.+Pshezhetskyauthor=L.+I.+Ashmarina&title=Desialylation+of+surface+receptors+as+a+new+dimension+in+cell+signaling&doi=10.1134%2FS0006297913070067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1134%2FS0006297913070067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1134%252FS0006297913070067%26sid%3Dliteratum%253Aachs%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26aulast%3DAshmarina%26aufirst%3DL.%2BI.%26atitle%3DDesialylation%2520of%2520surface%2520receptors%2520as%2520a%2520new%2520dimension%2520in%2520cell%2520signaling%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D78%26spage%3D736%26epage%3D745%26doi%3D10.1134%2FS0006297913070067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harada, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, M. D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passarelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintão, E. C. R.</span></span> <span> </span><span class="NLM_article-title">Lipoprotein desialylation simultaneously enhances the cell cholesterol uptake and impairs the reverse cholesterol transport system: in vitro evidences utilizing neuraminidase-treated lipoproteins and mouse peritoneal macrophages</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/S0021-9150(98)00057-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2FS0021-9150%2898%2900057-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1998&pages=65-75&author=L.+M.+Haradaauthor=M.+D.+T.+Carvalhoauthor=M.+Passarelliauthor=E.+C.+R.+Quint%C3%A3o&title=Lipoprotein+desialylation+simultaneously+enhances+the+cell+cholesterol+uptake+and+impairs+the+reverse+cholesterol+transport+system%3A+in+vitro+evidences+utilizing+neuraminidase-treated+lipoproteins+and+mouse+peritoneal+macrophages&doi=10.1016%2FS0021-9150%2898%2900057-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0021-9150%2898%2900057-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9150%252898%252900057-4%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DL.%2BM.%26aulast%3DCarvalho%26aufirst%3DM.%2BD.%2BT.%26aulast%3DPassarelli%26aufirst%3DM.%26aulast%3DQuint%25C3%25A3o%26aufirst%3DE.%2BC.%2BR.%26atitle%3DLipoprotein%2520desialylation%2520simultaneously%2520enhances%2520the%2520cell%2520cholesterol%2520uptake%2520and%2520impairs%2520the%2520reverse%2520cholesterol%2520transport%2520system%253A%2520in%2520vitro%2520evidences%2520utilizing%2520neuraminidase-treated%2520lipoproteins%2520and%2520mouse%2520peritoneal%2520macrophages%26jtitle%3DAtherosclerosis%26date%3D1998%26volume%3D139%26spage%3D65%26epage%3D75%26doi%3D10.1016%2FS0021-9150%2898%2900057-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Vliet, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lino, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kooyk, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadokoro, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Videira, P. A.</span></span> <span> </span><span class="NLM_article-title">Sialic acid removal from dendritic cells improves antigen cross presentation and boosts anti-tumor immune responses</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">41053</span>– <span class="NLM_lpage">41066</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.9419</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.18632%2Foncotarget.9419" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=41053-41066&author=M.+Silvaauthor=Z.+Silvaauthor=G.+Marquesauthor=T.+Ferroauthor=M.+Goncalvesauthor=M.+Monteiroauthor=S.+J.+van+Vlietauthor=E.+Mohrauthor=A.+C.+Linoauthor=A.+R.+Fernandesauthor=F.+A.+Limaauthor=Y.+van+Kooykauthor=T.+Matosauthor=C.+E.+Tadokoroauthor=P.+A.+Videira&title=Sialic+acid+removal+from+dendritic+cells+improves+antigen+cross+presentation+and+boosts+anti-tumor+immune+responses&doi=10.18632%2Foncotarget.9419"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.9419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.9419%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DM.%26aulast%3DSilva%26aufirst%3DZ.%26aulast%3DMarques%26aufirst%3DG.%26aulast%3DFerro%26aufirst%3DT.%26aulast%3DGoncalves%26aufirst%3DM.%26aulast%3DMonteiro%26aufirst%3DM.%26aulast%3Dvan%2BVliet%26aufirst%3DS.%2BJ.%26aulast%3DMohr%26aufirst%3DE.%26aulast%3DLino%26aufirst%3DA.%2BC.%26aulast%3DFernandes%26aufirst%3DA.%2BR.%26aulast%3DLima%26aufirst%3DF.%2BA.%26aulast%3Dvan%2BKooyk%26aufirst%3DY.%26aulast%3DMatos%26aufirst%3DT.%26aulast%3DTadokoro%26aufirst%3DC.%2BE.%26aulast%3DVideira%26aufirst%3DP.%2BA.%26atitle%3DSialic%2520acid%2520removal%2520from%2520dendritic%2520cells%2520improves%2520antigen%2520cross%2520presentation%2520and%2520boosts%2520anti-tumor%2520immune%2520responses%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D41053%26epage%3D41066%26doi%3D10.18632%2Foncotarget.9419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, M.</span></span> <span> </span><span class="NLM_article-title">CD8+ T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">27445</span>, <span class="refDoi"> DOI: 10.1038/srep27445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1038%2Fsrep27445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=27321376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVahu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=27445&author=J.+Qiuauthor=X.+Liuauthor=X.+Liauthor=X.+Zhangauthor=P.+Hanauthor=H.+Zhouauthor=L.+Shaoauthor=Y.+Houauthor=Y.+Minauthor=Z.+Kongauthor=Y.+Wangauthor=Y.+Weiauthor=X.+Liuauthor=H.+Niauthor=J.+Pengauthor=M.+Hou&title=CD8%2B+T+cells+induce+platelet+clearance+in+the+liver+via+platelet+desialylation+in+immune+thrombocytopenia&doi=10.1038%2Fsrep27445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">CD8+ T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia</span></div><div class="casAuthors">Qiu, Jihua; Liu, Xuena; Li, Xiaoqing; Zhang, Xu; Han, Panpan; Zhou, Hai; Shao, Linlin; Hou, Yu; Min, Yanan; Kong, Zhangyuan; Wang, Yawen; Wei, Yu; Liu, Xinguang; Ni, Heyu; Peng, Jun; Hou, Ming</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27445</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In addn. to antiplatelet autoantibodies, CD8+ cytotoxic T lymphocytes (CTLs) play an important role in the increased platelet destruction in immune thrombocytopenia (ITP).  Recent studies have highlighted that platelet desialylation leads to platelet clearance via hepatocyte asialoglycoprotein receptors (ASGPRs).  Whether CD8+ T cells induce platelet desialylation in ITP remains unclear.  Here, we investigated the cytotoxicity of CD8+ T cells towards platelets and platelet desialylation in ITP.  We found that the desialylation of fresh platelets was significantly higher in ITP patients with pos. cytotoxicity of CD8+ T cells than those without cytotoxicity and controls.  In vitro, CD8+ T cells from ITP patients with pos. cytotoxicity induced significant platelet desialylation, neuraminidase-1 expression on the platelet surface, and platelet phagocytosis by hepatocytes.  To study platelet survival and clearance in vivo, CD61 knockout mice were immunized and their CD8+ splenocytes were used.  Platelets co-cultured with these CD8+ splenocytes demonstrated decreased survival in the circulation and increased phagocytosis in the liver.  Both neuraminidase inhibitor and ASGPRs competitor significantly improved platelet survival and abrogated platelet clearance caused by CD8+ splenocytes.  These findings suggest that CD8+ T cells induce platelet desialylation and platelet clearance in the liver in ITP, which may be a novel mechanism of ITP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz8sAP_9UlprVg90H21EOLACvtfcHk0ljw_V3PaDYrJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVahu7vJ&md5=9a2e9106fe8efc64a3dc8f9849ca1738</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fsrep27445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep27445%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DShao%26aufirst%3DL.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DMin%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DNi%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DM.%26atitle%3DCD8%252B%2520T%2520cells%2520induce%2520platelet%2520clearance%2520in%2520the%2520liver%2520via%2520platelet%2520desialylation%2520in%2520immune%2520thrombocytopenia%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D27445%26doi%3D10.1038%2Fsrep27445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashmarina, M.</span></span> <span> </span><span class="NLM_article-title">Keeping it trim: roles of neuraminidases in CNS function</span>. <i>Glycoconjugate J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1007/s10719-018-9837-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1007%2Fs10719-018-9837-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=30088207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVKiu7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2018&pages=375-386&author=A.+V.+Pshezhetskyauthor=M.+Ashmarina&title=Keeping+it+trim%3A+roles+of+neuraminidases+in+CNS+function&doi=10.1007%2Fs10719-018-9837-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Keeping it trim: roles of neuraminidases in CNS function</span></div><div class="casAuthors">Pshezhetsky, Alexey V.; Ashmarina, Mila</div><div class="citationInfo"><span class="NLM_cas:title">Glycoconjugate Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-386</span>CODEN:
                <span class="NLM_cas:coden">GLJOEW</span>;
        ISSN:<span class="NLM_cas:issn">0282-0080</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The sialylated glyconjugates (SGC) are found in abundance on the surface of brain cells, where they form a dense array of glycans mediating cell/cell and cell/protein recognition in numerous physiol. and pathol. processes.  Metabolic genetic blocks in processing and catabolism of SGC result in development of severe storage disorders, dominated by CNS involvement including marked neuroinflammation and neurodegeneration, the pathophysiol. mechanisms of which are still discussed.  SGC patterns in the brain are cell and organelle-specific, dynamic and maintained by highly coordinated processes of their biosynthesis, trafficking, processing and catabolism.  The changes in the compn. of SGC during development and aging of the brain cannot be explained based solely on the regulation of the SGC-synthesizing enzymes, sialyltransferases, suggesting that neuraminidases (sialidases) hydrolyzing the removal of terminal sialic acid residues also play an essential role.  In the current review we summarize the roles of three mammalian neuraminidases: neuraminidase 1, neuraminidase 3 and neuraminidase 4 in processing brain SGC.  Emerging data demonstrate that these enzymes with different, yet overlapping expression patterns, intracellular localization and substrate specificity play essential roles in the physiol. of the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVPfxjHp8mYbVg90H21EOLACvtfcHk0ljw_V3PaDYrJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVKiu7bI&md5=822d7a61e43df9316c5a8f9ef311826e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs10719-018-9837-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10719-018-9837-4%26sid%3Dliteratum%253Aachs%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26aulast%3DAshmarina%26aufirst%3DM.%26atitle%3DKeeping%2520it%2520trim%253A%2520roles%2520of%2520neuraminidases%2520in%2520CNS%2520function%26jtitle%3DGlycoconjugate%2520J.%26date%3D2018%26volume%3D35%26spage%3D375%26epage%3D386%26doi%3D10.1007%2Fs10719-018-9837-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonten, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arts, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covanis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donati, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zammarchi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Azzo, A.</span></span> <span> </span><span class="NLM_article-title">Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2715</span>– <span class="NLM_lpage">2725</span>, <span class="refDoi"> DOI: 10.1093/hmg/9.18.2715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fhmg%2F9.18.2715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=11063730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVKktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=2715-2725&author=E.+J.+Bontenauthor=W.+F.+Artsauthor=M.+Beckauthor=A.+Covanisauthor=M.+A.+Donatiauthor=R.+Pariniauthor=E.+Zammarchiauthor=A.+d%E2%80%99Azzo&title=Novel+mutations+in+lysosomal+neuraminidase+identify+functional+domains+and+determine+clinical+severity+in+sialidosis&doi=10.1093%2Fhmg%2F9.18.2715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis</span></div><div class="casAuthors">Bonten, Erik. J.; Arts, Willem F.; Beck, Michael; Covanis, A.; Donati, Maria A.; Parini, Rossella; Zammarchi, Enrico; D'Azzo, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2715-2725</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Lysosomal neuraminidase is the key enzyme for the intralysosomal catabolism of sialylated glycoconjugates and is deficient in two neurodegenerative lysosomal disorders, sialidosis and galactosialidosis.  Here we report the identification of eight novel mutations in the neuraminidase gene of 11 sialidosis patients with various degrees of disease penetrance.  Comparison of the primary structure of human neuraminidase with the primary and tertiary structures of bacterial sialidases indicated that most of the single amino acid substitutions occurred in functional motifs or conserved residues.  On the basis of the subcellular distribution and residual catalytic activity of the mutant neuraminidases we assigned the mutant proteins to three groups: (i) catalytically inactive and not lysosomal; (ii) catalytically inactive, but localized in lysosome; and (iii) catalytically active and lysosomal.  In general, there was a close correlation between the residual activity of the mutant enzymes and the clin. severity of disease.  Patients with the severe infantile type II disease had mutations from group I, whereas patients with a mild form of type I disease had at least one mutation from group III.  Mutations from the second group were mainly found in juvenile type II patients with intermediate clin. severity.  Overall, our findings explain the clin. heterogeneity obsd. in sialidosis and may help in the assignment of existing or new allelic combinations to specific phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWsEJ32DIivLVg90H21EOLACvtfcHk0ljw_V3PaDYrJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVKktbs%253D&md5=0473d7520bb409273c0c3d13bcfa3188</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F9.18.2715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F9.18.2715%26sid%3Dliteratum%253Aachs%26aulast%3DBonten%26aufirst%3DE.%2BJ.%26aulast%3DArts%26aufirst%3DW.%2BF.%26aulast%3DBeck%26aufirst%3DM.%26aulast%3DCovanis%26aufirst%3DA.%26aulast%3DDonati%26aufirst%3DM.%2BA.%26aulast%3DParini%26aufirst%3DR.%26aulast%3DZammarchi%26aufirst%3DE.%26aulast%3Dd%25E2%2580%2599Azzo%26aufirst%3DA.%26atitle%3DNovel%2520mutations%2520in%2520lysosomal%2520neuraminidase%2520identify%2520functional%2520domains%2520and%2520determine%2520clinical%2520severity%2520in%2520sialidosis%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2000%26volume%3D9%26spage%3D2715%26epage%3D2725%26doi%3D10.1093%2Fhmg%2F9.18.2715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carubelli, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamatos, N. M.</span></span> <span> </span><span class="NLM_article-title">Sialidase expression in activated human T lymphocytes influences production of IFN-γ</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1189/jlb.1105692</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1189%2Fjlb.1105692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=17028199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A280%3ADC%252BD28jkslWhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=284-296&author=X.+Nanauthor=I.+Carubelliauthor=N.+M.+Stamatos&title=Sialidase+expression+in+activated+human+T+lymphocytes+influences+production+of+IFN-%CE%B3&doi=10.1189%2Fjlb.1105692"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Sialidase expression in activated human T lymphocytes influences production of IFN-gamma</span></div><div class="casAuthors">Nan Xinli; Carubelli Ivan; Stamatos Nicholas M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of leukocyte biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">284-96</span>
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    </div><div class="casAbstract">Sialidases influence cellular activity by removing terminal sialic acid from glycoproteins and glycolipids.  Four genetically distinct sialidases (Neu1-4) have been identified in mammalian cells.  In this study, we demonstrate that only lysosomal Neu1 and plasma membrane-associated Neu3 are detected in freshly isolated and activated human T lymphocytes.  Activation of lymphocytes by exposure to anti-CD3 and anti-CD28 IgG resulted in a ninefold increase in Neu1-specific activity after growth of cells in culture for 5 days.  In contrast, the activity of Neu3 changed minimally in activated lymphocytes.  The increase in Neu1 enzyme activity correlated with increased synthesis of Neu1-specific mRNA.  Neu1 was present on the surface of freshly isolated and activated CD4 and CD8 T lymphocytes, as determined by staining intact cells with anti-Neu1 IgG and analysis by flow cytometry and by Western blot analysis of biotin-labeled cell surface proteins.  Cell surface Neu1 was found tightly associated with a subunit of protective protein/cathepsin A (PPCA).  Compared with freshly isolated lymphocytes, activated cells expressed more surface binding sites for galactose-recognizing lectins Erythrina cristagalli (ECA) and Arachis hypogaea.  Growth of cells in the presence of sialidase inhibitors 2,3-dehydro-2-deoxy-N-acetylneuraminic acid or 4-guanidino-2-deoxy-2,3-dehydro-N-acetylneuraminic acid resulted in a smaller increase in number of ECA-binding sites and a greater amount of cell surface sialic acid in activated cells.  Inhibition of sialidase activity also resulted in reduced expression of IFN-gamma in activated cells.  The down-regulation of IFN-gamma occurred at the transcriptional level.  Thus, sialidase activity in activated T lymphocytes contributes to the hyposialylation of specific cell surface glycoconjugates and to the production of IFN-gamma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQwcLV8JlYIRe4jJGKT5N0fW6udTcc2eaElcXbfTj_Wrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jkslWhtQ%253D%253D&md5=3cfd524c10437f334b8e83cdba8fec2b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1189%2Fjlb.1105692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.1105692%26sid%3Dliteratum%253Aachs%26aulast%3DNan%26aufirst%3DX.%26aulast%3DCarubelli%26aufirst%3DI.%26aulast%3DStamatos%26aufirst%3DN.%2BM.%26atitle%3DSialidase%2520expression%2520in%2520activated%2520human%2520T%2520lymphocytes%2520influences%2520production%2520of%2520IFN-%25CE%25B3%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2007%26volume%3D81%26spage%3D284%26epage%3D296%26doi%3D10.1189%2Fjlb.1105692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, O. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Läubli, H.</span></span> <span> </span><span class="NLM_article-title">Sialic acids in cancer biology and immunity</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1093/glycob/cwv097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fglycob%2Fcwv097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=26518624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12rsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=111-128&issue=2&author=O.+M.+T.+Pearceauthor=H.+L%C3%A4ubli&title=Sialic+acids+in+cancer+biology+and+immunity&doi=10.1093%2Fglycob%2Fcwv097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Sialic acids in cancer biology and immunity</span></div><div class="casAuthors">Pearce, Oliver M. T.; Laeubli, Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Glycobiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-128</span>CODEN:
                <span class="NLM_cas:coden">GLYCE3</span>;
        ISSN:<span class="NLM_cas:issn">0959-6658</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">During malignant transformation, glycosylation is heavily altered compared with healthy tissue due to differential expression of glycosyltransferases, glycosidases and monosaccharide transporters within the cancer microenvironment.  One key change of malignant tissue glycosylation is the alteration of sialic acid processing that leads to a general upregulation of sialylated glycans (hypersialylation) on cell surfaces and an increased introduction of the non-human sialic acid N-glycolylneuraminic acid (Neu5Gc) instead of N-acetyl-neuraminic acid into cell surface glycans.  These changes have been shown to be the result of altered sialyltransferase and sialidase expression.  Functionally, cancer-assocd. hypersialylation appears to directly impact tumor cell interaction with the microenvironment, in particular the modulation of sialic acid-binding lectins on immune cells.  Moreover, Neu5Gc expression in human tissues enhances inflammation due to an anti-Neu5Gc immune response, which can potentially influence inflammation-induced cancer and cancer-assocd. inflammation.  In this review, we summarize the changes of sialic acid biol. within the malignant microenvironment and the resulting effect on cancer immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLNZJ4KazaIrVg90H21EOLACvtfcHk0lj461C9CnQ8yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12rsbnN&md5=f208432a974f6c9312952ce697a40b18</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcwv097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcwv097%26sid%3Dliteratum%253Aachs%26aulast%3DPearce%26aufirst%3DO.%2BM.%2BT.%26aulast%3DL%25C3%25A4ubli%26aufirst%3DH.%26atitle%3DSialic%2520acids%2520in%2520cancer%2520biology%2520and%2520immunity%26jtitle%3DGlycobiology%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D111%26epage%3D128%26doi%3D10.1093%2Fglycob%2Fcwv097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alghamdi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulkhalek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amith, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczuk, M. R.</span></span> <span> </span><span class="NLM_article-title">A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1368</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2014.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.cellsig.2014.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=24583283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltl2ksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=1355-1368&author=F.+Alghamdiauthor=M.+Guoauthor=S.+Abdulkhalekauthor=N.+Crawfordauthor=S.+R.+Amithauthor=M.+R.+Szewczuk&title=A+novel+insulin+receptor-signaling+platform+and+its+link+to+insulin+resistance+and+type+2+diabetes&doi=10.1016%2Fj.cellsig.2014.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes</span></div><div class="casAuthors">Alghamdi, Farah; Guo, Merry; Abdulkhalek, Samar; Crawford, Nicola; Amith, Schammim Ray; Szewczuk, Myron R.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1355-1368</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Insulin-induced insulin receptor (IR) tyrosine kinase activation and insulin cell survival responses have been reported to be under the regulation of a membrane assocd. mammalian neuraminidase-1 (Neu1).  The mol. mechanism(s) behind this process is unknown.  Here, we uncover a novel Neu1 and matrix metalloproteinase-9 (MMP-9) cross-talk in alliance with neuromedin B G-protein coupled receptor (GPCR), which is essential for insulin-induced IR activation and cellular signaling.  Neu1, MMP-9 and neuromedin B GPCR form a complex with IRβ subunit on the cell surface.  Oseltamivir phosphate (Tamiflu), anti-Neu1 antibodies, broad range MMP inhibitors piperazine and galardin (GM6001), MMP-9 specific inhibitor (MMP-9i), and GPCR neuromedin B specific antagonist BIM-23127 dose-dependently inhibited Neu1 activity assocd. with insulin stimulated rat hepatoma cells (HTCs) that overly express human IRs (HTC-IR).  Tamiflu, anti-Neu1 antibodies and MMP-9i attenuated phosphorylation of IRβ and insulin receptor substrate-1 (IRS1) assocd. with insulin-stimulated cells.  Olanzapine, an antipsychotic agent assocd. with insulin resistance, induced Neu3 sialidase activity in WG544 or 1140F01 human sialidosis fibroblast cells genetically defective in Neu1.  Neu3 antagonist 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) and anti-Neu3 antibodies inhibited sialidase activity assocd. with olanzapine treated murine Neu4 knockout macrophage cells.  Olanzapine attenuated phosphorylation of IGF-R and IRS1 assocd. with insulin-stimulated human wild-type fibroblast cells.  Our findings identify a novel insulin receptor-signaling platform that is critically essential for insulin-induced IRβ tyrosine kinase activation and cellular signaling.  Olanzapine-induced Neu3 sialidase activity attenuated insulin-induced IGF-R and IRS1 phosphorylation contributing to insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2rVeu0VmYnrVg90H21EOLACvtfcHk0lj3Wg7XKixe_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltl2ksLc%253D&md5=a5c585d8c4ba2dc091309bae8c8ae5b6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2014.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2014.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DAlghamdi%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DAbdulkhalek%26aufirst%3DS.%26aulast%3DCrawford%26aufirst%3DN.%26aulast%3DAmith%26aufirst%3DS.%2BR.%26aulast%3DSzewczuk%26aufirst%3DM.%2BR.%26atitle%3DA%2520novel%2520insulin%2520receptor-signaling%2520platform%2520and%2520its%2520link%2520to%2520insulin%2520resistance%2520and%2520type%25202%2520diabetes%26jtitle%3DCell.%2520Signalling%26date%3D2014%26volume%3D26%26spage%3D1355%26epage%3D1368%26doi%3D10.1016%2Fj.cellsig.2014.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dridi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyrantepe, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fougerat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneil, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibault, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heveker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issad, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span> <span> </span><span class="NLM_article-title">Positive regulation of insulin signaling by neuraminidase 1</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2338</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.2337/db12-1825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.2337%2Fdb12-1825" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=2338-46&author=L.+Dridiauthor=V.+Seyrantepeauthor=A.+Fougeratauthor=X.+Panauthor=E.+Bonneilauthor=P.+Thibaultauthor=A.+Moreauauthor=G.+A.+Mitchellauthor=N.+Hevekerauthor=C.+W.+Cairoauthor=T.+Issadauthor=A.+Hinekauthor=A.+V.+Pshezhetsky&title=Positive+regulation+of+insulin+signaling+by+neuraminidase+1&doi=10.2337%2Fdb12-1825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2337%2Fdb12-1825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb12-1825%26sid%3Dliteratum%253Aachs%26aulast%3DDridi%26aufirst%3DL.%26aulast%3DSeyrantepe%26aufirst%3DV.%26aulast%3DFougerat%26aufirst%3DA.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DBonneil%26aufirst%3DE.%26aulast%3DThibault%26aufirst%3DP.%26aulast%3DMoreau%26aufirst%3DA.%26aulast%3DMitchell%26aufirst%3DG.%2BA.%26aulast%3DHeveker%26aufirst%3DN.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26aulast%3DIssad%26aufirst%3DT.%26aulast%3DHinek%26aufirst%3DA.%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26atitle%3DPositive%2520regulation%2520of%2520insulin%2520signaling%2520by%2520neuraminidase%25201%26jtitle%3DDiabetes%26date%3D2013%26volume%3D62%26spage%3D2338%26epage%3D46%26doi%3D10.2337%2Fdb12-1825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinokio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunoda, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aburatani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oka, Y.</span></span> <span> </span><span class="NLM_article-title">Increased hepatic expression of ganglioside-specific sialidase, NEU3, improves insulin sensitivity and glucose tolerance in mice</span>. <i>Metab., Clin. Exp.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">420</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1016/j.metabol.2006.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.metabol.2006.10.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=17292733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1CltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=420-429&author=S.+Yoshizumiauthor=S.+Suzukiauthor=M.+Hiraiauthor=Y.+Hinokioauthor=T.+Yamadaauthor=T.+Yamadaauthor=U.+Tsunodaauthor=H.+Aburataniauthor=K.+Yamaguchiauthor=T.+Miyagiauthor=Y.+Oka&title=Increased+hepatic+expression+of+ganglioside-specific+sialidase%2C+NEU3%2C+improves+insulin+sensitivity+and+glucose+tolerance+in+mice&doi=10.1016%2Fj.metabol.2006.10.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Increased hepatic expression of ganglioside-specific sialidase, NEU3, improves insulin sensitivity and glucose tolerance in mice</span></div><div class="casAuthors">Yoshizumi, Shinsuke; Suzuki, Susumu; Hirai, Masashi; Hinokio, Yoshinori; Yamada, Tetsuya; Yamada, Takahiro; Tsunoda, Uiko; Aburatani, Hiroyuki; Yamaguchi, Kazunori; Miyagi, Taeko; Oka, Yoshitomo</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">420-429</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Membrane microdomains rich in gangliosides are recognized as being crit. for proper compartmentalization of insulin signaling.  Plasma membrane-assocd. sialidase, NEU3, is a key enzyme for ganglioside hydrolysis.  We previously reported that mice overexpressing NEU3 mainly in muscles developed severe insulin-resistant diabetes.  To examine the possible contributions of NEU3 to in vivo insulin sensitivity and glucose tolerance, NEU3 was expressed by using adenoviral vectors in the livers of C57BL/6 mice on std. and high-fat diets, and insulin-resistant KKAy mice on std. diets.  Hepatic NEU3 overexpression paradoxically improved glucose tolerance and insulin sensitivity in the C57BL/6 mice fed std. diets, and glucose tolerance in the C57BL/6 mice fed high-fat diets and in KKAy mice.  Hepatic NEU3 overexpression increased hepatic glycogen deposition and triglyceride accumulation, and enhanced the hepatic peroxisome proliferator-activated receptor γ and fetuin expression in the C57BL/6 mice on std. and high-fat diets, and in KKAy mice.  Thin-layer chromatog. anal. demonstrated increased levels of GM1 and markedly reduced GM3 in the livers of mice with hepatic NEU3 overexpression (NEU3 mice).  Basal and insulin-stimulated tyrosine phosphorylations of insulin receptor substrate 1 were significantly increased, but tyrosine phosphorylations of the insulin receptor and insulin receptor substrate 2 in the NEU3 liver were unchanged.  Insulin-stimulated tyrosine phosphorylations of the insulin receptor were increased in adipose tissues of NEU3 mice.  These results suggest that hepatic NEU3 overexpression improves insulin sensitivity and glucose tolerance through modification of ganglioside compn. and peroxisome proliferator-activated receptor γ signaling.  Our findings also provide further evidence that NEU3 is an important regulator of insulin sensitivity and glucose tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaWiBCD5SS9rVg90H21EOLACvtfcHk0ljM0dYYIHqY0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1CltL8%253D&md5=63fce3323abb7b6e63f1664963392450</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2006.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2006.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DYoshizumi%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DHirai%26aufirst%3DM.%26aulast%3DHinokio%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DT.%26aulast%3DYamada%26aufirst%3DT.%26aulast%3DTsunoda%26aufirst%3DU.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DOka%26aufirst%3DY.%26atitle%3DIncreased%2520hepatic%2520expression%2520of%2520ganglioside-specific%2520sialidase%252C%2520NEU3%252C%2520improves%2520insulin%2520sensitivity%2520and%2520glucose%2520tolerance%2520in%2520mice%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D2007%26volume%3D56%26spage%3D420%26epage%3D429%26doi%3D10.1016%2Fj.metabol.2006.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nardi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grace, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundal, H. S.</span></span> <span> </span><span class="NLM_article-title">NEU3 sialidase as a marker of insulin sensitivity: Regulation by fatty acids</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1742</span>– <span class="NLM_lpage">1750</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2015.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.cellsig.2015.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=26022181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC2MXps1els7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=1742-1750&author=C.+Lipinaauthor=F.+Nardiauthor=H.+Graceauthor=H.+S.+Hundal&title=NEU3+sialidase+as+a+marker+of+insulin+sensitivity%3A+Regulation+by+fatty+acids&doi=10.1016%2Fj.cellsig.2015.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">NEU3 sialidase as a marker of insulin sensitivity: Regulation by fatty acids</span></div><div class="casAuthors">Lipina, Christopher; Nardi, Francesca; Grace, Helen; Hundal, Harinder S.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1742-1750</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The plasma membrane-assocd. enzyme NEU3 sialidase functions to cleave sialic acid residues from the ganglioside GM3 thereby promoting its degrdn., and has been implicated in the modulation of insulin action.  Herein, we report for the first time that impaired insulin sensitivity in skeletal muscle and liver of obese Zucker fatty rats and aged C57BL/6 mice coincides with reduced NEU3 protein abundance.  In addn., high fat feeding was found to significantly reduce NEU3 protein in white adipose tissue of rats.  Notably, we also demonstrate the ability of the fatty acids palmitate and oleate to repress and induce NEU3 protein in L6 myotubes, concomitant with their insulin desensitizing and enhancing effects, resp.  Moreover, we show that the palmitate-driven loss in NEU3 protein is mediated, at least in part, by intracellular ceramide synthesis but does not involve the proteasomal pathway.  Strikingly, we further reveal that protein kinase B (PKB/Akt) acts as a key pos. modulator of NEU3 protein abundance.  Together, our findings implicate NEU3 as a potential biomarker of insulin sensitivity, and provide novel mechanistic insight into the regulation of NEU3 expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKEUyRJGfHTbVg90H21EOLACvtfcHk0ljM0dYYIHqY0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXps1els7w%253D&md5=6851d7ddfae36f4b5ca5ae60b4ccffb7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2015.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2015.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DLipina%26aufirst%3DC.%26aulast%3DNardi%26aufirst%3DF.%26aulast%3DGrace%26aufirst%3DH.%26aulast%3DHundal%26aufirst%3DH.%2BS.%26atitle%3DNEU3%2520sialidase%2520as%2520a%2520marker%2520of%2520insulin%2520sensitivity%253A%2520Regulation%2520by%2520fatty%2520acids%26jtitle%3DCell.%2520Signalling%26date%3D2015%26volume%3D27%26spage%3D1742%26epage%3D1750%26doi%3D10.1016%2Fj.cellsig.2015.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyulay, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trigatti, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igdoura, S. A.</span></span> <span> </span><span class="NLM_article-title">Hypomorphic sialidase expression decreases serum cholesterol by downregulation of VLDL production in mice</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2573</span>– <span class="NLM_lpage">2585</span>, <span class="refDoi"> DOI: 10.1194/jlr.M027300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1194%2Fjlr.M027300" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=2573-2585&author=A.+Yangauthor=G.+Gyulayauthor=M.+Mitchellauthor=E.+Whiteauthor=B.+L.+Trigattiauthor=S.+A.+Igdoura&title=Hypomorphic+sialidase+expression+decreases+serum+cholesterol+by+downregulation+of+VLDL+production+in+mice&doi=10.1194%2Fjlr.M027300"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M027300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M027300%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DA.%26aulast%3DGyulay%26aufirst%3DG.%26aulast%3DMitchell%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DE.%26aulast%3DTrigatti%26aufirst%3DB.%2BL.%26aulast%3DIgdoura%26aufirst%3DS.%2BA.%26atitle%3DHypomorphic%2520sialidase%2520expression%2520decreases%2520serum%2520cholesterol%2520by%2520downregulation%2520of%2520VLDL%2520production%2520in%2520mice%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2012%26volume%3D53%26spage%3D2573%26epage%3D2585%26doi%3D10.1194%2Fjlr.M027300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">d’Azzo, A.</span></span> <span> </span><span class="NLM_article-title">LSDs caused by deficiency of components of the PPCA/NEU1/beta-GAL enzyme complex: pathogenesis and therapy</span>. <i>Mol. Genet. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2005&pages=199-199&author=A.+d%E2%80%99Azzo&title=LSDs+caused+by+deficiency+of+components+of+the+PPCA%2FNEU1%2Fbeta-GAL+enzyme+complex%3A+pathogenesis+and+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dd%25E2%2580%2599Azzo%26aufirst%3DA.%26atitle%3DLSDs%2520caused%2520by%2520deficiency%2520of%2520components%2520of%2520the%2520PPCA%252FNEU1%252Fbeta-GAL%2520enzyme%2520complex%253A%2520pathogenesis%2520and%2520therapy%26jtitle%3DMol.%2520Genet.%2520Metab.%26date%3D2005%26volume%3D84%26spage%3D199%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Golovanova, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gracheva, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Il’inskaya, O.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tararak, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokazova, N. V.</span></span> <span> </span><span class="NLM_article-title">Sialidase activity in normal and atherosclerotic human aortic intima</span>. <i>Biochemistry (Moscow)</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1230</span>– <span class="NLM_lpage">1234</span>, <span class="refDoi"> DOI: 10.1023/A:1021393119906</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1023%2FA%3A1021393119906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=12495418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD38XptFOjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=1230-1234&author=N.+K.+Golovanovaauthor=E.+V.+Grachevaauthor=O.%0AP.+Il%E2%80%99inskayaauthor=E.+M.+Tararakauthor=N.+V.+Prokazova&title=Sialidase+activity+in+normal+and+atherosclerotic+human+aortic+intima&doi=10.1023%2FA%3A1021393119906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sialidase Activity in Normal and Atherosclerotic Human Aortic Intima</span></div><div class="casAuthors">Golovanova, N. K.; Gracheva, E. V.; Il'inskaya, O. P.; Tararak, E. M.; Prokazova, N. V.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry (Moscow, Russian Federation)(Translation of Biokhimiya (Moscow, Russian Federation))</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1230-1234</span>CODEN:
                <span class="NLM_cas:coden">BIORAK</span>;
        ISSN:<span class="NLM_cas:issn">0006-2979</span>.
    
            (<span class="NLM_cas:orgname">MAIK Nauka/Interperiodica Publishing</span>)
        </div><div class="casAbstract">Sialidase activity has been detd. in homogenates of human aortic intima by measuring the amt. of GM1 formed during the incubation of ganglioside GD1a with the tissue homogenates.  Areas with atherosclerotic lesions as well as adjacent areas without histol. evidence of atherosclerosis were taken for comparison.  The rate of GM1 formation from GD1a in the presence of homogenates of the atherosclerotic intima was 20 pmol/h per mg protein.  Homogenates of the unaffected intima did not desialylate GD1a.  Sialidase activity of the atherosclerotic intima was linear for 1.5 h at GD1a content up to 1.5 nmol and at homogenate protein up to 1 μg.  NH4Cl and NeuAc2en, inhibitors of lysosomal function and plasma membrane-bound sialidase, resp., reduced sialidase activity of homogenates of the atherosclerotic intima by 94%.  The results indicate that atherosclerotic lesions and unaffected intima differ in their activity and specificity of sialidases that cleave gangliosides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2F-d5AnTchrVg90H21EOLACvtfcHk0ljAnbjz7560Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptFOjt7g%253D&md5=3d10ca1763f0a43e47256d3b60c7578f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1023%2FA%3A1021393119906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1021393119906%26sid%3Dliteratum%253Aachs%26aulast%3DGolovanova%26aufirst%3DN.%2BK.%26aulast%3DGracheva%26aufirst%3DE.%2BV.%26aulast%3DIl%25E2%2580%2599inskaya%26aufirst%3DO.%2BP.%26aulast%3DTararak%26aufirst%3DE.%2BM.%26aulast%3DProkazova%26aufirst%3DN.%2BV.%26atitle%3DSialidase%2520activity%2520in%2520normal%2520and%2520atherosclerotic%2520human%2520aortic%2520intima%26jtitle%3DBiochemistry%2520%2528Moscow%2529%26date%3D2002%26volume%3D67%26spage%3D1230%26epage%3D1234%26doi%3D10.1023%2FA%3A1021393119906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abekura, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. H.</span></span> <span> </span><span class="NLM_article-title">Monosialyl ganglioside GM3 decreases apolipoprotein B-100 secretion in liver cells</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">2168</span>– <span class="NLM_lpage">2181</span>, <span class="refDoi"> DOI: 10.1002/jcb.25860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1002%2Fjcb.25860" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2017&pages=2168-2181&author=H.+Choiauthor=U.+H.+Jinauthor=S.+K.+Kangauthor=F.+Abekuraauthor=J.+Y.+Parkauthor=K.+M.+Kwonauthor=S.+J.+Suhauthor=S.+H.+Choauthor=K.+T.+Haauthor=Y.+C.+Leeauthor=T.+W.+Chungauthor=C.+H.+Kim&title=Monosialyl+ganglioside+GM3+decreases+apolipoprotein+B-100+secretion+in+liver+cells&doi=10.1002%2Fjcb.25860"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fjcb.25860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.25860%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DU.%2BH.%26aulast%3DKang%26aufirst%3DS.%2BK.%26aulast%3DAbekura%26aufirst%3DF.%26aulast%3DPark%26aufirst%3DJ.%2BY.%26aulast%3DKwon%26aufirst%3DK.%2BM.%26aulast%3DSuh%26aufirst%3DS.%2BJ.%26aulast%3DCho%26aufirst%3DS.%2BH.%26aulast%3DHa%26aufirst%3DK.%2BT.%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DChung%26aufirst%3DT.%2BW.%26aulast%3DKim%26aufirst%3DC.%2BH.%26atitle%3DMonosialyl%2520ganglioside%2520GM3%2520decreases%2520apolipoprotein%2520B-100%2520secretion%2520in%2520liver%2520cells%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2017%26volume%3D118%26spage%3D2168%26epage%3D2181%26doi%3D10.1002%2Fjcb.25860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of the human neuraminidase enzymes</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1074</span>, <span class="refDoi"> DOI: 10.1039/C4MD00089G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1039%2FC4MD00089G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1067-1074&author=C.+W.+Cairo&title=Inhibitors+of+the+human+neuraminidase+enzymes&doi=10.1039%2FC4MD00089G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the human neuraminidase enzymes</span></div><div class="casAuthors">Cairo, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1067-1074</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The human neuraminidase enzymes (hNEU) are a family of four isoenzymes that hydrolyze sialosides, including gangliosides and glycoproteins.  These enzymes are proposed to play roles in several important signaling pathways and are implicated in diseases such as diabetes and cancer.  Despite their importance, only a limited no. of studies have sought to identify potent inhibitors for these enzymes.  This review summarizes the substrate specificity and known inhibitors of the hNEU isoenzymes, as well as the emerging work on development of isoenzyme-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqigoQZk4kNMLVg90H21EOLACvtfcHk0lg3CL9qRqGiWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrrL&md5=e8cf43cbe3af6d8200f27b0c25c307af</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC4MD00089G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00089G%26sid%3Dliteratum%253Aachs%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DInhibitors%2520of%2520the%2520human%2520neuraminidase%2520enzymes%26jtitle%3DMedChemComm%26date%3D2014%26volume%3D5%26spage%3D1067%26epage%3D1074%26doi%3D10.1039%2FC4MD00089G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richards, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Molecular dynamics simulations of viral neuraminidase inhibitors with the human neuraminidase enzymes: Insights into isoenzyme selectivity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5349</span>– <span class="NLM_lpage">5358</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.05.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.bmc.2018.05.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=29903413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFWhs7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=5349-5358&author=M.+R.+Richardsauthor=T.+Guoauthor=C.+D.+Hunterauthor=C.+W.+Cairo&title=Molecular+dynamics+simulations+of+viral+neuraminidase+inhibitors+with+the+human+neuraminidase+enzymes%3A+Insights+into+isoenzyme+selectivity&doi=10.1016%2Fj.bmc.2018.05.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics simulations of viral neuraminidase inhibitors with the human neuraminidase enzymes: Insights into isoenzyme selectivity</span></div><div class="casAuthors">Richards, Michele R.; Guo, Tianlin; Hunter, Carmanah D.; Cairo, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5349-5358</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibitors of viral neuraminidase enzymes have been previously developed as therapeutics.  Humans can express multiple forms of neuraminidase enzymes (NEU1, NEU2, NEU3, NEU4) that share a similar active site and enzymic mechanism with their viral counterparts.  Using a panel of purified human neuraminidase enzymes, we tested the inhibitory activity of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (DANA), zanamivir, oseltamivir, and peramivir against each of the human isoenzymes.  We find that, with the exceptions of DANA and zanamivir, these compds. show generally poor activity against the human neuraminidase enzymes.  To provide insight into the interactions of viral inhibitors with human neuraminidases, we conducted mol. dynamics simulations using homol. models based on coordinates reported for NEU2.  Simulations revealed that an organized water is displaced by zanamivir in binding to NEU2 and NEU3 and confirmed the crit. importance of engaging the binding pocket of the C7-C9 glycerol sidechain.  Our results suggest that compds. designed to target the human neuraminidases should provide more selective tools for interrogating these enzymes.  Furthermore, they emphasize a need for addnl. structural data to enable structure-based drug design in these systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvC3eNA252U7Vg90H21EOLACvtfcHk0lg3CL9qRqGiWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFWhs7zJ&md5=c996a2e9279bdf31454c5d7a8132128b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.05.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.05.035%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DM.%2BR.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DHunter%26aufirst%3DC.%2BD.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DMolecular%2520dynamics%2520simulations%2520of%2520viral%2520neuraminidase%2520inhibitors%2520with%2520the%2520human%2520neuraminidase%2520enzymes%253A%2520Insights%2520into%2520isoenzyme%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D5349%26epage%3D5358%26doi%3D10.1016%2Fj.bmc.2018.05.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koseki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yingsakmongkon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodeoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Itzstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, T.</span></span> <span> </span><span class="NLM_article-title">Limited inhibitory effects of oseltamivir and zanamivir on human sialidases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3484</span>– <span class="NLM_lpage">3491</span>, <span class="refDoi"> DOI: 10.1128/AAC.00344-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1128%2FAAC.00344-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=18694948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3484-3491&author=K.+Hataauthor=K.+Kosekiauthor=K.+Yamaguchiauthor=S.+Moriyaauthor=Y.+Suzukiauthor=S.+Yingsakmongkonauthor=G.+Hiraiauthor=M.+Sodeokaauthor=M.+Von+Itzsteinauthor=T.+Miyagi&title=Limited+inhibitory+effects+of+oseltamivir+and+zanamivir+on+human+sialidases&doi=10.1128%2FAAC.00344-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Limited inhibitory effects of oseltamivir and zanamivir on human sialidases</span></div><div class="casAuthors">Hata, Keiko; Koseki, Koichi; Yamaguchi, Kazunori; Moriya, Setsuko; Suzuki, Yasuo; Yingsakmongkon, Sangchai; Hirai, Go; Sodeoka, Mikiko; von Itzstein, Mark; Miyagi, Taeko</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3484-3491</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Oseltamivir (Tamiflu) and zanamivir (Relenza), two extensively used clin. effective anti-influenza drugs, are viral sialidase (also known as neuraminidase) inhibitors that prevent the release of progeny virions and thereby limit the spread of infection.  Recently mortalities and neuropsychiatric events have been reported with the use of oseltamivir, esp. in pediatric cases in Japan, suggesting that these drugs might also inhibit endogenous enzymes involved in sialic acid metab., including sialidase, sialyltransferase, and CMP-synthase, in addn. to their inhibitory effects on the viral sialidase.  The possible inhibition could account for some of the rare side effects of oseltamivir.  However, there has been little direct evidence in regard to the sensitivities of animal sialidases to these drugs.  Here, we examd. whether these inhibitors might indeed affect the activities of human sialidases, which differ in primary structures and enzyme properties but possess tertiary structures similar to those of the viral enzymes.  Using recombinant enzymes corresponding to the four human sialidases identified so, far we found that oseltamivir carboxylate scarcely affected the activities of any of the sialidases, even at 1 mM, while zanamivir significantly inhibited the human sialidases NEU3 and NEU2 in the micromolar range (Ki, 3.7 ± 0.48 and 12.9 ± 0.07 μM, resp.), providing a contrast to the low nanomolar concns. at which these drugs block the activity of the viral sialidases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp11nk1bBmG_rVg90H21EOLACvtfcHk0lhuKWVinb1Jqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjO&md5=88b0081e7eb7bb7f944c64399afb2041</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.00344-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00344-08%26sid%3Dliteratum%253Aachs%26aulast%3DHata%26aufirst%3DK.%26aulast%3DKoseki%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DMoriya%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DYingsakmongkon%26aufirst%3DS.%26aulast%3DHirai%26aufirst%3DG.%26aulast%3DSodeoka%26aufirst%3DM.%26aulast%3DVon%2BItzstein%26aufirst%3DM.%26aulast%3DMiyagi%26aufirst%3DT.%26atitle%3DLimited%2520inhibitory%2520effects%2520of%2520oseltamivir%2520and%2520zanamivir%2520on%2520human%2520sialidases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3484%26epage%3D3491%26doi%3D10.1128%2FAAC.00344-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="note"><p class="first last">This compound has been previously named as a C9-butyl-<i>N</i>-amide derivative of DANA (C9-BA-DANA). This could more appropriately be named as a C9-pentylamide, but we maintain the previous nomenclature for consistency with the literature.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: Selective inhibitors of lysosomal sialidase (Neu1)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.11.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.bmcl.2007.11.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=18068975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosFWgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=532-537&author=S.+Mageshauthor=S.+Moriyaauthor=T.+Suzukiauthor=T.+Miyagiauthor=H.+Ishidaauthor=M.+Kiso&title=Design%2C+synthesis%2C+and+biological+evaluation+of+human+sialidase+inhibitors.+Part+1%3A+Selective+inhibitors+of+lysosomal+sialidase+%28Neu1%29&doi=10.1016%2Fj.bmcl.2007.11.084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: Selective inhibitors of lysosomal sialidase (NEU1)</span></div><div class="casAuthors">Magesh, Sadagopan; Moriya, Setsuko; Suzuki, Tohru; Miyagi, Taeko; Ishida, Hideharu; Kiso, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">532-537</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We here report the design and synthesis of selective human lysosomal sialidase (NEU1) inhibitors.  A series of amide-linked C9 modified DANA (2-deoxy-2,3-dehydro-N-acetylneuraminic acid) analogs were synthesized and their inhibitory activities against all four human sialidases (NEU1-NEU4) were detd.  Structure-based approach was used to investigate the basis of selectivity of the compds. with exptl. obsd. activity.  Results from the present study are found to be informative in a qual. manner for the further design of isoform selective human sialidase inhibitors for therapeutic value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdeSV9eH47GLVg90H21EOLACvtfcHk0lhuKWVinb1Jqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosFWgtQ%253D%253D&md5=3beef27b55b27fa8b688d9a7e06d207b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.11.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.11.084%26sid%3Dliteratum%253Aachs%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DMoriya%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DKiso%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520human%2520sialidase%2520inhibitors.%2520Part%25201%253A%2520Selective%2520inhibitors%2520of%2520lysosomal%2520sialidase%2520%2528Neu1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D532%26epage%3D537%26doi%3D10.1016%2Fj.bmcl.2007.11.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albohy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smutova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Identification of selective nanomolar inhibitors of the human neuraminidase, NEU4</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1021/ml400080t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400080t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=532-537&author=A.+Albohyauthor=Y.+Zhangauthor=V.+Smutovaauthor=A.+V.+Pshezhetskyauthor=C.+W.+Cairo&title=Identification+of+selective+nanomolar+inhibitors+of+the+human+neuraminidase%2C+NEU4&doi=10.1021%2Fml400080t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU4</span></div><div class="casAuthors">Albohy, Amgad; Zhang, Yi; Smutova, Victoria; Pshezhetsky, Alexey V.; Cairo, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">532-537</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The human neuraminidase enzymes (hNEU) play important roles in human physiol. and pathol.  The lack of potent and selective inhibitors toward these enzymes has limited our understanding of their function and the development of therapeutic applications.  Here we report the evaluation of a panel of compds. against the four human neuraminidase isoenzymes.  Among the compds. tested, we identified the first selective, nanomolar inhibitors of the human neuraminidase 4 enzyme (NEU4).  The most potent NEU4 inhibitor (5-acetamido-9-[4-hydroxymethyl[1,2,3]triazol-1-yl]-2,3,5,9-tetradeoxy-D-glycero-D-galacto-2-nonulopyranosonic acid) was found to have an inhibitory const. (Ki) of 30±19 nM and was 500-fold selective for its target over the other hNEU isoenzymes tested in vitro (NEU1, NEU2, and NEU3).  This is the first report of any inhibitor of hNEU with nanomolar potency, and this confirms that the 2,3-didehydro-2-deoxy-N-acetylneuraminic acid (DANA) scaffold can be exploited to develop new, potent, and selective inhibitors that target this important family of human enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnSRXjEnHBnbVg90H21EOLACvtfcHk0lj6GgqMU2TlJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtrg%253D&md5=d582936f805cd74ccfd888334e8e0fdb</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fml400080t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400080t%26sid%3Dliteratum%253Aachs%26aulast%3DAlbohy%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSmutova%26aufirst%3DV.%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DIdentification%2520of%2520selective%2520nanomolar%2520inhibitors%2520of%2520the%2520human%2520neuraminidase%252C%2520NEU4%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D532%26epage%3D537%26doi%3D10.1021%2Fml400080t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datwyler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fougerat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Selective inhibitors of human neuraminidase 3</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1990</span>– <span class="NLM_lpage">2008</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01574</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVGktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1990-2008&author=T.+Guoauthor=P.+Datwylerauthor=E.+Deminaauthor=M.+R.+Richardsauthor=P.+Geauthor=C.+Zouauthor=R.+Zhengauthor=A.+Fougeratauthor=A.+V.+Pshezhetskyauthor=B.+Ernstauthor=C.+W.+Cairo&title=Selective+inhibitors+of+human+neuraminidase+3&doi=10.1021%2Facs.jmedchem.7b01574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibitors of Human Neuraminidase 3</span></div><div class="casAuthors">Guo, Tianlin; Datwyler, Philipp; Demina, Ekaterina; Richards, Michele R.; Ge, Peng; Zou, Chunxia; Zheng, Ruixiang; Fougerat, Anne; Pshezhetsky, Alexey V.; Ernst, Beat; Cairo, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1990-2008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5-Acetamido-9-pentanamido-2,6-anhydro-3,5-dideoxy-D-glycero-D-galacto-non-2-enonic Acid.  Human neuraminidases (NEU) are assocd. with human diseases including cancer, atherosclerosis, and diabetes.  To obtain small mol. inhibitors as research tools for the study of their biol. functions, we designed a library of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogs with modifications at C4 and C9 positions.  This library allowed us to discover selective inhibitors targeting the human NEU3 isoenzyme.  Our most selective inhibitor for NEU3 has a Ki of 320 ± 40 nM and a 15-fold selectivity over other human neuraminidase isoenzymes.  This inhibitor blocks glycolipid processing by NEU3 in vitro.  To improve their pharmacokinetic properties, various esters of the best inhibitors were synthesized and evaluated.  Finally, we confirmed that our best compds. exhibited selective inhibition of NEU orthologues from murine brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzyYhfRWnhorVg90H21EOLACvtfcHk0lj6GgqMU2TlJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVGktr8%253D&md5=7f8d7e91e8259b237cf3138dfad55dc2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01574%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DDatwyler%26aufirst%3DP.%26aulast%3DDemina%26aufirst%3DE.%26aulast%3DRichards%26aufirst%3DM.%2BR.%26aulast%3DGe%26aufirst%3DP.%26aulast%3DZou%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DR.%26aulast%3DFougerat%26aufirst%3DA.%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26aulast%3DErnst%26aufirst%3DB.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DSelective%2520inhibitors%2520of%2520human%2520neuraminidase%25203%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1990%26epage%3D2008%26doi%3D10.1021%2Facs.jmedchem.7b01574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiarto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1039/c0mb00244e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1039%2Fc0mb00244e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=21206954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFGht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=1060-1072&author=Y.+Liauthor=H.+Caoauthor=H.+Yuauthor=Y.+Chenauthor=K.+Lauauthor=J.+Quauthor=V.+Thonauthor=G.+Sugiartoauthor=X.+Chen&title=Identifying+selective+inhibitors+against+the+human+cytosolic+sialidase+NEU2+by+substrate+specificity+studies&doi=10.1039%2Fc0mb00244e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies</span></div><div class="casAuthors">Li, Yan-Hong; Cao, Hong-Zhi; Yu, Hai; Chen, Yi; Lau, Kam; Qu, Jing-Yao; Thon, Vireak; Sugiarto, Go; Chen, Xi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1060-1072</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Aberrant expression of human sialidases has been shown to assoc. with various pathol. conditions.  Despite the effort in the sialidase inhibitor design, less attention has been paid to designing specific inhibitors against human sialidases and characterizing the substrate specificity of different sialidases regarding diverse terminal sialic acid forms and sialyl linkages.  This is mainly due to the lack of sialoside probes and efficient screening methods, as well as limited access to human sialidases.  A low cellular expression level of the human sialidase NEU2 hampers its functional and inhibitory studies.  Here we report the successful cloning and expression of the human sialidase NEU2 in E. coli.  About 11 mg of sol. active NEU2 was routinely obtained from 1 L of E. coli cell culture.  Substrate specificity studies of the recombinant human NEU2 using twenty p-nitrophenol (pNP)-tagged α2-3- or α2-6-linked sialyl galactosides contg. different terminal sialic acid forms including common N-acetylneuraminic acid (Neu5Ac), non-human N-glycolylneuraminic acid (Neu5Gc), 2-keto-3-deoxy-d-glycero-d-galacto-nonulosonic acid (Kdn), or their C5-derivs. in a microtiter plate-based high-throughput colorimetric assay identified a unique structural feature specifically recognized by the human NEU2 but not two bacterial sialidases.  The results obtained from substrate specificity studies were used to guide the design of a sialidase inhibitor that was selective against human NEU2.  The selectivity of the inhibitor was revealed by the comparison of sialidase crystal structures and inhibitor docking studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX23NmQCdm_7Vg90H21EOLACvtfcHk0lgSKlxZE2pFaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFGht7s%253D&md5=8aac070f465e3dd1b0fb425b5a122110</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2Fc0mb00244e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0mb00244e%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DQu%26aufirst%3DJ.%26aulast%3DThon%26aufirst%3DV.%26aulast%3DSugiarto%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DIdentifying%2520selective%2520inhibitors%2520against%2520the%2520human%2520cytosolic%2520sialidase%2520NEU2%2520by%2520substrate%2520specificity%2520studies%26jtitle%3DMol.%2520BioSyst.%26date%3D2011%26volume%3D7%26spage%3D1060%26epage%3D1072%26doi%3D10.1039%2Fc0mb00244e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khedri, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthana, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">6112</span>– <span class="NLM_lpage">6120</span>, <span class="refDoi"> DOI: 10.1039/c2ob25335f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1039%2Fc2ob25335f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=22641268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSmu7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=6112-6120&author=Z.+Khedriauthor=Y.+Liauthor=H.+Caoauthor=J.+Quauthor=H.+Yuauthor=M.+M.+Muthanaauthor=X.+Chen&title=Synthesis+of+selective+inhibitors+against+V.+cholerae+sialidase+and+human+cytosolic+sialidase+NEU2&doi=10.1039%2Fc2ob25335f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2</span></div><div class="casAuthors">Khedri, Zahra; Li, Yanhong; Cao, Hongzhi; Qu, Jingyao; Yu, Hai; Muthana, Musleh M.; Chen, Xi</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">6112-6120</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Sialidases or neuraminidases catalyze the hydrolysis of terminal sialic acid residues from sialyl oligosaccharides and glycoconjugates.  Despite successes in developing potent inhibitors specifically against influenza virus neuraminidases, the progress in designing and synthesizing selective inhibitors against bacterial and human sialidases has been slow.  Guided by sialidase substrate specificity studies and sialidase crystal structural anal., a no. of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (DANA or Neu5Ac2en) analogs with modifications at C9 or at both C5 and C9 were synthesized.  Inhibition studies of various bacterial sialidases and human cytosolic sialidase NEU2 revealed that Neu5Gc9N32en and Neu5AcN39N32en are selective inhibitors against V. cholerae sialidase and human NEU2, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxY07DjtFooLVg90H21EOLACvtfcHk0lgSKlxZE2pFaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSmu7fE&md5=9efb3730ef24448630f75d955cf1643e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1039%2Fc2ob25335f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob25335f%26sid%3Dliteratum%253Aachs%26aulast%3DKhedri%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DQu%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DMuthana%26aufirst%3DM.%2BM.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DSynthesis%2520of%2520selective%2520inhibitors%2520against%2520V.%2520cholerae%2520sialidase%2520and%2520human%2520cytosolic%2520sialidase%2520NEU2%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26spage%3D6112%26epage%3D6120%26doi%3D10.1039%2Fc2ob25335f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albohy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandbhor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of human neuraminidase 3 (NEU3) by <i>C</i>9-triazole derivatives of 2,3-didehydro-<i>N</i>-acetyl-neuraminic acid</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">7529</span>– <span class="NLM_lpage">7533</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.09.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.bmcl.2010.09.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKjtbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7529-7533&author=Y.+Zouauthor=A.+Albohyauthor=M.+Sandbhorauthor=C.+W.+Cairo&title=Inhibition+of+human+neuraminidase+3+%28NEU3%29+by+C9-triazole+derivatives+of+2%2C3-didehydro-N-acetyl-neuraminic+acid&doi=10.1016%2Fj.bmcl.2010.09.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-N-acetyl-neuraminic acid</span></div><div class="casAuthors">Zou, Yao; Albohy, Amgad; Sandbhor, Mahendra; Cairo, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7529-7533</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report the synthesis of a series of C9 and N5Ac modified analogs of 2,3-didehydro-N-acetyl-neuraminic acid (DANA) and their inhibitory potency for the human neuraminidase 3 (NEU3) enzyme.  We were able to generate a small library of compds. through the synthesis of azide derivs. of DANA, followed by Cu-catalyzed azide-alkyne cycloaddn. (CuAAC) to generate triazole-contg. inhibitors.  Our results suggest that NEU3 can tolerate large hydrophobic groups at the C9 position; however, none of the derivs. made at the N5Ac side-chain were active.  We identify three new inhibitors that have comparable potency to the best reported inhibitors of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtln8QUVkF9rVg90H21EOLACvtfcHk0ljTiP_cVoj40g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKjtbvF&md5=27a65cd223b8b80263f6f9120a004662</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.111%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DY.%26aulast%3DAlbohy%26aufirst%3DA.%26aulast%3DSandbhor%26aufirst%3DM.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DInhibition%2520of%2520human%2520neuraminidase%25203%2520%2528NEU3%2529%2520by%2520C9-triazole%2520derivatives%2520of%25202%252C3-didehydro-N-acetyl-neuraminic%2520acid%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7529%26epage%3D7533%26doi%3D10.1016%2Fj.bmcl.2010.09.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albohy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smutova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2948</span>– <span class="NLM_lpage">2958</span>, <span class="refDoi"> DOI: 10.1021/jm301892f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301892f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2948-2958&author=Y.+Zhangauthor=A.+Albohyauthor=Y.+Zouauthor=V.+Smutovaauthor=A.+V.+Pshezhetskyauthor=C.+W.+Cairo&title=Identification+of+selective+inhibitors+for+human+neuraminidase+isoenzymes+using+C4%2CC7-modified+2-deoxy-2%2C3-didehydro-N-acetylneuraminic+acid+%28DANA%29+analogues&doi=10.1021%2Fjm301892f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm301892f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301892f%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DAlbohy%26aufirst%3DA.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DSmutova%26aufirst%3DV.%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DIdentification%2520of%2520selective%2520inhibitors%2520for%2520human%2520neuraminidase%2520isoenzymes%2520using%2520C4%252CC7-modified%25202-deoxy-2%252C3-didehydro-N-acetylneuraminic%2520acid%2520%2528DANA%2529%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2948%26epage%3D2958%26doi%3D10.1021%2Fjm301892f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hyun, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verceles, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kommagalla, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kona, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzina, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atamas, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piepenbrink, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundberg, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lillehoj, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldblum, S. E.</span></span> <span> </span><span class="NLM_article-title">The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">834</span>– <span class="NLM_lpage">849</span>, <span class="refDoi"> DOI: 10.1093/glycob/cww060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fglycob%2Fcww060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=27226251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKms7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=834-849&author=S.+W.+Hyunauthor=A.+G.+Liuauthor=Z.+G.+Liuauthor=A.+S.+Crossauthor=A.+C.+Vercelesauthor=S.+Mageshauthor=Y.+Kommagallaauthor=C.+Konaauthor=H.+Andoauthor=I.+G.+Luzinaauthor=S.+P.+Atamasauthor=K.+H.+Piepenbrinkauthor=E.+J.+Sundbergauthor=W.+Guangauthor=H.+Ishidaauthor=E.+P.+Lillehojauthor=S.+E.+Goldblum&title=The+NEU1-selective+sialidase+inhibitor%2C+C9-butyl-amide-DANA%2C+blocks+sialidase+activity+and+NEU1-mediated+bioactivities+in+human+lung+in+vitro+and+murine+lung+in+vivo&doi=10.1093%2Fglycob%2Fcww060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo</span></div><div class="casAuthors">Hyun, Sang W.; Liu, Anguo; Liu, Zhenguo; Cross, Alan S.; Verceles, Avelino C.; Magesh, Sadagopan; Kommagalla, Yadagiri; Kona, Chandrababunaidu; Ando, Hiromune; Luzina, Irina G.; Atamas, Sergei P.; Piepenbrink, Kurt H.; Sundberg, Eric J.; Guang, Wei; Ishida, Hideharu; Erik, P.; Goldblum, Simeon E.</div><div class="citationInfo"><span class="NLM_cas:title">Glycobiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">834-849</span>CODEN:
                <span class="NLM_cas:coden">GLYCE3</span>;
        ISSN:<span class="NLM_cas:issn">0959-6658</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Neuraminidase-1 (NEU1) is the predominant sialidase expressed in human airway epithelia and lung microvascular endothelia where it mediates multiple biol. processes.  We tested whether the NEU1-selective sialidase inhibitor, C9-butyl-amide-2-deoxy-2,3-dehydro-N-acetylneuraminic acid (C9-BA-DANA), inhibits one or more established NEU1-mediated bioactivities in human lung cells.  We established the IC50 values of C9-BA-DANA for total sialidase activity in human airway epithelia, lung microvascular endothelia and lung fibroblasts to be 3.74 μM, 13.0 μM and 4.82 μM, resp.  In human airway epithelia, C9-BA-DANA dose-dependently inhibited flagellin-induced, NEU1-mediated mucin-1 ectodomain desialylation, adhesiveness for Pseudomonas aeruginosa and shedding.  In lung microvascular endothelia, C9-BA-DANA reversed NEU1-driven restraint of cell migration into a wound and disruption of capillary-like tube formation.  NEU1 and its chaperone/transport protein, protective protein/cathepsin A (PPCA), were differentially expressed in these same cells.  Normalized NEU1 protein expression correlated with total sialidase activity whereas PPCA expression did not.  In contrast to eukaryotic sialidases, C9-BA-DANA exerted far less inhibitory activity for three selected bacterial neuraminidases (IC50 > 800 μM).  Structural modeling of the four human sialidases and three bacterial neuraminidases revealed a loop between the seventh and eighth strands of the β-propeller fold, that in NEU1, was substantially shorter than that seen in the six other enzymes.  Predicted steric hindrance between this loop and C9-BA-DANA could explain its selectivity for NEU1.  Finally, pretreatment of mice with C9-BA-DANA completely protected against flagellin-induced increases in lung sialidase activity.  Our combined data indicate that C9-BA-DANA inhibits endogenous and ectopically expressed sialidase activity and established NEU1-mediated bioactivities in human airway epithelia, lung microvascular endothelia, and fibroblasts in vitro and murine lungs in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk2UrrjX8jl7Vg90H21EOLACvtfcHk0lgcZKMy4GvJlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKms7jM&md5=09ea6103345880a5e0d1059df7ec9f9d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcww060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcww060%26sid%3Dliteratum%253Aachs%26aulast%3DHyun%26aufirst%3DS.%2BW.%26aulast%3DLiu%26aufirst%3DA.%2BG.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26aulast%3DCross%26aufirst%3DA.%2BS.%26aulast%3DVerceles%26aufirst%3DA.%2BC.%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DKommagalla%26aufirst%3DY.%26aulast%3DKona%26aufirst%3DC.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DLuzina%26aufirst%3DI.%2BG.%26aulast%3DAtamas%26aufirst%3DS.%2BP.%26aulast%3DPiepenbrink%26aufirst%3DK.%2BH.%26aulast%3DSundberg%26aufirst%3DE.%2BJ.%26aulast%3DGuang%26aufirst%3DW.%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DLillehoj%26aufirst%3DE.%2BP.%26aulast%3DGoldblum%26aufirst%3DS.%2BE.%26atitle%3DThe%2520NEU1-selective%2520sialidase%2520inhibitor%252C%2520C9-butyl-amide-DANA%252C%2520blocks%2520sialidase%2520activity%2520and%2520NEU1-mediated%2520bioactivities%2520in%2520human%2520lung%2520in%2520vitro%2520and%2520murine%2520lung%2520in%2520vivo%26jtitle%3DGlycobiology%26date%3D2016%26volume%3D26%26spage%3D834%26epage%3D849%26doi%3D10.1093%2Fglycob%2Fcww060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulkhalek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neufeld, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczuk, M. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.2147/OTT.S55344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.2147%2FOTT.S55344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=24470763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ynu77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=117-134&author=L.+K.+O%E2%80%99Sheaauthor=S.+Abdulkhalekauthor=S.+Allisonauthor=R.+J.+Neufeldauthor=M.+R.+Szewczuk&title=Therapeutic+targeting+of+Neu1+sialidase+with+oseltamivir+phosphate+%28Tamiflu%29+disables+cancer+cell+survival+in+human+pancreatic+cancer+with+acquired+chemoresistance&doi=10.2147%2FOTT.S55344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance</span></div><div class="casAuthors">O'Shea, Leah K.; Abdulkhalek, Samar; Allison, Stephanie; Neufeld, Ronald J.; Szewczuk, Myron R.</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117-134, 18 pp.</span>CODEN:
                <span class="NLM_cas:coden">OTNHAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Resistance to drug therapy, along with high rates of metastasis, contributes to the low survival rate in patients diagnosed with pancreatic cancer.  An alternate treatment for human pancreatic cancer involving targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu) was investigated in human pancreatic cancer (PANC1) cells with acquired resistance to cisplatin and gemcitabine.  Its efficacy in overcoming the intrinsic resistance of the cell to chemotherapeutics and metastasis was evaluated.  Methods: Microscopic imaging, immunocytochem., immunohistochem., and WST-1 cell viability assays were used to evaluate cell survival, morphol. changes, and expression levels of E-cadherin, N-cadherin, and VE-cadherin before and after treatment with oseltamivir phosphate in PANC1 cells with established resistance to cisplatin, gemcitabine, or a combination of the two agents, and in archived paraffin-embedded PANC1 tumors grown in RAGxCγ double mutant mice.  Results: Oseltamivir phosphate overcame the chemoresistance of PANC1 to cisplatin and gemcitabine alone or in combination in a dose-dependent manner, and disabled the cancer cell survival mechanism(s).  Oseltamivir phosphate also reversed the epithelial-mesenchymal transition characteristic of the phenotypic E-cadherin to N-cadherin changes assocd. with resistance to drug therapy.  Low-dose oseltamivir phosphate alone or in combination with gemcitabine in heterotopic xenografts of PANC1 tumors growing in RAGxCγ double mutant mice did not prevent metastatic spread to the liver and lung.  Conclusion: Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate at the growth factor receptor level disables the intrinsic signaling platform for cancer cell survival in human pancreatic cancer with acquired chemoresistance.  These findings provide evidence for oseltamivir phosphate (Tamiflu) as a potential therapeutic agent for pancreatic cancer resistant to drug therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogNMCU3s0MmrVg90H21EOLACvtfcHk0lgcZKMy4GvJlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ynu77L&md5=d9a8d9851d043209ccd3e9720719328b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2147%2FOTT.S55344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S55344%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DL.%2BK.%26aulast%3DAbdulkhalek%26aufirst%3DS.%26aulast%3DAllison%26aufirst%3DS.%26aulast%3DNeufeld%26aufirst%3DR.%2BJ.%26aulast%3DSzewczuk%26aufirst%3DM.%2BR.%26atitle%3DTherapeutic%2520targeting%2520of%2520Neu1%2520sialidase%2520with%2520oseltamivir%2520phosphate%2520%2528Tamiflu%2529%2520disables%2520cancer%2520cell%2520survival%2520in%2520human%2520pancreatic%2520cancer%2520with%2520acquired%2520chemoresistance%26jtitle%3DOncoTargets%2520Ther.%26date%3D2014%26volume%3D7%26spage%3D117%26epage%3D134%26doi%3D10.2147%2FOTT.S55344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, M.</span></span> <span> </span><span class="NLM_article-title">Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: Hints for the design of selective NEU3 inhibitors</span>. <i>J. Mol. Graphics Modell.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">196</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1016/j.jmgm.2005.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.jmgm.2005.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Gis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=196-207&author=S.+Mageshauthor=T.+Suzukiauthor=T.+Miyagiauthor=H.+Ishidaauthor=M.+Kiso&title=Homology+modeling+of+human+sialidase+enzymes+NEU1%2C+NEU3+and+NEU4+based+on+the+crystal+structure+of+NEU2%3A+Hints+for+the+design+of+selective+NEU3+inhibitors&doi=10.1016%2Fj.jmgm.2005.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: Hints for the design of selective NEU3 inhibitors</span></div><div class="casAuthors">Magesh, Sadagopan; Suzuki, Tohru; Miyagi, Taeko; Ishida, Hideharu; Kiso, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-207</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Four types of human sialidases have been cloned and characterized at the mol. level.  They are classified according to their major intracellular location as intralysomal (NEU1), cytosolic (NEU2), plasma membrane (NEU3) and lysosomal or mitochondrial membrane (NEU4) assocd. sialidases.  These human isoforms are distinct from each other in their enzymic properties as well as their substrate specificity.  Altered expression of sialidases has been correlated with malignant transformation of cells and different sialidases have been known to behave differently during carcinogenesis.  Particularly, increased expression of NEU3 has been implicated in the survival of various cancer cells and also in the development of insulin resistance.  In the present study, we have modeled three-dimensional structures of NEU1, NEU3 and NEU4 based on the crystal structure of NEU2 using the homol. modeling program MODELER.  The best model in each enzyme case was chosen on the basis of various std. protein anal. programs.  Predicted structures and the exptl. protein-ligand complex of NEU2 were compared to identify similarities and differences among the active sites.  The mol. electrostatic potential (MEP) was calcd. for the predicted models to identify the differences in charge distribution around the active site and its vicinity.  The primary objective of the present work is to identify the structural differences between the different isoforms of human sialidases, namely NEU1, NEU2, NEU3 and NEU4, thus providing a better insight into the differences in the active sites of these enzymes.  This can in turn guide us in the better understanding and rationale of the differential substrate recognition and activity, thereby aiding in the structure-based design of selective NEU3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgAbMhbiWborVg90H21EOLACvtfcHk0lht-v_z5VupxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Gis78%253D&md5=835062eb55957af9dbe7a8b8bd3321ad</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2005.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2005.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DKiso%26aufirst%3DM.%26atitle%3DHomology%2520modeling%2520of%2520human%2520sialidase%2520enzymes%2520NEU1%252C%2520NEU3%2520and%2520NEU4%2520based%2520on%2520the%2520crystal%2520structure%2520of%2520NEU2%253A%2520Hints%2520for%2520the%2520design%2520of%2520selective%2520NEU3%2520inhibitors%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2006%26volume%3D25%26spage%3D196%26epage%3D207%26doi%3D10.1016%2Fj.jmgm.2005.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonta, C.</span></span> <span> </span><span class="NLM_article-title">From structure to chemical shift and vice-versa</span>. <i>Prog. Nucl. Magn. Reson. Spectrosc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1016/j.pnmrs.2005.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.pnmrs.2005.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFaktrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2005&pages=27-39&author=C.+A.+Hunterauthor=M.+J.+Packerauthor=C.+Zonta&title=From+structure+to+chemical+shift+and+vice-versa&doi=10.1016%2Fj.pnmrs.2005.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">From structure to chemical shift and vice-versa</span></div><div class="casAuthors">Hunter, Christopher A.; Packer, Martin J.; Zonta, Cristiano</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Nuclear Magnetic Resonance Spectroscopy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">27-39</span>CODEN:
                <span class="NLM_cas:coden">PNMRAT</span>;
        ISSN:<span class="NLM_cas:issn">0079-6565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmNFFSXwPhNLVg90H21EOLACvtfcHk0lht-v_z5VupxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFaktrfM&md5=8e7504692a5452ca58f19d106916291b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.pnmrs.2005.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnmrs.2005.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DC.%2BA.%26aulast%3DPacker%26aufirst%3DM.%2BJ.%26aulast%3DZonta%26aufirst%3DC.%26atitle%3DFrom%2520structure%2520to%2520chemical%2520shift%2520and%2520vice-versa%26jtitle%3DProg.%2520Nucl.%2520Magn.%2520Reson.%2520Spectrosc.%26date%3D2005%26volume%3D47%26spage%3D27%26epage%3D39%26doi%3D10.1016%2Fj.pnmrs.2005.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonten, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Spoel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fornerod, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosveld, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Azzo, A.</span></span> <span> </span><span class="NLM_article-title">Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3156</span>– <span class="NLM_lpage">3169</span>, <span class="refDoi"> DOI: 10.1101/gad.10.24.3156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1101%2Fgad.10.24.3156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=8985184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADyaK2sXjsFWjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=3156-3169&author=E.+Bontenauthor=A.+van+der+Spoelauthor=M.+Fornerodauthor=G.+Grosveldauthor=A.+d%E2%80%99Azzo&title=Characterization+of+human+lysosomal+neuraminidase+defines+the+molecular+basis+of+the+metabolic+storage+disorder+sialidosis&doi=10.1101%2Fgad.10.24.3156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis</span></div><div class="casAuthors">Bonten, Erik; van der Spoel, Aarnoud; Fornerod, Maarten; Grosveld, Gerard; d'Azzo, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3156-3169</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Neuraminidases (sialidases) have an essential role in the removal of terminal sialic acid residues from sialoglycoconjugates and are distributed widely in nature.  The human lysosomal enzyme occurs in complex with β-galactosidase and protective protein/cathepsin A (PPCA), and is deficient in two genetic disorders: sialidosis, caused by a structural defect in the neuraminidase gene, and galactosialidosis, in which the loss of neuraminidase activity is secondary to a deficiency of PPCA.  The authors identified a full-length cDNA clone in the dbEST data base, of which the predicted amino acid sequence has extensive homol. to other mammalian and bacterial neuraminidases, including the F(Y)RIP domain and "Asp-boxes".  In situ hybridization localized the human neuraminidase gene to chromosome band 6p21, a region known to contain the HLA locus.  Transient expression of the cDNA in deficient human fibroblasts showed that the enzyme is compartmentalized in lysosomes and restored neuraminidase activity in a PPCA-dependent manner.  The authenticity of the cDNA was verified by the identification of three independent mutations in the open reading frame of the mRNA from clin. distinct sialidosis patients.  Coexpression of the mutant cDNAs with PPCA failed to generate neuraminidase activity, confirming the inactivating effect of the mutations.  These results establish the mol. basis of sialidosis in these patients, and clearly identify the cDNA-encoded protein as lysosomal neuraminidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUaX03DrwFRLVg90H21EOLACvtfcHk0lh3T-V4eD2F1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsFWjtg%253D%253D&md5=3af0ff8e03dd21760dde6209b4bc7a4e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1101%2Fgad.10.24.3156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.10.24.3156%26sid%3Dliteratum%253Aachs%26aulast%3DBonten%26aufirst%3DE.%26aulast%3Dvan%2Bder%2BSpoel%26aufirst%3DA.%26aulast%3DFornerod%26aufirst%3DM.%26aulast%3DGrosveld%26aufirst%3DG.%26aulast%3Dd%25E2%2580%2599Azzo%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520human%2520lysosomal%2520neuraminidase%2520defines%2520the%2520molecular%2520basis%2520of%2520the%2520metabolic%2520storage%2520disorder%2520sialidosis%26jtitle%3DGenes%2520Dev.%26date%3D1996%26volume%3D10%26spage%3D3156%26epage%3D3169%26doi%3D10.1101%2Fgad.10.24.3156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loka, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadek, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romaniuk, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Conjugation of synthetic N-acetyl-lactosamine to azide-containing proteins using the Staudinger ligation</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1842</span>– <span class="NLM_lpage">1849</span>, <span class="refDoi"> DOI: 10.1021/bc100209r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc100209r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=1842-1849&author=R.+S.+Lokaauthor=C.+M.+Sadekauthor=N.+A.+Romaniukauthor=C.+W.+Cairo&title=Conjugation+of+synthetic+N-acetyl-lactosamine+to+azide-containing+proteins+using+the+Staudinger+ligation&doi=10.1021%2Fbc100209r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation of Synthetic N-Acetyl-Lactosamine to Azide-Containing Proteins Using the Staudinger Ligation</span></div><div class="casAuthors">Loka, Ravi S.; Sadek, Christopher M.; Romaniuk, Nikolas A.; Cairo, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1842-1849</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Generation of defined glycoconjugates is necessary for the study of glycoprotein function, as well as the development of therapeutics.  The biosynthesis of glycoproteins produces multiple glycoforms, proteins which differ only in the structure of the attached glycan.  This inherent heterogeneity complicates the study of isolated glycans and, in particular, could obscure the role of individual glycan epitopes in biol. function.  The authors present a general strategy based on the Staudinger ligation to introduce specific glycan epitopes onto azide-contg. proteins.  The use of a phosphane-based Staudinger reagent allows for extremely mild reaction conditions which can be applied to aq. proteins or cells.  The authors demonstrate that multiple carbohydrate epitopes can be incorporated onto a protein backbone, and that the resulting glycans are competent for recognition by lectins.  The authors propose that this general strategy will allow for testing the role of specific glycan epitopes in cellular and biochem. assays and increasing the stability of protein conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6TgKAnJPzM7Vg90H21EOLACvtfcHk0lh3T-V4eD2F1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtLrL&md5=cecfefeaa87a4ffdecc8d3f9ec78acae</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fbc100209r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc100209r%26sid%3Dliteratum%253Aachs%26aulast%3DLoka%26aufirst%3DR.%2BS.%26aulast%3DSadek%26aufirst%3DC.%2BM.%26aulast%3DRomaniuk%26aufirst%3DN.%2BA.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DConjugation%2520of%2520synthetic%2520N-acetyl-lactosamine%2520to%2520azide-containing%2520proteins%2520using%2520the%2520Staudinger%2520ligation%26jtitle%3DBioconjugate%2520Chem.%26date%3D2010%26volume%3D21%26spage%3D1842%26epage%3D1849%26doi%3D10.1021%2Fbc100209r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shidmoossavee, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennet, A. J.</span></span> <span> </span><span class="NLM_article-title">Chemical insight into the emergence of influenza virus strains that are resistant to Relenza</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">13254</span>– <span class="NLM_lpage">13257</span>, <span class="refDoi"> DOI: 10.1021/ja405916q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja405916q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGntbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=13254-13257&author=F.+S.+Shidmoossaveeauthor=J.+N.+Watsonauthor=A.+J.+Bennet&title=Chemical+insight+into+the+emergence+of+influenza+virus+strains+that+are+resistant+to+Relenza&doi=10.1021%2Fja405916q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Insight into the Emergence of Influenza Virus Strains That Are Resistant to Relenza</span></div><div class="casAuthors">Shidmoossavee, Fahimeh S.; Watson, Jacqueline N.; Bennet, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">13254-13257</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A reagent panel contg. ten 4-substituted 4-nitrophenyl α-d-sialosides and a second panel of the corresponding sialic acid glycals were synthesized and used to probe the inhibition mechanism for two neuraminidases, the N2 enzyme from influenza type A virus and the enzyme from Micromonospora viridifaciens.  For the viral enzyme the logarithm of the inhibition const. (Ki) correlated with neither the logarithm of the catalytic efficiency (kcat/Km) nor catalytic proficiency (kcat/Kmkun).  These linear free energy relationship data support the notion that these inhibitors, which include the therapeutic agent Relenza, are not transition state mimics for the enzyme-catalyzed hydrolysis reaction.  Moreover, for the influenza enzyme, a correlation (slope, 0.80 ± 0.08) is obsd. between the logarithms of the inhibition (Ki) and Michaelis (Km) consts.  We conclude that the free energy for Relenza binding to the influenza enzyme mimics the enzyme-substrate interactions at the Michaelis complex.  Thus, an influenza mutational response to a 4-substituted sialic acid glycal inhibitor can weaken the interactions between the inhibitor and the viral neuraminidase without a concomitant decrease in free energy of binding for the substrate at the enzyme-catalyzed hydrolysis transition state.  The current findings make it clear that new structural motifs and/or substitution patterns need to be developed in the search for a bona fide influenza viral neuraminidase transition state analog inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc1UqIwwur7rVg90H21EOLACvtfcHk0lh3T-V4eD2F1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGntbbM&md5=6b65e745d148c69c0e96750de39219ce</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fja405916q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja405916q%26sid%3Dliteratum%253Aachs%26aulast%3DShidmoossavee%26aufirst%3DF.%2BS.%26aulast%3DWatson%26aufirst%3DJ.%2BN.%26aulast%3DBennet%26aufirst%3DA.%2BJ.%26atitle%3DChemical%2520insight%2520into%2520the%2520emergence%2520of%2520influenza%2520virus%2520strains%2520that%2520are%2520resistant%2520to%2520Relenza%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D13254%26epage%3D13257%26doi%3D10.1021%2Fja405916q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Potier, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mameli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bélisle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallaire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melancon, S. B.</span></span> <span> </span><span class="NLM_article-title">Fluorometric assays of neuraminidase with a sodium (4-methylumbellifery-α-D-N-Acetylneuraminate) substrate</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1016/0003-2697(79)90362-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2F0003-2697%2879%2990362-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1979&pages=287-296&author=M.-C.+Potierauthor=L.+Mameliauthor=M.+B%C3%A9lisleauthor=L.+Dallaireauthor=S.+B.+Melancon&title=Fluorometric+assays+of+neuraminidase+with+a+sodium+%284-methylumbellifery-%CE%B1-D-N-Acetylneuraminate%29+substrate&doi=10.1016%2F0003-2697%2879%2990362-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2879%2990362-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252879%252990362-2%26sid%3Dliteratum%253Aachs%26aulast%3DPotier%26aufirst%3DM.-C.%26aulast%3DMameli%26aufirst%3DL.%26aulast%3DB%25C3%25A9lisle%26aufirst%3DM.%26aulast%3DDallaire%26aufirst%3DL.%26aulast%3DMelancon%26aufirst%3DS.%2BB.%26atitle%3DFluorometric%2520assays%2520of%2520neuraminidase%2520with%2520a%2520sodium%2520%25284-methylumbellifery-%25CE%25B1-D-N-Acetylneuraminate%2529%2520substrate%26jtitle%3DAnal.%2520Biochem.%26date%3D1979%26volume%3D94%26spage%3D287%26epage%3D296%26doi%3D10.1016%2F0003-2697%2879%2990362-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warner, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, J. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2′-(4-methylumbelliferyl)-.alpha.-D-N-acetylneuraminic acid and detection of skin fibroblast neuraminidase in normal humans and in sialidosis</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2783</span>– <span class="NLM_lpage">2787</span>, <span class="refDoi"> DOI: 10.1021/bi00580a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00580a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1979&pages=2783-2787&author=T.+G.+Warnerauthor=J.+S.+O%E2%80%99Brien&title=Synthesis+of+2%E2%80%B2-%284-methylumbelliferyl%29-.alpha.-D-N-acetylneuraminic+acid+and+detection+of+skin+fibroblast+neuraminidase+in+normal+humans+and+in+sialidosis&doi=10.1021%2Fbi00580a014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fbi00580a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00580a014%26sid%3Dliteratum%253Aachs%26aulast%3DWarner%26aufirst%3DT.%2BG.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BS.%26atitle%3DSynthesis%2520of%25202%25E2%2580%25B2-%25284-methylumbelliferyl%2529-.alpha.-D-N-acetylneuraminic%2520acid%2520and%2520detection%2520of%2520skin%2520fibroblast%2520neuraminidase%2520in%2520normal%2520humans%2520and%2520in%2520sialidosis%26jtitle%3DBiochemistry%26date%3D1979%26volume%3D18%26spage%3D2783%26epage%3D2787%26doi%3D10.1021%2Fbi00580a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Aragão, C. D. B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco-Martin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priestman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturiale, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garozzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platt, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamarche-Vane, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span> <span> </span><span class="NLM_article-title">Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3467</span>– <span class="NLM_lpage">3483</span>, <span class="refDoi"> DOI: 10.1096/fj.201601299R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1096%2Ffj.201601299R" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=3467-3483&issue=8&author=X.+Panauthor=C.+D.+B.+P.+De+Arag%C3%A3oauthor=J.+P.+Velasco-Martinauthor=D.+A.+Priestmanauthor=H.+Y.+Wuauthor=K.+Takahashiauthor=K.+Yamaguchiauthor=L.+Sturialeauthor=D.+Garozzoauthor=F.+M.+Plattauthor=N.+Lamarche-Vaneauthor=C.+R.+Moralesauthor=T.+Miyagiauthor=A.+V.+Pshezhetsky&title=Neuraminidases+3+and+4+regulate+neuronal+function+by+catabolizing+brain+gangliosides&doi=10.1096%2Ffj.201601299R"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1096%2Ffj.201601299R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201601299R%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DX.%26aulast%3DDe%2BArag%25C3%25A3o%26aufirst%3DC.%2BD.%2BB.%2BP.%26aulast%3DVelasco-Martin%26aufirst%3DJ.%2BP.%26aulast%3DPriestman%26aufirst%3DD.%2BA.%26aulast%3DWu%26aufirst%3DH.%2BY.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DSturiale%26aufirst%3DL.%26aulast%3DGarozzo%26aufirst%3DD.%26aulast%3DPlatt%26aufirst%3DF.%2BM.%26aulast%3DLamarche-Vane%26aufirst%3DN.%26aulast%3DMorales%26aufirst%3DC.%2BR.%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26atitle%3DNeuraminidases%25203%2520and%25204%2520regulate%2520neuronal%2520function%2520by%2520catabolizing%2520brain%2520gangliosides%26jtitle%3DFASEB%2520J.%26date%3D2017%26volume%3D31%26issue%3D8%26spage%3D3467%26epage%3D3483%26doi%3D10.1096%2Ffj.201601299R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koseki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagi, T.</span></span> <span> </span><span class="NLM_article-title">Human cytosolic sialidase Neu2-low general tissue expression but involvement in PC-3 prostate cancer cell survival</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>428</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2012.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.bbrc.2012.10.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=23068092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsF2ms7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2012&pages=142-149&author=K.+Kosekiauthor=T.+Wadaauthor=M.+Hosonoauthor=K.+Hataauthor=K.+Yamaguchiauthor=K.+Nittaauthor=T.+Miyagi&title=Human+cytosolic+sialidase+Neu2-low+general+tissue+expression+but+involvement+in+PC-3+prostate+cancer+cell+survival&doi=10.1016%2Fj.bbrc.2012.10.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Human cytosolic sialidase NEU2-low general tissue expression but involvement in PC-3 prostate cancer cell survival</span></div><div class="casAuthors">Koseki, Koichi; Wada, Tadashi; Hosono, Masahiro; Hata, Keiko; Yamaguchi, Kazunori; Nitta, Kazuo; Miyagi, Taeko</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">142-149</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Unlike other human sialidases, human cytosolic sialidase NEU2 expression as assessed by quant. real-time PCR was found to be extremely low or undetectable in many human tissues and cells, with notable exceptions like the placenta and testis.  The gene forms obtained by PCR with cDNAs synthesized from poly (A)+ RNA of human brain and colon were verified to encode cytosolic sialidase with appropriate activity, regardless of the brain gene feature of SNPs.  Among a series of human cancer cell lines examd., only prostate cancer PC-3 cells exhibited relatively high expression and NEU2-silencing with an siRNA resulted in decreased cell survival and motility.  To gain insights into the significance of the high levels, transcription factors in the promoter region of the NEU2 gene were surveyed for involvement.  PC-3 cells were characterized by high expression of Runx2 and Sp3, and their silencing reduced NEU2, suggesting regulatory roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHeKiTVafo17Vg90H21EOLACvtfcHk0lgdwe3NTQ5Y7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsF2ms7nF&md5=4f62010bfa811792c96c13b970b12fe5</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2012.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2012.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DKoseki%26aufirst%3DK.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DHata%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DNitta%26aufirst%3DK.%26aulast%3DMiyagi%26aufirst%3DT.%26atitle%3DHuman%2520cytosolic%2520sialidase%2520Neu2-low%2520general%2520tissue%2520expression%2520but%2520involvement%2520in%2520PC-3%2520prostate%2520cancer%2520cell%2520survival%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2012%26volume%3D428%26spage%3D142%26epage%3D149%26doi%3D10.1016%2Fj.bbrc.2012.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngamukote, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagisawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R. K.</span></span> <span> </span><span class="NLM_article-title">Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">2327</span>– <span class="NLM_lpage">2341</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2007.04910.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1111%2Fj.1471-4159.2007.04910.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=17883393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOns7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2007&pages=2327-2341&author=S.+Ngamukoteauthor=M.+Yanagisawaauthor=T.+Arigaauthor=S.+Andoauthor=R.+K.+Yu&title=Developmental+changes+of+glycosphingolipids+and+expression+of+glycogenes+in+mouse+brains&doi=10.1111%2Fj.1471-4159.2007.04910.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains</span></div><div class="casAuthors">Ngamukote, Sathaporn; Yanagisawa, Makoto; Ariga, Toshio; Ando, Susumu; Yu, Robert K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2327-2341</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Glycosphingolipids (GSLs) and their sialic acid-contg. derivs., gangliosides, are important cellular components and are abundant in the nervous system.  They are known to undergo dramatic changes during brain development.  However, knowledge on the mechanisms underlying their qual. and qual. changes is still fragmentary.  In this investigation, we have provided a detailed study on the developmental changes of the expression patterns of GSLs, GM3, GM1, GD3, GD1a, GD2, GD1b, GT1b, GQ1b, A2B5 antigens (c-series gangliosides such as GT3 and GQ1c), Chol-1α (GT1aα and GQ1bα), glucosylceramide, galactosylceramide (O1 antigen), sulfatide (O4 antigen), stage-specific embryonic antigen-1 (Lewis x) glycolipids, and human natural killer-1 glycolipid (sulfoglucuronosyl paragloboside) in developing mouse brains [embryonic day 12 (E12) to adult].  In E12-E14 brains, GD3 was a predominant ganglioside.  After E16, the concns. of GD3 and GM3 markedly decreased, and the concns. of a-series gangliosides, such as GD1a, increased.  GT3, glucosylceramide, and stage-specific embryonic antigen-1 were expressed in embryonic brains.  Human natural killer-1 glycolipid was expressed transiently in embryonic brains.  On the other hand, Chol-1α, galactosylceramide, and sulfatide were exclusively found after birth.  To provide a better understanding of the metabolic basis for these changes, we analyzed glycogene expression patterns in the developing brains and found that GSL expression is regulated primarily by glycosyltransferases, and not by glycosidases.  In parallel studies using primary neural precursor cells in culture as a tool for studying developmental events, dramatic changes in ganglioside and glycosyltransferase gene expression were also detected in neurons induced to differentiate from neural precursor cells, including the expression of GD3, followed by up-regulation of complex a- and b-series gangliosides.  These changes in cell culture systems resemble that occurring in brain.  We conclude that the dramatic changes in GSL pattern and content can serve as useful markers in neural development and that these changes are regulated primarily at the level of glycosyltransferase gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrutKcdeKaAV7Vg90H21EOLACvtfcHk0lgdwe3NTQ5Y7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOns7jE&md5=94feefc56b74193ce73bfcfca1c55e3b</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.04910.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.04910.x%26sid%3Dliteratum%253Aachs%26aulast%3DNgamukote%26aufirst%3DS.%26aulast%3DYanagisawa%26aufirst%3DM.%26aulast%3DAriga%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DR.%2BK.%26atitle%3DDevelopmental%2520changes%2520of%2520glycosphingolipids%2520and%2520expression%2520of%2520glycogenes%2520in%2520mouse%2520brains%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D103%26spage%3D2327%26epage%3D2341%26doi%3D10.1111%2Fj.1471-4159.2007.04910.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Geest, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonten, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sousa-Hitzler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Azzo, A.</span></span> <span> </span><span class="NLM_article-title">Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1455</span>– <span class="NLM_lpage">1464</span>, <span class="refDoi"> DOI: 10.1093/hmg/11.12.1455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fhmg%2F11.12.1455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=12023988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD38XksFWmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=1455-1464&author=N.+de%0AGeestauthor=E.+Bontenauthor=L.+Mannauthor=J.+de+Sousa-Hitzlerauthor=C.+Hahnauthor=A.+d%E2%80%99Azzo&title=Systemic+and+neurologic+abnormalities+distinguish+the+lysosomal+disorders+sialidosis+and+galactosialidosis+in+mice&doi=10.1093%2Fhmg%2F11.12.1455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice</span></div><div class="casAuthors">De Geest, Natalie; Bonten, Erik; Mann, Linda; De Sousa-Hitzler, Jean; Hahn, Christopher; D'Azzo, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1455-1464</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Neuraminidase initiates the hydrolysis of sialo-glycoconjugates by removing their terminal sialic acid residues.  In humans, primary or secondary deficiency of this enzyme leads to two clin. similar neurodegenerative lysosomal storage disorders: sialidosis and galactosialidosis (GS).  Mice nullizygous at the Neu1 locus develop clin. abnormalities reminiscent of early-onset sialidosis in children, including severe nephropathy, progressive edema, splenomegaly, kyphosis and urinary excretion of sialylated oligosaccharides.  Although the sialidosis mouse model shares clin. and histopathol. features with GS mice and GS patients, we have identified phenotypic abnormalities that seem specific for sialidosis mice.  These include progressive deformity of the spine, high incidence of premature death, age-related extramedullary hematopoiesis, and lack of early degeneration of cerebellar Purkinje cells.  The differences and similarities identified in these sialidosis and GS mice may help to better understand the pathophysiol. of these diseases in children and to identify more targeted therapies for each of these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdVVFAz7idcrVg90H21EOLACvtfcHk0lifw4ehyW_jWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksFWmsLk%253D&md5=a9c4e88ef9af3417c8945df577a28d66</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F11.12.1455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F11.12.1455%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BGeest%26aufirst%3DN.%26aulast%3DBonten%26aufirst%3DE.%26aulast%3DMann%26aufirst%3DL.%26aulast%3Dde%2BSousa-Hitzler%26aufirst%3DJ.%26aulast%3DHahn%26aufirst%3DC.%26aulast%3Dd%25E2%2580%2599Azzo%26aufirst%3DA.%26atitle%3DSystemic%2520and%2520neurologic%2520abnormalities%2520distinguish%2520the%2520lysosomal%2520disorders%2520sialidosis%2520and%2520galactosialidosis%2520in%2520mice%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2002%26volume%3D11%26spage%3D1455%26epage%3D1464%26doi%3D10.1093%2Fhmg%2F11.12.1455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocharova, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocharov, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuznetsov, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawecki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocquet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorisse, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghirardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaise, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martiny, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauchez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efremov, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debelle, L.</span></span> <span> </span><span class="NLM_article-title">New insights into molecular organization of human neuraminidase-1: transmembrane topology and dimerization ability</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">38363</span>, <span class="refDoi"> DOI: 10.1038/srep38363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1038%2Fsrep38363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=27917893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC2sXps1OitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=38363&author=P.+Mauriceauthor=S.+Baudauthor=O.+V.+Bocharovaauthor=E.+V.+Bocharovauthor=A.+S.+Kuznetsovauthor=C.+Kaweckiauthor=O.+Bocquetauthor=B.+Romierauthor=L.+Gorisseauthor=M.+Ghirardiauthor=L.+Ducaauthor=S.+Blaiseauthor=L.+Martinyauthor=M.+Dauchezauthor=R.+G.+Efremovauthor=L.+Debelle&title=New+insights+into+molecular+organization+of+human+neuraminidase-1%3A+transmembrane+topology+and+dimerization+ability&doi=10.1038%2Fsrep38363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">New Insights into Molecular Organization of Human Neuraminidase-1: Transmembrane Topology and Dimerization Ability</span></div><div class="casAuthors">Maurice, Pascal; Baud, Stephanie; Bocharova, Olga V.; Bocharov, Eduard V.; Kuznetsov, Andrey S.; Kawecki, Charlotte; Bocquet, Olivier; Romier, Beatrice; Gorisse, Laetitia; Ghirardi, Maxime; Duca, Laurent; Blaise, Sebastien; Martiny, Laurent; Dauchez, Manuel; Efremov, Roman G.; Debelle, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38363</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuraminidase 1 (NEU1) is a lysosomal sialidase catalyzing the removal of terminal sialic acids from sialyloconjugates.  A plasma membrane-bound NEU1 modulating a plethora of receptors by desialylation, has been consistently documented from the last ten years.  Despite a growing interest of the scientific community to NEU1, its membrane organization is not understood and current structural and biochem. data cannot account for such membrane localization.  By combining mol. biol. and biochem. analyses with structural biophysics and computational approaches, we identified here two regions in human NEU1 - segments 139-159 (TM1) and 316-333 (TM2) - as potential transmembrane (TM) domains.  In membrane mimicking environments, the corresponding peptides form stable α-helixes and TM2 is suited for self-assocn.  This was confirmed with full-size NEU1 by co-immunopptns. from membrane prepns. and split-ubiquitin yeast two hybrids.  The TM2 region was shown to be crit. for dimerization since introduction of point mutations within TM2 leads to disruption of NEU1 dimerization and decrease of sialidase activity in membrane.  In conclusion, these results bring new insights in the mol. organization of membrane-bound NEU1 and demonstrate, for the first time, the presence of two potential TM domains that may anchor NEU1 in the membrane, control its dimerization and sialidase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGhOsakHzPzbVg90H21EOLACvtfcHk0lifw4ehyW_jWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXps1OitQ%253D%253D&md5=7f1a7d3e9fc04e7cf47d3ea909b744a5</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fsrep38363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep38363%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DP.%26aulast%3DBaud%26aufirst%3DS.%26aulast%3DBocharova%26aufirst%3DO.%2BV.%26aulast%3DBocharov%26aufirst%3DE.%2BV.%26aulast%3DKuznetsov%26aufirst%3DA.%2BS.%26aulast%3DKawecki%26aufirst%3DC.%26aulast%3DBocquet%26aufirst%3DO.%26aulast%3DRomier%26aufirst%3DB.%26aulast%3DGorisse%26aufirst%3DL.%26aulast%3DGhirardi%26aufirst%3DM.%26aulast%3DDuca%26aufirst%3DL.%26aulast%3DBlaise%26aufirst%3DS.%26aulast%3DMartiny%26aufirst%3DL.%26aulast%3DDauchez%26aufirst%3DM.%26aulast%3DEfremov%26aufirst%3DR.%2BG.%26aulast%3DDebelle%26aufirst%3DL.%26atitle%3DNew%2520insights%2520into%2520molecular%2520organization%2520of%2520human%2520neuraminidase-1%253A%2520transmembrane%2520topology%2520and%2520dimerization%2520ability%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D38363%26doi%3D10.1038%2Fsrep38363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haxho, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neufeld, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczuk, M. R.</span></span> <span> </span><span class="NLM_article-title">Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">40860</span>– <span class="NLM_lpage">40903</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.8396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.18632%2Foncotarget.8396" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=40860-40903&author=F.+Haxhoauthor=R.+J.+Neufeldauthor=M.+R.+Szewczuk&title=Neuraminidase-1%3A+A+novel+therapeutic+target+in+multistage+tumorigenesis&doi=10.18632%2Foncotarget.8396"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8396%26sid%3Dliteratum%253Aachs%26aulast%3DHaxho%26aufirst%3DF.%26aulast%3DNeufeld%26aufirst%3DR.%2BJ.%26aulast%3DSzewczuk%26aufirst%3DM.%2BR.%26atitle%3DNeuraminidase-1%253A%2520A%2520novel%2520therapeutic%2520target%2520in%2520multistage%2520tumorigenesis%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D40860%26epage%3D40903%26doi%3D10.18632%2Foncotarget.8396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itakura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoda, M.</span></span> <span> </span><span class="NLM_article-title">Sialylation regulates myofibroblast differentiation of human skin fibroblasts</span>. <i>Stem Cell Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">81</span>, <span class="refDoi"> DOI: 10.1186/s13287-017-0534-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1186%2Fs13287-017-0534-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=28420408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFyjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=81&issue=1&author=N.+Sasakiauthor=Y.+Itakuraauthor=M.+Toyoda&title=Sialylation+regulates+myofibroblast+differentiation+of+human+skin+fibroblasts&doi=10.1186%2Fs13287-017-0534-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Sialylation regulates myofibroblast differentiation of human skin fibroblasts</span></div><div class="casAuthors">Sasaki, Norihiko; Itakura, Yoko; Toyoda, Masashi</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cell Research & Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">81/1-81/13</span>CODEN:
                <span class="NLM_cas:coden">SCRTEK</span>;
        ISSN:<span class="NLM_cas:issn">1757-6512</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Fibroblasts are key players in maintaining skin homeostasis and in orchestrating physiol. tissue repair and skin regeneration.  Dysfunctions in fibroblasts that occur with aging and the senescent process lead to the delayed healing obsd. in elderly people.  The mol. mechanisms leading to fibroblast dysfunction during aging and the senescent process have not yet been clarified.  Previously, changes in patterns of glycosylation were obsd. in fibroblasts in aging and the senescent process, but the effect of these changes on the function of fibroblasts has not been well documented.  Here, we investigated whether changes in glycosylation during the process to senescence may have functional effects on fibroblasts.  Methods: The changes in cell surface glycans on skin fibroblasts during the process to senescence were examd. in early-passage (EP) and late-passage (LP) skin fibroblasts by fluorescence-activated cell sorting anal. using lectins.  The contributors to the changes in cell surface glycans were examd. by real-time polymerase chain reaction or Western blot anal.  The effects of changes in glycosylation on proliferation, migration, induction of cellular senescence, and myofibroblast differentiation induced by transforming growth factor (TGF)-β1 stimulation were examd. in EP fibroblasts.  The changes in glycosylation were performed by GalNAc-α-O-benzyl or sialidase treatment.  Results: A decrease in sialylation of glycoproteins and an increase in sialidase NEU1 were obsd. in LP fibroblasts.  The redn. of sialylation did not have any effect on proliferation, migration, or induction of cellular senescence.  On the other hand, myofibroblast differentiation was inhibited by the redn. of sialylation, indicating that sialylation is important for myofibroblast differentiation.  The localization of CD44 in lipid rafts, which is required for myofibroblast differentiation, was inhibited by the redn. of sialylation.  Furthermore, reduced myofibroblast differentiation in LP fibroblasts was restored by a sialidase inhibitor.  Conclusions: Desialylation of CD44 with increased sialidase during the process to senescence reduced the localization of CD44 in lipid rafts after TGF-β1 stimulation, leading to the inhibition of myofibroblast differentiation.  Thus, regulation of sialylation may be an attractive strategy for the prevention and regenerative therapy of age-related skin diseases, cosmetic skin alterations, and chronic wounds caused by delayed healing in elderly people.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVqDduTOTPM7Vg90H21EOLACvtfcHk0liD29mnwqnBpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFyjt7o%253D&md5=8c904ff4e9074caffb5d000f2b5182f2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1186%2Fs13287-017-0534-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13287-017-0534-1%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DN.%26aulast%3DItakura%26aufirst%3DY.%26aulast%3DToyoda%26aufirst%3DM.%26atitle%3DSialylation%2520regulates%2520myofibroblast%2520differentiation%2520of%2520human%2520skin%2520fibroblasts%26jtitle%3DStem%2520Cell%2520Res.%2520Ther.%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D81%26doi%3D10.1186%2Fs13287-017-0534-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forcella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Difrancesco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernasconi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonnis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedeschi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzucchelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fusi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frattini, M.</span></span> <span> </span><span class="NLM_article-title">NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levels</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">868</span>, <span class="refDoi"> DOI: 10.1093/glycob/cwv026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fglycob%2Fcwv026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=855-868&author=A.+Mozziauthor=M.+Forcellaauthor=A.+Rivaauthor=C.+Difrancescoauthor=F.+Molinariauthor=V.+Martinauthor=N.+Papiniauthor=B.+Bernasconiauthor=S.+Nonnisauthor=G.+Tedeschiauthor=L.+Mazzucchelliauthor=E.+Montiauthor=P.+Fusiauthor=M.+Frattini&title=NEU3+activity+enhances+EGFR+activation+without+affecting+EGFR+expression+and+acts+on+its+sialylation+levels&doi=10.1093%2Fglycob%2Fcwv026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcwv026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcwv026%26sid%3Dliteratum%253Aachs%26aulast%3DMozzi%26aufirst%3DA.%26aulast%3DForcella%26aufirst%3DM.%26aulast%3DRiva%26aufirst%3DA.%26aulast%3DDifrancesco%26aufirst%3DC.%26aulast%3DMolinari%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DV.%26aulast%3DPapini%26aufirst%3DN.%26aulast%3DBernasconi%26aufirst%3DB.%26aulast%3DNonnis%26aufirst%3DS.%26aulast%3DTedeschi%26aufirst%3DG.%26aulast%3DMazzucchelli%26aufirst%3DL.%26aulast%3DMonti%26aufirst%3DE.%26aulast%3DFusi%26aufirst%3DP.%26aulast%3DFrattini%26aufirst%3DM.%26atitle%3DNEU3%2520activity%2520enhances%2520EGFR%2520activation%2520without%2520affecting%2520EGFR%2520expression%2520and%2520acts%2520on%2520its%2520sialylation%2520levels%26jtitle%3DGlycobiology%26date%3D2015%26volume%3D25%26spage%3D855%26epage%3D868%26doi%3D10.1093%2Fglycob%2Fcwv026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. J.</span></span> <span> </span><span class="NLM_article-title">Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">116</span>, <span class="refDoi"> DOI: 10.1186/s13045-015-0216-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1186%2Fs13045-015-0216-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=26497387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsFyntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=116&author=X.+H.+Zhangauthor=Q.+M.+Wangauthor=J.+M.+Zhangauthor=F.+E.+Fengauthor=F.+R.+Wangauthor=H.+Chenauthor=Y.+Y.+Zhangauthor=Y.+H.+Chenauthor=W.+Hanauthor=L.+P.+Xuauthor=K.+Y.+Liuauthor=X.+J.+Huang&title=Desialylation+is+associated+with+apoptosis+and+phagocytosis+of+platelets+in+patients+with+prolonged+isolated+thrombocytopenia+after+allo-HSCT&doi=10.1186%2Fs13045-015-0216-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT</span></div><div class="casAuthors">Zhang, Xiao-Hui; Wang, Qian-Ming; Zhang, Jia-Min; Feng, Fei-Er; Wang, Feng-Rong; Chen, Huan; Zhang, Yuan-Yuan; Chen, Yu-Hong; Han, Wei; Xu, Lan-Ping; Liu, Kai-Yan; Huang, Xiao-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">116/1-116/15</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Prolonged isolated thrombocytopenia (PT) is a frequent complication in patients who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT), and it is assocd. with an adverse prognosis.  In this study, we hypothesized that desialylation on platelet surfaces was assocd. with PT after allo-HSCT.  The mechanisms participating in this process may include NEU1 translocation, platelet apoptosis, and phagocytosis by macrophages.  Methods: PT was defined as a peripheral platelet count less than 100 × 109/L without sustained anemia or leukopenia for more than 3 mo after allo-HSCT.  34 Patients were identified consecutively from a cohort of 255 patients who underwent allo-HSCT for hematol. malignancies between May and Oct. 2014 at Peking University Institute of Hematol.  Desialylation, enzyme expression, and phagocytosis were detected using flow cytometry, immunofluorescence, RT-PCR, Western blot, and so on.  Results: Platelets from the PT patients had significantly fewer sialic acids (P = .001) and increased β-galactose exposure indicative of desialylation on the surface (P = .042), and serum from the PT patients showed a higher sialic acid concn. (8.400 ± 0.2209 μmol/L, P < .001).  The sialidase NEU1 was over-expressed from mRNA to protein levels, and its catalytic activity was increased in platelets from the PT patients.  Desialylation of GPIba in the PT patients was correlated with changes in 14-3-3ζ distribution, which, relative to Bad activation, modulated the expression of Bcl-2 family proteins, depolarized the inner membrane of the mitochondria, and initiated the intrinsic mitochondria-dependent pathway of apoptosis.  Macrophages derived from the THP-1 cell line preferred to phagocytize desialylated platelets from the PT patients in vitro.  We also revealed that oseltamivir (400 μmol/L) could inhibit 50 % of the sialidase activity on platelets and could protect 20 % of platelets from phagocytosis in vitro.  Conclusions: Desialylation of platelets was assocd. with platelet apoptosis and phagocytosis, whereas oseltamivir could reduce platelet destruction in the periphery, indicating a potential novel treatment for PT after allo-HSCT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruw3Ghdm9j1bVg90H21EOLACvtfcHk0liD29mnwqnBpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsFyntro%253D&md5=35ae044b173926da8b3bc5ff003ef44c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1186%2Fs13045-015-0216-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13045-015-0216-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%2BH.%26aulast%3DWang%26aufirst%3DQ.%2BM.%26aulast%3DZhang%26aufirst%3DJ.%2BM.%26aulast%3DFeng%26aufirst%3DF.%2BE.%26aulast%3DWang%26aufirst%3DF.%2BR.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%2BY.%26aulast%3DChen%26aufirst%3DY.%2BH.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DL.%2BP.%26aulast%3DLiu%26aufirst%3DK.%2BY.%26aulast%3DHuang%26aufirst%3DX.%2BJ.%26atitle%3DDesialylation%2520is%2520associated%2520with%2520apoptosis%2520and%2520phagocytosis%2520of%2520platelets%2520in%2520patients%2520with%2520prolonged%2520isolated%2520thrombocytopenia%2520after%2520allo-HSCT%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2015%26volume%3D8%26spage%3D116%26doi%3D10.1186%2Fs13045-015-0216-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fougerat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smutova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heveker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issad, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrivee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span> <span> </span><span class="NLM_article-title">Neuraminidase 1 activates insulin receptor and reverses insulin resistance in obese mice</span>. <i>Mol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/j.molmet.2018.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.molmet.2018.03.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=29735266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFWiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=76-88&author=A.+Fougeratauthor=X.+Panauthor=V.+Smutovaauthor=N.+Hevekerauthor=C.+W.+Cairoauthor=T.+Issadauthor=B.+Larriveeauthor=J.+A.+Medinauthor=A.+V.+Pshezhetsky&title=Neuraminidase+1+activates+insulin+receptor+and+reverses+insulin+resistance+in+obese+mice&doi=10.1016%2Fj.molmet.2018.03.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Neuraminidase 1 activates insulin receptor and reverses insulin resistance in obese mice</span></div><div class="casAuthors">Fougerat, Anne; Pan, Xuefang; Smutova, Victoria; Heveker, Nikolaus; Cairo, Christopher W.; Issad, Tarik; Larrivee, Bruno; Medin, Jeffrey A.; Pshezhetsky, Alexey V.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">76-88</span>CODEN:
                <span class="NLM_cas:coden">MMOEAS</span>;
        ISSN:<span class="NLM_cas:issn">2212-8778</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Neuraminidase 1 (NEU1) cleaves terminal sialic acids of glycoconjugates during lysosomal catabolism.  It also modulates the structure and activity of cellular surface receptors affecting diverse pathways.  Previously we demonstrated that NEU1 activates the insulin receptor (IR) and that NEU1-deficient CathAS190A-Neo mice (hypomorph of the NEU1 activator protein, cathepsin A/CathA) on a high-fat diet (HFD) develop hyperglycemia and insulin resistance faster than wild-type animals.  The major objective of the current work was to reveal the mol. mechanism by which NEU1 desialylation activates the IR and to test if increase of NEU1 activity in insulin target tissues reverses insulin resistance and glucose intolerance.To test if desialylation causes a conformational change in the IR dimer we measured interaction between the receptor subunits by Bioluminescence Resonance Energy Transfer in the HEK293T cells either overexpressing NEU1 or treated with the NEU1 inhibitor.  The influence of NEU1 overexpression on insulin resistance was studied in vitro in palmitate-treated HepG2 cells transduced with NEU1-expressing lentivirus and in vivo in C57Bl6 mice treated with HFD and either pharmacol. inducer of NEU1, Ambroxol or NEU1-expressing adenovirus.  NEU1-deficient CathAS190A-Neo mice were used as a control.By desialylation of IR, NEU1 induced formation of its active dimer leading to insulin signaling.  Overexpression of NEU1 in palmitate-treated HepG2 cells restored insulin signaling, suggesting that increased NEU1 levels may reverse insulin resistance.  Five-day treatment of glycemic C57Bl6 mice receiving HFD with the activator of the lysosomal gene network, Ambroxol, increased NEU1 expression and activity in muscle tissue, normalized fasting glucose levels, and improved physiol. and mol. responses to glucose and insulin.  Ambroxol did not improve insulin sensitivity in obese insulin-resistant CathAS190A-Neo mice indicating that the Ambroxol effect is mediated through NEU1 induction.  Sustained increase of liver NEU1 activity through adenovirus-based gene transfer failed to attenuate insulin resistance most probably due to neg. feedback regulation of IR expression.Together our results demonstrate that increase of NEU1 activity in insulin target tissues reverses insulin resistance and glucose intolerance suggesting that a pharmacol. modulation of NEU1 activity may be potentially explored for restoring insulin sensitivity and resolving hyperglycemia assocd. with T2DM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcXl6lWll-mLVg90H21EOLACvtfcHk0lioM518fTpEXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFWiu74%253D&md5=b88f10399b04d21d87c0cdec2ace4118</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.molmet.2018.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmet.2018.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DFougerat%26aufirst%3DA.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DSmutova%26aufirst%3DV.%26aulast%3DHeveker%26aufirst%3DN.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26aulast%3DIssad%26aufirst%3DT.%26aulast%3DLarrivee%26aufirst%3DB.%26aulast%3DMedin%26aufirst%3DJ.%2BA.%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26atitle%3DNeuraminidase%25201%2520activates%2520insulin%2520receptor%2520and%2520reverses%2520insulin%2520resistance%2520in%2520obese%2520mice%26jtitle%3DMol.%2520Metab.%26date%3D2018%26volume%3D12%26spage%3D76%26epage%3D88%26doi%3D10.1016%2Fj.molmet.2018.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezaei Darestani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klassen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Human neuraminidase isoenzymes show variable activities for 9-O-acetyl-sialoside substrates</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">922</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00952</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00952" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=922-932&author=C.+D.+Hunterauthor=N.+Khannaauthor=M.+R.+Richardsauthor=R.+Rezaei+Darestaniauthor=C.+Zouauthor=J.+S.+Klassenauthor=C.+W.+Cairo&title=Human+neuraminidase+isoenzymes+show+variable+activities+for+9-O-acetyl-sialoside+substrates&doi=10.1021%2Facschembio.7b00952"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00952%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DC.%2BD.%26aulast%3DKhanna%26aufirst%3DN.%26aulast%3DRichards%26aufirst%3DM.%2BR.%26aulast%3DRezaei%2BDarestani%26aufirst%3DR.%26aulast%3DZou%26aufirst%3DC.%26aulast%3DKlassen%26aufirst%3DJ.%2BS.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DHuman%2520neuraminidase%2520isoenzymes%2520show%2520variable%2520activities%2520for%25209-O-acetyl-sialoside%2520substrates%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D922%26epage%3D932%26doi%3D10.1021%2Facschembio.7b00952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albohy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Insight into substrate recognition and catalysis by the human neuraminidase 3 (Neu3) through molecular modeling and site-directed mutagenesis</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1127</span>– <span class="NLM_lpage">1138</span>, <span class="refDoi"> DOI: 10.1093/glycob/cwq077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fglycob%2Fcwq077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=20511247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFSqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1127-1138&author=A.+Albohyauthor=M.+D.+Liauthor=R.+B.+Zhengauthor=C.+Zouauthor=C.+W.+Cairo&title=Insight+into+substrate+recognition+and+catalysis+by+the+human+neuraminidase+3+%28Neu3%29+through+molecular+modeling+and+site-directed+mutagenesis&doi=10.1093%2Fglycob%2Fcwq077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into substrate recognition and catalysis by the human neuraminidase 3 (NEU3) through molecular modeling and site-directed mutagenesis</span></div><div class="casAuthors">Albohy, Amgad; Li, Matthew D.; Zheng, Ruixiang Blake; Zou, Chunxia; Cairo, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Glycobiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1127-1138</span>CODEN:
                <span class="NLM_cas:coden">GLYCE3</span>;
        ISSN:<span class="NLM_cas:issn">0959-6658</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The mammalian neuraminidase (NEU) enzymes are found in diverse cellular compartments.  Members of the family, such as NEU2 and NEU1, are cytosolic or lysosomal, while NEU3 and NEU4 are membrane-assocd.  NEU enzymes that act on substrates in the plasma membrane could modulate cellular signaling, cell surface glycoforms and the compn. of plasma membrane glycolipids.  Therefore, their substrates and mechanism of action are of interest for discerning their physiol. roles.  We have studied the structure of the human NEU3 using mol. modeling to predict residues involved in the recognition and hydrolysis of glycolipid substrates.  To test the model, we have used site-directed mutagenesis of the recombinant protein.  Enzymic studies of the relative activity of these mutants, as well as their pH profiles and inhibition by 2-deoxy-2,3-dehydro-N-acetylneuraminic acid, are reported.  Using NMR spectroscopy, we confirmed that the enzyme is a retaining exo-sialidase, and we propose that the key catalytic residues of the enzyme consist of the general acid-base D50 and the nucleophilic Y370-E225 pair.  Mutations of residues expected to interact directly with the sialic acid N5-acetyl (A160, M87, I105) and C7-C9 glycerol side-chain (E113, Y179, Y181) reduced enzymic activity.  We identified several active mutants of the enzyme which contain modifications at the periphery of the active site.  Truncations at the N- or C-terminus of more than 10 residues abolished enzyme activity.  We propose a catalytic mechanism consistent with the data and identify residues that contribute to glycolipid recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzBrTTIbVQZLVg90H21EOLACvtfcHk0li4jg72BkCE8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFSqtrk%253D&md5=0e04279a474d6e4a795f261ddbb999db</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcwq077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcwq077%26sid%3Dliteratum%253Aachs%26aulast%3DAlbohy%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DM.%2BD.%26aulast%3DZheng%26aufirst%3DR.%2BB.%26aulast%3DZou%26aufirst%3DC.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DInsight%2520into%2520substrate%2520recognition%2520and%2520catalysis%2520by%2520the%2520human%2520neuraminidase%25203%2520%2528Neu3%2529%2520through%2520molecular%2520modeling%2520and%2520site-directed%2520mutagenesis%26jtitle%3DGlycobiology%26date%3D2010%26volume%3D20%26spage%3D1127%26epage%3D1138%26doi%3D10.1093%2Fglycob%2Fcwq077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albohy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairo, C. W.</span></span> <span> </span><span class="NLM_article-title">Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2817</span>– <span class="NLM_lpage">2822</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.03.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.bmc.2011.03.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2817-2822&author=A.+Albohyauthor=S.+Mohanauthor=R.+B.+Zhengauthor=B.+M.+Pintoauthor=C.+W.+Cairo&title=Inhibitor+selectivity+of+a+new+class+of+oseltamivir+analogs+against+viral+neuraminidase+over+human+neuraminidase+enzymes&doi=10.1016%2Fj.bmc.2011.03.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.03.039%26sid%3Dliteratum%253Aachs%26aulast%3DAlbohy%26aufirst%3DA.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DR.%2BB.%26aulast%3DPinto%26aufirst%3DB.%2BM.%26aulast%3DCairo%26aufirst%3DC.%2BW.%26atitle%3DInhibitor%2520selectivity%2520of%2520a%2520new%2520class%2520of%2520oseltamivir%2520analogs%2520against%2520viral%2520neuraminidase%2520over%2520human%2520neuraminidase%2520enzymes%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2817%26epage%3D2822%26doi%3D10.1016%2Fj.bmc.2011.03.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, M.</span></span> <span> </span><span class="NLM_article-title">Association of N-acetylgalactosamine-6-sulfate sulfatase with the multienzyme lysosomal complex of β-galactosidase, cathepsin A, and neuraminidase: possible implication for intralysosomal catabolism of keratan sulfate</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">28359</span>– <span class="NLM_lpage">28365</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.45.28359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1074%2Fjbc.271.45.28359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=8910459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADyaK28XmvVWqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=28359-28365&author=A.+V.+Pshezhetskyauthor=M.+Potier&title=Association+of+N-acetylgalactosamine-6-sulfate+sulfatase+with+the+multienzyme+lysosomal+complex+of+%CE%B2-galactosidase%2C+cathepsin+A%2C+and+neuraminidase%3A+possible+implication+for+intralysosomal+catabolism+of+keratan+sulfate&doi=10.1074%2Fjbc.271.45.28359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Association of N-acetylgalactosamine-6-sulfate sulfatase with the multienzyme lysosomal complex of β-galactosidase, cathepsin A, and neuraminidase. Possible implication for intralysosomal catabolism of keratan sulfate</span></div><div class="casAuthors">Pshezhetsky, Alexey V.; Potier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">28359-28365</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">N-Acetylgalactosamine-6-sulfate sulfatase (GALNS) catalyzes the first step of intralysosomal keratan sulfate (KS) catabolism.  In Morquio type A syndrome GALNS deficiency causes the accumulation of KS in tissues and results in generalized skeletal dysplasia in affected patients.  We show that in normal cells GALNS is in a 1.27-MDa complex with three other lysosomal hydrolases: β-galactosidase, α-neuraminidase, and cathepsin A (protective protein).  GALNS copurifies with the complex by different chromatog. techniques: affinity chromatog. on both cathepsin a-binding and β-galactosidase-binding columns, gel filtration, and chromatofocusing.  Anti-human cathepsin A rabbit antiserum coppts. GALNS together with cathepsin A, β-galactosidase, and α-neuraminidase in both a purified prepn. of the 1.27-MDa complex and crude glycoprotein fraction from human placenta ext.  Gel filtration anal. of fibroblast exts. of patients deficient in either β-galactosidase (β-galactosidosis) or cathepsin A (galactosialidosis), which accumulate KS, demonstrates that the 1.27-MDa complex is disrupted and that GALNS is present only in free homodimeric form.  The GALNS activity and cross-reacting material are reduced in the fibroblasts of patients affected with galactosialidosis, indicating that the complex with cathepsin A may protect GALNS in the lysosome.  We suggest that the 1.27-MDa complex of lysosomal hydrolases is essential for KS catabolism and that the disruption of this complex may be responsible for the KS accumulation in β-galactosidosis and galactosialidosis patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptD6yEfSo5VrVg90H21EOLACvtfcHk0li4jg72BkCE8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvVWqsLw%253D&md5=2dd0842ddcfc12006ade3106307761ba</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.45.28359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.45.28359%26sid%3Dliteratum%253Aachs%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26aulast%3DPotier%26aufirst%3DM.%26atitle%3DAssociation%2520of%2520N-acetylgalactosamine-6-sulfate%2520sulfatase%2520with%2520the%2520multienzyme%2520lysosomal%2520complex%2520of%2520%25CE%25B2-galactosidase%252C%2520cathepsin%2520A%252C%2520and%2520neuraminidase%253A%2520possible%2520implication%2520for%2520intralysosomal%2520catabolism%2520of%2520keratan%2520sulfate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D28359%26epage%3D28365%26doi%3D10.1074%2Fjbc.271.45.28359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">Reversible Inhibitors</span>.  <i>Enzymes</i>; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2002</span>; Chapter 8, pp  <span class="NLM_fpage">266</span>– <span class="NLM_lpage">304</span>, <span class="refDoi"> DOI: 10.1002/0471220639.ch8</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1002%2F0471220639.ch8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=266-304&author=R.+A.+Copeland&title=Enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2F0471220639.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471220639.ch8%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DReversible%2520Inhibitors%26btitle%3DEnzymes%26pub%3DWiley-VCH%26date%3D2002%26spage%3D266%26epage%3D304%26doi%3D10.1002%2F0471220639.ch8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T. P.</span></span> <span> </span><span class="NLM_article-title">Enzymes as Drug Targets</span>. In  <i>Pharmacology in Drug Discovery</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T. P.</span></span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Boston, MA</span>, <span class="NLM_year">2012</span>; Chapter 6, pp  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">124</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2FB978-0-12-384856-7.00006-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=105-124&author=T.+P.+Kenakinauthor=T.+P.+Kenakin&title=Pharmacology+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-384856-7.00006-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-384856-7.00006-9%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26atitle%3DEnzymes%2520as%2520Drug%2520Targets%26btitle%3DPharmacology%2520in%2520Drug%2520Discovery%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26pub%3DAcademic%2520Press%26date%3D2012%26spage%3D105%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, P. H.</span></span> <span> </span><span class="NLM_article-title">Identification, synthesis, and evaluation of new neuraminidase inhibitors</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5060</span>– <span class="NLM_lpage">5063</span>, <span class="refDoi"> DOI: 10.1021/ol502410x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol502410x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKnsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=5060-5063&author=V.+Kumarauthor=C.+K.+Changauthor=K.+P.+Tanauthor=Y.+S.+Jungauthor=S.+H.+Chenauthor=Y.+S.+Chengauthor=P.+H.+Liang&title=Identification%2C+synthesis%2C+and+evaluation+of+new+neuraminidase+inhibitors&doi=10.1021%2Fol502410x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Identification, Synthesis, and Evaluation of New Neuraminidase Inhibitors</span></div><div class="casAuthors">Kumar, Vathan; Chang, Chih-Kang; Tan, Kian-Pin; Jung, Young-Sik; Chen, Shih-Hsun; Cheng, Yih-Shyun E.; Liang, Po-Huang</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5060-5063</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High-throughput screening was performed on ∼6800 compds. to identify KR-72039 as an inhibitor of H1N1 and H5N1 neuraminidases (NAs).  Structure-activity relationship studies led to I, which inhibited H5N1 NA with an IC50 of 2.8 μM and blocked viral replication.  Docking anal. shows that compds. bind to loop-430 around the NA active site.  Compd. II addnl. inhibited H7N9 NA, making it a dual inhibitor of N1- and N2-type NAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSoAkL_PI7qbVg90H21EOLACvtfcHk0ljIfClqAs4s7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKnsL%252FL&md5=5e6785dd3c756c3abb8277726f37c1c8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fol502410x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol502410x%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DChang%26aufirst%3DC.%2BK.%26aulast%3DTan%26aufirst%3DK.%2BP.%26aulast%3DJung%26aufirst%3DY.%2BS.%26aulast%3DChen%26aufirst%3DS.%2BH.%26aulast%3DCheng%26aufirst%3DY.%2BS.%26aulast%3DLiang%26aufirst%3DP.%2BH.%26atitle%3DIdentification%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520new%2520neuraminidase%2520inhibitors%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D5060%26epage%3D5063%26doi%3D10.1021%2Fol502410x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. S.</span></span> <span> </span><span class="NLM_article-title">Selective and slow-binding inhibition of shikonin derivatives isolated from Lithospermum erythrorhizon on glycosyl hydrolase 33 and 34 sialidases</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1740</span>– <span class="NLM_lpage">1748</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2012.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.bmc.2012.01.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1740-1748&author=J.+Y.+Kimauthor=H.+J.+Jeongauthor=J.-Y.+Parkauthor=Y.+M.+Kimauthor=S.-J.+Parkauthor=J.+K.+Choauthor=K.+H.+Parkauthor=Y.+B.+Ryuauthor=W.+S.+Lee&title=Selective+and+slow-binding+inhibition+of+shikonin+derivatives+isolated+from+Lithospermum+erythrorhizon+on+glycosyl+hydrolase+33+and+34+sialidases&doi=10.1016%2Fj.bmc.2012.01.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DJeong%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DJ.-Y.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DPark%26aufirst%3DS.-J.%26aulast%3DCho%26aufirst%3DJ.%2BK.%26aulast%3DPark%26aufirst%3DK.%2BH.%26aulast%3DRyu%26aufirst%3DY.%2BB.%26aulast%3DLee%26aufirst%3DW.%2BS.%26atitle%3DSelective%2520and%2520slow-binding%2520inhibition%2520of%2520shikonin%2520derivatives%2520isolated%2520from%2520Lithospermum%2520erythrorhizon%2520on%2520glycosyl%2520hydrolase%252033%2520and%252034%2520sialidases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D1740%26epage%3D1748%26doi%3D10.1016%2Fj.bmc.2012.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uddin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis-Long, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuk, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. H.</span></span> <span> </span><span class="NLM_article-title">Potent bacterial neuraminidase inhibitors, anthraquinone glucosides from Polygonum cuspidatum and their inhibitory mechanism</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.jep.2016.08.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1016%2Fj.jep.2016.08.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2016&pages=283-292&author=Z.+Uddinauthor=Y.+H.+Songauthor=M.+J.+Curtis-Longauthor=J.+Y.+Kimauthor=H.+J.+Yukauthor=K.+H.+Park&title=Potent+bacterial+neuraminidase+inhibitors%2C+anthraquinone+glucosides+from+Polygonum+cuspidatum+and+their+inhibitory+mechanism&doi=10.1016%2Fj.jep.2016.08.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.jep.2016.08.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jep.2016.08.026%26sid%3Dliteratum%253Aachs%26aulast%3DUddin%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DY.%2BH.%26aulast%3DCurtis-Long%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DYuk%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DK.%2BH.%26atitle%3DPotent%2520bacterial%2520neuraminidase%2520inhibitors%252C%2520anthraquinone%2520glucosides%2520from%2520Polygonum%2520cuspidatum%2520and%2520their%2520inhibitory%2520mechanism%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2016%26volume%3D193%26spage%3D283%26epage%3D292%26doi%3D10.1016%2Fj.jep.2016.08.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seyrantepe, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canuel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpentier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caqueret, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gravel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchesini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwingmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levade, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pshezhetsky, A. V.</span></span> <span> </span><span class="NLM_article-title">Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1556</span>– <span class="NLM_lpage">1568</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddn043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1093%2Fhmg%2Fddn043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=18270209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFSrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1556-1568&author=V.+Seyrantepeauthor=M.+Canuelauthor=S.+Carpentierauthor=K.+Landryauthor=S.+Durandauthor=F.+Liangauthor=J.+Zengauthor=A.+Caqueretauthor=R.+A.+Gravelauthor=S.+Marchesiniauthor=C.+Zwingmannauthor=J.+Michaudauthor=C.+R.+Moralesauthor=T.+Levadeauthor=A.+V.+Pshezhetsky&title=Mice+deficient+in+Neu4+sialidase+exhibit+abnormal+ganglioside+catabolism+and+lysosomal+storage&doi=10.1093%2Fhmg%2Fddn043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage</span></div><div class="casAuthors">Seyrantepe, Volkan; Canuel, Maryssa; Carpentier, Stephane; Landry, Karine; Durand, Stephanie; Liang, Feng; Zeng, Jibin; Caqueret, Aurore; Gravel, Roy A.; Marchesini, Sergio; Zwingmann, Claudia; Michaud, Jacques; Morales, Carlos R.; Levade, Thierry; Pshezhetsky, Alexey V.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1556-1568</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mammalian sialidase Neu4, ubiquitously expressed in human tissues, is located in the lysosomal and mitochondrial lumen and has broad substrate specificity against sialylated glycoconjugates.  To investigate whether Neu4 is involved in ganglioside catabolism, we transfected β-hexosaminidase-deficient neuroglia cells from a Tay-Sachs patient with a Neu4-expressing plasmid and demonstrated the correction of storage due to the clearance of accumulated GM2 ganglioside.  To further clarify the biol. role of Neu4, we have generated a stable loss-of-function phenotype in cultured HeLa cells and in mice with targeted disruption of the Neu4 gene.  The silenced HeLa cells showed reduced activity against gangliosides and had large heterogeneous lysosomes contg. lamellar structures.  Neu4-/- mice were viable, fertile and lacked gross morphol. abnormalities, but showed a marked vacuolization and lysosomal storage in lung and spleen cells.  Lysosomal storage bodies were also present in cultured macrophages preloaded with gangliosides.  Thin-layer chromatog. showed increased relative level of GD1a ganglioside and a markedly decreased level of GM1 ganglioside in brain of Neu4-/- mice suggesting that Neu4 may be important for desialylation of brain gangliosides and consistent with the in situ hybridization data.  Increased levels of cholesterol, ceramide and polyunsatd. fatty acids were also detected in the lungs and spleen of Neu4-/- mice by high-resoln. NMR spectroscopy.  Together, our data suggest that Neu4 is a functional component of the ganglioside-metabolizing system, contributing to the postnatal development of the brain and other vital organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqZLR9yo-jXLVg90H21EOLACvtfcHk0lgpt18MrifQgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFSrtbk%253D&md5=269b30e8fde885fb728c0a3216a28f04</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddn043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddn043%26sid%3Dliteratum%253Aachs%26aulast%3DSeyrantepe%26aufirst%3DV.%26aulast%3DCanuel%26aufirst%3DM.%26aulast%3DCarpentier%26aufirst%3DS.%26aulast%3DLandry%26aufirst%3DK.%26aulast%3DDurand%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DCaqueret%26aufirst%3DA.%26aulast%3DGravel%26aufirst%3DR.%2BA.%26aulast%3DMarchesini%26aufirst%3DS.%26aulast%3DZwingmann%26aufirst%3DC.%26aulast%3DMichaud%26aufirst%3DJ.%26aulast%3DMorales%26aufirst%3DC.%2BR.%26aulast%3DLevade%26aufirst%3DT.%26aulast%3DPshezhetsky%26aufirst%3DA.%2BV.%26atitle%3DMice%2520deficient%2520in%2520Neu4%2520sialidase%2520exhibit%2520abnormal%2520ganglioside%2520catabolism%2520and%2520lysosomal%2520storage%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2008%26volume%3D17%26spage%3D1556%26epage%3D1568%26doi%3D10.1093%2Fhmg%2Fddn043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chavas, L. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tringali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fusi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venerando, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tettamanti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakatsuki, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the human cytosolic sialidase Neu2 - Evidence for the dynamic nature of substrate recognition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1074/jbc.M411506200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;key=10.1074%2Fjbc.M411506200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=469-475&author=L.+M.+G.+Chavasauthor=C.+Tringaliauthor=P.+Fusiauthor=B.+Venerandoauthor=G.+Tettamantiauthor=R.+Katoauthor=E.+Montiauthor=S.+Wakatsuki&title=Crystal+structure+of+the+human+cytosolic+sialidase+Neu2+-+Evidence+for+the+dynamic+nature+of+substrate+recognition&doi=10.1074%2Fjbc.M411506200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M411506200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M411506200%26sid%3Dliteratum%253Aachs%26aulast%3DChavas%26aufirst%3DL.%2BM.%2BG.%26aulast%3DTringali%26aufirst%3DC.%26aulast%3DFusi%26aufirst%3DP.%26aulast%3DVenerando%26aufirst%3DB.%26aulast%3DTettamanti%26aufirst%3DG.%26aulast%3DKato%26aufirst%3DR.%26aulast%3DMonti%26aufirst%3DE.%26aulast%3DWakatsuki%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520cytosolic%2520sialidase%2520Neu2%2520-%2520Evidence%2520for%2520the%2520dynamic%2520nature%2520of%2520substrate%2520recognition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D469%26epage%3D475%26doi%3D10.1074%2Fjbc.M411506200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1VCU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1VCU','PDB','1VCU'); return false;">PDB: 1VCU</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i82"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01411">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_81338"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01411">10.1021/acs.jmedchem.8b01411</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Protein expression protocols, HPLC traces for intermediates and final products, IC<sub>50</sub> curves, <i>K</i><sub>i</sub> determinations, <sup>1</sup>H and <sup>13</sup>C NMR data, and HR-MS data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01411/suppl_file/jm8b01411_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and IC<sub>50</sub> data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01411/suppl_file/jm8b01411_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01411/suppl_file/jm8b01411_si_001.pdf">jm8b01411_si_001.pdf (22.7 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01411/suppl_file/jm8b01411_si_002.csv">jm8b01411_si_002.csv (5.14 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01411&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01411%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-24%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01411" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b727ae9c93d94","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
